fluorodeoxyglucose f18 has been researched along with Acute Confusional Senile Dementia in 1099 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 36 (3.28) | 18.7374 |
| 1990's | 79 (7.19) | 18.2507 |
| 2000's | 201 (18.29) | 29.6817 |
| 2010's | 572 (52.05) | 24.3611 |
| 2020's | 211 (19.20) | 2.80 |
| Authors | Studies |
|---|---|
| Eo, JS; Han, CE; Hyung, WSW; Jeong, HG; Lee, ES; Suh, S; Youn, H | 1 |
| Cabrera-Martín, MN; Delgado-Alonso, C; Delgado-Álvarez, A; Matías-Guiu, J; Matias-Guiu, JA; Pytel, V | 1 |
| Choi, H; Kim, JM; Lee, R; Park, KY; Seok, JW | 1 |
| Altmann, A; Dawson, SJ; Scelsi, MA; Zainul Abidin, FN | 1 |
| Arnaldi, D; Bauckneht, M; Biassoni, E; Brugnolo, A; Chincarini, A; Donegani, MI; Girtler, N; Guerra, UP; Massa, F; Mattioli, P; Morbelli, S; Nobili, F; Orso, B; Pagani, M; Pardini, M; Peira, E; Raffa, S | 1 |
| Casagrande, CC; Johnson, CM; May, PE; Mundorf, VM; Murman, DL; Wiesman, AI; Wilson, TW; Wolfson, SL | 1 |
| Chen, SD; Dong, Q; Guo, Y; Huang, YY; Shen, XN; Tan, L; Yu, JT | 1 |
| Arahata, Y; Bundo, M; Ikenuma, H; Ito, K; Iwata, K; Kato, T; Kimura, Y; Nakamura, A; Nihashi, T; Okamura, N; Sakurai, K; Sakurai, T; Suzuki, K; Takeda, A; Washimi, Y; Yamaoka, A; Yanai, K | 1 |
| Abdolalizadeh, A; Ashraf-Ganjouei, A; Faghani, S; Fatehi, F; Khomeijani-Farahani, M; Moradi, K | 1 |
| Abe, M; Eguchi, A; Kimura, N; Matsubara, E; Sasaki, Y | 1 |
| Guan, Z; Li, B; Li, Y; Zhang, M; Zhang, Y | 1 |
| An, Y; Li, W; Liu, M; Lu, J; Qi, Z; Qiao, L; Wang, G; Yan, S; Zhao, Z | 1 |
| Dunzinger, A; Ehrlich, D; Grün, B; Hodolic, M; Kainz, E; Malsiner-Walli, G; Pichler, R; Topakian, R | 1 |
| Ahn, H; Byun, MS; Chu, K; Han, D; Joung, H; Jung, G; Lee, DY; Lee, JH; Lee, Y; Sung, K; Yi, D | 1 |
| Apostolova, I; Buchert, R; Grothe, MJ; Lange, C; Mäurer, A; Steffen, IG; Suppa, P | 1 |
| Arias, JF; Benedet, A; Bezgin, G; Bunai, T; Kang, MS; Lussier, F; Matsudaira, T; Obi, T; Ottoy, J; Ouchi, Y; Pascoal, TA; Poltronetti, NM; Rosa-Neto, P; Savard, M; Terada, T; Therriault, J; Tissot, C; Tsukada, H; Wang, YT | 1 |
| Alberts, I; Han, Y; Initiative, FTADN; Jiang, J; Li, T; Rominger, A; Shi, K; Sun, X; Wang, M; Zuo, C | 1 |
| Graff-Radford, J; Josephs, KA; Lowe, VJ; Machulda, MM; Pham, NTT; Whitwell, JL | 1 |
| Calsolaro, V; Edison, P; Gentleman, S; Gunn, RN; Hinz, R; Livingston, NR; Matthews, PM; Murphy, PS; Myers, J; Nowell, J; Nutt, DJ; Parker, CA; Perneczky, R; Rabiner, EA; Raza, S; Tyacke, RJ; Venkataraman, AV; Wren, PB | 1 |
| Hong, JH; Ji, HD; Kim, HW; Kim, S; Lee, JI; Lee, SW; Lim, JS; Song, BI; Won, KS | 1 |
| Ge, Q; Gu, F; Li, P; Li, Y; Lu, J; Ng, YL; Paranjpe, MD; Wang, X; Yan, S; Zhou, Y | 1 |
| Liu, Y; Tan, L; Tan, MS; Wang, ZT; Xu, W | 1 |
| Boeve, BF; Botha, H; Corriveau-Lecavalier, N; Fields, JA; Graff-Radford, J; Jack, CR; Jones, DT; Knopman, DS; Lowe, VJ; Machulda, MM; Petersen, RC; Stricker, NH | 1 |
| Imabayashi, E; Ishibashi, K; Ishii, K; Kamitaka, Y; Kobayashi, R; Koike, E; Miwa, K; Miyaji, N; Nezu, S; Sugamata, Y; Toyohara, J; Wagatsuma, K; Yamao, T; Yoshii, T | 1 |
| Colloby, SJ; Firbank, MJ; Ingram, M; Lloyd, JJ; O'Brien, JT; Taylor, JP | 1 |
| Guan, Z; Hu, J; Huang, X; Li, B; Li, W; Li, Y; Lin, X; Liu, J; Meng, H; Sun, W; Wang, J; Ye, G; Zhang, M; Zhang, Y | 1 |
| Cao, XP; Guo, Y; Han, PR; Hu, H; Liu, Y; Ou, YN; Tan, L; Wang, ZT; Yu, JT | 1 |
| Caplan, GA; Close, J; Nitchingham, A; Oxenham, V; Pereira, JV; Wegner, EA | 1 |
| Goto, M; Kimura, N; Matsubara, E | 1 |
| Graff-Radford, J; Jack, CR; Josephs, KA; Lowe, VJ; Machulda, MM; Pham, NTT; Shir, D; Whitwell, JL | 1 |
| Baik, K; Jeon, S; Kang, SW; Lee, PH; Lee, YG; Park, M; Sohn, YH; Ye, BS; Yoon, SH | 1 |
| Jang, H; Kim, HJ; Kim, S; Kim, SJ; Kim, YJ; Na, DL; Seo, SW; Woo, SY | 1 |
| Barnard, L; Boeve, B; Botha, H; Graff-Radford, J; Gunter, J; Jack, C; Jones, D; Knopman, D; Lowe, V; Murphy, MC; Murray, M; Petersen, R; Senjem, M; Wiepert, D; Wiste, H | 1 |
| Appollonio, I; Crivellaro, C; Ferrarese, C; Ferri, F; Formenti, A; Gallivanone, F; Guerra, L; Isella, V; Mapelli, C; Morzenti, S; Musarra, M; Pacella, S | 1 |
| Bastin, C; Bernard, C; Hustinx, R; Lamaye, C; Salmon, E; Withofs, N | 1 |
| Bonanni, L; Da Ronch, C; Fiore, V; Gallucci, M; Grassivaro, F | 1 |
| Endo, H; Higuchi, M; Hirano, S; Ichise, M; Kawamura, K; Kimura, Y; Kubota, M; Kuwabara, S; Matsuoka, K; Nakano, Y; Ono, M; Sahara, N; Sano, Y; Shimada, H; Shinotoh, H; Suhara, T; Tagai, K; Takado, Y; Takahata, K; Yamamoto, Y; Zhang, MR | 1 |
| Bernardini, S; Camedda, R; Chiaravalloti, A; Fernandes, M; Izzi, F; Liguori, C; Manfredi, N; Mercuri, NB; Nuccetelli, M; Placidi, F; Schillaci, O | 1 |
| Chen, G; Han, Y; Jiang, J; Jiang, X; Jin, S; Li, L; Liu, C; Sheng, C | 1 |
| Bernardini, S; Camedda, R; Chiaravalloti, A; Fernandes, M; Giambrone, MP; Izzi, F; Liguori, C; Mari, L; Mercuri, NB; Nuccetelli, M; Paoli, B; Placidi, F; Schillaci, O | 1 |
| Cross, D; Drzezga, A; Foster, NL; Minoshima, S; Thientunyakit, T | 1 |
| Bagnoli, S; Berti, V; Bessi, V; De Cristofaro, MT; Ferrari, C; Giacomucci, G; Lassi, M; Lombardi, G; Mattei, M; Mazzeo, S; Mazzoni, A; Nacmias, B; Padiglioni, S; Passeri, A; Polito, C; Sorbi, S | 1 |
| Bladowska, J; Sąsiadek, M; Statkiewicz, M; Trypka, E; Wabik, A; Zimny, A | 1 |
| Aluisantonio, L; Chiaravalloti, A; Di Santo, S; Fernandes, M; Franchini, F; Izzi, F; Liguori, C; Manfredi, N; Mercuri, NB; Placidi, F; Schillaci, O | 1 |
| Álvarez-Sanchez, L; Aparici-Robles, F; Baquero-Toledo, M; Cerdá-Alberich, L; Cháfer-Pericás, C; Gandia-Ferrero, MT; Gómez-Rico, I; Martí-Bonmatí, L; Martínez-Sanchis, B; Prats-Climent, J; Rodríguez-Álvarez, MJ; Torres-Espallardo, I | 1 |
| Asken, BM; Edwards, L; Gorno-Tempini, ML; Iaccarino, L; Kramer, JH; La Joie, R; Malpetti, M; Mellinger, T; Miller, BL; Miller, Z; Mundada, NS; Perry, DC; Pham, J; Possin, K; Rabinovici, GD; Rosen, HJ; Soleimani-Meigooni, DN; Strom, A; Tanner, JA | 1 |
| Eidelberg, D; Emeršič, A; Jamšek, J; Perovnik, M; Tang, C; Tomše, P; Trošt, M | 1 |
| Bischof, GN; Bohn, KP; Doering, E; Drzezga, A; Ellingsen, LM; Hoenig, MC; van Eimeren, T | 1 |
| Ashton, NJ; Benedet, AL; Blennow, K; Cacciaglia, R; Falcon, C; Fauria, K; Gispert, JD; Kollmorgen, G; Milà-Alomà, M; Minguillon, C; Molinuevo, JL; Niñerola-Baizán, A; Operto, G; Perissinotti, A; Salvadó, G; Shekari, M; Suárez-Calvet, M; Suridjan, I; Wild, N; Zetterberg, H | 1 |
| Barceló, M; Boada, M; Castell-Conesa, J; Cuberas-Borrós, G; Grifols, C; López, OL; Núñez, L; Páez, A; Pareto, D; Roca, I | 1 |
| Chen, H; He, X; Liu, Y; Qing, L; Xu, Y; Zhang, J | 1 |
| Allali, G; Altomare, D; Assal, F; Caprioglio, C; Frisoni, GB; Frölich, L; Garibotto, V; Jessen, F | 1 |
| Appollonio, I; Crivellaro, C; Ferrarese, C; Ferri, F; Impagnatiello, V; Isella, V; Licciardo, D; Mapelli, C; Morzenti, S; Musarra, M; Nastasi, G | 1 |
| Crowson, CS; Davis Iii, JM; Duong, SQ; Jones, DT; Mielke, MM; Myasoedova, E; Nguyen, A; Vassilaki, M; Vemuri, P | 1 |
| Buchert, R; Grothe, MJ; Lange, C; Moscoso, A; Nelson, PT; Nho, K; Saykin, AJ; Schöll, M; Silva-Rodríguez, J; Teipel, S | 1 |
| Coutinho, AM; Studart-Neto, A | 1 |
| Dartora, CM; de Moura, LV; Koole, M; Marques da Silva, AM | 1 |
| Grothe, MJ; Labrador-Espinosa, MA; Mir, P; Moscoso, A; Schöll, M; Silva-Rodríguez, J | 2 |
| Diehl-Schmid, J; Grimmer, T; Hedderich, DM; Jiang, J; Lizarraga, A; Navab, N; Rominger, A; Schultz, T; Schutte, M; Shi, K; Wang, M; Yakushev, I; Yan, Z; Ziegler, S | 1 |
| Deatsch, A; Jeraj, R; Namías, M; Perovnik, M; Trošt, M | 1 |
| Albensi, BC; Beheshti, I; Geddert, N; Gupta, V; Ko, JH; Perron, J | 1 |
| Agnello, L; Blandino, V; Ciaccio, M; Colletti, T; Gambino, CM; Giglio, RV; Graziano, F; Guajana, F; La Bella, V; Lo Sasso, B; Maniscalco, L; Matranga, D; Piccoli, T | 1 |
| Feng, Y; Kim, M; Liu, K; Long, Q; Shen, L; Yao, X | 1 |
| Cai, Q; Huang, G; Li, W; Li, Z; Liu, W; Ma, G; Meng, X; Wang, S; Zhang, Y | 1 |
| Hu, Y; Ning, Y; Shi, X; Sun, B; Wu, Y; Zhou, N | 1 |
| Chen, Y; Cheng, J; Liu, F; Wang, H; Wei, S | 1 |
| Bentham, P; Gauthier, S; Kook, K; Miller, S; Schelter, BO; Wischik, CM | 1 |
| Diehl-Schmid, J; Eidelberg, D; Grimmer, T; Jamšek, J; Nguyen, N; Perovnik, M; Rus, T; Šurlan Popović, K; Tang, C; Trošt, M; Vo, A; Yakushev, I | 1 |
| De Santi, LA; Genovesi, D; Pasini, E; Positano, V; Santarelli, MF | 1 |
| Snekhalatha, U; Thakur, M | 1 |
| Kim, K; Lee, MH; Lee, Y; Yun, CS | 1 |
| Brucki, SMD; Buchpiguel, CA; Busatto, G; Carneiro, CG; Coutinho, AM; da Costa, NA; da Silveira, PS; Duran, FLS; Faria, DP; Forlenza, OV; Garcez, AT; Nitrini, R; Ono, CR | 1 |
| Li, R; Li, W; Lu, J; Qi, Z; Shan, Y; Yan, S; Zhao, Z | 1 |
| Aghakhanyan, G; Baldacci, F; Fornai, F; Galgani, A; Giorgi, FS; Guidoccio, F; Leo, A; Lombardo, F; Martini, N; Pavese, N; Siciliano, G; Tognoni, G; Vergallo, A; Volterrani, D | 1 |
| Bouter, C; Hansen, N; Khadhraoui, E; Lange, C; Müller, SJ; Sahlmann, CO; Timäus, C; Wiltfang, J; Woyk, K | 1 |
| Jia, J; Jia, L; Li, Y; Liu, W; Shi, Y; Wang, S; Yin, X; Zhang, Y; Zhao, T; Zhou, A | 1 |
| Bartenstein, P; Barthel, H; Beyer, L; Brendel, M; Bui, N; Cumming, P; Eckenweber, F; Franzmeier, N; Hong, J; Katzdobler, S; Levin, J; Palleis, C; Patt, M; Perneczky, R; Rauchmann, BS; Rominger, A; Sabri, O; Scheifele, M; Shi, K; Völter, F | 1 |
| Hou, J; Jin, H; Peng, J; Qin, X; Shu, Z; Song, Q; Wang, W; Wei, Y; Yuan, Z | 1 |
| Bonomi, CG; Camedda, R; Chiaravalloti, A; Di Donna, MG | 1 |
| Faruque Reza, M; M Iqbal, S; Normala, I; Siti Aishah, AA | 1 |
| Barnard, LR; Boeve, BF; Botha, H; Corriveau-Lecavalier, N; Dicks, E; Graff-Radford, J; Jack, CR; Jones, DT; Knopman, DS; Lee, J; Lowe, VJ; Machulda, MM; Petersen, RC | 1 |
| Devanand, DP; Masurkar, AV; Wisniewski, T | 1 |
| Beg, MF; Heywood, A; Popuri, K; Rosen, H; Stocks, J; Wang, L | 1 |
| Balabandian, M; Nabizadeh, F; Valizadeh, P | 1 |
| Abedi, A; Dargahi, L; Foroutan, T; Mohaghegh Shalmani, L | 1 |
| Bourgeat, P; Cummins, TL; Doré, V; Elias, A; Feizpour, A; Hopwood, M; Krishnadas, N; Lamb, F; Landau, S; Rowe, CC; Villemagne, VL; Weiner, M; Williams, R | 1 |
| Borrie, MJ; Camicioli, R; Chekouo, T; Forkert, ND; Ganesh, A; Hogan, DB; Hsiung, GR; Ismail, Z; Masellis, M; Moorhouse, P; Sajobi, TT; Seitz, DP; Smith, EE; Tartaglia, MC; Wang, M | 1 |
| Ai, L; Cai, L; Chen, Y; Cui, R; Gan, J; Guan, YH; Ji, Y; Liu, S; Shi, Z; Zhang, N; Zhao, X; Zuo, C | 1 |
| Chen, K; Ge, J; Guan, Y; He, Z; Ju, Z; Lin, H; Liu, F; Lu, J; Sun, Y; Wang, M; Wu, P; Zhao, Q; Zuo, C | 1 |
| Cao, Y; Chen, S; Cui, W; Jiang, X; Leng, Y; Peng, Y; Yan, C; Yan, Z; Zheng, J | 1 |
| Chu, M; Cui, Y; Jiang, D; Jing, D; Liu, L; Liu, Y; Lv, X; Song, W; Wang, Y; Wu, L; Yang, C | 1 |
| Bhalla, M; Chun, JH; Chung, JI; Han, YE; Heo, J; Hyeon, SJ; Jo, HH; Ju, YH; Kim, D; Kim, H; Kim, KJ; Kim, SY; Ko, HY; Kong, M; Kwon, J; Lee, CJ; Lee, GH; Lee, H; Lee, S; Lee, SE; Nam, MH; Oh, KT; Oh, SJ; Park, KD; Park, MA; Park, YM; Ryu, H; Stein, TD; Won, W; Yun, M | 1 |
| Andica, C; Aoki, S; Kamagata, K; Naganawa, S; Owaki, M; Saito, Y; Takabayashi, K; Taoka, T; Tuerxun, R; Uchida, W; Yamazaki, K; Yoshida, S | 1 |
| Chen, K; Ge, J; Guan, Y; Ju, Z; Lin, H; Lu, J; Nie, B; Pan, T; Shan, B; Wang, M; Wu, P; Zhang, H; Zhao, Q; Zuo, C | 1 |
| Eidelberg, D; Namías, M; Perovnik, M; Tang, CC | 1 |
| Diehl-Schmid, J; Förstl, H; Goldhardt, O; Grimmer, T; Hedderich, DM; Lanz, K; Logan, CA; Müller-Sarnowski, F; Ortner, M; Simon, M; Weinberger, JP; Yakushev, I | 1 |
| Dong, G; Zhang, ZC; Zhao, X; Zhao, XM | 1 |
| Alavi, A; Barrio, JR; Høilund-Carlsen, PF; Revheim, ME | 1 |
| Bao, W; Chen, L; Ding, D; Ge, J; Guan, Y; Ju, Z; Li, M; Liang, X; Lu, J; Ma, X; Wu, J; Wu, P; Xiao, Z; Yen, TC; Zhang, H; Zhao, Q; Zheng, L; Zuo, C | 1 |
| Boccardi, M; Tang, Y; Teipel, S | 1 |
| Hershey, LA; Lichter, DG | 1 |
| Feng, LR; Frederiksen, KS; Hasselbalch, SG; Henriksen, OM; Law, I; Mellergaard, C; Vogel, A; Waldemar, G | 1 |
| Bromfman Pianta, D; Caribé, P; da Silva, AMM; Narciso, L; Pinto, S; Sebastião Matushita, C | 1 |
| Kimura, N; Masuda, T; Matsubara, E; Yabuuchi, K | 1 |
| Carli, G; de Jong, BM; Ferini-Strambi, L; Galbiati, A; Leenders, KL; Meles, SK; Padovani, A; Perani, D; Pilotto, A; Reesink, FE | 1 |
| Choi, HJ; Kim, A; Park, SH; Seo, M | 1 |
| Ahmed, R; Breen, N; Fulham, M; McMillan, J; Nikpour, A; Thayer, Z; Zhang, X | 1 |
| Ashton, NJ; Blennow, K; Chiotis, K; Graff, C; Johansson, C; Nordberg, A; Rodriguez-Vieitez, E; Zetterberg, H | 1 |
| Braskie, MN; Chui, HC; Hapenney, M; King, K; Mack, WJ; Matsiyevskiy, E; Thompson, PM; Tubi, MA; Wheeler, K | 1 |
| Goel, N; Kishore, N | 1 |
| Blazhenets, G; Frings, L; Maurer, C; Meyer, PT; Rau, A; Schröter, N; Urbach, H | 1 |
| Akdemir, UO; Arsava, EM; Atay, LO; Balcı, E; Saka, E; Topcuoglu, MA; Yetim, E | 1 |
| Albert, NL; Bartenstein, P; Beyer, L; Brendel, M; Buerger, K; Catak, C; Danek, A; Ewers, M; Kazmierczak, P; Levin, J; Meyer-Wilmes, J; Perneczky, R; Pogarell, O; Prix, C; Rominger, A; Schnabel, J; Schönecker, S; Unterrainer, M | 1 |
| Ceyssens, S; De Roeck, E; Engelborghs, S; Niemantsverdriet, E; Ottoy, J; Staelens, S; Stroobants, S; Van Broeckhoven, C; Verhaeghe, J; Wyffels, L | 1 |
| Dietlein, M; Dillen, K; Dronse, J; Fink, GR; Jacobs, HIL; Kracht, L; Kukolja, J; Langen, KJ; Nellessen, N; Neumaier, B; Onur, OA; Richter, N | 1 |
| Adel, M; Fossati, C; Gaidon, T; Guedj, E; Pan, X; Wojak, J | 1 |
| Beretta, L; Caffarra, P; Caminiti, SP; Ferrari-Pellegrini, F; Magnani, G; Perani, D; Santangelo, R | 1 |
| Meguro, K; Meguro, M; Takahashi, K; Tashiro, M; Yamaguchi, S | 1 |
| Cabrera-Martín, MN; Chanteloup, G; Cordonnier, M; Garrido, C; Gobbo, J; Gómez-Pinedo, U; Matías-Guiu, J; Matías-Guiu, JA; Moreno-Ramos, T; Pytel, V | 1 |
| Beg, MF; Popuri, K; Yee, E | 1 |
| Baghel, V; Bal, C; Damle, NA; Dey, AB; Gupta, R; Kumar, P; Kumar, R; Parida, G; Tripathi, M; Yadav, S | 1 |
| Delbeuck, X; Fahmi, R; Jaillard, A; Kuchcinski, G; Leclerc, X; Lopes, R; Pasquier, F; Semah, F; Sillaire, AR; Vanhoutte, M | 1 |
| Blazhenets, G; Eidelberg, D; Frings, L; Ma, Y; Meyer, PT; Rücker, G; Schiller, F; Sörensen, A | 2 |
| Diehl-Schmid, J; Drost, R; Förstl, H; Goldhardt, O; Grimmer, T; Hedderich, D; Müller-Sarnowski, F; Ortner, M; Yakushev, I | 1 |
| Bauckneht, M; Capello, E; Dottorini, ME; Eusebi, P; Farotti, L; Massa, F; Morbelli, S; Nobili, F; Parnetti, L; Tranfaglia, C | 1 |
| Amaro, E; Felício, AC; Ferrari, BL; Gamarra, LF; Lacerda, SS; Mamani, JB; Neto, GCC; Nucci, MP | 1 |
| Beaver, J; Bennacef, I; Lohith, TG; Martarello, L; Purohit, A; Salinas, C; Struyk, A; Sur, C | 1 |
| Choi, H; Kim, YK; Lee, DS; Lee, JY; Yoon, EJ | 1 |
| Imai, M; Ishibashi, K; Ishii, K; Kanemaru, K; Murayama, S; Nishina, Y; Sakata, M; Sengoku, R; Tago, T; Tanaka, M; Toyohara, J; Wagatsuma, K | 1 |
| Alegret, M; Arbizu, J; Boada, M; Buendía, M; Guillen, F; Hernández, I; Martínez-Lage, P; Monleón, I; Munuera, J; Pérez-Grijalba, V; Pesini, P; Prieto, E; Romero, J; Ruiz, A; San-José, I; Sarasa, L; Sarasa, M; Sotolongo-Grau, O; Tárraga, L | 1 |
| Choi, Y; Chung, SJ; Lee, PH; Lee, S; Lee, YH; Sohn, YH; Ye, BS; Yoo, H; Yun, M | 1 |
| Caprioglio, C; Iannaccone, S; Magnani, G; Perani, D; Sala, A; Santangelo, R; Vanoli, EG | 1 |
| Anderberg, L; Andersen, BB; Bjerregaard, E; Frederiksen, KS; Gjerum, L; Hasselbalch, SG; Hejl, AM; Henriksen, OM; Høgh, P; Law, I | 1 |
| Jiang, J; Wang, M; Yan, Z | 1 |
| Gu, X; Han, X; Liu, L; Zhao, M | 1 |
| Barbagallo, G; Chiaravalloti, A; De Lucia, V; Koch, G; Martorana, A; Ricci, M; Schillaci, O | 1 |
| Fujiwara, Y; Ishibashi, K; Ishii, K; Onishi, A; Wagatsuma, K | 1 |
| Brucki, SMD; Buchpiguel, CA; Busatto, GF; Coutinho, AM; de Gobbi Porto, FH; de Oliveira, MO; de Paula Faria, D; de Souza Duran, FL; Forlenza, OV; Garcez, AT; Nitrini, R; Ono, CR; Squarzoni, P; Tres, ES | 1 |
| Gonzalez-Escamilla, G; Groppa, S; Grothe, MJ; Miederer, I; Muthuraman, M; Schreckenberger, M | 1 |
| Ando, I; Bunai, T; Futatsubashi, M; Matsudaira, T; Obi, T; Ouchi, Y; Terada, T; Tsukada, H; Yoshikawa, E | 1 |
| Allegri, R; Barthélemy, NR; Bateman, RJ; Benzinger, TLS; Berman, SB; Buckles, V; Chhatwal, J; Fagan, AM; Farlow, M; Fox, NC; Gabelle, A; Goate, AM; Gordon, BA; Graff-Radford, NR; Hassenstab, J; Ikeuchi, T; Joseph-Mathurin, N; Jucker, M; Karch, CM; Lehmann, S; Levin, J; Li, Y; Martins, RN; Masters, CL; McDade, E; Mendez, PC; Mori, H; Morris, JC; Noble, J; O'Connor, A; Perrin, RJ; Salloway, S; Sato, C; Schofield, PR; Shimada, H; Shoji, M; Suzuki, K; Xiong, C | 1 |
| Iizuka, T; Kameyama, M | 1 |
| Boles Ponto, LL; DeVries, SD; Harlynn, EL; Magnotta, VA; Menda, Y; Moser, DJ; Oleson, JJ; Schultz, SK; Wemmie, JA | 1 |
| Hu, B; Hu, T; Li, Y; Teng, L; Yao, Z; Zhang, Z; Zhao, Y | 1 |
| Alberts, I; Ge, J; Jiang, J; Rominger, A; Shi, K; Wang, M; Yan, Z; Yu, J; Zhang, H; Zuo, C | 1 |
| Caminiti, SP; Iaccarino, L; Iannaccone, S; Magnani, G; Perani, D; Presotto, L; Santangelo, R; Tondo, G | 1 |
| Cabello, J; Calhoun, V; Diehl-Schmid, J; Goldhardt, O; Grimmer, T; Hedderich, D; Riedl, V; Ripp, I; Savio, A; Stadhouders, T; Yakushev, I | 1 |
| Jones, G; Kalff, V; Krishnadas, N; Lichtenstein, M; Nadebaum, DP; Poon, AMT; Rowe, CC; Villemagne, VL | 1 |
| Agosta, F; Caminiti, SP; Caso, F; Cecchetti, G; Filippi, M; Magnani, G; Martinelli, V; Masserini, F; Passerini, G; Perani, D; Pinto, P; Sala, A; Santangelo, R | 1 |
| Baroni, M; Bruun, M; Dottorini, ME; Frederiksen, KS; Gjerum, L; Hasselbalch, SG; Henriksen, OM; Koikkalainen, J; Law, I; Lötjönen, J; Mecocci, P; Simonsen, AH | 1 |
| Buck, A; Delso, G; Huellner, M; Kaushik, S; Kemp, B; Sekine, T; Ter Voert, EEGW; Veit-Haibach, P; Warnock, G; Wiesinger, F | 1 |
| Boeve, BF; Botha, H; Buciuc, M; Dickson, DW; Jack, CR; Jones, DT; Josephs, KA; Knopman, DS; Lowe, V; Murray, ME; Parisi, JE; Petersen, RC; Petrucelli, L; Schwarz, CG; Senjem, ML; Whitwell, JL | 1 |
| Castellano, CA; Croteau, E; Cunnane, SC; Dieumegarde, L; Duchesne, S; Nugent, S; Potvin, O | 1 |
| Bocti, C; Castellano, CA; Croteau, E; Cunnane, SC; Descoteaux, M; Fortier, M; Fulop, T; Houde, JC; Rheault, F; Roy, M; St-Pierre, V; Turcotte, ÉE | 1 |
| Ben Bouallègue, F; Kucharczak, F; Mariano-Goulart, D; Strauss, O; Suau, M | 1 |
| Andrews, R; Brinton, RD; de Leon, MJ; Diaz, I; Dyke, J; Hoffman, K; Hristov, H; Isaacson, RS; Jackson, H; Jett, S; Lee, A; Matthews, D; Mosconi, L; Pahlajani, S; Rahman, A; Sarva, H; Schelbaum, E | 1 |
| Alcolea, D; Altuna, M; Annus, T; Barroeta, I; Belbin, O; Benejam, B; Blesa, R; Camacho, V; Carmona-Iragui, M; Clarimón, J; Estellés, T; Fernández, S; Fortea, J; Giménez, S; González-Ortiz, S; Holland, AJ; Illán-Gala, I; Lehmann, S; Lleó, A; Montal, V; Muñoz, L; Osorio, RS; Pegueroles, J; Valldeneu, S; Videla, L; Videla, S; Vilaplana, E; Wilson, LR; Zaman, SH | 1 |
| Christianson, TJ; Geda, YE; Jack, CR; Knopman, DS; Krell-Roesch, J; Kremers, WK; Lowe, VJ; Machulda, MM; Mielke, MM; Petersen, RC; Stokin, GB; Syrjanen, JA; Vassilaki, M; Vemuri, P | 1 |
| Byun, MS; Jeon, SY; Kang, KM; Kim, JW; Kim, YK; Lee, DY; Lee, JH; Lee, JY; Shin, SA; Sohn, BK; Sohn, CH; Yi, D | 1 |
| Carlson, ML; Chao, SZ; DiGiacomo, PS; Fan, AP; Goubran, M; James, ML; Khalighi, MM; Mormino, E; Vasanawala, M; Wintermark, M; Zaharchuk, G; Zeineh, MM | 1 |
| Anderson, H; Becker, A; Bothwell, R; Brooks, W; Burns, JM; Choi, IY; Clutton, J; Harris, RA; Lee, P; Mahnken, JD; Mosconi, L; Pleen, J; Reed, G; Sherry, E; Swerdlow, RH; Vidoni, ED; Wilkins, HM; Zhang, N | 1 |
| Kadir, A; Nordberg, A; Perini, G; Rodriguez-Vieitez, E; Sala, A; Savitcheva, I | 1 |
| Chen, SD; Dong, Q; Li, HQ; Shen, XN; Wang, RZ; Wang, Y; Yang, YX; Yu, JT | 1 |
| Raji, CA; Silverman, DHS; Torosyan, N | 1 |
| Kim, HW; Lee, HE; Lee, S; Oh, K; Yoo, SK; Yun, M | 1 |
| Adel, M; Fossati, C; Gaidon, T; Guedj, E; Pan, X; Phan, TL; Wojak, J | 1 |
| Anile, C; Calcagni, ML; Mangiola, A; Mattoli, MV; Treglia, G; Trevisi, G | 1 |
| Jiang, J; Wang, M; Xiao, SY; Yan, Z; Zuo, C | 1 |
| Beauregard, JM; Bergeron, D; Bouchard, RW; Cabrera-Martín, MN; Laforce, R; Matias-Guiu, JA; Poulin, S; Soucy, JP; Verret, L | 1 |
| Brucki, SMD; Buchpiguel, CA; Busatto, GF; Costa, NAD; Coutinho, AM; Duran, FLS; Faria, DP; Forlenza, OV; Nitrini, R; Porto, FHG; Squarzoni, P; Yassuda, MS | 1 |
| Arnaldi, D; Bauckneht, M; Brugnolo, A; De Carli, F; Doglione, E; Filippi, L; Girtler, N; Grisanti, S; Massa, F; Morbelli, S; Nobili, F; Origone, P; Orso, B; Pagani, M; Pardini, M | 1 |
| Berti, V; Cappa, SF; Catricalà, E; Conca, F; Esposito, V; Filippi, M; Gasparri, C; Iannaccone, S; Magnani, G; Perani, D; Polito, C; Presotto, L; Pupi, A; Sala, A; Sorbi, S | 1 |
| Bettendorff, L; Chen, H; Chen, Z; Cirio, R; Flowers, SA; Fonzetti, P; Franchino-Elder, J; Gerber, LM; Gibson, GE; Grandville, T; Habeck, C; Hirsch, JA; Jordan, B; Luchsinger, JA; Schupf, N; Stern, Y; Xu, H | 1 |
| Ewers, M; Franzmeier, N; Neitzel, J; Rubinski, A | 1 |
| Andrieu, S; Cantet, C; Carrie, I; Delrieu, J; Payoux, P; Saint-Aubert, L; Vellas, B; Voisin, T | 1 |
| Angelidis, G; Georgoulias, P; Psimadas, D; Tsougos, I; Valotassiou, V | 1 |
| Blazhenets, G; Frings, L; Meyer, PT; Sörensen, A | 1 |
| Boenink, M; Isaacs, JD | 1 |
| Agosta, F; Arbizu, J; Barkhof, F; Barthel, H; Brooks, DJ; Carrillo, MC; Chételat, G; Drzezga, A; Dubois, B; Fjell, AM; Frisoni, GB; Garibotto, V; Hansson, O; Herholz, K; Hutton, BF; Jack, CR; Lammertsma, AA; Landau, SM; Law, I; Minoshima, S; Morbelli, S; Nobili, F; Nordberg, A; Ossenkoppele, R; Oyen, WJG; Perani, D; Rabinovici, GD; Scheltens, P; van de Giessen, E; Villemagne, VL; Zetterberg, H | 1 |
| da Silva, AR; Diao, Y; Jelescu, IO; Lanz, B; Pierzchala, K; Poitry-Yamate, C; Tristão Pereira, C; Yin, T | 1 |
| Fukushima, M; Kojima, S; Neuroimaging Initiative, TAD; Tanabe, K; Teramukai, S; Zhou, B | 1 |
| Carli, G; Cerami, C; Filippi, M; Iannaccone, S; Magnani, G; Mattoli, MV; Perani, D; Presotto, L; Santangelo, R; Tondo, G | 1 |
| Aranha, MR; Barbosa, ER; Brucki, SMD; Buchpiguel, CA; Coutinho, AM; de Almeida, IJ; de Godoi Carneiro, C; Fontoura Solla, DJ; Nitrini, R; Ono, CR; Parmera, JB; Studart-Neto, A | 1 |
| Edison, P; Femminella, GD; Harold, D; Scott, J; Williams, J | 1 |
| Hakulinen, M; Hallikainen, M; Koivisto, AM; Könönen, M; Korhonen, V; Laitinen, T; Laitinen, TM; Lehtola, JM; Mervaala, E; Mussalo, H; Poutiainen, P; Remes, AM; Saari, T; Vanninen, R; Ylä-Herttuala, S | 1 |
| Baker, SL; Boxer, A; DeCarli, C; Edwards, L; Gorno-Tempini, M; Grinberg, LT; Hepker, M; Huang, E; Hwang, JL; Iaccarino, L; Jagust, WJ; Janabi, M; La Joie, R; Lesman-Segev, OH; Lobach, I; Miller, BL; Olichney, J; Pham, J; Rabinovici, GD; Rosen, HJ; Seeley, WW; Seo, SW; Spina, S | 1 |
| Baker, MC; Bigio, EH; Buciuc, M; Dickson, DW; Duffy, JR; Flanagan, ME; Franczak, MB; Ghetti, BF; Graff-Radford, J; Graff-Radford, NR; Josephs, KA; Kasanuki, K; Lowe, VJ; Machulda, MM; Parisi, JE; Rademakers, R; Raghunathan, A; Reichard, RR; Ross, OA; Rush, BK; Strand, EA; Whitwell, JL | 1 |
| Aikawa, T; Chang, SY; Kanekiyo, T; Nesbitt, J; Ostroot, MA; Pichurin, NP; Stojakovic, A; Trushina, E | 1 |
| Benedet, AL; Chan, YH; Gauthier, S; Greenwood, CMT; Jiang, L; Kandiah, N; Mathotaarachchi, S; Ng, KP; Pascoal, TA; Rosa-Neto, P; Shin, M; Therriault, J | 1 |
| Blazhenets, G; Eidelberg, D; Frings, L; Ma, Y; Meyer, PT; Sörensen, A; Wiltfang, J | 1 |
| Chen, J; Dong, C; Jing, J; Xie, J; Zhang, F; Zhang, Y; Zhao, L; Zhong, R | 1 |
| Ances, BM; Bateman, RJ; Benzinger, TLS; Berman, SB; Brickman, AM; Brooks, WS; Cash, DM; Cash, L; Chhatwal, JP; Cruchaga, C; Dincer, A; Fagan, AM; Farlow, MR; Flores, S; Fox, NC; Fulham, MJ; Ghetti, B; Gordon, BA; Hassenstab, J; Hornbeck, R; Jack, CR; Joseph-Mathurin, N; Jucker, M; Karch, CM; Klunk, W; Koeppe, R; Koudelis, D; Kuffner, T; Levin, J; Luckett, PH; Marcus, D; Masters, CL; McCarthy, J; McCullough, A; McDade, E; Meeker, KL; Mori, H; Morris, JC; Noble, JM; Oh, H; Perrin, RJ; Salloway, S; Schofield, PR; Stern, A; Strain, J; Su, Y; Swisher, L; Vöglein, J; Wang, Q; Weiner, M; Xiong, C | 1 |
| Dubois, B; Habert, MO; Hampel, H; Lemercier, P; Lista, S; Lukiw, WJ; Potier, MC; Teipel, SJ; Vergallo, A; Zhao, Y | 1 |
| Aarsland, D; Arnaldi, D; Bauckneht, M; Beyer, L; Brendel, M; Bruffaerts, R; Camacho, V; Chincarini, A; Davidsson, A; Donegani, MI; Frisoni, GB; Garibotto, V; Kramberger, MG; Lemstra, AW; Miceli, A; Morbelli, S; Nicastro, N; Nobili, F; Ochoa-Figueroa, MA; Padovani, A; Pardini, M; Peira, E; Pilotto, A; Raffa, S; Rominger, A; Sambuceti, G; Trost, M; van Berckel, BNM; Vandenberghe, R | 1 |
| Cross, D; Minoshima, S; Mosci, K; Thientunyakit, T | 1 |
| Beg, MF; Chausse, G; Jenkins, LM; Ma, D; Popuri, K; Probst, S; Stocks, JK; Wang, L; Yee, E | 1 |
| Antelmi, L; Berckel, BV; Bosco, P; Didic, M; Drzezga, A; Frisoni, GB; Garibotto, V; Giannakopoulos, P; Gold, G; Guedj, E; Morbelli, S; Nobili, F; Ossenkoppele, R; Perneczky, R; Rager, O; Ratib, O; Redolfi, A; Tabouret-Viaud, C; Trombella, S | 1 |
| Archer, H; Ballard, C; Bannister, C; Brooks, DJ; Busza, G; Calsolaro, V; Carver, S; Coulthard, E; Donaldson, A; Edison, P; Femminella, GD; Frangou, E; Harrison, J; Holmes, C; Holscher, C; Junaid, K; Karim, S; Knight, L; Koranteng, P; Kshemendran, S; Lawrence, RM; Livingston, NR; Love, S; Macharouthu, A; Malik, N; Mate, V; McFarlane, B; McGuinness, B; Nilforooshan, R; Passmore, AP; Prasanna, A; Raza, S; Ridha, BH; Ritchie, CW; Russell, G; Tadros, G; Tan, T; Thacker, S; Underwood, B; van der Doef, T; Walker, Z | 1 |
| Buchert, R; Dyrba, M; Ferreira, D; Grothe, MJ; Lange, C; Levin, F; Teipel, SJ; Westman, E | 1 |
| Cabanel, N; Hooshyar Yousefi, B; Kircher, T; Librizzi, D; Luster, M; Riehl, E; Zavorotnyy, M | 1 |
| Chang, CJ; Chen, LF; Fuh, JL; Guo, WY; Hsu, TW; Huang, WS; Wang, DW; Wu, HM | 1 |
| Bartlett, PF; Jiang, T; Liu, B; Liu, Y; Zhang, Y; Zhou, X; Zhuo, J | 1 |
| Andersen, BB; Bruun, M; Frederiksen, KS; Gjerum, L; Hasselbalch, SG; Henriksen, OM; Law, I; Simonsen, AH | 1 |
| Arnsten, AF; Carson, RE; Chen, MK; Finnema, SJ; Gallezot, JD; Huang, Y; Lin, SF; McDonald, JW; Mecca, AP; Michalak, HR; Mondal, J; Nabulsi, NB; Naganawa, M; O'Dell, RS; Toyonaga, T; van Dyck, CH; Vander Wyk, B | 1 |
| Krause, BJ; Kuhla, A; Lindner, T; Müller, L; Power Guerra, N; Rühlmann, C; Stenzel, J; Teipel, S; Vollmar, B | 1 |
| Dong, QY; Han, Y; Jiang, JH; Jiang, XY; Li, TR; Wang, XN | 1 |
| Arunraj, ST; Baghel, V; Bal, C; Dey, AB; Jaleel, J; Khan, D; Kumar, P; Tripathi, M | 1 |
| Ahn, H; Byun, MS; Joung, H; Lee, DY; Lee, JH; Lee, Y; Yi, D | 1 |
| Berti, V; Bessi, V; Cappelletto, P; Ferrari, C; Lombardi, G; Lucidi, G; Polito, C; Sorbi, S | 1 |
| Chang, CC; Chang, YT; Chiu, PY; Chuang, KS; Hsiao, IT; Hung, GU; Lin, KJ; Lin, WB; Lin, ZK; Ni, YC; Pai, MC; Tseng, FP | 1 |
| De Vincentis, G; Frantellizzi, V; Madeddu, G; Nuvoli, S; Palumbo, B; Spanu, A; Stazza, ML; Tanda, G | 1 |
| Barkhof, F; Chen, JQA; Crane, PK; Dicks, E; Groot, C; Mac Donald, CL; Mez, J; Mukherjee, S; Ossenkoppele, R; Risacher, SL; Saykin, AJ; Scheltens, P; Trittschuh, EH; van der Flier, WM | 1 |
| Booth, S; Gupta, V; Ko, JH | 1 |
| Cai, Q; Huang, G; Li, W; Li, Z; Liu, W; Meng, X; Wang, S; Zhang, D; Zhang, X; Zhang, Y; Zheng, Y | 1 |
| Carson, RE; Chen, MK; Liu, C; Liu, H; Liu, Y; Ma, T; Mecca, AP; Naganawa, M; O'Dell, RS; Onofrey, JA; Shi, L; Toyonaga, T; Tsai, YJ; van Dyck, CH; Wang, R; Wu, J | 1 |
| Abbas, A; Chételat, G; Chocat, A; Dautricourt, S; de la Sayette, V; Landeau, B; Manrique, A; Sherif, S; Vanhoutte, M | 1 |
| Boeve, BF; Botha, H; Chen, Q; Ferman, TJ; Fields, J; Graff-Radford, J; Graff-Radford, N; Gunte, JL; Jack, CR; Jain, M; Jones, DT; Kantarci, K; Knopman, DS; Lesnick, TG; Lowe, VJ; Min, P; Miyagawa, T; Petersen, RC; Przybelski, SA; Savica, R; Schwarz, CG; Senjem, ML | 1 |
| Ding, C; Du, W; Han, Y; Jiang, J; Wang, L; Zhang, Q | 1 |
| Aarsland, D; Agudelo-Cifuentes, M; Bauckneht, M; Brendel, M; Bruffaerts, R; Byttner, S; Camacho, V; Chang, JR; Chincarini, A; Davidsson, A; Etminani, K; Frisoni, GB; Garibotto, V; Kramberger, MG; Lemstra, AW; Martínez-Sanchis, B; Morbelli, S; Nicastro, N; Nobili, F; Ochoa-Figueroa, M; Padovani, A; Pilotto, A; Ressner, M; Rominger, A; Soliman, A; Stegeran, R; Trost, M; van Berckel, BNM; Vandenberghe, R | 1 |
| Bouckaert, F; De Winter, FL; Dupont, P; Emsell, L; Koole, M; Sunaert, S; Takamiya, A; Van den Stock, J; Van Laere, K; Vande Casteele, T; Vandenberghe, R; Vandenbulcke, M | 1 |
| Bueno, H; Gómez, EJ; Gómez-Grande, A; González-Sánchez, M; Sánchez-González, P; Seiffert, AP; Villarejo-Galende, A | 1 |
| Baker, SL; Edwards, L; Gorno-Tempini, ML; Iaccarino, L; Jagust, WJ; La Joie, R; Landau, SM; Lesman-Segev, OH; Miller, BL; Pham, J; Rabinovici, GD; Rosen, HJ; Soleimani-Meigooni, DN; Strom, A | 1 |
| Boccardi, M; Garibotto, V; Herholz, K; Nobili, F; Nordberg, A; Picco, A; Ratib, O; Varrone, A | 1 |
| Bejanin, A; Horng, A; Jagust, WJ; Landau, SM; Lockhart, SN; Schreiber, F; Schreiber, S | 1 |
| Alexopoulos, P; Perneczky, R; Robb, C; Schöpe, J; Udeh-Momoh, C; Wagenpfeil, S | 1 |
| Barkhof, F; Croon, PM; Danfors, T; Egger, K; Fällmar, D; Haller, S; Kellner, E; Kilander, L; Larsson, EM; Lilja, J; Ossenkoppele, R; Tolboom, N; van Berckel, BNM; Verfaillie, SCJ | 1 |
| Ba, M; Benedet, AL; Chung, CO; Gauthier, S; Kandiah, N; Kang, MS; Li, X; Mathotaarachchi, S; Ng, KP; Pascoal, TA; Rosa-Neto, P; Shin, M | 1 |
| Becker, JA; Donovan, NJ; Gatchel, JR; Johnson, KA; Locascio, JJ; Marshall, GA; Rentz, DM; Sperling, RA | 1 |
| Avolio, C; Bozzali, M; Caltagirone, C; Carapelle, E; Falcone, M; Modoni, S; Serra, L; Specchio, LM | 1 |
| Chu, YC; Chuang, WL; Hsiao, IT; Hsieh, CJ; Huang, CC; Huang, CY; Huang, KL; Kung, MP; Kuo, HC; Lin, KJ; Wai, YY; Yen, TC | 1 |
| Bischof, GN; Drzezga, A; van Eimeren, T | 1 |
| Bai, CH; Chang, CC; Fan, YC; Hsiao, IT; Hsu, JL; Hsu, WC; Lin, KJ | 1 |
| Almkvist, O; Antoni, G; Chiotis, K; Jonasson, M; Leuzy, A; Lubberink, M; Nordberg, A; Rodriguez-Vieitez, E; Saint-Aubert, L; Savitcheva, I; Wall, A | 2 |
| Asthana, S; Bendlin, BB; Boots, EA; Carlsson, CM; Christian, BT; Cook, DB; Dougherty, RJ; Edwards, D; Gallagher, CL; Hermann, BP; Johnson, SC; Kirby, TK; Oh, JM; Okonkwo, OC; Sager, MA; Schultz, SA | 1 |
| Nation, DA; Yew, B | 1 |
| Bartha, R; Borrie, MJ; Gómez, FA; Kazemifar, S; Manning, KY; Menon, RS; Rajakumar, N; Soddu, A | 1 |
| Baghel, V; Bal, C; Bansal, A; Kumar, P; Tripathi, M | 1 |
| Dillen, KNH; Fink, GR; Jacobs, HIL; Kukolja, J; Langen, KJ; Onur, ÖA; Richter, N; von Reutern, B | 1 |
| Ali, S; Coleman, RA; Liang, C; Mukherjee, J; Patel, R | 1 |
| Arnaldi, D; Bauckneht, M; Brugnolo, A; Chincarini, A; De Carli, F; Girtler, N; Giuliani, A; Jonsson, C; Morbelli, S; Nobili, F; Öberg, J; Pagani, M; Picco, A; Piva, R; Sambuceti, G | 1 |
| Almkvist, O; Alongi, P; Bettinardi, V; Cerami, C; Chiotis, K; Gianolli, L; Iaccarino, L; Nordberg, A; Perani, D; Wall, A | 1 |
| Bocti, C; Castellano, CA; Croteau, E; Cunnane, SC; Fortier, M; Fulop, T; Paquet, N | 1 |
| Barbagallo, G; Chiaravalloti, A; Fiorentini, A; Koch, G; Martorana, A; Schillaci, O; Tavolozza, M; Ursini, F | 1 |
| Frisoni, GB; Guerra, UP; Moretti, DV; Paghera, B; Pievani, M; Pini, L | 1 |
| Chen, L; Huang, J; Jin, H; Li, L; Liang, S; Lin, B; Lin, R; Liu, W; Tao, J; Wang, Z; Wu, J; Zhang, Y; Zhuo, P | 1 |
| Arnaldi, D; Bauckneht, M; Brugnolo, A; Buschiazzo, A; Chincarini, A; De Carli, F; Girtler, N; Morbelli, S; Nieri, A; Nobili, F; Pagani, M; Pardini, M; Picco, A; Sambuceti, G | 1 |
| Inui, Y; Ito, K; Kato, T; Kimura, Y; Kizawa, T | 1 |
| Byun, MS; Choi, HJ; Kim, YK; Lee, DY; Lee, JH; Lee, JY; Sohn, BK; Yi, D | 1 |
| Berti, V; Brinton, RD; de Leon, MJ; Isaacson, RS; McHugh, P; Mosconi, L; Osorio, RS; Petrongolo, G; Pupi, A; Quinn, C; Vallabhajosula, S; Varsavsky, I | 1 |
| Fanale, CM; Melrose, RJ; Sultzer, DL; Veliz, JV; Weissberger, GH | 1 |
| Dubois, B; Epelbaum, S; Hampel, H; Levy Nogueira, M; Lista, S; Samri, D; Spies, L; Suppa, P; Teichmann, M | 1 |
| Delbeuck, X; Fahmi, R; Jaillard, A; Kuchcinski, G; Lopes, R; Maureille, A; Pasquier, F; Petyt, G; Rollin Sillaire, A; Semah, F; Vanhoutte, M | 1 |
| Cho, J; Furumoto, S; Ido, T; Jeong, HJ; Kang, H; Kang, JM; Lee, H; Lee, KM; Lee, SY; Lee, YB; Na, DL; Noh, Y; Okamura, N; Park, KH; Seo, S; Seong, JK; Shin, DH; Villemagne, VL; Woo, SH; Yanai, K; Yeon, BK | 1 |
| Aghourian, M; Bédard, MA; Gauthier, S; Gravel, P; Kostikov, A; Legault-Denis, C; Rosa-Neto, P; Soucy, JP | 1 |
| Inui, Y; Ito, K; Kato, T | 1 |
| Chen, Y; Guo, Z; Mao, YF; Zhang, B; Zheng, T | 1 |
| Arnaldi, D; De Carli, F; Dessi, B; Jonsson, C; Leenders, KL; Meles, SK; Morbelli, S; Nobili, F; Pagani, M; Sambuceti, G | 1 |
| Chen, X; Gutknecht, J; Hu, B; Majoe, D; Xie, Y; Yao, Z | 1 |
| Bisdas, S; Rice, L | 1 |
| Eliassen, CF; Fladby, T; Grambaite, R; Hessen, E; Reinvang, I; Selnes, P | 1 |
| Arcos, G; Boada, M; Ciudin, A; Diego, S; Hernández, C; Hernández, I; Sanabria, Á; Simó, R; Simó-Servat, O; Sotolongo, Ó | 1 |
| Berti, V; Brinton, RD; Connaughty, C; de Leon, MJ; Isaacson, RS; McHugh, P; Mosconi, L; Osorio, RS; Petrongolo, G; Pupi, A; Quinn, C; Swerdlow, RH; Vallabhajosula, S | 1 |
| Harwood, D; Mandelkern, M; Melrose, RJ; Natta, L; Sultzer, DL; Weissberger, GH; Young, S | 1 |
| Barbagallo, G; Chiaravalloti, A; Karalis, G; Martorana, A; Ricci, M; Sannino, P; Schillaci, O; Ursini, F | 1 |
| Aliaga, A; Cuello, AC; Dea, D; Do Carmo, S; Fonov, VS; Gauthier, S; Kang, MS; Kostikov, A; Mathieu, A; Parent, MJ; Poirier, J; Rosa-Neto, P; Shin, M; Soucy, JP; Zimmer, ER | 1 |
| Cabrera-Martín, MN; Carreras, JL; Curiel, RE; Loewenstein, DA; Matías-Guiu, J; Matias-Guiu, JA; Moreno-Ramos, T; Rognoni, T; Valles-Salgado, M | 1 |
| Buchert, R; Lange, C; Makowski, MR; Peters, O; Pietrzyk, U; Spies, L; Suppa, P | 1 |
| Barnhart, TE; Betthauser, TJ; Bulova, PD; Christian, BT; Cohen, AD; Devenny, DA; Handen, BL; Hartley, SL; Johnson, SC; Klunk, WE; Lao, PJ; Lopresti, BJ; Mathis, CA; Mihaila, I; Murali, D; Price, JC; Stone, CK; Tudorascu, DL; Tumuluru, RV | 1 |
| Burrell, LD; Holley, D | 1 |
| Kang, H; Riddle, WR; Shokouhi, S | 1 |
| Jeong, YJ; Kang, DY; Yoon, HJ | 1 |
| Bartha, R; Bindseil, GA; Chronik, BA; Hudson, RHE; Kovacs, M; Pasternak, SH; Snir, JA; Suchy, M | 1 |
| Chen, K; Li, J; Liu, X; Lure, F; Weidman, D; Wu, T | 1 |
| Ballarini, T; Caminiti, SP; Cerami, C; Fallanca, F; Gianolli, L; Iannaccone, S; Magnani, G; Perani, D; Presotto, L; Sala, A; Santangelo, R; Vanoli, EG | 1 |
| Benedet, AL; Gauthier, S; Kang, MS; Massarweh, G; Mathotaarachchi, S; Mohades, S; Park, AY; Pascoal, TA; Rosa-Neto, P; Shin, M; Soucy, JP | 1 |
| Ances, BM; Bateman, RJ; Benzinger, TLS; Berman, SB; Blazey, TM; Brickman, AM; Cairns, NJ; Cash, DM; Chhatwal, JP; Christensen, J; Correia, S; Dincer, A; Fagan, AM; Flores, S; Förster, S; Fox, NC; Gordon, BA; Graff-Radford, NR; Hari-Raj, A; Hassenstab, J; Holtzman, DM; Hornbeck, RC; Jack, CR; la Fougère, C; Levin, J; Marcus, DS; Masters, CL; McDade, E; Morris, JC; Paumier, KL; Raichle, ME; Rossor, MN; Salloway, S; Saykin, AJ; Schofield, PR; Su, Y; Thompson, PM; Wang, G; Weiner, MM; Xiong, C | 1 |
| Alexopoulos, P; Beller, E; Bohn, KP; Drzezga, A; Göttler, J; Grimmer, T; Kaczmarz, S; Pasquini, L; Preibisch, C; Riederer, I; Sorg, C; Yakushev, I; Zimmer, C | 1 |
| Ben Bouallègue, F; Mariano-Goulart, D; Payoux, P | 1 |
| Choi, H; Jin, KH | 1 |
| Bandy, DJ; Burns, CM; Caselli, RJ; Chen, K; Kaszniak, AW; Lee, W; Reiman, EM | 1 |
| Bao, W; Chen, Z; Fei, G; Guan, Y; Jiao, F; Jin, L; Liu, H; Pan, S; Pan, X; Ren, S; Sang, S; Shi, H; Wang, C; Wang, Y; Yu, X; Zeng, F; Zhang, Y; Zhong, C; Zhou, W | 1 |
| Balachandar, R; Beg, MF; Ding, GW; Lu, D; Popuri, K | 2 |
| Adam, G; Apostolova, I; Buchert, R; Grothe, MJ; Klutmann, S; Lange, C; Spies, L; Suppa, P | 1 |
| Frisoni, GB; Garibotto, V; Mainta, IC; Trombella, S; Unschuld, PG; Vargas, MI | 1 |
| Bauckneht, M; Morbelli, S | 1 |
| Ortner, MM | 1 |
| Ances, BM; Bateman, R; Benzinger, TLS; Buckles, VD; Cairns, NJ; Chhatwal, JP; Danek, A; Farlow, MR; Galasko, DR; Ghetti, B; Hedden, T; Jack, C; Jaimes, S; Johnson, KA; Kinnunen, KM; Koeppe, RA; Laske, C; Levin, J; Marcus, DS; Martins, RN; Masters, CL; McDade, E; Morris, JC; Ringman, JM; Salloway, S; Schofield, PR; Schultz, AP; Sperling, RA; Xiong, C; Yakushev, I | 1 |
| Coppola, G; Huang, SC; Jann, K; Liu, CY; Mack, WJ; Ringman, JM; Wang, DJJ; Wong, KP; Yan, L | 1 |
| Arnemann, KL; Jagust, WJ; Narayan, S; Rabinovici, GD; Stöber, F | 1 |
| Bormann, T; Buchert, R; Frings, L; Hellwig, S; Meyer, PT; Spehl, TS | 1 |
| Kwak, K; Lee, JM; Park, G; Yun, HJ | 1 |
| Huang, Z; Jiang, J; Li, S; Neuroimaging Initiative, AD; Shi, K; Sun, Y; Wu, P; Zhou, H; Zuo, C | 1 |
| Arnaldi, D; Bauckneht, M; Chincarini, A; Efeturk, H; Girtler, N; Grazzini, M; Massa, F; Morbelli, S; Nobili, F; Pagani, M; Pardini, M; Piva, R; Sambuceti, G | 1 |
| Alexander, GE; Bauer, RJ; Caselli, RJ; Chen, K; Chen, Y; Lee, W; Locke, DEC; Reiman, EM; Savage, CR; Sharieff, S; Stonnington, CM; Thiyyagura, P | 1 |
| Andrews, R; Berti, V; de Leon, MJ; Isaacson, RS; Logue, M; Matthews, DC; Mosconi, L; Osorio, RS; Pupi, A; Quinn, CG; Sterling, J; Vallabhajosula, S; Walters, M | 1 |
| Agosta, F; Altomare, D; Arbizu, J; Barthel, H; Boccardi, M; Bouwman, F; Drzezga, A; Festari, C; Frisoni, GB; Nestor, P; Nobili, F; Orini, S; Rivolta, J; Walker, Z | 1 |
| Aiello, M; Baron, JC; Cachia, A; Cavaliere, C; Marchitelli, R; Milan, G; Montella, P; Pappatà, S; Postiglione, A; Quarantelli, M; Salvatore, E; Salvatore, M; Tedeschi, G | 1 |
| Agosta, F; Altomare, D; Arbizu, J; Boccardi, M; Bouwman, F; Drzezga, A; Festari, C; Frisoni, GB; Law, I; Nestor, PJ; Nobili, F; Orini, S; Rivolta, J; Walker, Z | 1 |
| Agosta, F; Altomare, D; Arbizu, J; Boccardi, M; Bouwman, F; Drzezga, A; Festari, C; Frisoni, GB; Herholz, K; Nestor, P; Nobili, F; Orini, S; Walker, Z | 1 |
| Byun, MS; Choi, JE; Im, HJ; Kang, JM; Kim, YK; Lee, DY; Lee, JH; Lee, JY; Ryu, YH; Sohn, BK; Son, SK | 1 |
| Alexopoulos, P; Assimakopoulos, K; Economou, P; Gourzis, P; Grimmer, T; Ortner, M; Perneczky, R; Politis, A; Thierjung, N | 1 |
| Cai, L; Gao, S; Ji, Y; Li, Y; Shi, Z; Wang, Y; Xing, X; Yang, H; Yao, S; Zhang, N | 1 |
| Boeve, BF; Botha, H; Graff-Radford, J; Jack, CR; Jones, DT; Knopman, DS; Lowe, V; Petersen, RC; Senjem, ML; Townley, RA | 1 |
| Bocti, C; Castellano, CA; Croteau, E; Cunnane, SC; Duchesne, S; Fortier, M; Fülöp, T; Lepage, M; Nugent, S; Richard, MA; Turcotte, ÉE; Whittingstall, K | 1 |
| Edison, P; Femminella, GD; Scott, J; Taylor-Davies, G | 1 |
| Eo, JS; Jeong, HG; Lee, ES; Lee, S; Suh, S; Youn, H | 1 |
| Brayne, C; Hyde, C; Kelly, S; Lafortune, L; Smailagic, N | 1 |
| Adams, J; Jagust, WJ; Kang, J; Li, L; Lockhart, SN | 1 |
| Adel, M; Fossati, C; Gaidon, T; Guedj, E; Pan, X | 1 |
| Abrunhosa, A; Barroca, D; Cardoso, E; Castelo-Branco, M; Cruz, Â; de Mendonça, A; Moreira, AP; Oliveira, FPM; Rio, J; Verdelho, A; Xavier, C | 1 |
| Bonneville, F; Dumas, H; Gane, A; Guerrier, L; Le Men, J; Pariente, J; Payoux, P; Péran, P; Planton, M; Salabert, AS | 1 |
| Benedet, AL; Bennacef, I; Bouhachi, R; Chamoun, M; Chartrand, D; Gauthier, S; Hopewell, R; Hsiao, HH; Kang, MS; Massarweh, G; Mathotaarachchi, S; Ng, KP; Pascoal, TA; Rosa-Neto, P; Shin, M; Soucy, JP; Therriault, J | 1 |
| Hansson, O; Jögi, J; Mattsson, N; Ohlsson, T; Ossenkoppele, R; Palmqvist, S; Smith, R; Stomrud, E; Strandberg, O | 1 |
| Benvenutto, A; Ceccaldi, M; Didic, M; Felician, O; Giusiano, B; Guedj, E; Gueriot, C; Guye, M; Koric, L | 1 |
| Bacci, M; Bertin, H; Bertrand, A; Bottani, S; Burgos, N; Colliot, O; Durrleman, S; Evgeniou, T; Fontanella, S; Guillon, J; Habert, MO; Lu, P; Marcoux, A; Routier, A; Samper-González, J; Wen, J | 1 |
| Gianolli, L; Luzi, L; Malpetti, M; Perani, D; Sala, A; Vanoli, EG | 1 |
| Aljuaid, M; Bybel, B; Goertzen, AL; Kang, DY; Katako, A; Kim, SM; Ko, JH; Lee, CS; Levin, D; Shelton, P; Yoon, HJ | 1 |
| Boellaard, R; De Deyn, PP; de Jong, BM; Dierckx, RA; García, DV; Huitema, RB; Meles, SK; Peretti, DE; Reesink, FE; Sánchez-Catasús, CA; Willemsen, AT | 1 |
| Hsiao, IT; Hsu, JL; Huang, SY; Lin, KJ; Liu, HL; Wey, SP | 1 |
| Wang, Z; Zhang, J; Zhou, B; Zhou, W | 1 |
| Baran, TM; Lin, FV | 1 |
| Boxer, AL; Cho, H; Choi, JY; Gorno-Tempini, ML; Hansson, O; Janelidze, S; Jögi, J; Kramer, J; La Joie, R; Lyoo, CH; Mattsson, N; Miller, BL; Ohlsson, T; Ossenkoppele, R; Palmqvist, S; Rabinovici, GD; Ryu, YH; Santillo, A; Schöll, M; Smith, R; Strandberg, O; Tsai, R | 1 |
| Ahmad, S; Arnold, M; Baillie, R; Blach, C; Doraiswamy, PM; Han, X; Hankemeier, T; Jia, W; Kaddurah-Daouk, R; Kastenmüller, G; Kueider-Paisley, A; Louie, G; MahmoudianDehkordi, S; Nho, K; Risacher, SL; Saykin, AJ; Shaw, LM; Trojanowski, JQ; van Duijn, CM; Weiner, MW; Xie, G | 1 |
| Arnaldi, D; Bauckneht, M; De Carli, F; Grazzini, M; Jonsson, C; Massa, F; Morbelli, S; Nobili, F; Pagani, M; Peira, E | 1 |
| Aboian, MS; Behr, SC; Copeland, TP; Ding, Y; Flavell, RR; Franc, BL; Hadley, D; Harnish, R; Hawkins, RA; Hernandez Pampaloni, M; Huang, SY; Jenkins, NW; Kawczynski, MG; Lituiev, D; Mari Aparici, C; Nardo, L; Seo, Y; Sohn, JH; Trivedi, H; Zalocusky, KA | 1 |
| Larvie, M | 1 |
| Albert, NL; Bartenstein, P; Baumann, K; Blume, T; Brendel, M; Deussing, M; Focke, C; Gildehaus, FJ; Herms, J; Lindner, S; Ozmen, L; Peters, F; Rominger, A; von Ungern-Sternberg, B | 1 |
| de Mello Rieder, CR; Gauthier, S; Mathotaarachchi, S; Palmini, A; Pascoal, TA; Rosa-Neto, P; Schilling, LP; Shin, M; Zimmer, ER | 1 |
| Carter, SF; Chiotis, K; Nordberg, A; Rodriguez-Vieitez, E | 1 |
| Drubach, DA; Graff-Radford, J; Jack, CR; Josephs, KA; Lowe, VJ; Machulda, MM; Martin, PR; Reid, RI; Schwarz, CG; Senjem, ML; Sintini, I; Spychalla, AJ; Whitwell, JL | 1 |
| Blazhenets, G; Frings, L; Meyer, PT; Rücker, G; Schiller, F; Sörensen, A | 1 |
| Arbizu, J; Boada, M; Martínez-Lage, P; Monleón, I; Munuera, J; Pérez-Grijalba, V; Pesini, P; Romero, J; Ruiz, A; San-José, I; Sarasa, L; Sarasa, M; Tárraga, L | 1 |
| Babic Perhoc, A; Bagaric, R; Farkas, V; Grünblatt, E; Knezovic, A; Osmanovic Barilar, J; Riederer, P; Salkovic-Petrisic, M; Svarc, A | 1 |
| Ishibashi, K; Ishii, K; Kameyama, M | 1 |
| Andreasen, N; Blennow, K; Chiotis, K; Cicognola, C; Höglund, K; Lemoine, L; Leuzy, A; Nordberg, A; Saint-Aubert, L; Ye, K; Zetterberg, H | 1 |
| Boellaard, R; De Deyn, PP; de Jong, BM; Dierckx, RAJO; Peretti, DE; Reesink, FE; Vállez García, D; van der Goot, T | 1 |
| Bom, HS; Cho, SG; Choi, KH; Kang, SR; Kim, J; Kwon, SY; Min, JJ; Song, HC; Yoo, SW | 1 |
| Arnaldi, D; Bauckneht, M; Brugnolo, A; Chincarini, A; De Carli, F; Didic, M; Dottorini, ME; Drzezga, A; Frisoni, GB; Galluzzi, S; Grazzini, M; Guedj, E; Jonsson, C; Massa, F; Mecocci, P; Morbelli, S; Nobili, F; Ossenkoppele, R; Pagani, M; Pardini, M; Perneczky, R; Sambuceti, G; van Berckel, BNM | 1 |
| Arcolin, M; Bertoldo, A; Dipasquale, O; Expert, P; Fisher, PM; Howes, O; Khan, W; Moro, L; Rizzo, G; Svarer, C; Turkheimer, FE; Veronese, M | 1 |
| Fernández-Guinea, S; Fernández-Mateos, C; Garcia, E; Mucientes, J; Pascual, ML; Vaquero, J; Zurita, M | 1 |
| Larvie, M; Léger, GC; Leverenz, JB; Pillai, JA; Tousi, B; Wu, G | 1 |
| Gillard, JH; Manavaki, R; O'Brien, JT; Priest, AN; Sajjadi, SA; Sheikh-Bahaei, N | 1 |
| Eskola, O; Haaparanta-Solin, M; López-Picón, FR; Rinne, JO; Snellman, A; Solin, O; Takkinen, JS | 1 |
| Choi, H; Ha, S; Kang, H; Lee, DS; Lee, H | 1 |
| Andreasson, U; Blennow, K; Cullen, NC; Mattsson, N; Zetterberg, H | 1 |
| Anatharam, V; Clark, BE; Kanthasamy, A; Klinedinst, B; McLimans, KE; Pappas, C; Plagman, A; Willette, AA | 1 |
| Bunai, T; Kakimoto, A; Ouchi, Y; Terada, T; Yoshikawa, E | 1 |
| Liu, Z; Maere, C; Sheng, VS; Song, Y; Xu, C; Xue, K; Yang, K | 1 |
| Domschke, K; Hellwig, S; Meyer, PT | 1 |
| Aston, JAD; Benedet, AL; Chamoun, M; Cuello, AC; Gauthier, S; Hwang, H; Kang, MS; Mathotaarachchi, S; Misic, B; Mohaddes, S; Parent, MJ; Park, AY; Pascoal, TA; Rosa-Neto, P; Shin, M; Soucy, JP; Therriault, J | 1 |
| Chiba, Y; Fujishiro, H; Iseki, E; Kasanuki, K; Sato, K | 1 |
| Barbagallo, G; Castellano, AE; Chiaravalloti, A; Martorana, A; Schillaci, O; Ursini, F | 1 |
| Iaccarino, L; Perani, D; Sala, A | 1 |
| Bakardjian, H; Corsi, MC; De Vico Fallani, F; Diego Sitt, J; Dubois, B; Epelbaum, S; Gagliardi, G; Gaubert, S; Habert, MO; Hermann, B; Houot, M; Naccache, L; Oudiette, D; Raimondo, F | 1 |
| Chen, Z; Han, X; Kuang, L; Xing, J; Xiong, F; Zhao, D | 1 |
| Chen, KL; Cui, M; Dong, Q; Guo, Y; Huang, YY; Li, JQ; Ou, YN; Tan, L; Xu, W; Yu, JT | 1 |
| Diehl-Schmid, J; Förstl, H; Goldhardt, O; Grimmer, T; Kurz, A; Miners, S; Ortner, M; Perneczky, R; Sorg, C; Yakushev, I | 1 |
| Altomare, D; Barkhof, F; Caroli, A; Carter, SF; Choo, ILH; Drzezga, A; Ferrari, C; Frisoni, GB; Galluzzi, S; Grimmer, T; Nordberg, A; Ossenkoppele, R; Prestia, A; Redolfi, A; Scheltens, P; Schöll, M; Teunissen, CE; Van Berckel, B; van der Flier, WM; Wall, A | 1 |
| Alavi, A; Khosravi, M; Newberg, AB; Peter, J; Serruya, M; Shamchi, SP; Werner, TJ; Wintering, NA | 1 |
| Berg, D; Blum, D; Gasser, T; la Fougère, C; Liepelt-Scarfone, I; Reimold, M | 1 |
| Ahmad, S; Arnold, M; Baillie, R; Blach, C; Doraiswamy, PM; Han, X; Kaddurah-Daouk, R; Kastenmüller, G; Kueider-Paisley, A; Louie, G; MahmoudianDehkordi, S; Nho, K; Risacher, SL; Saykin, AJ; Shaw, LM; Trojanowski, JQ; van Duijn, C; Weiner, MW | 1 |
| Al-Tawil, N; Boellaard, R; Borg, J; Eriksdotter, M; Forsberg, A; Gulyás, B; Halldin, C; Hoffmann, A; Lammertsma, AA; Mattsson, P; Nag, S; Schultze-Mosgau, M; Takano, A; Thiele, A; Varrone, A; Zimmermann, T | 1 |
| Barthel, H; Becker, G; Dukart, J; Frisch, S; Horstmann, A; Müller, K; Sabri, O; Schroeter, ML; Villringer, A; Vogt, B | 1 |
| Andrews, RD; Matthews, DC; Mosconi, L | 1 |
| Ikari, Y; Ishii, K; Ito, K; Iwatsubo, T; Kato, T; Makishi, Y; Nishio, T; Senda, M; Takahashi, R | 1 |
| Chen, S; Cheng, B; Kaufer, DI; Shen, D; Zhang, D | 1 |
| Chuang, WL; Hsiao, IT; Hsieh, CJ; Hsu, WC; Huang, CC; Huang, KL; Kung, MP; Kuo, HC; Lin, KJ; Wai, YY; Wey, SP; Yen, TC | 1 |
| Jagust, WJ; Landau, SM; Madison, CM; Oh, H; Rabinovici, GD; Wirth, M | 1 |
| Adaszewski, S; Draganski, B; Dukart, J; Frackowiak, RS; Kherif, F; Mueller, K; Schroeter, ML | 1 |
| Alexopoulos, P; Bujo, H; Drzezga, A; Förster, S; Grimmer, T; Guo, LH; Jiang, M; Kurz, A; Perneczky, R | 1 |
| Beaufils, E; Camus, V; Cottier, JP; Gissot, V; Guilloteau, D; Hommet, C; Mondon, K; Ribeiro, MJ; Tauber, C; Vercouillie, J; Vierron, E | 1 |
| Duffy, JR; Gunter, JL; Jack, CR; Josephs, KA; Lowe, VJ; Machulda, MM; Madhavan, A; Petersen, RC; Senjem, ML; Strand, EA; Tosakulwong, N; Weigand, SD; Whitwell, JL | 1 |
| Chew, J; Silverman, DH | 1 |
| Jack, CR; Jordan, L; Knopman, D; Lowe, VJ; Montoya Quintero, C; Peller, PJ; Petersen, RC; Senjem, ML; Tosakulwong, N; Vemuri, P; Weigand, SD | 1 |
| Christen, E; Davies, P; Goldberg, TE; Greenwald, BS; Koppel, J; Sunday, S | 1 |
| Jhoo, JH; Kim, JW; Kim, SG; Lee, DY; Park, SY; Seo, EH; Shon, JM; Sohn, BK; Woo, JI | 1 |
| Arbizu, J; García-Granero, M; Gómez-Isla, MT; Lamet, I; Martí-Climent, JM; Martínez-Lage, P; Pastor, P; Peñuelas, I; Prieto, E; Richter, JA; Riverol, M; Weiner, MW | 1 |
| Aeinehband, S; Almkvist, O; Darreh-Shori, T; Ekdahl, KN; Långström, B; Lindblom, RP; Nilsson, B; Nordberg, A; Piehl, F; Vijayaraghavan, S | 1 |
| Hatashita, S; Yamasaki, H | 1 |
| Cappa, SF; Florea, I; Garibotto, V; Marcone, A; Moresco, R; Panzacchi, A; Perani, D; Rinne, J; Tettamanti, M; Virta, JR | 1 |
| Huo, YR; Ji, Y; Liu, M; Liu, S; Shi, Z; Wang, J; Wisniewski, T | 1 |
| Martínez-Montes, E; Melie-Garcia, L; Sanabria-Diaz, G | 1 |
| Buus, S; Hansen, LB; Schafer-Nielsen, C | 1 |
| Barkhof, F; Black, SE; Bocchetta, M; Brooks, DJ; Carrillo, MC; Chételat, G; de Leon, MJ; Decarli, C; Fox, NC; Frisoni, GB; Herholz, K; Jack, CR; Jagust, WJ; Johnson, KA; Kaye, J; Nordberg, A; Pasqualetti, P; Rabinovici, GD; Reiman, EM; Rowe, CC; Scheltens, P; Sperling, RA; Thies, W; Wahlund, LO; Weiner, MW | 1 |
| Arai, H; Asada, T; Ikari, Y; Ishii, K; Ito, K; Iwatsubo, T; Kato, T; Nishio, T; Senda, M; Silverman, DH; Sugishita, M; Yamane, T | 1 |
| Bahri, MA; Bastin, C; Collette, F; d'Argembeau, A; Feyers, D; Jaspar, M; Jedidi, H; Salmon, E | 1 |
| Chen, K; Huang, Q; Li, C; Li, G; Li, X; Lin, Z; Reiman, EM; Wang, T; Xiao, S | 1 |
| Bahri, S; Chien, DT; Elizarov, A; Kolb, HC; Lerner, AJ; Mu, F; Shankle, WR; Su, MY; Szardenings, AK; Walsh, JC; Xia, C | 1 |
| Case, M; Hake, A; Hochstetler, H; Schuh, K; Sun, J; Trzepacz, PT; Witte, MM; Yu, P | 1 |
| Coppola, G; Ghosh, PM; Huang, Y; Jagust, WJ; Karydas, A; Lehmann, M; Madison, C; Miller, BL; O'Neil, JP; Rabinovici, GD | 1 |
| Frings, L; Hüll, M; Meyer, PT; Spehl, TS; Weber, WA | 1 |
| Cabral, C; Silveira, M | 1 |
| Gregg, BE; Gunter, JL; Jack, CR; Jones, DT; Knopman, DS; Lowe, V; Mielke, MM; Pankratz, VS; Petersen, RC; Senjem, ML; Vemuri, P; Weigand, SD; Wiste, HJ | 1 |
| Adamczuk, K; Van Laere, K; Vandenberghe, R | 1 |
| Kung, HF; Ploessl, K; Zhu, L | 1 |
| Haase, CM; Jagust, WJ; Landau, SM; Madison, CM; Oh, H; Rabinovici, GD; Villeneuve, S; Wirth, M | 1 |
| Aisen, PS; Aldea, P; Ances, BM; Bateman, RJ; Benzinger, TL; Blazey, T; Brickman, A; Buckles, VD; Cairns, NJ; Cash, DM; Christensen, JJ; Correia, S; Ercole, L; Fagan, AM; Farrar, AM; Fox, NC; Ghetti, B; Goate, A; Holtzman, DM; Hornbeck, RC; Jack, CR; Jasielec, MS; Johnson, KA; Klunk, W; Koeppe, RA; Marcus, DS; Martins, R; Masters, CL; Mathis, CA; Mayeux, R; McDade, E; Morris, JC; Moulder, K; Ourselin, S; Owen, CJ; Raichle, ME; Ringman, J; Rossor, MN; Rowe, C; Salloway, S; Saykin, AJ; Schofield, PR; Snyder, AZ; Sperling, RA; Su, Y; Thompson, PM; Villemagne, VL; Weiner, MW; Xie, X; Xiong, C | 1 |
| Assal, F; Baskin, A; Garibotto, V; Giannakopoulos, P; Perani, D; Ratib, O; Seimbille, Y | 1 |
| Bartenstein, P; Brendel, M; Ewers, M; Rizk-Jackson, A; Rominger, A; Schuff, N; Weiner, MW | 1 |
| Arnaldi, D; Baglioni, M; Bastiani, P; Bossert, I; Brugnolo, A; Cecchetti, R; Dottorini, ME; Ferrara, M; Fiorucci, G; Mecocci, P; Morbelli, S; Nobili, F; Picco, A; Polidori, MC | 1 |
| Baranwal, A; Mukherjee, J; Patel, HH | 1 |
| Boxer, AL; Gesierich, B; Ghosh, PM; Gorno-Tempini, M; Grinberg, LT; Hagen, J; Henry, M; Huang, EJ; Jagust, WJ; Janabi, M; Kramer, JH; Miller, BL; O'Neil, JP; Rabinovici, GD; Rosen, HJ; Sánchez-Juan, P; Seeley, WW; Trojanowski, JQ; Vinters, HV | 1 |
| Duong, TQ; Yu, F; Zhou, Y | 1 |
| Arai, A; Arai, H; Furukawa, K; Furumoto, S; Iwata, R; Kaneta, T; Kudo, Y; Okamura, N; Takahashi, S; Takanami, K; Tashiro, M; Yanai, K | 1 |
| Byun, MS; Choe, YM; Lee, DY; Seo, EH; Sohn, BK; Woo, JI; Yi, D | 1 |
| D'Souza, MM; Damle, N; Jaimini, A; Kushwaha, S; Mondal, A; Saw, S; Sharma, R; Tripathi, M | 1 |
| Anton-Rodriguez, JM; Burns, A; Carter, SF; Embleton, KV; Herholz, K; Ralph, MA | 1 |
| Arnold, SE; Chen, K; Da, X; Davatzikos, C; Jack, C; Jagust, W; Reiman, EM; Shaw, LM; Toledo, JB; Trojanowski, JQ; Weiner, MW; Wolk, DA | 1 |
| Alexopoulos, P; Auer, F; Diehl-Schmid, J; Drzezga, A; Förster, S; Förstl, H; Grimmer, T; Kurz, A; Ortner, M; Perneczky, R; Sorg, C; Yousefi, BH | 1 |
| Conejero-Goldberg, C; Davies, P; Goldberg, TE; Gomar, JJ | 1 |
| Adriaanse, SM; Barkhof, F; Boellaard, R; Lammertsma, AA; Ossenkoppele, R; Reuter, M; Scheltens, P; Tolboom, N; van Berckel, BN; van der Flier, WM; van Dijk, KR; Windhorst, AD; Yaqub, M; Zwan, MD | 1 |
| Boeve, BF; Cha, RH; Geda, YE; Jack, CR; Kantarci, K; Knopman, DS; Lowe, VJ; Mielke, MM; Pankratz, VS; Petersen, RC; Roberts, RO | 1 |
| Arima, K; Imabayashi, E; Ito, K; Matsuda, H; Nakata, Y; Omachi, Y; Sato, N; Shimano, Y | 1 |
| Boeve, BF; Gunter, JL; Jack, CR; Kantarci, K; Knopman, DS; Lowe, VJ; Lundt, ES; Mielke, MM; Petersen, RC; Roberts, RO; Senjem, ML; Vemuri, P; Weigand, SD; Wiste, HJ | 1 |
| Antenora, A; Fabrizi, GM; Ferrarini, M; Filla, A; Padovani, A; Pappatà, S; Peluso, S; Russo, CV; Testi, S | 1 |
| Jagust, W | 1 |
| Bartsch, C; Bauer, A; Bührle, CP; Freund, HJ; Gruendler, T; Hardenacke, K; Häussermann, P; Hellmich, M; Klosterkötter, J; Kuhn, J; Lenartz, D; Maarouf, M; Mai, JK; Maintz, D; Matusch, A; Noreik, M; Schulz, RJ; Sturm, V; Ullsperger, M; Wiltfang, J; Woopen, C; Zilles, K | 1 |
| Bowen, CV; Brown, RE; Burrell, S; Darvesh, S; DeBay, DR; Jollymore, CT; Macdonald, IR; Martin, E; Mawko, G; O'Leary, TP; Reid, GA | 1 |
| Ewers, M; Grothe, MJ; Kljajevic, V; Teipel, S | 1 |
| Ghosh, P; Jagust, WJ; Laforce, R; Lehmann, M; Madison, CM; Miller, BL; Rabinovici, GD; Tosun, D; Weiner, MW | 1 |
| Cohen, AD; Klunk, WE | 1 |
| Arai, H; Chiba, Y; Fujishiro, H; Hirayasu, Y; Iseki, E; Kasanuki, K; Ota, K; Sato, K | 1 |
| Alexopoulos, P; Drzezga, A; Fellgiebel, A; Förster, S; Gray, K; Grimmer, T; Haller, B; Klupp, E; Kriett, L; Kurz, A; Laskaris, N; Perneczky, R; Yakushev, I | 1 |
| Drzezga, A; Förster, S; Grimmer, T; Klupp, E; Sorg, C; Tahmasian, M; Yakushev, I; Yousefi, BH | 2 |
| Becker, JA; Johnson, KA; Locascio, JJ; Lorius, N; Marshall, GA; Pepin, LC; Philiossaint, M; Rentz, DM; Roy, K; Sperling, RA | 1 |
| Ishibashi, K; Ishii, K; Ishiwata, K; Miura, Y; Oda, K | 1 |
| Perani, D | 1 |
| Andrews, RD; Capuano, AW; Colca, JR; Fleischman, DA; Matthews, DC; Shah, RC; VanderLugt, JT | 1 |
| Boutoleau-Bretonnière, C; Camus, V; Delrieu, J; Desmidt, T; Lebouvier, T; Mullin, E; Payoux, P; Sourdet, S; Vellas, B | 1 |
| Butler, T; Davies, M; de Leon, MJ; Glodzik, L; Li, Y; Marmar, CR; McHugh, P; Mosconi, L; Murray, J; Osorio, RS; Pirraglia, E; Spector, N; Tsui, WH; Vallabhajosula, S; Williams, S | 1 |
| Albin, RL; Dodge, HH; Harvey, D; Kaye, JA; Koeppe, RA; Saito, N; Silbert, LC; Zhu, J | 1 |
| Becker, G; Billard, T; Newman-Tancredi, A; Streichenberger, N; Zimmer, L | 1 |
| Fan, Y; Fu, L; Liu, L; Tian, J; Xu, B; Zhang, J | 1 |
| Bocti, C; Castellano, CA; Cunnane, SC; Fulop, T; Imbeault, H; Lacombe, G; Nugent, S; Paquet, N; Tremblay, S; Turcotte, É | 1 |
| Bertens, D; Knol, DL; Scheltens, P; Visser, PJ | 1 |
| Aguera, E; Bernabei, R; Bocchetta, M; Bullock, R; Ceccaldi, M; Dartigues, JF; de Mendonça, A; Didic, M; Eriksdotter, M; Félician, O; Frisoni, GB; Frölich, L; Galluzzi, S; Gertz, HJ; Hallikainen, M; Hasselbalch, SG; Hausner, L; Heuser, I; Jessen, F; Jones, RW; Kehoe, PG; Kurz, A; Lawlor, B; Lleo, A; Martinez-Lage, P; Mecocci, P; Mehrabian, S; Monsch, A; Nobili, F; Nordberg, A; Orgogozo, JM; Pasquier, F; Peters, O; Rikkert, MO; Salmon, E; Sánchez-Castellano, C; Santana, I; Sarazin, M; Traykov, L; Tsolaki, M; Visser, PJ; Wallin, ÅK; Wilcock, G; Wilkinson, D; Wolf, H; Yener, G; Zekry, D | 1 |
| Bahri, MA; Bastin, C; Collette, F; Diana, RA; Genon, S; Guillaume, B; Lemaire, C; Miévis, F; Salmon, E; Simon, J; Yonelinas, AP | 1 |
| de Vries, JJ; Dierckx, RA; Izaks, GJ; Leenders, KL; Renken, RJ; Roerdink, JB; Segbers, M; Strijkert, F; Teune, LK | 1 |
| Ahmed, I; Aman, Y; Brooks, DJ; Chetelat, G; Edison, P; Fan, Z; Landeau, B; Ray Chaudhuri, K | 1 |
| Jones, G; Rowe, CC; Varos, TA; Villemagne, VL; Woodward, MC | 1 |
| Hosokawa, C; Hosono, M; Hyodo, T; Ishii, K; Murakami, T; Sakaguchi, K; Shimamoto, K; Usami, K; Yamazoe, Y | 1 |
| Cheng, B; Jie, B; Shen, D; Zhang, D | 1 |
| Baxter, LC; Caselli, RJ; Chen, K; Gutman, B; Reiman, EM; Reschke, C; Shi, J; Stonnington, CM; Thompson, PM; Wang, Y | 1 |
| Bedell, BJ; Carbonell, F; Charil, A; Evans, AC; Zijdenbos, AP | 1 |
| Asthana, S; Bendlin, BB; Carlsson, CM; Christian, BT; Cook, D; Dowling, NM; Edwards, D; Gallagher, CL; Hermann, BP; Johnson, SC; Koscik, R; Larson, J; LaRue, A; Oh, JM; Okonkwo, OC; Rowley, HA; Sager, MA; Schultz, SA | 1 |
| Chung, MK; Kang, H; Lee, DS; Lee, H | 1 |
| Aarsland, D; Auning, E; Bjørnerud, A; Fladby, T; Grambaite, R; Haram, A; Hessen, E; Hol, PK; Løvli Stav, A; Muftuler løndalen, A; Šaltytė Benth, J; Selnes, P | 1 |
| Arnaldi, D; Bossert, I; Bottoni, G; Brugnolo, A; Buschiazzo, A; De Carli, F; Didic, M; Drzezga, A; Frisoni, GB; Galluzzi, S; Guedj, E; Morbelli, S; Nobili, F; Ossenkoppele, R; Pagani, M; Perneczky, R; Picco, A; Sambuceti, G; van Berckel, BN | 1 |
| Han, B; He, W; Li, G; Liu, D; Radua, J; Sun, Z | 1 |
| Herholz, K | 6 |
| DeCrumpe, A; Goswami, D; Herrmann, S; Morales, J; Osborne, J; Patel, P; Sarad, N; Schaffer, C | 1 |
| Benzinger, TL; Devous, MD; Jagust, WJ; Johnson, KA; Klunk, WE; Koeppe, RA; Mathis, CA; Minhas, D; Mintun, MA; Pontecorvo, MJ; Price, JC; Rowe, CC; Skovronsky, DM | 1 |
| Dowling, NM; Gleason, CE; Jagust, WJ; Johnson, SC | 1 |
| Bamford, C; Barnett, N; Davison, C; Donaldson, C; Firbank, MJ; Herholz, K; Lloyd, J; O'Brien, JT; Olsen, K; Williams, D | 1 |
| Buchpiguel, CA; Hespanhol, R; Leite, J | 1 |
| Almkvist, O; Kadir, A; Nordberg, A | 1 |
| Blennow, K; Donohue, M; Insel, PS; Jagust, WJ; Landau, S; Mattsson, N; Shaw, LM; Trojanowski, JQ; Weiner, MW; Zetterberg, H | 1 |
| Bailly, M; Camus, V; Gissot, V; Guilloteau, D; Hommet, C; Ribeiro, MJ; Vercouillie, J | 1 |
| Adjouadi, M; Barker, W; Cabrerizo, M; Duara, R; Goryawala, M; Loewenstein, D; Zhou, Q | 1 |
| Rodrigues, F; Silveira, M | 1 |
| Fujiwara, Y; Ishibashi, K; Ishii, K; Ishiwata, K; Onishi, A | 2 |
| Arahata, Y; Fujiwara, K; Fukuyama, H; Ikeda, M; Ishii, K; Ito, K; Kato, T; Maeda, K; Meguro, K; Mitsuyama, Y; Okumura, A; Ouchi, Y; Senda, M; Washimi, Y; Yamamoto, Y | 1 |
| Arnaldi, D; Brugnolo, A; Buschiazzo, A; Chincarini, A; De Carli, F; Didic, M; Drzezga, A; Ferrara, M; Frisoni, GB; Galluzzi, S; Guedj, E; Morbelli, S; Nobili, F; Öberg, J; Ossenkoppele, R; Pagani, M; Perneczky, R; Picco, A; Sambuceti, G; van Berckel, BN | 1 |
| Hyde, C; Martin, S; Sachpekidis, C; Smailagic, N; Ukoumunne, O; Vacante, M | 1 |
| Kang, H; Kim, E; Kim, H; Kim, YK; Lee, D; Lee, DS; Lee, H; Lee, Y | 1 |
| Chiaravalloti, A; di Biagio, D; di Pietro, B; Koch, G; Martorana, A; Schillaci, O; Toniolo, S | 1 |
| Barkhof, F; Caroli, A; Carter, SF; Choo, IH; Frisoni, GB; Nordberg, A; Ossenkoppele, R; Prestia, A; Scheltens, P; Schöll, M; Teunissen, CE; Van Berckel, B; van der Flier, WM; Wade, SK; Wall, A | 1 |
| Baker, MC; Duffy, JR; Jack, CR; Josephs, KA; Lowe, VJ; Machulda, MM; Perkerson, RB; Rademakers, R; Reid, R; Schwarz, CG; Senjem, ML; Strand, EA; Whitwell, JL | 1 |
| Amariglio, RE; Dagley, AS; Donovan, NJ; Hsu, DC; Johnson, KA; Marshall, GA; Mormino, EC; Okereke, OI; Rentz, DM; Schultz, AP; Sperling, RA | 1 |
| Baek, H; Byun, MS; Choe, YM; Choi, HJ; Han, JY; Lee, DY; Lee, JH; Sohn, BK; Woo, JI; Yi, D | 1 |
| Unschuld, PG | 1 |
| Fujishiro, H; Fukase, Y; Iseki, E; Kasanuki, K; Kondo, D; Murayama, N; Ota, K; Sato, K; Tagaya, H | 1 |
| Bandy, D; Belden, C; Chen, K; Fleisher, AS; Jacobson, S; Liebsack, C; Liu, X; Luo, J; Malek-Ahmadi, M; Powell, J; Protas, H; Reiman, EM; Rogers, J; Roontiva, A; Sabbagh, MN; Thiyyagura, P | 1 |
| Diehl-Schmid, J; Drzezga, A; Förster, S; Grimmer, T; Meng, C; Mulej Bratec, S; Pasquini, L; Riedl, V; Scherr, M; Schwaiger, M; Shi, K; Sorg, C; Tahmasian, M; Yakushev, I | 1 |
| Kim, J; Lee, JM; Park, H; Seo, J; Son, SJ | 1 |
| Adriaanse, SM; Barkhof, F; Benedictus, MR; Binnewijzend, MA; Boellaard, R; Kuijer, JP; Lammertsma, AA; Ossenkoppele, R; Pijnenburg, YA; Scheltens, P; van Berckel, BN; van der Flier, WM; Verfaillie, SC; Wattjes, MP | 1 |
| Bernard, R; Ceccaldi, M; Didic, M; Felician, O; Gour, N; Guedj, E; Mundler, O; Pécheux, C | 1 |
| Drzezga, A; Förster, S; Kramer, S; Kurz, A; Li, R; Perneczky, R; Yakushev, I | 1 |
| Cabrera-Martín, MN; Carreras, JL; Fernádez-Matarrubia, M; Matias-Guiu, J; Matias-Guiu, JA; Moreno-Ramos, T; Porta-Etessam, J; Valles-Salgado, M | 1 |
| Koeppe, R; Nan, B; Shu, H | 1 |
| Barber, R; Barnett, N; Colloby, SJ; Davison, C; Donaldson, C; Firbank, MJ; Herholz, K; Lloyd, J; O'Brien, JT; Olsen, K; Williams, D | 1 |
| Ishibashi, K; Ishii, K; Ishiwata, K; Kawasaki, K | 1 |
| Kwak, K; Lee, JM; Yun, HJ | 1 |
| Akanuma, K; Ishii, H; Meguro, K; Meguro, M; Tashiro, M; Yamaguchi, S | 1 |
| Antoni, G; Eriksson, JP; Ghetti, B; Gillberg, PG; Lemoine, L; Marutle, A; Nennesmo, I; Nordberg, A; Okamura, N; Saint-Aubert, L | 1 |
| Bottelbergs, A; Kelley, J; Langlois, X; Richardson, J; Schmidt, M; Staelens, S; Stroobants, S; Verhaeghe, J; Waldron, AM; Wyffels, L | 1 |
| Beer, AJ; Riepe, MW; Vonend, C; Walther, B | 1 |
| Van Laere, K; Vandenberghe, R; Verjans, S | 1 |
| Chen, K; Foster, NL; Jagust, WJ; Koeppe, RA; Landau, SM; Mathis, CA; Price, JC; Reiman, EM; Wang, AY | 1 |
| Grothe, MJ; Krause, B; Kurth, J; Teipel, SJ | 1 |
| Buckley, C; Heurling, K; Lubberink, M; Van Laere, K; Vandenberghe, R | 1 |
| Asthana, S; Bendlin, BB; Birdsill, AC; Christian, BT; Hermann, BP; Johnson, SC; Jonaitis, EM; Koscik, RL; La Rue, A; Okonkwo, OC; Sager, MA; Starks, EJ; Willette, AA | 1 |
| Chen, JT; Chen, TY; Ho, FM; Huang, YC; Hung, GU; Kao, CH; Wu, ST; Yen, PS | 1 |
| Zhang, J | 1 |
| Ballard, KJ; Burrell, JR; Hodges, JR; Leyton, CE; Piguet, O; Rowe, CC; Shimada, H; Taswell, C; Villemagne, VL; Yates, P | 1 |
| Mason, VL | 1 |
| Chen, XC; Dai, XM; Wei, Z; Wu, XL; Xiao, NA; Zhang, J; Zhou, M; Zhu, YG | 1 |
| Cai, L; Gao, S; Han, T; Ji, Y; Liu, S; Lu, H; Shi, Z; Wang, X; Wang, XD; Wang, Y; Zhou, Y | 1 |
| Fero, A; Jagust, WJ; Landau, SM; Schreiber, F; Schreiber, S | 1 |
| Bormann, T; Buchert, R; Frings, L; Heimbach, B; Hellwig, S; Klöppel, S; Meyer, PT; Minkova, L; Spehl, TS; Vach, W | 1 |
| Buchholz, HG; Gartenschläger, M; Reuss, S; Schreckenberger, M; Thiele, F; Wenzel, F; Young, S | 1 |
| Fellgiebel, A; Fischer, FU; Scheurich, A; Wolf, D | 1 |
| Barthel, H; Hoffmann, KT; Marschhauser, A; Obrig, H; Sabri, O; Schroeter, ML; Thöne-Otto, A; Tiepolt, S | 1 |
| Coppola, G; Geschwind, DH; Ghosh, PM; Khazenzon, AM; Lee, SE; Miller, BL; Pribadi, M; Rabinovici, GD; Rankin, KP; Sha, SJ | 1 |
| Jie, B; Shen, D; Ye, T; Zhang, D; Zu, C | 1 |
| Fukuyama, H; Ito, K; Oishi, N; Ota, K | 2 |
| Beaunieux, H; Chételat, G; Desgranges, B; Eustache, F; La Joie, R; Pitel, AL; Ritz, L; Segobin, S | 1 |
| Caminiti, SP; Cappa, SF; Cerami, C; Comi, G; Coppi, E; Falini, A; Ferrari, L; Gianolli, L; Iannaccone, S; Magnani, G; Passerini, G; Perani, D; Pinto, P; Santangelo, R | 1 |
| Alexander, DC; Ourselin, S; Oxtoby, NP; Schott, JM; Young, AL | 1 |
| Ahlgren, A; Danfors, T; Fällmar, D; Kilander, L; Larsson, EM; Lilja, J; Lubberink, M; van Osch, MJ; Velickaite, V | 1 |
| Boecker, H; Drzezga, AE; Götz, J; Granert, O; Häussermann, P; Kurz, A; Perneczky, R; van Eimeren, T | 1 |
| Barthel, H; Hoffmann, KT; Patt, M; Sabri, O; Schroeter, ML; Tiepolt, S | 1 |
| Hamaguchi, T; Matsunari, I; Noguchi-Shinohara, M; Ono, K; Samuraki, M; Shima, K; Yamada, M; Yoshita, M | 1 |
| Barnes, A; Chan, D; Contarino, VE; D'Incerti, L; Della Rosa, PA; Dickson, JC; Ell, PJ; Fallanca, F; Good, C; Michopoulou, S; Minati, L; Moodley, KK; Pennycook, F; Perani, D; Vanoli, EG | 1 |
| Adriaanse, SM; Barkhof, F; Boellaard, R; Lammertsma, AA; Ossenkoppele, R; Scheltens, P; Tijms, BM; van Berckel, BN; Verfaillie, SC; Wink, AM | 1 |
| Boeve, BF; Gunter, JL; Jack, CR; Jones, DT; Kantarci, K; Knopman, DS; Lowe, VJ; Lundt, ES; Machulda, MM; Mielke, MM; Petersen, RC; Roberts, RO; Senjem, ML; Vemuri, P; Weigand, SD; Wiste, HJ | 1 |
| Grothe, MJ; Teipel, SJ | 1 |
| Benoit, M; Bensamoun, D; Darcourt, J; David, R; Derreumaux, A; Furst, AJ; Guignard, R; Manera, V; Robert, PH | 1 |
| Baek, H; Byun, MS; Choe, YM; Choi, HJ; Han, JY; Kim, HJ; Lee, DY; Lee, JH; Seo, EH; Sohn, BK; Woo, JI; Yi, D | 1 |
| Brooks, DJ; Edison, P; Fan, Z; Okello, AA | 1 |
| Almkvist, O; Carter, SF; Graff, C; Långström, B; Nordberg, A; Rodriguez-Vieitez, E; Schöll, M; Thordardottir, S; Wall, A; Westman, E | 1 |
| Grothe, MJ; Teipel, S | 1 |
| Jagust, W; Schuff, N; Tosun, D; Weiner, MW | 1 |
| Castiglioni, I; Zippo, AG | 1 |
| Castiglioni, I; Della Rosa, PA; Gallivanone, F | 1 |
| Górriz, JM; Phillips, C; Ramírez, J; Segovia, F | 1 |
| Chen, S; Jie, B; Liu, M; Shen, D; Zhang, D; Zu, C | 1 |
| Brenner, W; Buchert, R; Frings, L; Lange, C; Spies, L; Suppa, P | 1 |
| Alexopoulos, P; Drzezga, A; Förster, S; Förstl, H; Goldhardt, O; Grimmer, T; Kurz, A; Ortner, M; Sorg, C; Wutz, C | 1 |
| Diehl-Schmid, J; Drzezga, A; Förster, S; Grimmer, T; Meng, C; Riedl, V; Shao, J; Sorg, C; Tahmasian, M; Yousefi, BH | 1 |
| Bertolino, A; Dukart, J; Sambataro, F | 1 |
| Chen, J; Cui, S; Huang, Y; Lu, Y; Nie, B; Ren, J; Shan, B; Tang, C; Xinsheng, L | 1 |
| Chang, JW; Chang, WS; Cho, ZH; Jeong, DU; Lee, J; Lee, JE; Oh, JH | 1 |
| Aizenstein, HJ; Boudhar, S; Cohen, AD; Klunk, WE; Laymon, CM; Mathis, CA; McDade, E; Mountz, JM; Price, JC; Zhang, Z | 1 |
| Bottelbergs, A; Kelley, JB; Langlois, X; Schmidt, ME; Staelens, S; Stroobants, S; Waldron, AM; Wintmolders, C | 1 |
| Diehl-Schmid, J; Drzezga, A; Grimmer, T; Li, J; Perneczky, R; Shi, K; Titov, D; Yakushev, I; Zou, N | 1 |
| Fujii, H | 1 |
| Bae, H; Chung, HS; Hwang, DS; Kim, JS; Lee, C; Shim, I; Ye, M; Yoon, MS; Yu, AR | 1 |
| Eustache, P; Nemmi, F; Pariente, J; Péran, P; Saint-Aubert, L | 1 |
| Hägerström, D; Hansson, O; Jögi, J; Olsson, T; Rabinovici, GD; Smith, R; Wibom, M | 1 |
| Arai, H; Chiba, Y; Fujishiro, H; Hirayasu, Y; Iseki, E; Kasanuki, K; Ota, K; Sato, K; Suzuki, M | 1 |
| Inui, Y; Ito, K; Kato, T; Nakamura, A | 1 |
| Balédent, O; Bouzerar, R; Chaarani, B; Daouk, J; Meyer, ME; Zmudka, J | 1 |
| Almkvist, O; Carter, SF; Chiotis, K; Långström, B; Leuzy, A; Nordberg, A; Rodriguez-Vieitez, E; Saint-Aubert, L; Schöll, M; Wall, A | 1 |
| Blennow, K; Breteler, MM; de Strooper, B; Frisoni, GB; Salloway, S; Scheltens, P; Van der Flier, WM | 1 |
| Andriuta, D; Devendeville, A; Godefroy, O; Meyer, ME; Moullart, V; Schraen, S | 1 |
| Chen, K; Guo, X; Li, R; Long, Z; Wu, X; Xu, L; Yao, L; Zhang, J | 1 |
| Ayakta, N; Baker, SL; Bettcher, BM; Cantwell, A; Gorno-Tempini, ML; Jagust, WJ; Janabi, M; Kramer, JH; Lazaris, A; Lockhart, SN; Miller, BL; Miller, ZA; O'Neil, JP; Ossenkoppele, R; Rabinovici, GD; Santos, M; Schöll, M; Schonhaut, DR; Vogel, J; Vossel, KA | 1 |
| Kodewitz, A; Lang, E; Lelandais, S; Tome, AM; Vigneron, V | 1 |
| Bartenstein, P; Brendel, M; Därr, S; Delker, A; Förster, S; Kalinowski, E; Levin, J; Pogarell, O; Reinisch, V; Rominger, A | 1 |
| Al-Baddai, S; Górriz, JM; Lang, EW; Neubauer, A; Puntonet, CG; Salas-Gonzalez, D; Tomé, AM; Vigneron, V | 1 |
| Frings, L; Hüll, M; Meyer, PT; Spehl, TS | 1 |
| Beaudry, T; Benedet, AL; Chung, CO; Gauthier, S; Kang, MS; Labbe, A; Mathotaarachchi, S; Mohades, S; Pascoal, TA; Rosa-Neto, P; Shin, M; Soucy, JP; Wang, S | 1 |
| Bartenstein, P; Brendel, M; Därr, S; Delker, A; Högenauer, M; Rominger, A; Weiss, M | 1 |
| Deleye, S; Langlois, X; Richardson, JC; Schmidt, M; Staelens, S; Stroobants, S; Waldron, AM | 1 |
| Atkinson, R; Brooks, DJ; Edison, P; Fan, Z; Femminella, GD; Ninan, S | 1 |
| Cabello, J; Lukas, M; Nekolla, SG; Pyka, T; Ribeiro, A; Rota Kops, E; Shah, NJ; Yakushev, I; Ziegler, SI | 1 |
| Chiotis, K; Leuzy, A; Nordberg, A; Rodriguez-Vieitez, E; Saint-Aubert, L; Wall, A | 1 |
| Cao, H; Chen, X; Gao, R; Han, D; Reid, S; Wang, R; Zhou, Y | 1 |
| Baker, S; Jagust, W; Madison, C; Oh, H; Rabinovici, G | 1 |
| Chiaravalloti, A; Liguori, C; Mercuri, NB; Pierantozzi, M; Sancesario, G; Sancesario, GM; Schillaci, O; Stefani, A | 1 |
| Assal, F; Démonet, JF; Frisoni, GB; Garibotto, V; Giannakopoulos, P; Gold, G; Trombella, S; Zekry, D | 1 |
| Calsolaro, V; Edison, P | 1 |
| Chu, LW; Ha, J; Lee, SC; Shea, YF | 1 |
| Brill, AB; Campbell, D; Gwirtsman, HE; Shokouhi, S | 1 |
| For The Alzheimer S Disease Neuroimaging Initiative, EY; Ishii, K; Takahashi, R; Yokoyama, K | 1 |
| Banzo, I; Bravo-Ferrer, Z; Carril, JM; De Arcocha-Torres, M; Jiménez-Bonilla, JF; Lavado-Pérez, C; Martínez-Rodríguez, I; Quirce, R; Rodríguez-Rodríguez, E; Sánchez-Juan, P | 1 |
| De Deyn, PP; Dierckx, RA; Sanchez, MA; Sanchez-Catasus, CA; Stormezand, GN; van Laar, PJ | 1 |
| Kornhuber, J; Lewczuk, P | 1 |
| Hansson, O; Mattsson, N; Palmqvist, S | 1 |
| Ayakta, N; Ballarini, T; Gorno-Tempini, ML; Iaccarino, L; Jagust, WJ; Magnani, G; Miller, BL; Perani, D; Rabinovici, GD | 1 |
| Boeve, BF; Gunter, JL; Jack, CR; Jones, DT; Kantarci, K; Knopman, DS; Lowe, VJ; Machulda, MM; Mielke, MM; Petersen, RC; Roberts, RO; Senjem, ML; Vemuri, P; Weigand, SD; Wiste, HJ | 1 |
| Arnaldi, D; Bauckneht, M; Brugnolo, A; Buschiazzo, A; Chincarini, A; Giuliani, A; Morbelli, S; Nobili, F; Öberg, J; Pagani, M; Picco, A; Sambuceti, G | 1 |
| Aldea, P; Ances, BM; Benzinger, TL; Cairns, NJ; Christensen, J; Fagan, AM; Friedrichsen, K; McConathy, J; Morris, JC; Su, Y; Wang, L | 1 |
| Brendel, M; Danek, A; Huber, M; Huppertz, HJ; Levin, J; Okamura, N; Rominger, A; Schönecker, S; Teipel, S; Vollmar, C | 1 |
| Belli, L; Chiaravalloti, A; Di Pietro, B; Fiorentini, A; Francesco, U; Koch, G; Martorana, A; Motta, C; Schillaci, O; Toniolo, S | 1 |
| Ahmed, S; Brindle, N; Chowdhury, FU; Jamieson, S; Motara, H; Olusoga, T; Patel, CN; Pillai, A; Russell, G; Scarsbrook, AF | 1 |
| Arai, H; Chiba, Y; Fujishiro, H; Hirayasu, Y; Iseki, E; Kasanuki, K; Kondo, D; Murayama, N; Ota, K; Sato, K | 1 |
| Andreasson, U; Baker, D; Blennow, K; Hanlon, D; Hansson, O; Insel, PS; Janelidze, S; Jeromin, A; Mattsson, N; Palmqvist, S; Shaw, LM; Song, L; Stomrud, E; Tan Hehir, CA; Trojanowski, JQ; Weiner, MW; Zetterberg, H | 1 |
| Gunter, JL; Jack, CR; Jones, DT; Kantarci, K; Knopman, DS; Lowe, VJ; Machulda, MM; Mielke, MM; Petersen, RC; Reyes, DA; Roberts, RO; Senjem, ML; Therneau, TM; Vemuri, P; Weigand, SD; Wiste, HJ | 1 |
| Biegon, A; Landau, S; Lipton, RB; Maki, PM; Rubin, LH; Sundermann, EE | 1 |
| Brandt, V; Dhawan, V; Eidelberg, D; Gordon, ML; Mattis, PJ; Nazem, A; Niethammer, M; Sako, W; Tang, CC | 1 |
| Bao, XJ; Lei, JF; Li, XY; Men, WW; Wang, RZ; Wang, ZJ; Zhu, H; Zhu, ZH; Zuo, FX | 1 |
| Bischof, GN; Dronse, J; Drzezga, A; Faber, J; Fink, GR; Fliessbach, K; Hammes, J; Jessen, F; Klockgether, T; Kuhnert, G; Kukolja, J; Neumaier, B; Onur, OA; van Eimeren, T; von Reutern, B | 1 |
| Harwood, D; Leskin, LP; Mandelkern, M; Melrose, RJ; Riskin-Jones, H; Staffaroni, AM; Sultzer, DL | 1 |
| Langlois, X; Richardson, JC; Schmidt, M; Staelens, S; Stroobants, S; Verhaeghe, J; Waldron, AM; Wyffels, L | 1 |
| McLimans, KE; Willette, AA | 1 |
| Baldinelli, S; Cafazzo, V; Fabi, K; Fringuelli, F; Gainotti, G; Luzzi, S; Provinciali, L; Ranaldi, V; Reverberi, C; Silvestrini, M | 1 |
| Cho, SG; Choi, KH; Choi, SM; Kang, SR; Kim, BC; Kim, J; Kwon, SY; Song, HC; Song, M | 1 |
| DeGrado, TR; Fletcher, JG; Gunderson, TM; Jiang, H; Johnson, GB; Kemp, BJ; Knopman, DS; Linscheid, LR; Lowe, VJ; McConnell, DM; Pandey, MK; Petersen, RC; Woodwick, AR | 1 |
| Ballarini, T; Bettinardi, V; Caminiti, SP; Gianolli, L; Perani, D; Presotto, L | 1 |
| Aigbirhio, FI; Allinson, KS; Arnold, R; Bevan-Jones, WR; Borchert, RJ; Cope, TE; Fryer, TD; Hong, YT; Jones, PS; Mak, E; O'Brien, JT; Passamonti, L; Rowe, JB; Sami, S; Su, L; Surendranathan, A; Vázquez Rodríguez, P; Williamson, D | 1 |
| Eliassen, CF; Fladby, T; Hessen, E; Reinvang, I; Selnes, P | 1 |
| Ayakta, N; Jagust, WJ; La Joie, R; Lockhart, SN; Rabinovici, GD; Winer, JR | 1 |
| Dichgans, M; Duering, M; Ewers, M; Franzmeier, N; Weiner, M | 1 |
| Harwood, D; Mandelkern, MA; Melrose, RJ; Narvaez, TA; Sultzer, DL; Weissberger, GH | 1 |
| Cai, W; Feng, DD; Fulham, M; Lu, S; Xia, Y | 1 |
| Cabrera-Martín, MN; Carreras, JL; Matías-Guiu, J; Matías-Guiu, JA; Moreno-Ramos, T; Pérez-Pérez, A; Rognoni, T; Valles-Salgado, M | 1 |
| Cabrera-Martín, MN; Carreras, JL; Fernández-Matarrubia, M; Matías-Guiu, J; Matías-Guiu, JA; Moreno-Ramos, T; Valles-Salgado, M | 1 |
| Miyazawa, N | 1 |
| Bark, JS; Betensky, RA; Chhatwal, JP; Cosio, DM; Hanseeuw, BJ; Johnson, KA; LaPoint, M; Mormino, EC; Papp, KV; Rentz, DM; Schultz, AP; Sepulcre, J; Sperling, RA | 1 |
| Alegret, M; Assal, F; Austin, M; Balasa, M; Bastin, C; Bocchetta, M; Bosco, P; Bougea, A; Chincarini, A; Collins, DL; Duchesne, S; Emek-Savaş, DD; Engelborghs, S; Ferrari, C; Frisoni, GB; Galluzzi, S; Grimmer, T; Grosu, G; Kramberger, MG; Lawlor, B; Mandic Stojmenovic, G; Maréchal, B; Marinescu, M; Mecocci, P; Mega, A; Molinuevo, JL; Morais, R; Niemantsverdriet, E; Nobili, F; Ntovas, K; O'Dwyer, S; Paraskevas, GP; Pelini, L; Picco, A; Popovic, KS; Redolfi, A; Roche, A; Salmon, E; Santana, I; Sensi, F; Sotolongo-Grau, O; Spiru, L; Stefanova, E; Tsolaki, M; Wolz, R; Yener, GG; Zekry, D | 1 |
| Alegret, M; Arbizu, J; Becker, JT; Boada, M; Buendía, M; Espinosa, A; Giménez, J; Hendrix, SB; Hernández, I; Ibarria, M; Lafuente, A; Landau, SM; Martínez-Lage, P; Munuera, J; Pesini, P; Pujadas, F; Ruiz, A; Ruiz, S; San José, I; Sarasa, M; Sotolongo-Grau, O; Tárraga, L; Tejero, MA; Valero, S | 1 |
| Accardo, J; Arnaldi, D; Bauckneht, M; Bongioanni, F; Chincarini, A; De Carli, F; Girtler, N; Giuliani, A; Jonsson, C; Morbelli, S; Nobili, F; Öberg, J; Pagani, M; Sambuceti, G | 1 |
| Anton-Rodriguez, J; Gerhard, A; Haense, C; Harris, JM; Herholz, K; Jones, M; Kobylecki, C; Richardson, AMT; Segobin, SH; Snowden, JS; Stopford, CL; Thompson, JC | 1 |
| Baron, JC; Chételat, G; de la Sayette, V; Desgranges, B; Eustache, F; Landeau, B; Mézenge, F; Viader, F; Villain, N | 1 |
| de Leon, MJ; DeSanti, S; Kemppainen, N; Kim, BC; Li, Y; Mosconi, L; Någren, K; Pirraglia, E; Rinne, JO; Rusinek, H; Tsui, W | 1 |
| Berghold, A; Enzinger, C; Fazekas, F; Kolassa, H; Ofner, P; Pendl, B; Ropele, S; Schmidt, H; Schmidt, R; Windisch, M | 1 |
| Fletcher, PT; Foster, NL; Hoffman, JM; Koeppe, RA; Tasdizen, T; Wang, AY | 1 |
| Brugnolo, A; Dessi, B; Girtler, N; Larsson, SA; Morbelli, S; Nobili, F; Pagani, M; Piccardo, A; Rodriguez, G; Salmaso, D | 1 |
| Ishii, K; Kanda, T; Kono, AK; Miyamoto, N; Mori, E; Uemura, T; Yoshikawa, T | 1 |
| Buchert, R | 1 |
| Bartenstein, P; Buchholz, HG; Fellgiebel, A; Hammers, A; Lieb, K; Peters, J; Scheurich, A; Schmidtmann, I; Schreckenberger, M; Yakushev, I | 1 |
| Buerger, K; Drzezga, A; Haense, C; Hampel, H; Heiss, WD; Herholz, K; Kalbe, E; Markiewicz, P; Teipel, SJ | 1 |
| Bruno, G; Lenzi, GL; Talarico, G; Tosto, G | 1 |
| Hertel, A; Kiessling, B; Nikisch, G; Wiedemann, G | 1 |
| Choo, IH; Jhoo, JH; Kim, KW; Kim, SG; Lee, DS; Lee, DY; Lee, JS; Seo, EH; Woo, JI; Youn, JC | 1 |
| Boussion, N; Hammers, A; Kanno, I; Shidahara, M; Suhara, T; Tsoumpas, C; Turkheimer, FE; Visvikis, D | 1 |
| Bartenstein, P; Buchholz, HG; Fellgiebel, A; Gerhard, A; Hammers, A; Landvogt, C; Scheurich, A; Schmidtmann, I; Schreckenberger, M; Yakushev, I | 1 |
| Borroni, B; Cappa, SF; Fazio, F; Garibotto, V; Herholz, K; Holtoff, V; Kalbe, E; Padovani, A; Perani, D; Salmon, E; Sorbi, S | 1 |
| Peskind, ER | 1 |
| Mintun, MA | 1 |
| Aalto, S; Järvenpää, T; Kaprio, J; Karrasch, M; Koskenvuo, M; Räihä, I; Rinne, JO; Viljanen, T; Virta, JJ | 1 |
| Dronkers, NF; Furst, AJ; Gorno-Tempini, ML; Jagust, WJ; Lal, RA; Miller, BL; Mormino, EC; O'Neil, JP; Ogar, JM; Rabinovici, GD; Racine, CA | 1 |
| Gu, ZX; Wei, WS; Yuan, Y | 1 |
| Ishii, H; Ishikawa, H; Meguro, K; Tashiro, M; Yamaguchi, S | 1 |
| Hertel, A; Hofmann, E; Kiessling, B; Krasz, D; Nikisch, G; Wagner, T; Wiedemann, G | 1 |
| de Leon, MJ; De Santi, S; Glodzik, L; Li, Y; Mistur, R; Mosconi, L; Pirraglia, E; Reisberg, B; Switalski, R; Tsui, WH; Wisniewski, T | 1 |
| Eberl, S; Feng, D; Fulham, M; Wen, L; Xia, Y | 1 |
| Apostolova, I; Arlt, S; Brassen, S; Buchert, R; Eichenlaub, M; Jahn, H; Thiele, F; Wenzel, F; Wilke, F; Young, S | 1 |
| Ono, M | 1 |
| Drzezga, A; Förstl, H; Grimmer, T; Henriksen, G; Klunk, WE; Kurz, A; Mathis, CA; Riemenschneider, M; Shiga, T; Wester, HJ | 1 |
| Barrio, JR; Huang, SC; Kepe, V; Petric, A; Satyamurthy, N; Small, GW | 1 |
| Campa, OM; Harwood, DG; Mandelkern, MA; Melrose, RJ; Osato, S; Sultzer, DL | 1 |
| Alexander, GE; Bandy, D; Chen, K; Fleisher, AS; Foster, NL; Jagust, WJ; Koeppe, RA; Langbaum, JB; Lee, W; Reiman, EM; Reschke, C; Weiner, MW | 1 |
| Declerck, J; Herholz, K; Markiewicz, PJ; Matthews, JC | 3 |
| Cross, DJ; Galasko, D; Minoshima, S; Peskind, ER; Petrie, EC; Raskind, MA; Schellenberg, GD | 1 |
| Drzezga, A; Förstl, H; Kurz, A; Perneczky, R; Riemenschneider, M; Vukovich, R | 1 |
| Boeve, B; Jack, CR; Kemp, BJ; Knopman, D; Lowe, VJ; Mullan, B; Petersen, RC; Senjem, M; Shiung, M; Smith, G; Weigand, S | 1 |
| Fessler, JA; Joshi, A; Koeppe, RA | 1 |
| Baron, JC; Chételat, G; de la Sayette, V; Desgranges, B; Duchesnay, E; Eustache, F; Fouquet, M; Landeau, B; Mézenge, F; Viader, F | 1 |
| Chung, MK; Hinrichs, C; Johnson, SC; Mukherjee, L; Singh, V; Xu, G | 1 |
| Finelli, PF | 1 |
| Attems, J; Booij, J; Bruecke, T; Dimou, E; Dudczak, R; Knoll, P; Kuntner, C; Langer, O; Mirzaei, S; Mostbeck, G; Prosch, H; Rodrigues, M; Zajicek, B | 1 |
| Futatsubashi, M; Nakamura, K; Ouchi, Y; Ueki, T; Yagi, S; Yoshikawa, E | 1 |
| Akanuma, K; Ishii, H; Meguro, K; Meguro, M; Yamaguchi, S | 1 |
| Foster, NL; Harvey, D; Jagust, WJ; Koeppe, RA; Landau, SM; Madison, CM; Reiman, EM; Weiner, MW | 1 |
| Landhuis, E | 1 |
| Barrio, JR; Bresjanac, M; Epperson, F; Farlow, MR; Ghetti, B; Huang, SC; Kepe, V; Liu, J; Miller, K; Murrell, JR; Petric, A; Piccardo, P; Repovs, G; Satyamurthy, N; Siddarth, P; Small, GW; Smid, LM; Wong, KP | 1 |
| Best, R; Bradshaw, J; Hopwood, M; Jones, G; Katsifis, A; Lim, SM; Merory, J; Rowe, CC; Saling, M; Villemagne, VL; Woodward, M | 1 |
| Ito, K; Kato, T | 1 |
| Barthel, H; Becker, G; Dukart, J; Frisch, S; Horstmann, A; Möller, HE; Mueller, K; Sabri, O; Schroeter, ML; Villringer, A; Vogt, B | 1 |
| Haense, C; Heiss, WD; Herholz, K; Jagust, WJ | 1 |
| Chang, KW; Chen, CC; Lee, SY; Wang, HE | 1 |
| Foster, NL; Jagust, WJ; Koeppe, RA; Landau, SM; Mathis, CA; Petersen, RC; Price, JC; Reiman, EM; Shaw, LM; Trojanowski, JQ; Weiner, MW | 1 |
| Baron, JC; Chételat, G; Desgranges, B; Eustache, F; Villain, N | 1 |
| Bartenstein, P; Bürger, K; Cumming, P; Förster, S; Fougere, Cl; Hampel, H; Haslbeck, M; Rominger, A; Teipel, S; Yakushev, I; Zach, C | 1 |
| Huber, R; Kirchheiner, J; Lebedeva, E; Ludolph, AC; Mottaghy, FM; Ozer, E; Tumani, H; Uttner, I; von Arnim, CA | 1 |
| Arai, H; Furukawa, K; Furumoto, S; Iwata, R; Kudo, Y; Okamura, N; Tashiro, M; Waragai, M; Yanai, K | 1 |
| Apostolova, I; Arlt, S; Buchert, R; Jahn, H; Thiele, F; Wenzel, F; Wilke, F; Young, S | 1 |
| Campa, OM; Harwood, DG; Mandelkern, MA; Melrose, RJ; Sultzer, DL; Walston, A; Woo, BK | 1 |
| Brewer, J; Dale, AM; Fennema-Notestine, C; Fjell, AM; Hagler, DJ; Jennings, RG; Karow, D; McEvoy, LK; Walhovd, KB | 1 |
| Bonetti, M; Caroli, A; Cotelli, M; Frisoni, GB; Geroldi, C; Lorenzi, M; Nobili, F; Paghera, B | 1 |
| Chui, HC; Jagust, W; Kuczynski, B; Madison, C; Reed, B; Targan, E; Weiner, M; Zhang, Y | 1 |
| Cao, Q; Jiang, K; Ma, Y; Shan, B; Tian, J; Wang, R; Yuan, X | 1 |
| Abbamondi, N; Anfossi, M; Bernardi, L; Bruni, AC; Bugiani, O; Clodomiro, A; Colao, R; Curcio, SA; Di Lorenzo, R; Foncin, JF; Forloni, G; Frangipane, F; Gallo, M; Geracitano, S; Giaccone, G; Leotta, A; Lio, SG; Maletta, R; Milan, G; Mirabelli, M; Muraca, MG; Nee, L; Pappatà, S; Pinessi, L; Postiglione, A; Puccio, G; Rainero, I; Rogaeva, E; Rubino, E; Smirne, N; Sorbi, S; Spillantini, MG; St George Hyslop, P; Terni, B; Tomaino, C | 1 |
| Adam, S; Aerts, J; Bastin, C; Collette, F; d'Ydewalle, G; Guillaume, B; Kerrouche, N; Lekeu, F; Lemaire, C; Salmon, E | 1 |
| Berti, V; de Leon, MJ; De Santi, S; Glodzik, L; Mosconi, L; Pupi, A | 1 |
| Berti, V; de Leon, MJ; De Santi, S; Li, Y; Mosconi, L; Osorio, RS | 1 |
| Almkvist, O; Engler, H; Forsberg, A; Långström, B; Nordberg, A; Wall, A | 1 |
| Boeve, BF; Frank, AR; Jack, CR; Kantarci, K; Kemp, BJ; Knopman, DS; Lowe, VJ; Petersen, RC; Senjem, ML; Shiung, MM; Weigand, SD; Wiste, HJ | 1 |
| Cheong, HK; Chin, J; Han, SH; Kim, SH; Lee, BH; Na, DL; Seo, SW; Yoon, DS | 1 |
| Berti, V; de Leon, M; Duara, R; Mosconi, L; Pupi, A; Swerdlow, RH | 1 |
| Cho, SJ; Kim, SH; Kim, SJ; Kim, YB; Lee, SY; Shin, J | 1 |
| Alexander, GE; Allen, AN; Bandy, D; Burns, CM; Caselli, RJ; Chen, K; Corneveaux, JJ; Fleisher, AS; Huentelman, MJ; Kaszniak, AW; Langbaum, JB; Lee, W; Pruzin, J; Reeder, SA; Reiman, EM; Reschke, C | 1 |
| Cuasay, K; Devanand, DP; Dileep Kumar, JS; Gunn, RN; Lai, R; Libri, V; Liu, X; Mann, JJ; Mikhno, A; Parsey, RV; Pelton, GH; Pradhaban, G; Upton, N; van Heertum, R | 1 |
| Carlis, JV; Dysken, MW; Fink, H; Kuskowski, MA; Lee, JT; Lewis, SM; McCarten, JR; McPherson, S; Munch, KR; Pardo, JV; Rottunda, S; Shah, HH; Sheikh, SA; Surerus, C | 1 |
| He, TT; Shen, L; Tian, JH; Yao, SL; Zhang, JM | 1 |
| Bandy, D; Chen, K; Foster, NL; Jagust, WJ; Koeppe, RA; Landau, SM; Mathis, CA; Price, JC; Reiman, EM; Skovronsky, D | 1 |
| Bertram, L; Craig, DW; Farrer, LA; Foroud, TM; Green, RC; Huentelman, MJ; Jack, CR; Kim, S; Moore, JH; Nho, K; Potkin, SG; Risacher, SL; Saykin, AJ; Shen, L; Stein, JL; Swaminathan, S; Thompson, PM; Weiner, MW | 1 |
| Archimandritis, S; Georgoulias, P; Papatriantafyllou, J; Sifakis, N; Valotassiou, V | 1 |
| Caroli, A; Frisoni, GB | 1 |
| Bouchard, RW; Buteau, JP; Houde, M; Laforce, R; Paquet, N; Verret, L | 1 |
| Barkhof, F; Boverhoff, J; Herholz, K; Lammertsma, AA; Raijmakers, PG; Scheltens, P; Tolboom, N; van Berckel, BN; van der Flier, WM; Wattjes, MP; Yaqub, M | 1 |
| Lucignani, G; Nobili, F | 1 |
| Chetelat, G; Lippa, CF | 1 |
| Aisen, PS; Foster, NL; Harvey, D; Jack, CR; Jagust, WJ; Landau, SM; Madison, CM; Petersen, RC; Reiman, EM; Shaw, LM; Trojanowski, JQ; Weiner, MW | 1 |
| Alexopoulos, P; Drzezga, A; Förschler, A; Förstl, H; Grimmer, T; Henriksen, G; Klunk, WE; Kurz, A; Mathis, CA; Perneczky, R; Sorg, C; Tholen, S; Yousefi, BH | 1 |
| Barkhof, F; Blankenstein, MA; Bouwman, FH; Klein, M; Kok, A; Scheltens, P; Sluimer, JD; van der Flier, WM; Verwey, NA | 1 |
| He, TT; Tian, JH; Wang, RM; Yao, SL; Zhang, JM | 1 |
| Kusne, Y; LaFerla, FM; Nicholson, RM; Nowak, LA; Reiman, EM; Valla, J | 1 |
| Andersen, A; Bastin, C; Bormans, G; Brooks, DJ; Buckley, C; Farrar, G; Garraux, G; Hasselbalch, S; Ivanoiu, A; Korner, A; Law, I; Minthon, L; Nelissen, N; Owenius, R; Salmon, E; Thurfjell, L; Triau, E; Van Laere, K; Vandenberghe, R | 1 |
| Almkvist, O; Engler, H; Forsberg, A; Kadir, A; Långström, B; Nordberg, A; Wall, A | 1 |
| Brewer, JB; Dale, AM; Fennema-Notestine, C; Hagler, DJ; Hoh, CK; Jennings, RG; Karow, DS; McEvoy, LK | 1 |
| Brooks, J; Geist, CL; Kenna, HA; Powers, B; Rasgon, NL; Silverman, DH; Williams, K; Wroolie, T | 1 |
| Jagust, WJ | 2 |
| Baker, LD; Belongia, D; Craft, S; Cross, DJ; Minoshima, S; Watson, GS | 1 |
| Bartenstein, P; Buerger, K; Cumming, P; Förster, S; Hampel, H; Hummel, T; Hundt, W; la Fougère, C; Mustafa, M; Rominger, A; Steinbach, S; Teipel, SJ; Vaitl, A; Yakushev, I | 1 |
| Bartenstein, P; Fellgiebel, A; Hiemke, C; Lotz, J; Müller, MJ; Scheurich, A; Siessmeier, T; Yakushev, I | 1 |
| Barbieri, P; Brugnolo, A; Dessi, B; Girtler, N; Mazzei, D; Morbelli, S; Nobili, F; Pagani, M; Rodriguez, G; Sambuceti, G | 1 |
| Ikeda, T; Ikeda, Y; Iwasa, K; Mastunari, I; Morinaga, A; Noguchi-Shinohara, M; Ono, K; Samuraki, M; Shima, K; Yamada, M; Yanase, D; Yoshita, M | 1 |
| Allen, AN; Bandy, D; Caselli, RJ; Chen, K; Corneveaux, JJ; Dunckley, T; Fleisher, AS; Huentelman, MJ; Jensen, K; Kaib, S; Langbaum, JB; Lee, W; Liang, WS; Meechoovet, B; Myers, A; Pruzin, J; Reiman, EM; Sidhar, K; Villa, S | 1 |
| Bandy, D; Bird, NP; Brown, AP; Castiglia, M; Chen, K; Cunningham, VJ; Dixon, IJ; Gold, M; Hallett, WA; Jeter, B; Lai, RY; Lotay, N; Matthews, JC; Matthews, PM; Mistry, P; Nichols, TE; Rabiner, EA; Reiman, EM; Searle, G; Tzimopoulou, S; Whitcher, B; Zvartau-Hind, M | 1 |
| Arbizu, J; Marti-Climent, J; Masdeu, JC; Olier, J; Pascual, B; Prieto, E | 1 |
| Aizenstein, HJ; Arnold, SE; Barbas, NR; Boeve, BF; Burke, JR; Clark, CM; DeCarli, CS; DeKosky, ST; Diaz-Arrastia, R; Farlow, MR; Foster, NL; Gabel, MJ; Heidebrink, JL; Higdon, R; Jagust, WJ; Kawas, CH; Koeppe, RA; Leverenz, JB; Lipton, AM; Peskind, ER; Turner, RS; Womack, KB; Zamrini, EY | 1 |
| Aizenstein, HJ; Arnold, SE; Barbas, NR; Boeve, BF; Burke, JR; Clark, CM; Dekosky, ST; Farlow, MR; Foster, NL; Gabel, MJ; Heidebrink, JL; Higdon, R; Jagust, WJ; Kawas, CH; Koeppe, RA; Leverenz, JB; Lipton, AM; Peskind, ER; Turner, RS; Womack, KB; Zamrini, EY | 1 |
| Chaves, R; Górriz, JM; Illán, IA; López, M; Padilla, P; Puntonet, CG; Ramírez, J; Salas-Gonzalez, D; Segovia, F | 1 |
| Akisaki, T; Hara, K; Kushida, S; Moriyama, H; Nagata, M; Sakurai, T; Taniguchi, M; Urakami, K; Yasuda, H; Yokono, K | 1 |
| Laakso, MP | 1 |
| Hajak, G; Hirschberger, B; Ibach, B; Klünemann, H; Männer, P; Marienhagen, J; Poljansky, S | 1 |
| Jagust, WJ; Madison, C; Rabinovici, GD; Rostomian, AH | 1 |
| Fellgiebel, A; Yakushev, I | 1 |
| Ishii, K; Miyamoto, N; Uemura, T; Yoshikawa, T | 1 |
| Almkvist, O; Bogdanovic, N; Långström, B; Nordberg, A; Schöll, M; Viitanen, M; Wall, A | 1 |
| Buchholz, HG; Fellgiebel, A; Gerhard, A; Hammers, A; Lorscheider, M; Müller, MJ; Schermuly, I; Schreckenberger, M; Stoeter, P; Weibrich, C; Yakushev, I | 1 |
| Adlard, PA; Barnham, KJ; Cao, D; Cappai, R; Cartwright, GA; Connor, AR; Fodero-Tavoletti, MT; Furumoto, S; Gong, S; Kudo, Y; Masters, CL; McLean, CA; Mulligan, RS; O'Keefe, G; Okamura, N; Rigopoulos, A; Rowe, CC; Villemagne, VL; Yanai, K | 1 |
| Chang, KT; Cho, ZH; Heo, JH; Jang, DP; Lee, KM; Lee, SR; Lee, ST; Oh, JH | 1 |
| Becker, JA; Drzezga, A; Greve, D; Johnson, KA; Putcha, D; Schultz, AP; Sepulcre, J; Sperling, RA; Sreenivasan, A; Sullivan, C; Talukdar, T; Van Dijk, KR | 1 |
| Bartenstein, P; Buchholz, HG; Buerger, K; Buschert, VC; Drzezga, A; Förster, S; Friese, U; Hampel, H; la Fougere, C; Rominger, A; Teipel, SJ; Zach, C | 1 |
| Agarwal, N; Alkalay, A; Baker, SL; Gorno-Tempini, ML; Growdon, M; Jagust, WJ; Janabi, M; Jang, J; Madison, C; Miller, BL; Mormino, EC; O'Neil, JP; Rabinovici, GD; Rosen, HJ; Rosenbloom, MH; Weiner, MW; Yen, IV | 1 |
| Rinne, JO; Scheinin, M; Scheinin, NM | 1 |
| McHugh, PF; Mosconi, L | 1 |
| Vallabhajosula, S | 1 |
| de Leon, MJ; During, EH; Elahi, FM; Mosconi, L; Osorio, RS | 1 |
| Heinz, TK; Margareta, H; Peter, F; Silvia, W; Susanne, J; Thomas, L; Wolfgang, K | 1 |
| Aisen, PS; Hubbard, AE; Jagust, WJ; Lo, RY; Petersen, RC; Shaw, LM; Trojanowski, JQ; Weiner, MW | 1 |
| Guenther, T; Haberkorn, U; Henze, M; Hunt, A; Schönknecht, OD; Schröder, J; Toro, P | 1 |
| Bartenstein, P; Dickerson, BC; Drzezga, A; Förster, S; Förstl, H; Graner, P; Grimmer, T; Henriksen, G; Kurz, A; Miederer, I; Wester, HJ; Yousefi, BH | 1 |
| Rowe, CC; Villemagne, VL | 1 |
| Dunn, G; Haense, C; Herholz, K; Westwood, S | 1 |
| Platt, B; Riedel, G; Welch, A | 1 |
| Cumming, P; Fellgiebel, A; Gerhard, A; Müller, MJ; Schermuly, I; Schreckenberger, M; Stoeter, P; Yakushev, I | 1 |
| Alberici, A; Archetti, S; Bonvicini, C; Borroni, B; Gennarelli, M; Lupi, A; Padovani, A; Pilotto, A | 1 |
| Ataka, S; Miki, T; Mori, H; Shimada, H; Takechi, H; Tomiyama, T | 1 |
| Chen, WP; Matsuda, H; Matsunari, I; Miyazaki, Y; Noguchi-Shinohara, M; Ono, K; Samuraki, M; Shima, K; Takeda, N; Yamada, M; Yanase, D; Yoshita, M | 1 |
| Barkhof, F; Hazewinkel, M | 1 |
| Archetti, S; Arnaldi, D; di Lorenzo, D; Ferrara, M; Morbelli, S; Nobili, F; Piccini, A; Picco, A; Serrati, C | 1 |
| Lewis, DH; McCue, TJ; Minoshima, S; Toney, LK | 1 |
| Eikelenboom, P; Schmand, B; van Gool, WA | 2 |
| Arbuckle, M; Baker, LD; Callaghan, M; Claxton, A; Craft, S; Cross, D; Gerton, B; Green, PS; Leverenz, J; Minoshima, S; Montine, TJ; Plymate, SR; Tsai, E; Watson, GS | 1 |
| Chen, WP; Matsunari, I; Miyazaki, Y; Nishimura, S; Ono, K; Samuraki, M; Shima, K; Takeda, N; Yamada, M; Yanase, D; Yoshita, M | 1 |
| Fallon, JT; Keator, DB; Kruggel, F; Lakatos, A; Macciardi, F; Potkin, SG; Rasmussen, JM; van Erp, TG | 1 |
| Furst, AJ; Lal, RA | 1 |
| Bartenstein, P; Buchholz, HG; Buerger, K; Buschert, VC; Drzezga, A; Förster, S; Friese, U; Hampel, H; Teipel, SJ | 1 |
| Reiman, EM | 1 |
| Alavi, A; Arnold, SE; Chen, Y; Detre, JA; Julin, P; Kimberg, DY; Korczykowski, M; Martinez, PM; Musiek, ES; Newberg, AB; Reddin, JS; Saboury, B; Wolk, DA | 1 |
| Boeve, BF; Dickson, DW; Ferman, TJ; Jack, CR; Kantarci, K; Knopman, DS; Lowe, VJ; Parisi, JE; Petersen, RC; Przybelski, SA; Senjem, ML; Smith, GE; Weigand, SD | 1 |
| Arai, H; Fujishiro, H; Furukawa, Y; Higashi, S; Hino, H; Iseki, E; Kasanuki, K; Katsuse, O; Kosaka, K; Minegishi, M; Sato, K; Togo, T; Uchikado, H; Yamamoto, R | 1 |
| Buchholz, HG; Fellgiebel, A; Hampel, H; Lang, U; Muller, MJ; Rossmann, H; Schreckenberger, M; Yakushev, I | 1 |
| Hellwig, S; Hüll, M; Meyer, PT | 1 |
| Benavides, J; Bourrin, E; Debeir, T; Delatour, B; Delzescaux, T; Dhenain, M; El Tannir El Tayara, N; Hantraye, P; Hérard, AS; Kober, F; Poisnel, G; Rooney, T; Volk, A | 1 |
| Bublak, P; Drzezga, A; Finke, K; Förstl, H; Grimmer, T; Kurz, A; Manoliu, A; Müller, HJ; Myers, N; Perneczky, R; Redel, P; Riedl, V; Sorg, C; Wohlschläger, AM | 1 |
| Arnold, SE; Chen, Y; Detre, JA; Greenberg, JH; Julin, P; Korczykowski, M; Martinez, PM; Musiek, ES; Newberg, AB; Reddin, JS; Wolk, DA | 1 |
| Hashimoto, H; Higashiyama, S; Inoue, K; Kai, T; Kataoka, K; Kawabe, J; Kawarada, Y; Kiriike, N; Nakanishi, A; Shimada, A; Shiomi, S; Tagawa, R | 1 |
| Blomquist, G; Engler, H; Forsberg, A; Långström, B; Nordberg, A | 1 |
| Agarwal, N; Alkalay, A; Dearmond, SJ; Furst, AJ; Gorno-Tempini, ML; Grinberg, LT; Growdon, ME; Huang, EJ; Jagust, WJ; Janabi, M; Jang, JY; Karydas, A; Kornak, J; Miller, BL; Mormino, EC; O'Neil, JP; Rabinovici, GD; Rosen, HJ; Seeley, WW; Trojanowski, JQ | 1 |
| Borroni, B; Cappa, SF; Garibotto, V; Padovani, A; Perani, D; Sorbi, S | 1 |
| Anzai, Y; Bohnen, NI; Djang, DS; Herholz, K; Minoshima, S | 1 |
| Chen, WP; Matsuda, H; Matsunari, I; Samuraki, M; Shima, K; Takeda, N; Yamada, M; Yanase, D | 1 |
| Almkvist, O; Carter, SF; Engler, H; Långström, B; Nordberg, A; Schöll, M; Wall, A | 1 |
| Aljabar, P; Gray, KR; Hammers, A; Heckemann, RA; Rueckert, D; Wolz, R | 1 |
| Brera, B; Carro, E; Cuadrado, A; de Ceballos, ML; Delgado, M; García-García, L; Innamorato, NG; Martín-Moreno, AM; Pozo, MA; Spuch, C | 1 |
| Ding, Y; Feng, J; Guo, Y; Han, D; Tan, X; Zhang, S | 1 |
| Hsiao, IT; Hsieh, CJ; Hsu, WC; Huang, CC; Kung, MP; Lin, KJ; Wey, SP; Yen, TC | 1 |
| Abbas, A; Barré, L; Delamare, J; Dhilly, M; Guilloteau, D; Moustié, O; Poisnel, G | 1 |
| Ayutyanont, N; Caroli, A; Chen, K; Frisoni, GB; Haense, C; Herholz, K; Jagust, WJ; Landau, SM; Madison, CM; Nobili, F; Prestia, A; Reiman, EM | 1 |
| Alexander, GE; Ayutyanont, N; Bandy, D; Caselli, RJ; Chen, K; Fleisher, AS; Langbaum, JB; Lee, W; Liu, X; Reiman, EM; Reschke, C | 1 |
| Brugnolo, A; Caroli, A; Didic, M; Drzezga, A; Frisoni, GB; Guedj, E; Morbelli, S; Nobili, F; Ossenkoppele, R; Pagani, M; Perneczky, R; Salmon, E; Sambuceti, G; van Berckel, BN | 1 |
| Duchesne, S; Mouiha, A | 1 |
| Aisen, PS; Bernstein, MA; Boeve, BF; Gunter, JL; Jack, CR; Kantarci, K; Knopman, DS; Lesnick, TG; Lowe, V; Petersen, RC; Senjem, ML; Shaw, LM; Trojanowski, JQ; Vemuri, P; Weigand, SD; Weiner, MW; Wiste, HJ | 1 |
| Fox, NC; Johnson, KA; Klunk, WE; Sperling, RA | 1 |
| Boeve, BF; Gunter, JL; Ivnik, RJ; Jack, CR; Kantarci, K; Knopman, DS; Lowe, V; Petersen, RC; Roberts, RO; Rocca, WA; Senjem, ML; Vemuri, P; Weigand, SD; Wiste, HJ | 1 |
| Jagust, WJ; Lo, RY | 1 |
| Narayan, VA; Thompson, PM; Wang, Y; Ye, J; Yuan, L | 1 |
| Cummings, M; de Leon, MJ; Glodzik, L; Goldsmith, SJ; Li, Y; McHugh, P; Mosconi, L; Murray, J; Någren, K; Pirraglia, E; Rinne, JO; Scheinin, N; Tsui, WH; Vallabhajosula, S; Viljanen, T; Williams, S | 1 |
| Bellec, P; Benali, H; Desarnaud, S; Doyon, J; Habert, MO; Lacomblez, L; Perlbarg, V; Toussaint, PJ | 1 |
| Jack, CR | 1 |
| Ahnert-Hilger, G; Buchert, R; Dalmau, J; Gomez, A; Harms, L; Höltje, M; Klingbeil, C; Kohler, S; Kopp, U; Maier, N; Probst, C; Prüss, H; Schmitz, D; Schwab, JM; Stoecker, W; Terborg, C; Wandinger, KP | 1 |
| Boeve, BF; Gunter, JL; Ivnik, RJ; Jack, CR; Kantarci, K; Knopman, DS; Lowe, V; Petersen, RC; Roberts, RO; Senjem, ML; Vemuri, P; Weigand, SD; Wiste, HJ | 1 |
| Adriaanse, SF; Barkhof, F; Boellaard, R; Kloet, RW; Lammertsma, AA; Ossenkoppele, R; Scheltens, P; Tolboom, N; van Assema, DM; van Berckel, BN; van der Flier, WM; Windhorst, AD; Zwan, MD | 1 |
| Alavi, A; Arnold, SE; Newberg, AB; Rovner, BW; Wintering, N | 1 |
| Backes, H; Heneka, MT; Hoehn, M; Jacobs, AH; Kummer, MP; Monfared, P; Neumaier, B; Rapic, S; Van der Linden, A; Viel, T; Vollmar, S | 1 |
| Bagnoli, S; Failli, Y; Piaceri, I; Rinnoci, V; Sorbi, S | 1 |
| Maldjian, JA; Whitlow, CT | 1 |
| Almkvist, O; Bogdanovic, N; Ferreira, D; Graff, C; Långström, B; Nordberg, A; Schöll, M; Thordardottir, S; Wall, A | 1 |
| Baek, MJ; Jang, JW; Kim, JE; Kim, S; Park, YH | 1 |
| Babiak, M; Caso, F; Comi, G; Filippi, M; Gesierich, B; Gorno-Tempini, ML; Henry, M; Huang, EJ; LaMarre, A; Magnani, G; Miller, BL; Rabinovici, GD; Seeley, WW; Sidhu, M | 1 |
| Bowman, FD; Derado, G; Zhang, L | 1 |
| Ikari, Y; Ito, K; Koeppe, RA; Makishi, Y; Miya, Y; Nishio, T; Senda, M | 1 |
| Carter, RE; Claassen, DO; Lehman, VT; Lowe, V; Murphy, RC; Peller, PJ; Petersen, RC | 1 |
| Tashiro, M | 1 |
| Bimonte-Nelson, H; Braden, BB; Emerson Lombardo, N; Engler-Chiurazzi, E; Garcia, AN; Kusne, Y; LaFerla, F; Lue, L; Moses, GS; Tran, H; Valla, J; Walker, DG; Wolf, AB; Young, N | 1 |
| Kato, S; Nishio, T; Ochi, S; Oda, K; Sakata, M; Tanizaki, Y; Tsushima, H | 1 |
| Chin, J; Kim, H; Kim, JH; Kim, YW; Lee, KH; Na, DL; Park, ES; Seo, SW; Suh, MK; Yoon, JH | 1 |
| Rong, XF; Wang, XL | 1 |
| Herzog, H | 1 |
| Drzezga, A; Förster, S; Förstl, H; Grimmer, T; Klupp, E; Kurz, A; Rominger, A; Wester, HJ; Yousefi, BH | 1 |
| Bibby, BM; Brock, B; Egefjord, L; Gejl, M; Gjedde, A; Holst, JJ; Lerche, S; Mengel, A; Møller, N; Rungby, J; Vang, K | 1 |
| Ataka, S; Kawabe, J; Miki, T; Mizuno, K; Mori, H; Shimada, H; Shiomi, S; Takeuchi, J; Wada, Y; Watanabe, Y | 1 |
| Jimenez, E; Kaiser, NC; Liu, C; Melrose, RJ; Mendez, MF; Monserratt, L; Su, M; Sultzer, DL | 1 |
| Vanitallie, TB | 1 |
| Arridge, S; Bousse, A; Erlandsson, K; Hutton, BF; Ourselin, S; Pedemonte, S; Thomas, BA | 1 |
| Almkvist, O; Choo, IH; Ni, R; Nordberg, A; Schöll, M; Wall, A | 1 |
| Delbeuck, X; Le Bouc, R; Lebert, F; Lenfant, P; Pasquier, F; Ravasi, L; Semah, F | 1 |
| Amicucci, G; Bocchio-Chiavetto, L; Bonetti, M; Bonvicini, C; Cotelli, M; Frisoni, GB; Galluzzi, S; Geroldi, C; Ghidoni, R; Paghera, B; Zanetti, O | 1 |
| Biskup, S; Fallgatter, AJ; Leyhe, T; Metzger, F; Reimold, M; Synofzik, M | 1 |
| Aalten, P; Adriaanse, SF; Handels, RL; Hoekstra, OS; Lammertsma, AA; Lemstra, AW; Ossenkoppele, R; Pijnenburg, YA; Prins, ND; Scheltens, P; van Berckel, BN; van Buchem, MA; van der Flier, WM; Verbeek, MM; Verhey, FR; Windhorst, AD; Wolfs, CA | 1 |
| Darcourt, J; Deudon, A; Fontaine, D; Lemaire, JJ; Razzouk, M; Robert, P; Viau, P | 1 |
| Crane, PK; DeCarli, C; Glymour, MM; Habeck, C; Kim, S; Lee, GJ; Mormino, E; Mukherjee, S; Nho, K; Risacher, S; Saykin, AJ | 1 |
| Essig, M; Giesel, F; Guenther, T; Haberkorn, U; Henze, R; Küntzelmann, A; Schönknecht, P; Schröder, J; Schroeter, ML | 1 |
| Adeli, A; Boeve, BF; Crum, BA; Dejesus-Hernandez, M; Fields, JA; Jack, CR; Knopman, DS; Lowe, VJ; Petersen, RC; Rademakers, R; Savica, R; Vemuri, P | 1 |
| Bares, R; Bender, B; Ernemann, U; Horger, M; Mänz, C; Reimold, M | 1 |
| Calhoun, VD; Choudhury, KR; Coleman, RE; Doraiswamy, PM; Petrella, JR; Shaffer, JL; Sheldon, FC | 1 |
| Adriaanse, SF; Barkhof, F; Boellaard, R; Lammertsma, AA; Ossenkoppele, R; Scheltens, P; van Berckel, BN; van der Flier, WM; Windhorst, AD; Zwan, MD | 1 |
| Choe, YM; Lee, DS; Lee, DY; Lee, JM; Park, JS; Seo, EH; Sohn, BK; Woo, JI | 1 |
| Corbetta-Rastelli, C; Ghosh, PM; Gorno-Tempini, ML; Greicius, MD; Jagust, WJ; Laforce, R; Lehmann, M; Madison, C; Miller, BL; Rabinovici, GD; Rosen, HJ; Seeley, WW; Weiner, MW | 1 |
| Caroli, A; Chen, K; Frisoni, GB; Herholz, K; Jagust, WJ; Prestia, A; Reiman, E | 1 |
| Alexander, GE; Hampel, H; Möller, HJ; Pogarell, O; Rapoport, SI; Teipel, SJ | 1 |
| Arai, H; Higuchi, S; Iwatsubo, T; Maruyama, M; Matsui, T; Matsushita, S; Ohmori, T; Okamura, N; Takasugi, K | 1 |
| Baron, JC; Blaizot, AX; Blaizot, X; Chavoix, C; Meguro, K; Millien, I | 1 |
| Imahori, Y; Kondo, M; Mori, S; Nakajima, K | 1 |
| Anchisi, D; Arahata, Y; Baron, JC; Beuthien-Baumann, B; Delbeuck, X; Desgranges, B; Eustache, F; Fazio, F; Frölich, L; Heiss, WD; Henze, M; Herholz, K; Holthoff, V; Ito, K; Kalbe, E; Kato, T; Kerrouche, N; Menzel, C; Mielke, R; Pelati, O; Perani, D; Salmon, E; Schönknecht, P; Schröder, J; Zündorf, G | 1 |
| Arai, H; Higuchi, M; Hu, X; Itoh, M; Maruyama, M; Okamura, N; Sasaki, H; Yamaguchi, K | 1 |
| Jhoo, JH; Kim, KW; Lee, DS; Lee, DY; Lee, JH; Lee, JS; Lee, KU; Lee, MC; Woo, JI; Yoon, JC | 1 |
| Brown, CV; Chen, ST; Cummings, JL; Mahler, ME; Mandelkern, MA; Mendez, MF; Sultzer, DL | 1 |
| Ishii, K | 2 |
| Calamia, KT; Klauser, A; Moncayo, R; Salvarani, C; Schirmer, M; Wenger, M | 1 |
| Baron, JC; Chételat, G; de la Sayette, V; Desgranges, B; Eustache, F; Viader, F | 1 |
| Aston, JA; Banati, RB; Cunningham, VJ; Riddell, C; Turkheimer, FE | 1 |
| Drzezga, A; Kurz, A; Lautenschlager, N; Minoshima, S; Riemenschneider, M; Schwaiger, M; Siebner, H; Willoch, F | 1 |
| Alavi, A; Brinkman, F; Clark, C; Cotter, A; Glosser, G; Newberg, A; Udeshi, M | 1 |
| Fryer, TD; Hodges, JR; Nestor, PJ; Smielewski, P | 1 |
| Ahonen, K; Järvenpää, T; Kaprio, J; Koskenvuo, M; Kurki, T; Laine, M; Räihä, I; Rinne, JO; Vahlberg, T; Viljanen, T | 1 |
| Haberkorn, U; Henze, M; Hunt, A; Klinga, K; Schönknecht, P; Schröder, J | 1 |
| Bagnoli, S; Bracco, L; Cellini, E; De Cristofaro, MT; Fayyaz, M; Herholz, K; Mosconi, L; Nacmias, B; Pupi, A; Sorbi, S | 1 |
| Caine, D; Clarke, J; Fryer, TD; Hodges, JR; Nestor, PJ | 1 |
| Alkire, MT; Cotman, CW; Haier, RJ; Head, E; Lott, IT; Uncapher, MR; White, NS | 1 |
| Bauer, B; Heiss, WD; Herholz, K; Kalbe, E; Lenz, O; Schröder, H; Weisenbach, S; Zündorf, G | 1 |
| Bracco, L; De Cristofaro, MT; Fayazz, M; Herholz, K; Mosconi, L; Nacmias, B; Pupi, A; Sorbi, S; Tedde, A | 1 |
| Antoni, G; Ausén, B; Barletta, J; Bergström, M; Blomqvist, G; Debnath, ML; Engler, H; Estrada, S; Holt, DP; Huang, GF; Klunk, WE; Koivisto, P; Långström, B; Lopresti, BJ; Mathis, CA; Nordberg, A; Price, JC; Sandell, J; Savitcheva, I; Wall, A; Wang, Y | 1 |
| De Cristofaro, MT; Fayyaz, M; Herholz, K; Mosconi, L; Pupi, A; Sorbi, S | 1 |
| Lee, AG; Martin, CO | 1 |
| Minoshima, S | 1 |
| Bracco, L; De Cristofaro, MT; Fayyaz, M; Herholz, K; Mosconi, L; Nacmias, B; Pupi, A; Sorbi, S | 1 |
| Diener, J; Döbert, N; Frölich, L; Grünwald, F; Hamscho, N; Kratzsch, T; Maurer, K; Menzel, C; Peters, J; Tsolakis, A; Zaplatnikov, K | 1 |
| Matchar, DB; McCrory, DC; Patwardhan, MB; Rutschmann, OT; Samsa, GP | 1 |
| Futatsubashi, M; Kaneko, M; Okada, H; Ouchi, Y; Torizuka, T; Yoshikawa, E | 1 |
| Bartenstein, P; Dahmen, N; Tonn, P | 1 |
| Bartenstein, P; Fellgiebel, A; Müller, MJ; Scheurich, A; Schmidt, LG; Siessmeier, T; Winterer, G | 1 |
| Bittner, D; Grön, G; Reske, SN; Riepe, MW; Schirrmeister, H | 1 |
| Hajak, G; Ibach, B; Männer, P; Marienhagen, J; Poljansky, S; Sommer, M | 1 |
| Hajak, G; Ibach, B; Männer, P; Marienhagen, J; Poljansky, S; Vogel, M | 1 |
| Bubrowski, P; Dykierek, P; Huell, M; Jost, E; Juengling, F; Talazko, J; Zahn, R | 1 |
| Bracco, L; De Cristofaro, MT; Fayyaz, M; Herholz, K; Mosconi, L; Nacmias, B; Prohovnik, I; Pupi, A; Sorbi, S | 1 |
| Hashimoto, M; Hirono, N; Ishii, K; Kazui, H; Mori, E | 1 |
| Baron, JC; Borroni, B; Bracco, L; De Cristofaro, MT; Franceschi, M; Herholz, K; Holthoff, V; Mosconi, L; Nacmias, B; Padovani, A; Perani, D; Pupi, A; Salmon, E; Sorbi, S | 1 |
| An, H; Gilman, S; Giordani, B; Heumann, M; Junck, L; Koeppe, RA; Little, R; Persad, C; Wernette, K | 1 |
| Drzezga, A; Grimmer, T; Knoll, A; Kurz, A; Minoshima, S; Peller, M; Riemenschneider, M; Schwaiger, M; Strassner, B; Wagenpfeil, S | 1 |
| Chételat, G; de la Sayette, V; Desgranges, B; Eustache, F; Kalpouzos, G; Viader, F | 1 |
| Arai, H; Furukawa, Y; Hamaguchi, T; Ihara, Y; Ishida, C; Katayama, S; Kawakami, A; Kitamoto, T; Kohriyama, T; Kuji, I; Kuroda, S; Maruyama, M; Mitani, K; Mizusawa, H; Murayama, S; Nakamura, Y; Nishinaka, T; Noguchi, M; Sato, T; Shiga, Y; Suzuki, N; Udaka, F; Yamada, M; Yamamoto, T; Yamashita, M | 1 |
| Montandon, ML; Zaidi, H | 1 |
| Mosconi, L | 1 |
| Chen, W; Fujikawa, A; Matsuda, H; Matsunari, I; Nishimura, S; Yajima, K; Yamada, M; Yanase, D | 1 |
| Fukuda, T; Ishii, K; Kono, AK; Miyamoto, N; Mori, E; Sasaki, H | 1 |
| Hosaka, K; Ishii, K; Mori, E; Mori, T; Sakamoto, S; Sasaki, M | 1 |
| Bakay, R; Blesch, A; Conner, J; Fallon, J; Gall, C; Hansen, L; Ho, G; Kordower, JH; Mufson, EJ; Patel, P; Pay, M; Potkin, SG; Salmon, DP; Thal, L; Tong, G; Tuszynski, MH; U, HS; Vahlsing, HL | 1 |
| Amezcua, H; Carter, MF; Chow, G; Cummings, JL; Davoodi, P; Dinov, ID; Mega, MS; O'Connor, SM; Porter, V; Reback, E | 1 |
| Bartenstein, P; Bürger, K; Drzezga, A; Engel, R; Hampel, H; Ishii, K; Möller, HJ; Schwaiger, M; Teipel, SJ; Willoch, F | 1 |
| Albin, RL; Frey, KA; Gilman, S; Heumann, M; Joshi, A; Junck, L; Koeppe, RA; Little, R; Liu, S | 1 |
| Boppana, M; Convit, A; de Leon, MJ; De Santi, S; Li, J; Li, Y; Mosconi, L; Rusinek, H; Tsui, WH | 1 |
| Almkvist, O; Forsberg, A; Långström, B; Nilsson, A; Nordberg, A; Stefanova, E; Wall, A | 1 |
| Bartenstein, P; Fellgiebel, A; Muller, MJ; Scheurich, A; Schmidt, LG; Siessmeier, T | 1 |
| Bartenstein, P; Bokde, AL; Born, C; Dong, W; Drzezga, A; Hampel, H; Leinsinger, G; Moeller, HJ; Schwaiger, M; Teipel, SJ; Thissen, J | 1 |
| Alexopoulus, P; Drzezga, A; Grimmer, T; Kurz, A; Lautenschlager, N; Minoshima, S; Riemenschneider, M; Schwaiger, M; Siebner, H | 1 |
| Chen, WP; Matsunari, I; Minoshima, S; Nishimura, S; Noda, A; Takeda, N; Yajima, K; Yamada, M; Yanase, D | 1 |
| Beuthien-Baumann, B; Collette, F; Delbeuck, X; Garraux, G; Herholz, K; Holthoff, V; Kalbe, E; Lespagnard, S; Marique, P; Pelati, O; Perani, D; Salmon, E | 1 |
| Brenner, W; Buchert, R; Chakrabarti, B; Clausen, M; Martin, B; Mester, J; Wilke, F | 1 |
| Linden, DE; Maurer, K; Prvulovic, D; Sack, AT; Van de Ven, V | 1 |
| Ishii, K; Minoshima, S | 1 |
| Nobili, FM; Pupi, A | 1 |
| Feil, D; Freedman, E; Harwood, DG; Mandelkern, MA; Monserratt, L; Sultzer, DL | 1 |
| Anchisi, D; Beuthien-Beumann, B; Borroni, B; Cappa, S; Fazio, F; Franceschi, M; Herholz, K; Holthoff, V; Kalbe, E; Kerrouche, N; Lenz, O; Ludecke, S; Marcone, A; Mielke, R; Ortelli, P; Padovani, A; Pelati, O; Perani, D; Pupi, A; Salmon, E; Scarpini, E; Sorbi, S; Weisenbach, S | 1 |
| Boppana, M; de Leon, MJ; De Santi, S; Li, J; Li, Y; Mosconi, L; Pupi, A; Tsui, WH; Zhan, J | 1 |
| Cao, QY; Jiang, KD; Liu, YC; Xiao, SF; Xue, HB; Zhang, MY; Zuo, CT | 1 |
| Barrio, JR; Cole, GM; Cummings, JL; Ercoli, L; Huang, SC; Kepe, V; Phelps, ME; Satyamurthy, N; Shoghi-Jadid, K; Siddarth, P; Small, GW | 1 |
| Lascola, C | 1 |
| Coleman, RE | 1 |
| Beckett, L; Jack, C; Jagust, W; Mueller, SG; Petersen, RC; Thal, LJ; Toga, AW; Trojanowski, JQ; Weiner, MW | 1 |
| Fukuda, T; Ishii, K; Kono, AK; Miyamoto, N; Mori, E; Sakamoto, S; Sasaki, H | 1 |
| Gitcho, A; Haan, M; Jagust, W; Kuczynski, B; Mungas, D; Sun, F | 1 |
| Baron, JC; Herholz, K; Holthoff, V; Kerrouche, N; Mielke, R | 1 |
| Iida, Y; Kawashima, H; Kuge, Y; Magata, Y; Nakagawa, M; Ogawa, M; Saji, H; Tominaga, A; Ueda, M | 1 |
| Ishii, K; Kawachi, T; Matsuda, H; Mori, E; Mori, T; Sakamoto, S; Sasaki, M; Yamashita, F | 1 |
| Bookheimer, SY; Ercoli, L; Huang, SC; Miller, K; Phelps, ME; Siddarth, P; Small, G; Wright, BC | 1 |
| Diehl-Schmid, J; Drzezga, A; Grimmer, T; Kars, S; Kurz, A; Monsch, A; Perneczky, R; Schmid, G; Wagenpfeil, S; Wohlschläger, A | 1 |
| Bartenstein, P; Drzezga, A; Hampel, H; Möller, HJ; Schwaiger, M; Teipel, SJ | 1 |
| Choo, IH; Jhoo, JH; Kang, EJ; Kang, WJ; Kim, KW; Lee, DS; Lee, DY; Lee, JS; Woo, JI; Youn, JC | 1 |
| de la Sayette, V; Desgranges, B; Eustache, F; Lalevée, C; Landeau, B; Mézenge, F; Pélerin, A; Piolino, P; Rauchs, G; Viader, F | 1 |
| Almkvist, O; Blomquist, G; Engler, H; Forsberg, A; Långström, B; Larsson, E; Nordberg, A; Ringheim, A; Savitcheva, I; Wall, A | 1 |
| Brenner, W; Buchert, R; Clausen, M; Martin, B; Mester, J; von Borczyskowski, D; Wilke, F | 1 |
| DeKosky, ST; Hoge, JA; Klunk, WE; Lopresti, BJ; Mathis, CA; Price, JC; Weissfeld, LA; Ziolko, SK | 1 |
| Miller, G | 1 |
| Barrio, JR; Kepe, V; Small, GW | 1 |
| Archer, HA; Brooks, DJ; Cutler, D; Edison, P; Fox, N; Hammers, A; Hinz, R; Hotton, G; Kennedy, A; Pavese, N; Rossor, M; Tai, YF | 1 |
| Bubrowski, P; Dykierek, P; Garrard, P; Gondan, M; Hull, M; Juengling, F; Koester, B; Slawik, H; Talazko, J; Zahn, R | 1 |
| Feil, D; Harwood, D; Hashimoto, H; Mandelkern, MA; Monserratt, L; Nguyen, P; Sultzer, DL | 1 |
| Barrio, JR; Bookheimer, SY; Burggren, AC; Cole, GM; Ercoli, LM; Huang, SC; Kepe, V; Lavretsky, H; Miller, KJ; Phelps, ME; Satyamurthy, N; Siddarth, P; Small, GW; Thompson, PM; Vinters, HV | 1 |
| Bateman, RJ; Eidelberg, D | 1 |
| Ishii, K; Kono, AK; Miyamoto, N; Mori, E; Sakamoto, S; Sofue, K | 1 |
| Bessi, V; Bracco, L; Mosconi, L; Piccini, C; Pupi, A; Sorbi, S | 1 |
| Ackermann, U; Berlangieri, S; Cherk, M; Gong, SJ; Jones, G; Lee, ST; Masters, CL; Ng, S; O'Keefe, G; Rowe, CC; Saunder, T; Smith, C; Tochon-Danguy, H; Villemagne, VL | 1 |
| Ishii, K; Kono, AK; Miyamoto, N; Mori, E; Murase, K; Sofue, K; Soma, T; Yoshikawa, T | 1 |
| Almkvist, O; Blomquist, G; Engler, H; Forsberg, A; Hagman, G; Långström, B; Nordberg, A; Ringheim, A; Wall, A | 1 |
| Borroni, B; Di Luca, M; Padovani, A; Premi, E | 1 |
| Chen, WP; Fujikawa, A; Matsuda, H; Matsunari, I; Nishimura, S; Samuraki, M; Takeda, N; Yajima, K; Yamada, M; Yanase, D | 1 |
| Haberkorn, U; Henze, M; Hunt, A; Schönknecht, P; Schröder, J; Seidl, U | 1 |
| Collette, F; Garraux, G; Guillaume, B; Lekeu, F; Luxen, A; Magis, D; Moonen, G; Salmon, E | 1 |
| Drzezga, A; Grimmer, T; Hartmann, J; Kurz, A; Perneczky, R | 1 |
| de Leon, MJ; De Santi, S; Drzezga, A; Minoshima, S; Mosconi, L; Pupi, A; Tsui, WH | 1 |
| Cummings, JL; Harwood, D; Mandelkern, M; Marshall, GA; Monserratt, L; Sultzer, DL | 1 |
| Fletcher, PT; Foster, NL; Joshi, SC; Powell, S | 1 |
| Beuthien-Baumann, B; Collette, F; Herholz, K; Holthoff, V; Kerrouche, N; Lekeu, F; Lemaire, C; Perani, D; Salmon, E; Sorbi, S | 1 |
| Arnold, SE; Barbas, NR; Clark, CM; DeCarli, CS; Foster, NL; Heidebrink, JL; Higdon, R; Jagust, WJ; Koeppe, RA; Minoshima, S; Turner, RS | 1 |
| Blennow, K; Brys, M; de Leon, MJ; De Santi, S; Glodzik-Sobanska, L; Mehta, PD; Mosconi, L; Pirraglia, E; Pratico, D; Rich, KE; Switalski, R; Tsui, WH; Zinkowski, R | 1 |
| Decarli, C; Ellis, W; Jagust, W; Mungas, D; Reed, B | 1 |
| Mariani, E; Mecocci, P; Monastero, R | 1 |
| Krisztal, E; Licht, E; McMurtray, AM; Mendez, MF; Saul, RE; Yeo, T | 1 |
| Diehl-Schmid, J; Drzezga, A; Kurz, A; Li, Y; Perneczky, R | 1 |
| DeKosky, S; Diehl-Schmid, J; Drzezga, A; Grimmer, T; Henriksen, G; Klunk, WE; Kurz, A; Mathis, CA; Perneczky, R; Price, J; Schwaiger, M; Stangier, I; Wester, HJ | 1 |
| Brys, M; de Leon, MJ; De Santi, S; Glodzik, L; Mistur, R; Mosconi, L; Pirraglia, E; Switalski, R; Tsui, W | 1 |
| Chen, WP; Kinuya, S; Matsuda, H; Matsunari, I; Ono, K; Samuraki, M; Takeda, N; Yamada, M; Yanase, D; Yoshita, M | 1 |
| Aalto, S; Karrasch, M; Kemppainen, NM; Någren, K; Oikonen, V; Parkkola, R; Rinne, JO; Savisto, N; Viitanen, M | 1 |
| Swerdlow, RH | 1 |
| Kaprio, J; Karrasch, M; Koskenvuo, M; Räihä, I; Rinne, JO; Viljanen, T; Virta, JJ | 1 |
| Boncoeur-Martel, MP; Maubon, A; Monteil, J | 1 |
| Hamza, TH; Stijnen, T; van Houwelingen, HC | 1 |
| Barrio, JR; Huang, SC; Kepe, V; Satyamurthy, N; Small, G | 1 |
| Adamson, JL; Alexander, GE; Bandy, D; Cannon, A; Caselli, RJ; Chen, K; Lee, W; Papassotiropoulos, A; Reiman, EM; Stephan, DA; Stephan, EA | 1 |
| Beuthien-Baumann, B; Caselli, R; Clerici, F; de Leon, MJ; Diehl-Schmid, J; Drzezga, A; Herholz, K; Holthoff, V; Kalbe, E; Kurz, A; Lucignani, G; Minoshima, S; Mosconi, L; Perneczky, R; Pupi, A; Reiman, EM; Sorbi, S; Tsui, WH | 1 |
| de la Sayette, V; Desgranges, B; Eustache, F; Giffard, B; Laisney, M; Mézenge, F | 1 |
| Alexopoulos, P; Drzezga, A; Foster, NL; Habeck, C; Koeppe, RA; Kurz, A; Perneczky, R; Stern, Y | 1 |
| Chen, WP; Matsunari, I; Nishimura, S; Ono, K; Samuraki, M; Shima, K; Takeda, N; Yamada, M; Yanase, D; Yoshita, M | 1 |
| Bates, KA; Campbell, A; Dhaliwal, SS; Foster, JK; Lenzo, NP; Martins, RN; McCarthy, M; Paton, A; Rimajova, M; Rodrigues, M; Rowe, C; Wu, JS | 1 |
| Borghetti, D; Ceravolo, R; Frosini, D; Giorgetti, A; Kiferle, L; Murri, L; Neglia, D; Petrozzi, L; Rossi, C; Sassi, N; Siciliano, G; Tognoni, G | 1 |
| Chiti, A; Clerici, F; Del Sole, A; Lecchi, M; Lucignani, G; Maggiore, L; Mariani, C; Mosconi, L | 1 |
| Cai, HC; Cheng, DF; Han, YJ; Lei, B; Wang, J; Wu, MX; Yin, DZ; Zhang, H; Zhang, L; Zheng, MQ | 1 |
| Carter, SF; Herholz, K; Jones, M | 1 |
| Azevedo, JC; Barbirato, GB; Boechat, Y; Cabral, H; Correa, PL; Dohmann, HF; Felix, RM; Manhães, AC; Mendes, MH; Mesquita, CT; Schmidt, GJ; Schmidt, SL; Tolentino, JC | 1 |
| El-Haddad, G; Lilien, DL; Patterson, JC; Takalkar, AM | 1 |
| Mazziotta, JC; Phelps, ME; Schelbert, HR | 1 |
| Creasey, H; Cutler, NR; Duara, R; Grady, CL; Haxby, JV; Rapoport, SI; Schapiro, MB | 1 |
| Brant-Zawadzki, M; Budinger, TF; Friedland, RP; Jagust, WJ | 1 |
| Brooks, R; Chase, TN; Di Chiro, G; Fedio, P; Foster, NL; Mansi, L; Patronas, NJ | 1 |
| Budinger, TF; Derenzo, SE; Friedland, RP; Ganz, E; Huesman, RH; Koss, B; Mathis, CA; Ober, BA; Yano, Y | 1 |
| Brooks, RA; Chase, TN; Di Chiro, G; Fedio, P; Foster, NL; Patronas, NJ | 1 |
| Benson, DF; Cummings, JL; Hawkins, RA; Kuhl, DE; Phelps, ME; Tsai, SY | 1 |
| Brooks, R; Chase, TN; Di Chiro, G; Fedio, P; Foster, NL; Kessler, R; Mansi, L | 1 |
| Alavi, A; Christman, DR; De Leon, MJ; Farkas, T; Ferris, SH; Fowler, JS; George, AE; Reisberg, B; Reivich, M; Wolf, AP | 1 |
| Heiss, WD; Herholz, K; Mielke, R; Szelies, B | 1 |
| Fink, G; Heiss, WD; Herholz, K; Kessler, J; Mielke, R | 1 |
| Frackowiak, RS; Kennedy, AM; Rossor, MN | 1 |
| Chase, TN; Tamminga, CA | 1 |
| Grond, M; Heiss, WD; Mielke, R; Szelies, B | 1 |
| Buchsbaum, MS; Evans, WJ; Guich, S; Nguyen, D; Nguyen, P; Rice, D; Siegel, BV; Stanley, J; Starr, A; Valladares-Neto, DC | 1 |
| Azari, NP; Pietrini, P | 1 |
| Foster, NL; Frey, KA; Koeppe, RA; Kuhl, DE; Minoshima, S | 1 |
| Akashi, Y; Fukumura, T; Ichimiya, A; Ichiya, Y; Kuwabara, Y; Masuda, K; Sasaki, M; Yoshida, T | 1 |
| Kerwin, R | 1 |
| Fink, GR; Heiss, WD; Herholz, K; Ichimiya, A; Jacobs, A; Kessler, J; Mielke, R; Pietrzyk, U | 1 |
| Foster, NL; Frey, KA; Koeppe, RA; Kuhl, DE; Meyer, M | 1 |
| Mayberg, HS | 1 |
| Heiss, WD; Herholz, K; Ichimiya, A; Kessler, J; Mielke, R; Slansky, I | 1 |
| Blin, J; Chase, TN; Giuffra, ME; Mouradian, MM; Piercey, MF | 1 |
| Frey, KA; Koeppe, RA; Kuhl, DE; Minoshima, S | 1 |
| Frey, KA; Ishihara, M; Koeppe, RA; Kuhl, DE; Minoshima, S | 1 |
| Heiss, WD; Herholz, K; Kessler, J; Mielke, R; Slansky, I; Szelies, B | 1 |
| Fukuyama, H; Kimura, J; Konishi, J; Ogawa, M; Yamaguchi, S; Yamauchi, H; Yonekura, Y | 1 |
| Barker, WW; Duara, R; Grady, C; Kippenhan, JS; Nagel, J | 1 |
| Del Sole, A; Franceschi, M; Gilardi, MC; Grassi, F; Lucignani, G; Messa, C; Perani, D; Rizzo, G; Zenorini, A; Zito, F | 1 |
| Hijdra, A; Scheltens, P; van Royen, EA; Weinstein, HC | 1 |
| Comar, D; Fazio, F; Franck, G; Heiss, WD; Herholz, K; Perani, D; Salmon, E | 1 |
| Alavi, A; Berlin, JA; Newberg, AB; Souder, E | 1 |
| Azari, NP; Grady, CL; Haxby, JV; Heston, LL; Horwitz, B; Pettigrew, KD; Pietrini, P; Rapoport, SI; Salerno, JA; Schapiro, MB | 1 |
| Foster, NL; Frey, KA; Groom, GN; Junck, L; Kuhl, DE | 1 |
| Berisford, MA; Cummings, JL; Hinkin, CH; Mahler, ME; Mandelkern, MA; Sultzer, DL; Van Gorp, WG | 1 |
| Ghaemi, M; Heiss, WD; Herholz, K; Kessler, J; Mielke, R | 1 |
| Berent, S; Giordani, B; Koeppe, RA; Kuhl, DE; Piert, M | 1 |
| Carr, CA; Fischman, AJ; González, RG; Growdon, JH; Guimaraes, AR; Halpern, EF; Rosen, BR; Stern, CE | 1 |
| Ishii, K; Jamzad, M; Senda, M; Toyama, H | 1 |
| Alexander, GE; Dani, A; Freo, U; Furey, ML; Grady, CL; Graff-Radford, N; Mentis, MJ; Pietrini, P; Schapiro, MB | 1 |
| Alexander, GE; Brady, DR; Furey, ML; Grady, CL; Mentis, MJ; Pietrini, P; Schapiro, MB | 1 |
| Albin, RL; Berent, S; Foster, NL; Frey, KA; Giordani, B; Koeppe, RA; Kuhl, DE; Minoshima, S; Vander Borght, T | 1 |
| Ishii, K; Kitagaki, H; Matsuda, K; Mori, E; Sakamoto, S; Sasaki, M; Yamaji, S | 1 |
| Berent, S; Foster, NL; Frey, KA; Giordani, B; Kuhl, DE; Minoshima, S | 1 |
| Alexander, GE; Dani, A; Freo, U; Furey, ML; Grady, CL; Haxby, JV; Horwitz, B; Mangot, D; Mentis, MJ; Pietrini, P; Schapiro, MB; Simon, EW | 1 |
| Convit, A; Daisley, K; de Leon, MJ; De Santi, S; Golomb, J; McEwen, B; McRae, T; Orentreich, N; Rusinek, H; Tarshish, C; Volkow, N | 1 |
| Hatazawa, J; Kondoh, Y; Nagata, K; Sasaki, H | 1 |
| Fujiwara, T; Itoh, M; Meguro, K; Yamadori, A; Yamaguchi, S | 1 |
| Chen, SS; Karaca, TJ; Mega, MS; Small, GW; Thompson, PM; Tiwari, A; Toga, AW; Vinters, HV; Woods, RP | 1 |
| Magistretti, PJ | 1 |
| Montz, HR | 1 |
| Blin, J; Coppens, A; De Volder, A; Ivanoiu, A; Labar, D; Laterre, EC; Michel, C | 1 |
| Hashimoto, M; Hirono, N; Ikejiri, Y; Imamura, T; Ishii, K; Mori, E; Sasaki, M; Shimomura, T; Yamashita, H | 1 |
| Ghaemi, M; Heiss, WD; Herholz, K; Kessler, J; Kittner, B; Mielke, R; Szelies, B | 1 |
| Baron, JC; Benali, K; de la Sayette, V; Desgranges, B; Eustache, F; Landeau, B; Lechevalier, B; Petit-Taboué, MC | 1 |
| Doraiswamy, PM; Pitchumoni, S; Steffens, DC; Tabrizi, S | 1 |
| Heiss, WD; Kessler, J; Mielke, R; Uhlhaas, S; Zerres, K | 1 |
| Hirono, N; Ikeda, M; Ikejiri, Y; Imamura, T; Ishii, K; Kitagaki, H; Mori, E; Sasaki, M; Shimomura, T; Yamashita, H | 1 |
| Hashimoto, M; Hirono, N; Imamura, T; Ishii, K; Kitagaki, H; Mori, E; Sakamoto, S; Sasaki, M; Shimomura, T; Yamaji, S | 1 |
| Hashimoto, M; Hirono, N; Ikejiri, Y; Imamura, T; Ishii, K; Mori, E; Sasaki, M; Shimomura, T; Yamashita, H; Yasuda, M | 1 |
| Bettinardi, V; Colleluori, A; Fazio, F; Frackowiak, RS; Friston, K; Grassi, F; Lucignani, G; Paulesu, E; Perani, D; Signorini, M | 1 |
| Alexander, GE; Dani, A; Furey, ML; Guazzelli, M; Mentis, MJ; Pietrini, P; Rapoport, SI; Schapiro, MB | 1 |
| Baron, JC; Blaizot, X; Chavoix, C; Kondoh, Y; Le Mestric, C; Meguro, K | 1 |
| Ishii, K; Kitagaki, H; Mori, E; Sakamoto, S; Sasaki, M; Yamaji, S | 1 |
| Arai, H; Higuchi, M; Itoh, M; Iwatsubo, T; Matsui, T; Okamura, N; Sasaki, H; Tashiro, M; Tomita, T | 1 |
| Chu, T; Cole, G; Frautschy, SA; Mazziotta, JC; Mega, MS; Shah, A; Thompson, PM; Toga, AW; Trivedi, KH | 1 |
| Cross, DJ; Foster, NL; Henry, TR; Kuhl, DE; Minoshima, S | 1 |
| Mountz, JM; San Pedro, EC; Sarangi, S | 1 |
| Arai, H; Hara, S; Higuchi, M; Higuchi, S; Itoh, M; Okamura, N; Sasaki, H; Shin, RW; Tashiro, M; Trojanowski, JQ | 1 |
| Ishii, K; Katayama, Y; Kitamura, S; Mishina, M; Ohyama, M; Senda, M; Tanizaki, N | 1 |
| Alexander, GE; Dani, A; Furey, ML; Guazzelli, M; Horwitz, B; Mentis, MJ; Pietrini, P; Rapoport, SI; Shapiro, MB | 1 |
| Berndt, JD; Callaway, NL; Chen, K; Games, D; Gonzalez-Lima, F; Minear, D; Reiman, EM; Uecker, A | 1 |
| Phelps, ME; Silverman, DH | 1 |
| Coleman, RE; Crain, B; Earl, N; Hanson, M; Hoffman, JM; Hulette, C; Welsh-Bohmer, KA | 1 |
| De Bleecker , J; De Reuck , J; Dierckx, R; Goethals, P; Lemahieu, I; Santens, P; Slegers, G; Strijckmans, K | 1 |
| Cummings, JL; Dinov, ID; Felix, J; Masterman, DL; Mega, MS; O'Connor, SM; Phelps, ME; Reback, E; Small, GW; Toga, AW | 1 |
| Abel, L; Buchsbaum, MS; Ciaravolo, TM; Davis, KL; Hazlett, EA; Luu-Hsia, C; Marin, D; Schröder, J; Shihabuddin, L; Spiegel-Cohen, J; Tang, C; Wei, TC | 1 |
| Arai, H; Higuchi, M; Hu, XS; Itoh, M; Matsui, T; Okamura, N; Sasaki, H; Takeda, A; Tashiro, M | 1 |
| Cross, DJ; Drzezga, A; Ficaro, EP; Ishii, K; Kuhl, DE; Minoshima, S; Schwaiger, M; Willoch, F | 1 |
| Alva, G; Anand, R; Carreon, D; Fallon, JH; Fleming, K; Hartman, R; Keator, D; Messina, J; Potkin, SG; Wu, JC | 1 |
| Fukuyama, H; Ihara, M; Kohara, N; Lee, T; Shibasaki, H; Takao, S | 1 |
| Ebmeier, K; Eschner, W; Heiss, WD; Herholz, K; Mielke, R; Scheidhauer, K; Schicha, H; Schmidt, M; Schopphoff, H | 1 |
| de Leon, MJ; Felder, CA; Mueller, K; Volkow, ND; Wang, GJ; Welsh, TF; Zhu, W | 1 |
| Baron, JC; de La Sayette, V; Desgranges, B; Eustache, F; Giffard, B; Lalevée, C; Viader, F | 1 |
| Berndt, JD; Chen, K; Cherry, SR; Games, D; Gonzalez-Lima, F; Reiman, EM; Valla, J | 1 |
| Alexander, GE; Chen, K; Pietrini, P; Rapoport, SI; Reiman, EM | 1 |
| Barker, WW; Chang, J; Duara, R; Loewenstein, DA; Pascal, S; Yoshii, F | 1 |
| Fairbanks, LA; Guze, BH; Mandelkern, MA; Min, CA; Small, GW; Stern, CE | 1 |
| Braun, A; Chase, TN; Coppola, R; Gibson, R; Gorey, J; Jones, D; Mann, U; Reba, RC; Weinberger, DR | 1 |
| Heiss, WD; Herholz, K; Holthoff, V; Huber, M; Karbe, H; Wagner, R; Wienhard, K | 1 |
| Baxter, LR; Guze, BH; Hoffman, JM; Mazziotta, JC; Phelps, ME | 2 |
| Heiss, WD; Herholz, K; Kessler, J; Szelies, B | 1 |
| Baxter, LR; Guze, BH; Mazziotta, JC; Phelps, ME; Schwartz, JM; Szuba, MP | 1 |
| Fukuyama, H; Harada, K; Kameyama, M; Kimura, J; Konishi, J; Miyoshi, T; Senda, M; Yamaguchi, S; Yamauchi, H; Yonekura, Y | 1 |
| Brandt, J; Burns, A; Folstein, MF; Frost, JJ; Harris, G; Mayberg, H; Sapp, J; Steele, C; Tune, L; Wagner, HN | 1 |
| Buchsbaum, MS; Chui, H; Cotman, CW; Hazlett, E; Kesslak, JP; Lynch, G; Sicotte, N; Teng, E; Wu, J | 1 |
| Budinger, TF; Coxson, PG; Huesman, RH; Jagust, WJ; Mathis, CA; Reed, BR; Seab, JP; Valk, PE | 1 |
| Friedland, RP; Grady, C; Haxby, JV; Kumar, A; Rapoport, SI; Salerno, JA; Schapiro, MB; Wagner, E | 1 |
| Blin, J; Chase, TN; Claus, JJ; Giuffra, M; Ludwig, C; Mohr, E | 1 |
| Grond, M; Heiss, WD; Herholz, K; Kessler, J | 1 |
| Hatazawa, J; Itoh, M; Kinomura, S; Matsui, H; Matsuzawa, T; Meguro, K; Ueda, M; Yamada, K; Yamaguchi, T | 1 |
| Friedland, RP; Grady, CL; Haxby, JV; Kumar, A; Schapiro, MB | 1 |
| Akiyama, H; Beattie, BL; Calne, DB; Crockett, D; Harrop, R; McGeer, EG; McGeer, PL; Parks, R; Peppard, RP; Tuokko, H | 1 |
| Budinger, TF; Derenzo, SE; Geyer, AB; Huesman, RH; Jagust, WJ; Valk, PE | 1 |
| Heiss, WD; Herholz, K; Pawlik, G; Szelies, B; Wienhard, K | 1 |
| Barker, W; Bowen, B; Duara, R; Loewenstein, D; Pascal, S | 1 |
| Akiyama, H; Harrop, R; McGeer, EG; McGeer, PL; Peppard, R | 1 |
| Akiyama, H; Harrop, R; McGeer, EG; McGeer, PL | 1 |
| Budinger, TF; Friedland, RP; Huesman, RH; Jagust, WJ; Knittel, B; Koss, E; Mathis, CA; Mazoyer, BM; Ober, BA | 1 |
| Cutler, NR; Davies, P; Haxby, JV; Heston, LL; Schapiro, MB | 1 |
| Cutler, NR | 1 |
| Kuhl, DE; Markham, CH; Mazziotta, JC; Metter, EJ; Phelps, ME; Riege, WH | 1 |
| Berg, G; Friedland, RP; Grady, CL; Haxby, JV; Horwitz, B; Rapoport, SI; Schapiro, M; Sundaram, M | 1 |
| Chase, TN; Fedio, P; Foster, NL; Gillespie, MM; Patronas, NJ | 1 |
| Cutler, NR; Duara, R; Grady, C; Haxby, J; Heston, L; Larson, S; Moore, A; Rapoport, SI; Schlageter, N; Sundaram, M | 1 |
| Harrop, R; Kamo, H; Li, DK; Martin, WR; McGeer, EG; McGeer, PL; Pate, BD | 1 |
| Brouwers, P; Chase, TN; Cox, C; Fedio, P; Foster, NL; Lalonde, F; Martin, A; Teleska, P | 1 |
| Berg, G; Grady, C; Haxby, JV; Luxenberg, JS; May, C; Moore, A; Rapoport, SI; Robinette, D; White, BJ | 1 |
| Duara, R; Grady, CL; Horwitz, B; Rapoport, SI; Schlageter, NL | 1 |
| Agranoff, BW; Aldrich, MS; Berent, S; Foster, NL; Gilman, S; Hichwa, RH; Sackellares, JC; VanDerSpek, AF | 1 |
| Brown, RT; Di Chiro, G; Feldman, RG; Nee, LE; Noble, H; Polinsky, RJ | 1 |
| Alavi, A; Alavi, J; Chawluk, J; Fazekas, F; Kushner, M; Reivich, M; Rosen, M; Tobin, M | 1 |
| Berg, G; Grady, CL; Haxby, JV; Horwitz, B; Rapoport, SI | 1 |
| Adam, MJ; Ammann, W; Beattie, BL; Calne, DB; Harrop, R; Kamo, H; Li, DK; McGeer, EG; McGeer, PL; Tuokko, H | 1 |
| Budinger, TF; Friedland, RP; Koss, E; Ober, BA | 1 |
| Friedland, RP; Jagust, WJ; Koss, E; Ober, BA | 1 |
| Hawkins, RA; Kuhl, DE; Metter, EJ; Riege, WH | 1 |
| Cutler, NR; Duara, R; Grady, CL; Haxby, JV; Heston, L; Margolin, RM; Moore, AM; Parisi, JE; Rapoport, SI; White, J | 1 |
| Budinger, TF; Friedland, RP; Jagust, WJ | 1 |
| Kuhl, DE; Metter, EJ; Riege, WH | 1 |
96 review(s) available for fluorodeoxyglucose f18 and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Predicting cognitive decline in older people by structural and molecular imaging.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Positron-Emission Tomography; Prognosis; tau Proteins | 2023 |
Presenilin-1 mutation is associated with a hippocampus defect in alzheimer's disease: Meta-Analysis for neuroimaging research.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Brain; Fluorodeoxyglucose F18; Glucose; Hippocampus; Humans; Magnetic Resonance Imaging; Neuroimaging; Organ Size; Positron-Emission Tomography; Presenilin-1; Radiopharmaceuticals; Thiazoles | 2020 |
Optimizing Use of Neuroimaging Tools in Evaluation of Prodromal Alzheimer's Disease and Related Disorders.
Topics: Alzheimer Disease; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Neuroimaging; Positron-Emission Tomography; Prodromal Symptoms | 2020 |
Usefulness of Brain Positron Emission Tomography with Different Tracers in the Evaluation of Patients with Idiopathic Normal Pressure Hydrocephalous.
Topics: Alzheimer Disease; Amyloid; Amyloidogenic Proteins; Brain; Cerebrovascular Circulation; Fluorodeoxyglucose F18; Humans; Hydrocephalus, Normal Pressure; Neurodegenerative Diseases; Positron-Emission Tomography; tau Proteins; Ventriculoperitoneal Shunt | 2020 |
Amyloid-PET and
Topics: Aged; Alzheimer Disease; Amyloid beta-Protein Precursor; Brain; Dementia, Vascular; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography | 2020 |
Brain [F-18]FDG PET for Clinical Dementia Workup: Differential Diagnosis of Alzheimer's Disease and Other Types of Dementing Disorders.
Topics: Alzheimer Disease; Brain; Dementia; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography | 2021 |
Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework.
Topics: Alzheimer Disease; Biomarkers; Brain; Cognitive Dysfunction; Dementia; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results | 2017 |
Current and future prospects of nuclear medicine in dementia.
Topics: Alzheimer Disease; Amyloidogenic Proteins; Brain; Dementia; Diagnosis, Differential; Early Diagnosis; Fluorodeoxyglucose F18; Humans; Nuclear Medicine; Positron-Emission Tomography; Radiopharmaceuticals; tau Proteins; Tomography, Emission-Computed, Single-Photon | 2017 |
The diagnostic value of FDG and amyloid PET in Alzheimer's disease-A systematic review.
Topics: Aged; Alzheimer Disease; Amyloid; Biomarkers; Brain; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2017 |
Use of multimodality imaging and artificial intelligence for diagnosis and prognosis of early stages of Alzheimer's disease.
Topics: Alzheimer Disease; Artificial Intelligence; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Machine Learning; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Prognosis | 2018 |
Clinical utility of FDG-PET for the clinical diagnosis in MCI.
Topics: Alzheimer Disease; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Positron-Emission Tomography | 2018 |
Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia.
Topics: Alzheimer Disease; Dementia; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Positron-Emission Tomography; Prospective Studies | 2018 |
Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer's disease.
Topics: Alzheimer Disease; Apolipoproteins E; Brain; Fluorodeoxyglucose F18; Genetic Predisposition to Disease; Humans; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals | 2018 |
18F-FDG PET for Prediction of Conversion to Alzheimer's Disease Dementia in People with Mild Cognitive Impairment: An Updated Systematic Review of Test Accuracy.
Topics: Alzheimer Disease; Brain; Cognitive Dysfunction; Disease Progression; Fluorodeoxyglucose F18; Humans; Neuropsychological Tests; Positron-Emission Tomography | 2018 |
Update on PET in neurodegenerative and neuroinflammatory disorders manifesting on a behavioural level: imaging for differential diagnosis.
Topics: Alzheimer Disease; Brain; Diagnosis, Differential; Fluorodeoxyglucose F18; Glucose; Humans; Inflammation; Neurodegenerative Diseases; Neuroimaging; Positron-Emission Tomography; Prospective Studies | 2019 |
Imaging markers for Alzheimer disease: which vs how.
Topics: Alzheimer Disease; Biomarkers; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Radiography; Tomography, Emission-Computed, Single-Photon | 2013 |
The interest of amyloid PET imaging in the diagnosis of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Brain; Fluorodeoxyglucose F18; Humans; Peptide Fragments; Positron-Emission Tomography; Reproducibility of Results | 2013 |
PET radiotracers for molecular imaging in dementia.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Biomarkers; Brain; Dementia; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Molecular Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Synucleins; tau Proteins | 2013 |
Time for tau.
Topics: Alzheimer Disease; Animals; Brain; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; tau Proteins | 2014 |
Early detection of Alzheimer's disease using PiB and FDG PET.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Biomarkers; Brain; Cognition; Cognitive Dysfunction; Fluorodeoxyglucose F18; Glucose; Humans; Positron-Emission Tomography; Thiazoles | 2014 |
FDG-PET and amyloid-PET imaging: the diverging paths.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Brain; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography | 2014 |
Meta-analytic comparison between PIB-PET and FDG-PET results in Alzheimer's disease and MCI.
Topics: Alzheimer Disease; Aniline Compounds; Cognitive Dysfunction; Fluorodeoxyglucose F18; Glucose; Humans; Positron-Emission Tomography; Thiazoles | 2015 |
Guidance for reading FDG PET scans in dementia patients.
Topics: Alzheimer Disease; Brain; Dementia; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Nuclear Medicine; Positron-Emission Tomography; Radiopharmaceuticals; Reference Values; Software | 2014 |
Biomarkers in the Diagnosis and Prognosis of Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Automation, Laboratory; Biomarkers; Brain; Early Diagnosis; Enzyme Multiplied Immunoassay Technique; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Neuroimaging; Neurons; Peptide Fragments; Phosphorylation; Positron-Emission Tomography; Prognosis; Protein Processing, Post-Translational; Radiopharmaceuticals; tau Proteins | 2015 |
Molecular imaging in genetics.
Topics: Alzheimer Disease; Brain; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Molecular Imaging; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
Topics: Aged; Alzheimer Disease; Brain; Cognitive Dysfunction; Dementia; Disease Progression; Early Diagnosis; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2015 |
[Possibilities of modern imaging technologies in early diagnosis of Alzheimer disease].
Topics: Aged; Alzheimer Disease; Atrophy; Brain; Early Diagnosis; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Plaque, Amyloid; Positron-Emission Tomography; Switzerland | 2015 |
The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015.
Topics: Alzheimer Disease; Apolipoprotein E4; Brain; Brain Mapping; Cognition Disorders; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Longitudinal Studies; Positron-Emission Tomography | 2015 |
How far is arterial spin labeling MRI from a clinical reality? Insights from arterial spin labeling comparative studies in Alzheimer's disease and other neurological disorders.
Topics: Alzheimer Disease; Animals; Arteries; Brain; Cerebrovascular Circulation; Cerebrovascular Disorders; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nervous System Diseases; Oxygen Isotopes; Positron-Emission Tomography; Rats; Spin Labels; Tomography, Emission-Computed, Single-Photon | 2016 |
FDG-PET Contributions to the Pathophysiology of Memory Impairment.
Topics: Aging; Alcoholism; Alzheimer Disease; Amyloid beta-Peptides; Atrophy; Brain; Female; Fluorodeoxyglucose F18; Glucose; Gray Matter; Humans; Image Processing, Computer-Assisted; Memory Disorders; Middle Aged; Neurodegenerative Diseases; Positron-Emission Tomography; Signal Processing, Computer-Assisted | 2015 |
Integration of (18)FDG-PET Metabolic and Functional Connectomes in the Early Diagnosis and Prognosis of the Alzheimer's Disease.
Topics: Alzheimer Disease; Disease Progression; Early Diagnosis; Electroencephalography; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography | 2016 |
Statistical Voxel-Based Methods and [18F]FDG PET Brain Imaging: Frontiers for the Diagnosis of AD.
Topics: Alzheimer Disease; Brain; Brain Mapping; Data Interpretation, Statistical; Fluorodeoxyglucose F18; Humans; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
[The PET, Past and Future].
Topics: Alzheimer Disease; Brain; Cardiovascular System; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Brain fluorodeoxyglucose (FDG) PET in dementia.
Topics: Alzheimer Disease; Animals; Dementia; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Brain; Cognition; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Risk Reduction Behavior; tau Proteins | 2016 |
[Brain imaging of Alzheimer' disease: state of the art and perspectives for clinicians].
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Brain; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Neuroimaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; tau Proteins | 2016 |
Alterations in Glucose Metabolism in Alzheimer's Disease.
Topics: Alzheimer Disease; Animals; Biomarkers; Blood Glucose; Brain; Diabetes Mellitus, Type 2; Drug Discovery; Fluorodeoxyglucose F18; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Nerve Degeneration; Neuroprotective Agents; Patents as Topic; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Risk Factors | 2016 |
FDG-PET for Prediction of AD Dementia in Mild Cognitive Impairment. A Review of the State of the Art with Particular Emphasis on the Comparison with Other Neuroimaging Modalities (MRI and Perfusion SPECT).
Topics: Alzheimer Disease; Cognitive Dysfunction; Disease Progression; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2017 |
Realizing the potential of positron emission tomography with 18F-fluorodeoxyglucose to improve the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Brain; Clinical Trials as Topic; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
Cerebrospinal fluid: when is it worthwhile to do a lumbar puncture?
Topics: Alzheimer Disease; Cognition Disorders; Creutzfeldt-Jakob Syndrome; Dementia; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Spinal Puncture; tau Proteins; Temporal Lobe | 2008 |
FDG and amyloid positron emission tomography.
Topics: Aged; Alzheimer Disease; Brain; Fluorodeoxyglucose F18; Humans; Plaque, Amyloid; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
Fluorodeoxyglucose-positron-emission tomography, single-photon emission tomography, and structural MR imaging for prediction of rapid conversion to Alzheimer disease in patients with mild cognitive impairment: a meta-analysis.
Topics: Alzheimer Disease; Cognition Disorders; Disease Progression; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Predictive Value of Tests; Severity of Illness Index; Tomography, Emission-Computed, Single-Photon | 2009 |
Three-year follow-up of a patient with early-onset Alzheimer's disease with presenilin-2 N141I mutation - case report and review of the literature.
Topics: Age of Onset; Alzheimer Disease; Cholinesterase Inhibitors; Codon; Donepezil; Electrophysiology; Excitatory Amino Acid Antagonists; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Indans; Male; Memantine; Middle Aged; Mutation, Missense; Neuropsychological Tests; Pedigree; Piperidines; Presenilin-2; Radiography; Radionuclide Imaging; Radiopharmaceuticals; tau Proteins; Time Factors; Treatment Outcome | 2008 |
[Molecular imaging by PET/SPECT].
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Drug Design; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Mice; Neoplasms; Neurofibrillary Tangles; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2009 |
Amyloid PET and MRI in Alzheimer's disease and mild cognitive impairment.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Benzothiazoles; Brain Mapping; Cognition Disorders; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Thiazoles | 2009 |
[Positron emission tomography: contribution to diagnosis of dementia and development of disease-modifying drugs].
Topics: Alzheimer Disease; Amyloid; Clinical Trials as Topic; Cohort Studies; Drug Discovery; Early Diagnosis; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Nimodipine; Nootropic Agents; Positron-Emission Tomography; Radiopharmaceuticals | 2009 |
Pre-clinical detection of Alzheimer's disease using FDG-PET, with or without amyloid imaging.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Brain; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography | 2010 |
Early detection of Alzheimer's disease with PET imaging.
Topics: Alzheimer Disease; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography | 2010 |
Maternal transmission of Alzheimer's disease: prodromal metabolic phenotype and the search for genes.
Topics: Age of Onset; Alzheimer Disease; Brain Mapping; Fluorodeoxyglucose F18; Genetic Predisposition to Disease; Humans; Mothers; Phenotype; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |
FDG-PET for early assessment of Alzheimer's disease: isn't the evidence base large enough?
Topics: Alzheimer Disease; Animals; Biomarkers; Early Diagnosis; Fluorodeoxyglucose F18; Humans; Multicenter Studies as Topic; Positron-Emission Tomography | 2010 |
Cerebral glucose metabolism in preclinical and prodromal Alzheimer's disease.
Topics: Alzheimer Disease; Brain; Cognition Disorders; Disease Progression; Fluorodeoxyglucose F18; Glucose; Humans; Positron-Emission Tomography | 2010 |
Amyloid imaging as a surrogate marker in clinical trials in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Biomarkers; Brain; Clinical Trials as Topic; Fluorodeoxyglucose F18; Humans; Models, Neurological; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles | 2011 |
FDG- and amyloid-PET in Alzheimer's disease: is the whole greater than the sum of the parts?
Topics: Aged; Aging; Alzheimer Disease; Amyloid beta-Peptides; Apolipoproteins E; Brain; Dementia; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2011 |
Positron emission tomography radiopharmaceuticals for imaging brain Beta-amyloid.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Aniline Compounds; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzothiazoles; Cerebral Cortex; Dementia; Ethylene Glycols; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neurofibrillary Tangles; Nitriles; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles | 2011 |
The concept of FDG-PET endophenotype in Alzheimer's disease.
Topics: Alzheimer Disease; Causality; Endophenotypes; Fluorodeoxyglucose F18; Genetic Markers; Humans; Neuroprotective Agents; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
Amyloid imaging.
Topics: Alzheimer Disease; Cerebral Cortex; Cognitive Dysfunction; Early Diagnosis; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Neuroimaging; Positron-Emission Tomography; Tomography, Emission-Computed, Single-Photon | 2011 |
Perfusion SPECT and FDG-PET.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cerebral Cortex; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Tomography, Emission-Computed, Single-Photon | 2011 |
FDG-PET imaging, EEG and sleep phenotypes as translational biomarkers for research in Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Biomarkers; Circadian Rhythm; Disease Models, Animal; Electroencephalography; Fluorodeoxyglucose F18; Humans; Mice; Mice, Transgenic; Phenotype; Positron-Emission Tomography; Sleep; Translational Research, Biomedical | 2011 |
Imaging Alzheimer in 2011.
Topics: Alzheimer Disease; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2011 |
Nuclear medicine imaging in dementia: a practical overview for hospitalists.
Topics: Aged; Alzheimer Disease; Amyloid; Dementia; Diagnosis, Computer-Assisted; Diagnosis, Differential; Dopamine Plasma Membrane Transport Proteins; Fluorodeoxyglucose F18; Hospitalists; Humans; Lewy Body Disease; Nuclear Medicine; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2011 |
Fluorodeoxyglucose positron emission tomography: emerging roles in the evaluation of putative Alzheimer's disease-modifying treatments.
Topics: Alzheimer Disease; Biomarkers; Brain; Clinical Trials as Topic; Endpoint Determination; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
Effectiveness and safety of 18F-FDG PET in the evaluation of dementia: a review of the recent literature.
Topics: Alzheimer Disease; Dementia; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Reference Standards; Safety | 2012 |
Diagnostic accuracy of 18 F-FDG and 11 C-PIB-PET for prediction of short-term conversion to Alzheimer's disease in subjects with mild cognitive impairment.
Topics: Aged; Alzheimer Disease; Aniline Compounds; Benzothiazoles; Clinical Trials as Topic; Cognitive Dysfunction; Cross-Sectional Studies; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Thiazoles | 2012 |
Brain imaging in Alzheimer disease.
Topics: Alzheimer Disease; Amyloid; Biomarkers; Brain; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neuroimaging; Positron-Emission Tomography; Prognosis; Radiography; Radiopharmaceuticals | 2012 |
Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Fluorodeoxyglucose F18; Humans; Incidence; Magnetic Resonance Imaging; Middle Aged; Neurobiology; Neuroimaging; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Risk Factors; United States | 2012 |
Mitochondria and Alzheimer's disease.
Topics: Alzheimer Disease; Brain; Fluorodeoxyglucose F18; Humans; Mitochondria; Oxidative Stress; Positron-Emission Tomography; tau Proteins | 2012 |
[An overview of biomarkers in Alzheimer's disease].
Topics: Adipokines; alpha 1-Antitrypsin; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Chitinase-3-Like Protein 1; Fluorodeoxyglucose F18; Humans; Lectins; Peptide Fragments; Phosphorylation; Positron-Emission Tomography; Presenilins; tau Proteins | 2012 |
Use of FDG PET as an imaging biomarker in clinical trials of Alzheimer's disease.
Topics: Alzheimer Disease; Biomarkers; Clinical Trials as Topic; Fluorodeoxyglucose F18; Glucose; Humans; Positron-Emission Tomography | 2012 |
Preclinical sporadic Alzheimer's disease: target for personalized diagnosis and preventive intervention.
Topics: Age Factors; Alzheimer Disease; Amyloid beta-Peptides; Apolipoprotein E4; Brain; Cellular Senescence; Disease Progression; Early Diagnosis; Fluorodeoxyglucose F18; Genetic Markers; Genetic Predisposition to Disease; Glucose; Humans; Magnetic Resonance Imaging; Mass Screening; Mitochondria; Neuroimaging; Positron-Emission Tomography; Precision Medicine; Radiopharmaceuticals; Risk Factors | 2013 |
[Imaging diagnosis of Alzheimer's disease].
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Atrophy; Brain; Carbon Radioisotopes; Cerebral Cortex; Diagnostic Imaging; Diffusion Tensor Imaging; Dominance, Cerebral; Energy Metabolism; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Nerve Net; Organ Size; Oxygen; Positron-Emission Tomography; Radiographic Image Enhancement; Regional Blood Flow; Thiazoles | 2012 |
Clinical application of positron emission tomography for diagnosis of dementia.
Topics: Alzheimer Disease; Brain; Dementia; Female; Fluorodeoxyglucose F18; Glucose; Health Care Surveys; Humans; Japan; Middle Aged; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed | 2002 |
18F-fluorodeoxyglucose-positron emission tomography: a new explorative perspective.
Topics: Aged; Alzheimer Disease; Animals; Aortic Aneurysm; Arteriosclerosis; Autoimmune Diseases; Fever of Unknown Origin; Fluorodeoxyglucose F18; Geriatrics; Humans; Inflammation; Models, Animal; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
PET studies in dementia.
Topics: Acetylcholine; Alzheimer Disease; Brain; Dementia; Dopamine; Fluorodeoxyglucose F18; Glucose; Humans; Image Interpretation, Computer-Assisted; Multicenter Studies as Topic; Neurotransmitter Agents; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Imaging Alzheimer's disease: clinical applications.
Topics: Alzheimer Disease; Autopsy; Biopsy; Brain; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Predictive Value of Tests; Radiopharmaceuticals; Stereotaxic Techniques; Tomography, Emission-Computed | 2003 |
Alzheimer disease: operating characteristics of PET--a meta-analysis.
Topics: Alzheimer Disease; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Severity of Illness Index; Tomography, Emission-Computed | 2004 |
Clinical diagnosis of MM2-type sporadic Creutzfeldt-Jakob disease.
Topics: 14-3-3 Proteins; Age of Onset; Aged; Alzheimer Disease; Biomarkers; Blotting, Western; Cerebral Cortex; Cerebrospinal Fluid Proteins; Cerebrovascular Circulation; Creutzfeldt-Jakob Syndrome; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Electroencephalography; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Phenotype; Positron-Emission Tomography; Prions; Supranuclear Palsy, Progressive; Thalamus; Tomography, Emission-Computed, Single-Photon | 2005 |
Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.
Topics: Alzheimer Disease; Animals; Brain; Cognition Disorders; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Severity of Illness Index; Tissue Distribution | 2005 |
Functional activation imaging in aging and dementia.
Topics: Aged; Aging; Alzheimer Disease; Brain; Cerebrovascular Circulation; Fluorodeoxyglucose F18; Functional Laterality; Humans; Magnetic Resonance Imaging; Nerve Degeneration; Positron-Emission Tomography; Prefrontal Cortex; Radiopharmaceuticals | 2005 |
Molecular imaging in Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Brain; Fluorodeoxyglucose F18; Humans; Mice; Molecular Biology; Molecular Probe Techniques; Positron-Emission Tomography; Tomography, Emission-Computed, Single-Photon | 2005 |
Positron emission tomography diagnosis of Alzheimer's disease.
Topics: Alzheimer Disease; Brain; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
The Alzheimer's disease neuroimaging initiative.
Topics: Aged; Alzheimer Disease; Biomarkers; Brain; Canada; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; United States | 2005 |
Seeing is believing: neuroimaging adds to our understanding of cerebral pathology.
Topics: Aging; Alzheimer Disease; Brain; Contrast Media; Fluorodeoxyglucose F18; Humans; Image Enhancement; Plaque, Amyloid; Positron-Emission Tomography | 2006 |
Combined biomarkers for early Alzheimer disease diagnosis.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cognition Disorders; Fluorodeoxyglucose F18; Humans; Neuropsychological Tests; Peptide Fragments; Positron-Emission Tomography; Proteome; Serum Amyloid A Protein; tau Proteins | 2007 |
Mild cognitive impairment: a systematic review.
Topics: Alzheimer Disease; Apolipoprotein E4; Brain; Cognition Disorders; Dementia, Vascular; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Memory Disorders; Neuropsychological Tests; Radiopharmaceuticals; Risk Factors; Severity of Illness Index | 2007 |
[Imaging of the Alzheimer's disease: MRI and functional imaging].
Topics: Alzheimer Disease; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Memory Disorders; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
Positron emission tomography imaging in dementia.
Topics: Alzheimer Disease; Blood Glucose; Brain; Cognition Disorders; Dementia; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Neurotransmitter Agents; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
Positron computed tomography for studies of myocardial and cerebral function.
Topics: Alzheimer Disease; Animals; Brain; Brain Neoplasms; Cardiomyopathies; Cerebrovascular Disorders; Deoxyglucose; Dogs; Epilepsy; Fatty Acids; Fluorodeoxyglucose F18; Glucose; Heart; Humans; Huntington Disease; Regional Blood Flow; Tomography, Emission-Computed | 1983 |
FDG PET and differential diagnosis of dementia.
Topics: Alzheimer Disease; Blood Glucose; Brain; Dementia; Dementia, Vascular; Deoxyglucose; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Tomography, Emission-Computed | 1995 |
Clinical correlates of PET- and SPECT-identified defects in dementia.
Topics: Alzheimer Disease; Brain; Cognition Disorders; Delusions; Dementia; Deoxyglucose; Depressive Disorder; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Organotechnetium Compounds; Oximes; Severity of Illness Index; Technetium Tc 99m Exametazime; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 1994 |
Functional imaging in dementia: an overview.
Topics: Alzheimer Disease; Brain; Dementia; Deoxyglucose; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1994 |
Neuro-imaging in the diagnosis of Alzheimer's disease. II. Positron and single photon emission tomography.
Topics: Alzheimer Disease; Brain; Cerebrovascular Circulation; Cognition Disorders; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Organotechnetium Compounds; Oximes; Technetium Tc 99m Exametazime; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1993 |
[Neurodegenerative disorders and functional imaging: role of astrocytes].
Topics: Alzheimer Disease; Astrocytes; Fluorodeoxyglucose F18; Genetic Testing; Humans; Radiopharmaceuticals; Risk Factors; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1997 |
Early recognition of Alzheimer's disease: what is consensual? What is controversial? What is practical?
Topics: Aged; Alzheimer Disease; Brain; Cognition Disorders; Decision Trees; Delirium; Dementia, Vascular; Depressive Disorder; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Incidence; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Memory Disorders; Severity of Illness Index; Tomography, Emission-Computed | 1998 |
[18F]-fluorodeoxyglucose (FDG) and positron emission tomography (PET) in aging and dementia. A decade of studies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Alzheimer Disease; Child; Deoxy Sugars; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radionuclide Imaging | 1989 |
NIH Conference. Alzheimer's disease and Down's syndrome: new insights.
Topics: Adult; Age Factors; Aged; Alzheimer Disease; Brain; Brain Chemistry; Cognition; Dementia; Deoxyglucose; Down Syndrome; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Memory; Middle Aged; Neurotransmitter Agents; Parasympathetic Nervous System; Psychological Tests; Tomography, Emission-Computed | 1985 |
Positron emission tomography in patients with clinically diagnosed Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Atrophy; Cerebellar Cortex; Cerebral Cortex; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Levodopa; Magnetic Resonance Spectroscopy; Male; Middle Aged; Oxygen; Psychological Tests; Radioisotopes; Tomography, Emission-Computed; Tomography, X-Ray Computed; Water | 1986 |
62 trial(s) available for fluorodeoxyglucose f18 and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Brain FDG PET for Short- to Medium-Term Prediction of Further Cognitive Decline and Need for Assisted Living in Acutely Hospitalized Geriatric Patients With Newly Detected Clinically Uncertain Cognitive Impairment.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Uncertainty | 2022 |
Neuroimaging analyses from a randomized, controlled study to evaluate plasma exchange with albumin replacement in mild-to-moderate Alzheimer's disease: additional results from the AMBAR study.
Topics: Albumins; Alzheimer Disease; Brain; Fluorodeoxyglucose F18; Humans; Immunoglobulins, Intravenous; Magnetic Resonance Imaging; Neuroimaging; Plasma Exchange; Positron-Emission Tomography | 2022 |
Oral Tau Aggregation Inhibitor for Alzheimer's Disease: Design, Progress and Basis for Selection of the 16 mg/day Dose in a Phase 3, Randomized, Placebo-Controlled Trial of Hydromethylthionine Mesylate.
Topics: Activities of Daily Living; Alzheimer Disease; Atrophy; Fluorodeoxyglucose F18; Humans; Mesylates | 2022 |
Predictive Value of
Topics: Aged; Alzheimer Disease; Aniline Compounds; Cognitive Dysfunction; Diagnosis, Differential; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Positron-Emission Tomography; Predictive Value of Tests | 2020 |
Brain
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Software | 2020 |
Safety and target engagement profile of two oxaloacetate doses in Alzheimer's patients.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cognition; Dose-Response Relationship, Drug; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glucose; Glutathione; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuropsychological Tests; Oxaloacetic Acid; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Benfotiamine and Cognitive Decline in Alzheimer's Disease: Results of a Randomized Placebo-Controlled Phase IIa Clinical Trial.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Apolipoprotein E4; Brain; Cognitive Dysfunction; Disease Progression; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Glycation End Products, Advanced; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Thiamine; Treatment Outcome | 2020 |
The impact of a multi-domain intervention on cerebral glucose metabolism: analysis from the randomized ancillary FDG PET MAPT trial.
Topics: Alzheimer Disease; Brain; Fatty Acids, Omega-3; Fluorodeoxyglucose F18; Glucose; Humans; Positron-Emission Tomography | 2020 |
Disrupted metabolic connectivity in dopaminergic and cholinergic networks at different stages of dementia from
Topics: Aged; Aged, 80 and over; alpha-Synuclein; Alzheimer Disease; Cholinergic Agents; Cognitive Dysfunction; Dopamine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nerve Net; Positron-Emission Tomography | 2021 |
Lower regional gray matter volume in the absence of higher cortical amyloid burden in late-life depression.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Amyloidogenic Proteins; Amyloidosis; Brain; Cognition; Depression; Depressive Disorder; Female; Fluorodeoxyglucose F18; Gray Matter; Humans; Late Onset Disorders; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Risk Factors | 2021 |
Prognosis of conversion of mild cognitive impairment to Alzheimer's dementia by voxel-wise Cox regression based on FDG PET data.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Positron-Emission Tomography; Prognosis | 2019 |
Effects of memantine on clinical ratings, fluorodeoxyglucose positron emission tomography measurements, and cerebrospinal fluid assays in patients with moderate to severe Alzheimer dementia: a 24-week, randomized, clinical trial.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Brain; Chi-Square Distribution; China; Cognition; Double-Blind Method; Excitatory Amino Acid Antagonists; Female; Fluorodeoxyglucose F18; Humans; Male; Memantine; Middle Aged; Peptide Fragments; Phosphorylation; Positron-Emission Tomography; Predictive Value of Tests; Psychiatric Status Rating Scales; Radiopharmaceuticals; Severity of Illness Index; tau Proteins; Time Factors; Treatment Outcome | 2013 |
An evaluation of MSDC-0160, a prototype mTOT modulating insulin sensitizer, in patients with mild Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain; Brain Mapping; Central Nervous System Agents; Double-Blind Method; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Mental Status Schedule; Positron-Emission Tomography; Pyridines; Radiopharmaceuticals; Thiazolidinediones; Treatment Outcome | 2014 |
The lower hippocampus global connectivity, the higher its local metabolism in Alzheimer disease.
Topics: Alzheimer Disease; Cognitive Dysfunction; Connectome; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Male; Middle Aged; Nerve Net; Parietal Lobe; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2015 |
Reduced uptake of 18F-FDG and 15O-H2O in Alzheimer's disease-related regions after glucose loading.
Topics: Adult; Alzheimer Disease; Blood Glucose; Female; Fluorodeoxyglucose F18; Humans; Insulin; Insulin Resistance; Male; Oxygen Isotopes; Positron-Emission Tomography; Radiography; Radiopharmaceuticals | 2015 |
Longitudinal multimodal imaging in mild to moderate Alzheimer disease: a pilot study with memantine.
Topics: Aged; Alzheimer Disease; Antiparkinson Agents; Biomarkers; Disease Progression; Double-Blind Method; Female; Fluorodeoxyglucose F18; Glucose; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Memantine; Middle Aged; Pilot Projects; Placebos | 2008 |
Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Blood Glucose; Cognitive Dysfunction; Disability Evaluation; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Neuropsychological Tests; Positron-Emission Tomography; Predictive Value of Tests; Severity of Illness Index | 2011 |
The 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies.
Topics: Aged; Alzheimer Disease; Autopsy; Cocaine; Cohort Studies; Diagnosis, Differential; Dopamine Plasma Membrane Transport Proteins; Female; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Image Interpretation, Computer-Assisted; Lewy Body Disease; Male; Positron-Emission Tomography; ROC Curve; Sensitivity and Specificity; Staining and Labeling; Tomography, Emission-Computed, Single-Photon | 2009 |
Performance of FDG PET for detection of Alzheimer's disease in two independent multicentre samples (NEST-DD and ADNI).
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Area Under Curve; Data Interpretation, Statistical; Databases, Factual; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results | 2009 |
Effects of age on the glucose metabolic changes in mild cognitive impairment.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Atrophy; Biomarkers; Blood Glucose; Cognition Disorders; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parietal Lobe; Positron-Emission Tomography; Reproducibility of Results; Temporal Lobe | 2010 |
18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial.
Topics: Aged; Alzheimer Disease; Aniline Compounds; Benzothiazoles; Brain; Cognition Disorders; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thiazoles | 2010 |
Differences in regional brain metabolism associated with specific formulations of hormone therapy in postmenopausal women at risk for AD.
Topics: Aged; Alzheimer Disease; Brain; Brain Chemistry; Chemistry, Pharmaceutical; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neuropsychological Tests; Organ Specificity; Positron-Emission Tomography; Postmenopause; Progesterone; Risk Factors | 2011 |
Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cerebral Cortex; Cognition; Cross-Over Studies; Diabetes Mellitus, Type 2; Fluorodeoxyglucose F18; Glucose; Humans; Insulin Resistance; Positron-Emission Tomography; Prediabetic State | 2011 |
A multi-center randomized proof-of-concept clinical trial applying [¹⁸F]FDG-PET for evaluation of metabolic therapy with rosiglitazone XR in mild to moderate Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Brain Mapping; Disease Progression; Double-Blind Method; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Rosiglitazone; Thiazolidinediones; Treatment Outcome | 2010 |
Effects of a 6-month cognitive intervention program on brain metabolism in amnestic mild cognitive impairment and mild Alzheimer's disease.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Amnesia; Brain; Cognition Disorders; Cognitive Behavioral Therapy; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Glucose; Humans; Longitudinal Studies; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial.
Topics: Administration, Intranasal; Aged; Alzheimer Disease; Amyloid beta-Peptides; Cognitive Dysfunction; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hospitals, Veterans; Humans; Hypoglycemic Agents; Immunoassay; Insulin; Least-Squares Analysis; Male; Neuropsychological Tests; Peptide Fragments; Pilot Projects; Positron-Emission Tomography; Psychiatric Status Rating Scales; Spinal Puncture; tau Proteins | 2012 |
Effects of a 6-month cognitive intervention on brain metabolism in patients with amnestic MCI and mild Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amnesia; Brain Mapping; Cerebral Cortex; Cognitive Behavioral Therapy; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Treatment Outcome | 2011 |
Voxel-level comparison of arterial spin-labeled perfusion MRI and FDG-PET in Alzheimer disease.
Topics: Aged; Alzheimer Disease; Cerebrovascular Circulation; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Angiography; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity | 2011 |
Head motion evaluation and correction for PET scans with 18F-FDG in the Japanese Alzheimer's disease neuroimaging initiative (J-ADNI) multi-center study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Artifacts; Female; Fluorodeoxyglucose F18; Head; Humans; Imaging, Three-Dimensional; Japan; Male; Middle Aged; Movement; Multimodal Imaging; Neuroimaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Visual assessment versus quantitative three-dimensional stereotactic surface projection fluorodeoxyglucose positron emission tomography for detection of mild cognitive impairment and Alzheimer disease.
Topics: Aged; Alzheimer Disease; Cognitive Dysfunction; Demography; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Longitudinal Studies; Male; Positron-Emission Tomography; Reference Standards; ROC Curve; Stereotaxic Techniques | 2012 |
Glucagon-like peptide-1 decreases intracerebral glucose content by activating hexokinase and changing glucose clearance during hyperglycemia.
Topics: Adult; Alzheimer Disease; Biological Transport; Blood-Brain Barrier; Brain Chemistry; Brain Ischemia; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Fluorodeoxyglucose F18; Glucagon-Like Peptide 1; Glucose; Glucose Clamp Technique; Glucose Transporter Type 1; Hexokinase; Humans; Hyperglycemia; Male; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Stroke | 2012 |
Impact of molecular imaging on the diagnostic process in a memory clinic.
Topics: Aged; Alzheimer Disease; Aniline Compounds; Brain; Carbon Radioisotopes; Dementia; Diagnosis, Differential; Disease Progression; Early Diagnosis; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; France; Frontotemporal Dementia; Humans; Lewy Body Disease; Male; Memory Disorders; Middle Aged; Molecular Imaging; Outpatient Clinics, Hospital; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Thiazoles; Treatment Outcome | 2013 |
Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET.
Topics: Aged; Aging; Alzheimer Disease; Brain Mapping; Databases, Factual; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Neuropsychological Tests; Radionuclide Imaging; Radiopharmaceuticals; Reference Values; Regression Analysis | 2002 |
Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study.
Topics: Aged; Alzheimer Disease; Brain Mapping; Cerebral Cortex; Cognition Disorders; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Longitudinal Studies; Male; Neuropsychological Tests; Prognosis; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Statistics as Topic; Tomography, Emission-Computed | 2003 |
Temporal cortex hypermetabolism in Down syndrome prior to the onset of dementia.
Topics: Adult; Aged; Alzheimer Disease; Down Syndrome; Entorhinal Cortex; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Gyrus Cinguli; Humans; Male; Middle Aged; Neuropsychological Tests; Reference Values; Reproducibility of Results; Temporal Lobe; Tomography, Emission-Computed | 2003 |
Functional interactions of the entorhinal cortex: an 18F-FDG PET study on normal aging and Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Brain; Brain Mapping; Entorhinal Cortex; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Neural Pathways; Radiopharmaceuticals; Statistics as Topic; Tomography, Emission-Computed | 2004 |
Contrasting metabolic impairment in frontotemporal degeneration and early onset Alzheimer's disease.
Topics: Age of Onset; Aged; Alzheimer Disease; Aphasia, Primary Progressive; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Male; Middle Aged; Nerve Degeneration; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Temporal Lobe | 2004 |
Differentiation of Alzheimer's disease from dementia with Lewy bodies utilizing positron emission tomography with [18F]fluorodeoxyglucose and neuropsychological testing.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Male; Middle Aged; Motor Activity; Neuropsychological Tests; Positron-Emission Tomography; Predictive Value of Tests | 2005 |
Comparison of gray matter and metabolic reduction in mild Alzheimer's disease using FDG-PET and voxel-based morphometric MR studies.
Topics: Algorithms; Alzheimer Disease; Brain; Brain Mapping; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Neurons; Positron-Emission Tomography; Radiopharmaceuticals; Severity of Illness Index; Signal Processing, Computer-Assisted | 2005 |
A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease.
Topics: Aged; Alzheimer Disease; Cholinergic Fibers; Cognition; Fibroblasts; Fluorodeoxyglucose F18; Genetic Therapy; Histological Techniques; Humans; Middle Aged; Nerve Growth Factor; Neuropsychological Tests; Positron-Emission Tomography; Prosencephalon | 2005 |
Metabolic patterns associated with the clinical response to galantamine therapy: a fludeoxyglucose f 18 positron emission tomographic study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Behavioral Symptoms; Brain; Brain Mapping; Cognition; Female; Fluorodeoxyglucose F18; Functional Laterality; Galantamine; Humans; Imaging, Three-Dimensional; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Nootropic Agents; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Treatment Outcome | 2005 |
Longitudinal PET evaluation of cerebral glucose metabolism in rivastigmine treated patients with mild Alzheimer's disease.
Topics: Adult; Aged; Alzheimer Disease; Brain; Cholinesterase Inhibitors; Cognition; Energy Metabolism; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Longitudinal Studies; Male; Neuropsychological Tests; Phenylcarbamates; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Nicotinic; Rivastigmine; Severity of Illness Index | 2006 |
Validating the DemTect with 18-fluoro-2-deoxy-glucose positron emission tomography as a sensitive neuropsychological screening test for early alzheimer disease in patients of a memory clinic.
Topics: Aged; Alzheimer Disease; Cognition; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Humans; Infarction, Middle Cerebral Artery; Male; Memory; Mental Recall; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve | 2005 |
Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET.
Topics: Aged; Alzheimer Disease; Apolipoproteins E; Cognition Disorders; Female; Fluorodeoxyglucose F18; Genetic Predisposition to Disease; Genetic Testing; Humans; Male; Phenotype; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity | 2005 |
Rapid scanning protocol for brain (18)F-FDG PET: a validation study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Artificial Intelligence; Brain; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Time Factors | 2005 |
Fully automatic diagnostic system for early- and late-onset mild Alzheimer's disease using FDG PET and 3D-SSP.
Topics: Age of Onset; Aged; Algorithms; Alzheimer Disease; Brain; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index | 2006 |
Effects of donepezil on cortical metabolic response to activation during (18)FDG-PET in Alzheimer's disease: a double-blind cross-over trial.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cerebral Cortex; Cholinesterase Inhibitors; Cross-Over Studies; Donepezil; Double-Blind Method; Female; Fluorodeoxyglucose F18; Humans; Indans; Learning; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Piperidines; Positron-Emission Tomography | 2006 |
Dysfunction of visual cortex contributes to disturbed processing of visual information in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain Chemistry; Deoxyglucose; Evoked Potentials, Visual; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Mental Processes; Middle Aged; Psychometrics; Radiography; Tomography, Emission-Computed; Vision, Ocular; Visual Cortex | 1995 |
P300 in Alzheimer's disease: relationships to dementia severity and glucose metabolism.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain Chemistry; Deoxyglucose; Electroencephalography; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Tomography, Emission-Computed | 1995 |
EEG delta, positron emission tomography, and memory deficit in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain Mapping; Delta Rhythm; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Memory Disorders; Psychiatric Status Rating Scales; Temporal Lobe; Tomography, Emission-Computed | 1995 |
HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern.
Topics: Aged; Aging; Alzheimer Disease; Brain; Cerebrovascular Circulation; Dementia, Vascular; Deoxyglucose; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Organotechnetium Compounds; Oximes; ROC Curve; Sensitivity and Specificity; Technetium Tc 99m Exametazime; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1994 |
Metabolic effects of scopolamine and physostigmine in human brain measured by positron emission tomography.
Topics: Aged; Alzheimer Disease; Brain; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neuropsychological Tests; Organ Specificity; Physostigmine; Reference Values; Scopolamine; Tomography, Emission-Computed | 1994 |
Activation PET as an instrument to determine therapeutic efficacy in Alzheimer's disease.
Topics: Alzheimer Disease; Analysis of Variance; Brain; Cognition; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Neuropsychological Tests; Patient Education as Topic; Phosphatidylserines; Pyrithioxin; Social Support; Tomography, Emission-Computed | 1993 |
Cortisol reduces hippocampal glucose metabolism in normal elderly, but not in Alzheimer's disease.
Topics: Aged; Aging; Alzheimer Disease; Blood Glucose; Brain; Female; Fluorodeoxyglucose F18; Glucose; Hippocampus; Humans; Hydrocortisone; Magnetic Resonance Imaging; Male; Radiopharmaceuticals; Reference Values; Tomography, Emission-Computed | 1997 |
Cholinergic neurotransmission has different effects on cerebral glucose consumption and blood flow in young normals, aged normals, and Alzheimer's disease patients.
Topics: Adult; Aged; Alzheimer Disease; Blood Glucose; Cerebral Cortex; Cholinergic Fibers; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Prefrontal Cortex; Reference Values; Regional Blood Flow; Synaptic Transmission; Tomography, Emission-Computed | 1997 |
Propentofylline enhances cerebral metabolic response to auditory memory stimulation in Alzheimer's disease.
Topics: Acoustic Stimulation; Adult; Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Brain; Double-Blind Method; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Memory; Middle Aged; Neuroprotective Agents; Prospective Studies; Psychometrics; Tomography, Emission-Computed; Xanthines | 1998 |
Alteration of regional cerebral glucose utilization with delusions in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain Chemistry; Delusions; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Prospective Studies; Psychiatric Status Rating Scales; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies.
Topics: Aged; Alleles; Alzheimer Disease; Apolipoprotein E4; Apolipoproteins E; Brain; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gene Frequency; Gliosis; Glucose; Humans; Immunohistochemistry; Lewy Bodies; Lewy Body Disease; Male; Nerve Tissue Proteins; Occipital Lobe; Sensitivity and Specificity; Synucleins; tau Proteins; Tomography, Emission-Computed; Ubiquitins; Visual Cortex | 2000 |
Cognitive and metabolic responses to metrifonate therapy in Alzheimer disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cholinesterase Inhibitors; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Male; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome; Trichlorfon | 2001 |
Brain metabolic and clinical effects of rivastigmine in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Brain Chemistry; Carbamates; Double-Blind Method; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuroprotective Agents; Phenylcarbamates; Radiopharmaceuticals; Rivastigmine; Tomography, Emission-Computed | 2001 |
Physostigmine in Alzheimer's disease: effects on cognitive functioning, cerebral glucose metabolism analyzed by positron emission tomography and cerebral blood flow analyzed by single photon emission tomography.
Topics: Aged; Alzheimer Disease; Amphetamines; Blood Glucose; Brain; Cerebrovascular Circulation; Deoxyglucose; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuropsychological Tests; Physostigmine; Pilot Projects; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1991 |
Nootropic drugs in Alzheimer's disease: symptomatic treatment with pramiracetam.
Topics: Aged; Alzheimer Disease; Deoxyglucose; Dose-Response Relationship, Drug; Fluorodeoxyglucose F18; Humans; Middle Aged; Neuropsychological Tests; Psychiatric Status Rating Scales; Psychotropic Drugs; Pyrrolidines; Tomography, Emission-Computed | 1991 |
941 other study(ies) available for fluorodeoxyglucose f18 and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
The effects of cerebral amyloidopathy on regional glucose metabolism in older adults with depression and mild cognitive impairment while performing memory tasks.
Topics: Aged; Alzheimer Disease; Brain; Cognitive Dysfunction; Depression; Fluorodeoxyglucose F18; Glucose; Humans; Positron-Emission Tomography | 2021 |
Design and Verbal Fluency in Alzheimer's Disease and Frontotemporal Dementia: Clinical and Metabolic Correlates.
Topics: Aged; Alzheimer Disease; Executive Function; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Neuropsychological Tests | 2022 |
Prediction of post-stroke cognitive impairment using brain FDG PET: deep learning-based approach.
Topics: Alzheimer Disease; Biomarkers; Brain; Cognitive Dysfunction; Deep Learning; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Quality of Life; Tomography, X-Ray Computed | 2022 |
Glucose hypometabolism in the Auditory Pathway in Age Related Hearing Loss in the ADNI cohort.
Topics: Alzheimer Disease; Auditory Pathways; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Genome-Wide Association Study; Glucose; Humans; Neuroimaging; Positron-Emission Tomography | 2021 |
Added value of semiquantitative analysis of brain FDG-PET for the differentiation between MCI-Lewy bodies and MCI due to Alzheimer's disease.
Topics: Alzheimer Disease; Biomarkers; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Positron-Emission Tomography; Reproducibility of Results | 2022 |
Somatosensory dysfunction is masked by variable cognitive deficits across patients on the Alzheimer's disease spectrum.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Cognition; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Functional Neuroimaging; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Magnetoencephalography; Male; Middle Aged; Neuropsychological Tests; Positron Emission Tomography Computed Tomography; Somatosensory Cortex | 2021 |
Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer's amyloid, tau and FDG PET status.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Fluorodeoxyglucose F18; Humans; tau Proteins | 2021 |
Patterns of Distribution of 18F-THK5351 Positron Emission Tomography in Alzheimer's Disease Continuum.
Topics: Aged; Alzheimer Disease; Aminopyridines; Amnesia; Aniline Compounds; Brain; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Quinolines; Radiopharmaceuticals; Severity of Illness Index; tau Proteins; Thiazoles | 2022 |
The Transition of Mild Cognitive Impairment Over Time: An AV45- and FDG-PET Study of Reversion and Conversion Phenomena.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Cognitive Dysfunction; Disease Progression; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Positron-Emission Tomography | 2021 |
Association between Benton Visual Retention Test Scores and PET Imaging in Elderly Adults.
Topics: Adult; Aged; Alzheimer Disease; Aniline Compounds; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Glucose; Humans; Positron-Emission Tomography | 2021 |
Distinct Functional and Metabolic Alterations of DMN Subsystems in Alzheimer's Disease: A Simultaneous FDG-PET/fMRI Study.
Topics: Alzheimer Disease; Cognition; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography | 2021 |
Multimodal Classification of Alzheimer's Disease and Amnestic Mild Cognitive Impairment: Integrated 18F-FDG PET and DTI Study.
Topics: Aged; Alzheimer Disease; Amnesia; Biomarkers; Cognitive Dysfunction; Diffusion Tensor Imaging; Female; Fluorodeoxyglucose F18; Humans; Male; Neuropsychological Tests; Positron-Emission Tomography | 2022 |
Lack of association between cortical amyloid deposition and glucose metabolism in early stage Alzheimer´s disease patients.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Fluorodeoxyglucose F18; Glucose; Humans; Positron Emission Tomography Computed Tomography | 2021 |
Functional Neural Correlates of Semantic Fluency Task Performance in Mild Cognitive Impairment and Alzheimer's Disease: An FDG-PET Study.
Topics: Aged; Alzheimer Disease; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Male; Neuropsychological Tests; Positron-Emission Tomography; Semantics; Task Performance and Analysis | 2022 |
Mitochondrial complex I abnormalities underlie neurodegeneration and cognitive decline in Alzheimer's disease.
Topics: Alzheimer Disease; Amyloidosis; Aniline Compounds; Atrophy; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Glucose; Humans; Positron-Emission Tomography | 2022 |
Using radiomics-based modelling to predict individual progression from mild cognitive impairment to Alzheimer's disease.
Topics: Alzheimer Disease; Biomarkers; Cognitive Dysfunction; Disease Progression; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography | 2022 |
Medial Temporal Atrophy in Posterior Cortical Atrophy and Its Relationship to the Cingulate Island Sign.
Topics: Alzheimer Disease; Atrophy; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Magnetic Resonance Imaging; Positron-Emission Tomography | 2022 |
Relationship between astrocyte reactivity, using novel
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Astrocytes; Brain; Fluorodeoxyglucose F18; Glucose; Gray Matter; Humans; Imidazoles; Indoles; Magnetic Resonance Imaging; Positron-Emission Tomography | 2022 |
Selective neurodegeneration of the hippocampus caused by chronic cerebral hypoperfusion: F-18 FDG PET study in rats.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Carotid Arteries; Disease Models, Animal; Fluorodeoxyglucose F18; Glucose; Hippocampus; Male; Maze Learning; Peptide Fragments; Positron-Emission Tomography; Rats; Rats, Wistar; tau Proteins | 2022 |
Tracer-specific reference tissues selection improves detection of
Topics: Alzheimer Disease; Amyloid; Aniline Compounds; Brain; Carbolines; Cognitive Dysfunction; Cross-Sectional Studies; Ethylene Glycols; Fluorodeoxyglucose F18; Glucose; Humans; Positron-Emission Tomography | 2022 |
Caspase-1 variant influencing CSF tau and FDG PET levels in non-demented elders from the ADNI cohort.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Caspase 1; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Neuroimaging; tau Proteins | 2022 |
Phenotypic subtypes of progressive dysexecutive syndrome due to Alzheimer's disease: a series of clinical cases.
Topics: Alzheimer Disease; Brain; Fluorodeoxyglucose F18; Humans; Memory, Short-Term; Neuropsychological Tests; Phenotype; Positron-Emission Tomography | 2022 |
Determination of optimal regularization factor in Bayesian penalized likelihood reconstruction of brain PET images using [
Topics: Algorithms; Alzheimer Disease; Aniline Compounds; Bayes Theorem; Brain; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Phantoms, Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Thiazoles | 2022 |
Spatial covariance analysis of FDG-PET and HMPAO-SPECT for the differential diagnosis of dementia with Lewy bodies and Alzheimer's disease.
Topics: Alzheimer Disease; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Positron-Emission Tomography; Tomography, Emission-Computed, Single-Photon | 2022 |
Disrupted coupling between salience network segregation and glucose metabolism is associated with cognitive decline in Alzheimer's disease - A simultaneous resting-state FDG-PET/fMRI study.
Topics: Alzheimer Disease; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging | 2022 |
A Multi-Dimensional Comparison of Alzheimer's Disease Neurodegenerative Biomarkers.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cognitive Dysfunction; Cross-Sectional Studies; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; tau Proteins | 2022 |
Regional cerebral hypometabolism on 18F-FDG PET/CT scan in delirium is independent of acute illness and dementia.
Topics: Acute Disease; Alzheimer Disease; Brain; Delirium; Fluorodeoxyglucose F18; Glucose; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Association of serum thyroid hormone levels with positron emission tomography imaging in non-demented older adults.
Topics: Aged; Alzheimer Disease; Amyloid; Brain; Fluorodeoxyglucose F18; Glucose; Humans; Positron-Emission Tomography; Thyroid Gland; Thyroid Hormones; Thyrotropin; Tomography, X-Ray Computed | 2022 |
Posterior cortical atrophy: Primary occipital variant.
Topics: Alzheimer Disease; Atrophy; Brain; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography | 2022 |
Effects of Alzheimer and Lewy Body Disease Pathologies on Brain Metabolism.
Topics: Alzheimer Disease; Brain; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Plaque, Amyloid; Positron-Emission Tomography | 2022 |
Development of prediction models for distinguishable cognitive trajectories in patients with amyloid positive mild cognitive impairment.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloidosis; Cognition; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography | 2022 |
A computational model of neurodegeneration in Alzheimer's disease.
Topics: Alzheimer Disease; Brain; Cognition; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography | 2022 |
Validity of cingulate-precuneus-temporo-parietal hypometabolism for single-subject diagnosis of biomarker-proven atypical variants of Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloidosis; Biomarkers; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Parietal Lobe; Positron-Emission Tomography | 2022 |
[Comparative analysis of the brain distribution of [18F]FDG in populations of patients with Alzheimer's disease with or without family history of dementia].
Topics: Alzheimer Disease; Brain; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2022 |
"Occipital Pole" Sign on 18 F-FDG PET for Dementia With Lewy Bodies and Posterior Cortical Atrophy : Evidence From the Treviso Dementia (TREDEM) Registry.
Topics: Alzheimer Disease; Atrophy; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Occipital Lobe; Positron-Emission Tomography; Registries | 2022 |
PET-based classification of corticobasal syndrome.
Topics: Alzheimer Disease; Corticobasal Degeneration; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; tau Proteins | 2022 |
Nocturnal Hypoxia and Sleep Fragmentation May Drive Neurodegenerative Processes: The Compared Effects of Obstructive Sleep Apnea Syndrome and Periodic Limb Movement Disorder on Alzheimer's Disease Biomarkers.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Fluorodeoxyglucose F18; Glucose; Humans; Hypoxia; Nocturnal Myoclonus Syndrome; Peptide Fragments; Positron-Emission Tomography; Sleep Apnea, Obstructive; Sleep Deprivation; Sleep Wake Disorders; tau Proteins | 2022 |
Glucose metabolism patterns: A potential index to characterize brain ageing and predict high conversion risk into cognitive impairment.
Topics: Aged; Aging; Alzheimer Disease; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Glucose; Humans; Positron-Emission Tomography | 2022 |
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cognition; Cognitive Dysfunction; Continuous Positive Airway Pressure; Fluorodeoxyglucose F18; Glucose; Humans; Positron-Emission Tomography; Sleep Apnea, Obstructive; tau Proteins | 2022 |
Topics: Aged; Alzheimer Disease; Fluorodeoxyglucose F18; Frontotemporal Dementia; Glucose; Humans; Neurodegenerative Diseases; Positron-Emission Tomography | 2022 |
Loss of speech and functional impairment in Alzheimer's disease-related primary progressive aphasia: predictive factors of decline.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Aphasia, Primary Progressive; Biomarkers; Brain; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Speech; tau Proteins | 2022 |
Comparison of dynamic susceptibility contrast enhanced MR and FDG-PET brain studies in patients with Alzheimer's disease and amnestic mild cognitive impairment.
Topics: Alzheimer Disease; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography | 2022 |
Cognitive functioning, cerebrospinal fluid Alzheimer's disease biomarkers and cerebral glucose metabolism in late-onset epilepsy of unknown aetiology: A prospective study.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cognition; Cognitive Dysfunction; Epilepsy; Fluorodeoxyglucose F18; Glucose; Humans; Peptide Fragments; Positron-Emission Tomography; Prospective Studies; tau Proteins | 2022 |
Artificial Intelligence on FDG PET Images Identifies Mild Cognitive Impairment Patients with Neurodegenerative Disease.
Topics: Alzheimer Disease; Artificial Intelligence; Cognitive Dysfunction; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Neurodegenerative Diseases; Positron-Emission Tomography | 2022 |
Amyloid, tau and metabolic PET correlates of cognition in early and late-onset Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid; Amyloidogenic Proteins; Biomarkers; Brain; Cognition; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; tau Proteins | 2022 |
Identification and validation of Alzheimer's disease-related metabolic brain pattern in biomarker confirmed Alzheimer's dementia patients.
Topics: Alzheimer Disease; Biomarkers; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography | 2022 |
Introducing a gatekeeping system for amyloid status assessment in mild cognitive impairment.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Amyloidosis; Apolipoprotein E4; Biomarkers; Cognitive Dysfunction; Fluorodeoxyglucose F18; Gatekeeping; Humans; Positron-Emission Tomography; Reproducibility of Results | 2022 |
Reactive astrogliosis is associated with higher cerebral glucose consumption in the early Alzheimer's continuum.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Fluorodeoxyglucose F18; Glial Fibrillary Acidic Protein; Gliosis; Glucose; Humans; Inflammation; tau Proteins | 2022 |
Multi-scale discriminative regions analysis in FDG-PET imaging for early diagnosis of Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain; Cognitive Dysfunction; Early Diagnosis; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography | 2022 |
The Clinical Use of Alzheimer's Disease Biomarkers in Patients with Mild Cognitive Impairment: A European Alzheimer's Disease Consortium Survey.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Atrophy; Biomarkers; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Peptide Fragments; Positron-Emission Tomography; tau Proteins | 2022 |
Clinical and metabolic imaging features of late-onset and early-onset posterior cortical atrophy.
Topics: Aged; Alzheimer Disease; Atrophy; Fluorodeoxyglucose F18; Glucose; Humans; Positron-Emission Tomography | 2022 |
Rheumatoid Arthritis, Cognitive Impairment, and Neuroimaging Biomarkers: Results from the Mayo Clinic Study of Aging.
Topics: Aged; Aging; Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Amyloidosis; Arthritis, Rheumatoid; Biomarkers; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neuroimaging; Positron-Emission Tomography | 2022 |
Differential diagnosis of amnestic dementia patients based on an FDG-PET signature of autopsy-confirmed LATE-NC.
Topics: Alzheimer Disease; Autopsy; Biomarkers; Brain; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Membrane Proteins; Nerve Tissue Proteins; Positron-Emission Tomography | 2023 |
From clinical phenotype to proteinopathy: molecular neuroimaging in neurodegenerative dementias.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Fluorodeoxyglucose F18; Humans; Neuroimaging; Phenotype; Positron-Emission Tomography; tau Proteins | 2022 |
Discriminating Aging Cognitive Decline Spectrum Using PET and Magnetic Resonance Image Features.
Topics: Alzheimer Disease; Biomarkers; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Quality of Life | 2022 |
Differential Effects of Tau Stage, Lewy Body Pathology, and Substantia Nigra Degeneration on
Topics: Alzheimer Disease; Fluorodeoxyglucose F18; Humans; Lewy Bodies; Lewy Body Disease; Substantia Nigra | 2023 |
Reducing instability of inter-subject covariance of FDG uptake networks using structure-weighted sparse estimation approach.
Topics: Alzheimer Disease; Brain; Brain Mapping; Fluorodeoxyglucose F18; Frontotemporal Dementia; Frontotemporal Lobar Degeneration; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Retrospective Studies | 2022 |
Development of a deep learning network for Alzheimer's disease classification with evaluation of imaging modality and longitudinal data.
Topics: Alzheimer Disease; Deep Learning; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neuroimaging; Positron-Emission Tomography | 2022 |
Monitoring Alzheimer's Disease Progression in Mild Cognitive Impairment Stage Using Machine Learning-Based FDG-PET Classification Methods.
Topics: Alzheimer Disease; Cognitive Dysfunction; Disease Progression; Fluorodeoxyglucose F18; Humans; Machine Learning; Prodromal Symptoms | 2022 |
Biomarkers Related to Synaptic Dysfunction to Discriminate Alzheimer's Disease from Other Neurological Disorders.
Topics: alpha-Synuclein; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Neurodegenerative Diseases; Neurogranin; tau Proteins | 2022 |
Deep multiview learning to identify imaging-driven subtypes in mild cognitive impairment.
Topics: Alzheimer Disease; Arachnodactyly; Brain; Cognitive Dysfunction; Contracture; Fluorodeoxyglucose F18; Genetic Markers; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography | 2022 |
Increasing brain glucose metabolism by ligustrazine piperazine ameliorates cognitive deficits through PPARγ-dependent enhancement of mitophagy in APP/PS1 mice.
Topics: Adenosine Triphosphate; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Brain; Cognition; Disease Models, Animal; Fluorodeoxyglucose F18; Glucose; Luciferases; Mice; Mice, Transgenic; Mitophagy; Piperazine; PPAR gamma; Presenilin-1; Protein Kinases; Pyrazines; Rats; Sequestosome-1 Protein; Ubiquitin-Protein Ligases | 2022 |
Perivascular Space Predicts Brain Hypometabolism of Individuals with Underlying Amyloid Pathology.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloidogenic Proteins; Amyloidosis; Biomarkers; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neuroimaging; Positron-Emission Tomography | 2022 |
Alzheimer's Disease Prediction Algorithm Based on Group Convolution and a Joint Loss Function.
Topics: Algorithms; Alzheimer Disease; Cognitive Dysfunction; Disease Progression; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography | 2022 |
Disease specific and nonspecific metabolic brain networks in behavioral variant of frontotemporal dementia.
Topics: Alzheimer Disease; Atrophy; Brain; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Magnetic Resonance Imaging | 2023 |
An Explainable Convolutional Neural Network for the Early Diagnosis of Alzheimer's Disease from 18F-FDG PET.
Topics: Alzheimer Disease; Artificial Intelligence; Early Diagnosis; Fluorodeoxyglucose F18; Humans; Neural Networks, Computer; Positron-Emission Tomography | 2023 |
Multi-stage classification of Alzheimer's disease from
Topics: Alzheimer Disease; Cognitive Dysfunction; Deep Learning; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography | 2022 |
Image restoration algorithm incorporating methods to remove noise and blurring from positron emission tomography imaging for Alzheimer's disease diagnosis.
Topics: Algorithms; Alzheimer Disease; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Positron-Emission Tomography; Signal-To-Noise Ratio | 2022 |
Evaluation of 10-minute post-injection 11C-PiB PET and its correlation with 18F-FDG PET in older adults who are cognitively healthy, mildly impaired, or with probable Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Brain; Carbon Radioisotopes; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography | 2022 |
Effect of APOE ε4 genotype on amyloid-β, glucose metabolism, and gray matter volume in cognitively normal individuals and amnestic mild cognitive impairment.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Apolipoprotein E4; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Follow-Up Studies; Genotype; Glucose; Gray Matter; Humans; Positron-Emission Tomography | 2023 |
Brain metabolic correlates of Locus Coeruleus degeneration in Alzheimer's disease: a multimodal neuroimaging study.
Topics: Alzheimer Disease; Brain; Fluorodeoxyglucose F18; Humans; Locus Coeruleus; Magnetic Resonance Imaging; Neuroimaging; Positron-Emission Tomography | 2023 |
Brain
Topics: Alzheimer Disease; Brain; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies | 2023 |
A 19-Year-Old Adolescent with Probable Alzheimer's Disease.
Topics: Adolescent; Aged; Alzheimer Disease; Amyloid beta-Peptides; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography | 2023 |
Assessment of perfusion deficit with early phases of [
Topics: Alzheimer Disease; Amyloid; Aniline Compounds; Brain; Fluorodeoxyglucose F18; Humans; Neurodegenerative Diseases; Perfusion; Positron-Emission Tomography | 2023 |
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Machine Learning; Male; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals; White Matter | 2023 |
Functional Correlates of Striatal Dopamine Transporter Cerebrospinal Fluid Levels in Alzheimer's Disease: A Preliminary
Topics: Alzheimer Disease; Brain; Dopamine Plasma Membrane Transport Proteins; Fluorodeoxyglucose F18; Glucose; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
Mapping cerebral atrophy and hypometabolism on
Topics: Alzheimer Disease; Atrophy; Brain; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography | 2023 |
Deciphering the clinico-radiological heterogeneity of dysexecutive Alzheimer's disease.
Topics: Alzheimer Disease; Brain; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neuroimaging; Positron-Emission Tomography | 2023 |
Vigorous, regular physical exercise may slow disease progression in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cognitive Dysfunction; Disease Progression; Exercise; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography | 2023 |
Longitudinal Spatial Relationships Between Atrophy and Hypometabolism Across the Alzheimer's Disease Continuum.
Topics: Alzheimer Disease; Atrophy; Brain; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neuroimaging; Positron-Emission Tomography; tau Proteins | 2023 |
Does statin use affect amyloid beta deposition and brain metabolism?
Topics: Alzheimer Disease; Amyloid beta-Peptides; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Positron-Emission Tomography | 2023 |
Sex-specific effects of high-fat diet on rat brain glucose metabolism and early-onset dementia symptoms.
Topics: Alzheimer Disease; Animals; Brain; Diet, High-Fat; Female; Fluorodeoxyglucose F18; Glucose; Male; Rats | 2023 |
Tau, β-Amyloid, and Glucose Metabolism Following Service-Related Traumatic Brain Injury in Vietnam War Veterans: The Australian Imaging Biomarkers and Lifestyle Study of Aging-Veterans Study (AIBL-VETS).
Topics: Aged; Aging; Alzheimer Disease; Amyloid beta-Peptides; Australia; Biomarkers; Brain Injuries, Traumatic; Case-Control Studies; Cognitive Dysfunction; Fluorodeoxyglucose F18; Glucose; Humans; Life Style; Male; Middle Aged; Positron-Emission Tomography; tau Proteins; Veterans; Vietnam | 2023 |
Expert elicitation of risk factors for progression to dementia in individuals with mild cognitive impairment.
Topics: Alzheimer Disease; Atrophy; Cognitive Dysfunction; Disease Progression; Fluorodeoxyglucose F18; Humans | 2023 |
Analysis of positron emission tomography hypometabolic patterns and neuropsychiatric symptoms in patients with dementia syndromes.
Topics: Alzheimer Disease; Brain; Fluorodeoxyglucose F18; Frontotemporal Dementia; Frontotemporal Lobar Degeneration; Humans; Positron-Emission Tomography; Syndrome | 2023 |
Optimized Cingulate Island Sign in Discriminating Dementia With Lewy Bodies From Alzheimer Disease.
Topics: Alzheimer Disease; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Lewy Body Disease; Positron-Emission Tomography | 2023 |
Multimodal cross enhanced fusion network for diagnosis of Alzheimer's disease and subjective memory complaints.
Topics: Alzheimer Disease; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neural Networks, Computer; Positron-Emission Tomography | 2023 |
Neurofunctional Correlates of Activities of Daily Living in Patients with Posterior Cortical Atrophy.
Topics: Activities of Daily Living; Alzheimer Disease; Atrophy; Cerebral Cortex; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography | 2023 |
Visualizing reactive astrocyte-neuron interaction in Alzheimer's disease using 11C-acetate and 18F-FDG.
Topics: Alzheimer Disease; Animals; Astrocytes; Brain; Carbon Radioisotopes; Fluorodeoxyglucose F18; gamma-Aminobutyric Acid; Gliosis; Humans; Mice; Positron-Emission Tomography; Rats | 2023 |
Multisite harmonization of diffusion tensor image analysis along the perivascular space using the COMBined Association Test.
Topics: Alzheimer Disease; Bayes Theorem; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging | 2023 |
Metabolic Asymmetry Relates to Clinical Characteristics and Brain Network Abnormalities in Alzheimer's Disease.
Topics: Alzheimer Disease; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Metabolic Networks and Pathways; Positron-Emission Tomography | 2023 |
Longitudinal changes in metabolic network activity in early Alzheimer's disease.
Topics: Alzheimer Disease; Brain; Cognitive Dysfunction; Disease Progression; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography | 2023 |
Elecsys Cerebrospinal Fluid Immunoassays Accurately Detect Alzheimer's Disease Regardless of Concomitant Small Vessel Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Fluorodeoxyglucose F18; Humans; Immunoassay; Peptide Fragments; tau Proteins | 2023 |
Improving Alzheimer's Disease Diagnosis With Multi-Modal PET Embedding Features by a 3D Multi-Task MLP-Mixer Neural Network.
Topics: Alzheimer Disease; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neural Networks, Computer; Positron-Emission Tomography | 2023 |
Characteristics of amnestic patients with hypometabolism patterns suggestive of Lewy body pathology.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Cognitive Dysfunction; Fluorodeoxyglucose F18; Hallucinations; Humans; Lewy Bodies; Lewy Body Disease; Positron-Emission Tomography | 2023 |
FDG PET (and MRI) for Monitoring Immunotherapy in Alzheimer Disease.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Fluorodeoxyglucose F18; Humans; Immunotherapy; Magnetic Resonance Imaging; Positron-Emission Tomography; United States | 2023 |
Head-to-head comparison of plasma and PET imaging ATN markers in subjects with cognitive complaints.
Topics: Alzheimer Disease; Cognition; Fluorodeoxyglucose F18; Glucose; Humans; Positron-Emission Tomography; tau Proteins | 2023 |
Proposal to Add FDG-PET as an Outcome Measure for Clinical Trials in Patients With Prodromal Lewy Body Dementia.
Topics: Alzheimer Disease; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Outcome Assessment, Health Care; Positron-Emission Tomography; Prodromal Symptoms | 2023 |
Clinical validation of the cingulate island sign visual rating scale in dementia with Lewy bodies.
Topics: Alzheimer Disease; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Positron-Emission Tomography | 2023 |
Aiming for [
Topics: Alzheimer Disease; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Positron-Emission Tomography; Retrospective Studies | 2023 |
Comparison of Brain Amyloid Deposition and Cortical Glucose Metabolism Between Clinic- and Community-Based Cohort.
Topics: Aged; Alzheimer Disease; Amyloid; Aniline Compounds; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Glucose; Humans; Positron-Emission Tomography; Prospective Studies | 2023 |
Comparison of univariate and multivariate analyses for brain [18F]FDG PET data in α-synucleinopathies.
Topics: Alzheimer Disease; Brain; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Multiple System Atrophy; Multivariate Analysis; Parkinson Disease; Positron-Emission Tomography; Synucleinopathies | 2023 |
Generation of Conventional
Topics: Alzheimer Disease; Fluorodeoxyglucose F18; Humans; Neuroimaging; Positron-Emission Tomography | 2023 |
Late-onset epilepsy with cognitive symptoms: Comparison of cognitive and imaging profiles with probable Alzheimer's disease.
Topics: Alzheimer Disease; Cognition; Cognitive Dysfunction; Epilepsy; Fluorodeoxyglucose F18; Humans; Neuropsychological Tests; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Seizures | 2023 |
Tracking reactive astrogliosis in autosomal dominant and sporadic Alzheimer's disease with multi-modal PET and plasma GFAP.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Fluorodeoxyglucose F18; Glial Fibrillary Acidic Protein; Gliosis; Humans; Inflammation | 2023 |
White matter hyperintensity volume modifies the association between CSF vascular inflammatory biomarkers and regional FDG-PET along the Alzheimer's disease continuum.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Brain; C-Reactive Protein; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Inflammation; Magnetic Resonance Imaging; Positron-Emission Tomography; Vascular Endothelial Growth Factor A; White Matter | 2023 |
Deep learning based diagnosis of Alzheimer's disease using FDG-PET images.
Topics: Alzheimer Disease; Brain; Cognitive Dysfunction; Deep Learning; Fluorodeoxyglucose F18; Humans; Neuroimaging; Positron-Emission Tomography | 2023 |
The metabolic spatial covariance pattern of definite idiopathic normal pressure hydrocephalus: an FDG PET study with principal components analysis.
Topics: Alzheimer Disease; Brain; Fluorodeoxyglucose F18; Humans; Hydrocephalus, Normal Pressure; Neurodegenerative Diseases; Positron-Emission Tomography | 2023 |
Hybrid PET/MRI with Flutemetamol and FDG in Alzheimer's Disease Clinical Continuum.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography | 2023 |
Neuronal injury biomarkers for assessment of the individual cognitive reserve in clinically suspected Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Biomarkers; Brain; Cognitive Dysfunction; Cognitive Reserve; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; tau Proteins | 2019 |
Topics: Aged; Alzheimer Disease; Aniline Compounds; Brain; Cerebrovascular Circulation; Cognitive Dysfunction; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Severity of Illness Index | 2019 |
Spatial distributions of cholinergic impairment and neuronal hypometabolism differ in MCI due to AD.
Topics: Acetates; Acetylcholinesterase; Aged; Aged, 80 and over; Alzheimer Disease; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Piperidines; Positron-Emission Tomography; Radiopharmaceuticals | 2019 |
Multiscale spatial gradient features for
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography | 2019 |
Two distinct pathological substrates associated with MMSE-pentagons item deficit in DLB and AD.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Female; Fluorodeoxyglucose F18; Frontal Lobe; Gyrus Cinguli; Humans; Lewy Body Disease; Male; Mental Status and Dementia Tests; Middle Aged; Neuropsychological Tests; Occipital Lobe; Parietal Lobe; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Spatial Processing; Temporal Lobe | 2019 |
Alzheimer's deterioration in intellectual and neurobiological staging supports the retrogenesis model: a double dissociation between verbal/non-verbal judgments and the left/right parieto-temporal glucose metabolism. A retrospective data analysis from the
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Atrophy; Brain; Data Analysis; Disease Progression; Female; Fluorodeoxyglucose F18; Glucose; Hippocampus; Humans; Judgment; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Retrospective Studies; Stanford-Binet Test; Temporal Lobe | 2020 |
Exosomal HSP70 for Monitoring of Frontotemporal Dementia and Alzheimer's Disease: Clinical and FDG-PET Correlation.
Topics: Aged; Alzheimer Disease; Biomarkers; Correlation of Data; Exosomes; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; HSP70 Heat-Shock Proteins; Humans; Male; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals | 2019 |
Quantifying brain metabolism from FDG-PET images into a probability of Alzheimer's dementia score.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cerebral Cortex; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Male; Neural Networks, Computer; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals | 2020 |
In Vivo Assessment of Tau Deposition in Alzheimer Disease and Assessing Its Relationship to Regional Brain Glucose Metabolism and Cognition.
Topics: Aged; Alzheimer Disease; Brain; Cognition; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography | 2019 |
Three-year changes of cortical
Topics: Alzheimer Disease; Brain; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neuropsychological Tests; Positron-Emission Tomography | 2020 |
Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer's disease.
Topics: Alzheimer Disease; Biomarkers; Brain; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography | 2019 |
Reciprocal Incremental Value of 18F-FDG-PET and Cerebrospinal Fluid Biomarkers in Mild Cognitive Impairment Patients Suspected for Alzheimer's Disease and Inconclusive First Biomarker.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Brain; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Retrospective Studies; tau Proteins | 2019 |
The accuracy of hippocampal volumetry and glucose metabolism for the diagnosis of patients with suspected Alzheimer's disease, using automatic quantitative clinical tools.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognitive Dysfunction; Early Diagnosis; Female; Fluorodeoxyglucose F18; Glucose; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiographic Image Interpretation, Computer-Assisted; Retrospective Studies; Sensitivity and Specificity | 2019 |
Test-retest characteristic of [
Topics: Adult; Alzheimer Disease; Brain; Cognition; Female; Fluorodeoxyglucose F18; Humans; Isoquinolines; Male; Neurofibrillary Tangles; Positron-Emission Tomography | 2020 |
Cognitive signature of brain FDG PET based on deep learning: domain transfer from Alzheimer's disease to Parkinson's disease.
Topics: Alzheimer Disease; Brain; Cognition; Cognitive Dysfunction; Deep Learning; Fluorodeoxyglucose F18; Humans; Parkinson Disease; Positron-Emission Tomography | 2020 |
Metabolic Network Topology of Alzheimer's Disease and Dementia with Lewy Bodies Generated Using Fluorodeoxyglucose Positron Emission Tomography.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Brain Mapping; Female; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Lewy Body Disease; Male; Metabolic Networks and Pathways; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reference Values; Temporal Lobe | 2020 |
Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Cognitive Dysfunction; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Male; Peptide Fragments; Positron-Emission Tomography | 2019 |
Distinguishing between dementia with Lewy bodies and Alzheimer's disease using metabolic patterns.
Topics: Aged; Alzheimer Disease; Brain; Diagnosis, Differential; Dopamine Plasma Membrane Transport Proteins; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Magnetic Resonance Imaging; Male; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals; Tetrabenazine | 2020 |
Brain metabolic signatures across the Alzheimer's disease spectrum.
Topics: Alzheimer Disease; Brain; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Retrospective Studies | 2020 |
A visual rating scale for cingulate island sign on 18F-FDG-PET to differentiate dementia with Lewy bodies and Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Positron-Emission Tomography | 2020 |
Brain metabolic connectome classify mild cognitive impairment into Alzheimer's dementia
Topics: Alzheimer Disease; Brain; Cognitive Dysfunction; Connectome; Disease Progression; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography | 2019 |
The role of epsilon phenotype in brain glucose consumption in Alzheimer's disease.
Topics: Age Factors; Aged; Alzheimer Disease; Amyloid; Brain; Cerebrospinal Fluid; Education; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Mental Status and Dementia Tests; Middle Aged; Phenotype; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Risk Factors; Sex Factors; tau Proteins | 2020 |
Longitudinal 18F-FDG Images in Patients With Alzheimer Disease Over More Than 9 Years From a Preclinical Stage.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2020 |
Brain PET amyloid and neurodegeneration biomarkers in the context of the 2018 NIA-AA research framework: an individual approach exploring clinical-biomarker mismatches and sociodemographic parameters.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Tomography, X-Ray Computed | 2020 |
Metabolic and amyloid PET network reorganization in Alzheimer's disease: differential patterns and partial volume effects.
Topics: Alzheimer Disease; Amyloid; Aniline Compounds; Brain; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography | 2021 |
In vivo mitochondrial and glycolytic impairments in patients with Alzheimer disease.
Topics: Aged; Alzheimer Disease; Brain; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Mitochondria; Pyridines; Radiopharmaceuticals | 2020 |
A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease.
Topics: Adult; Aged; Alzheimer Disease; Amyloid; Atrophy; Brain; Cognition; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Inheritance Patterns; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Phosphorylation; Plaque, Amyloid; Solubility; tau Proteins | 2020 |
Spatial metabolic profiles to discriminate dementia with Lewy bodies from Alzheimer disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cerebral Cortex; Deep Learning; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Magnetic Resonance Imaging; Male; Neuroimaging; Positron-Emission Tomography; Supervised Machine Learning | 2020 |
Comparison of T
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Pilot Projects; Positron-Emission Tomography; Thiazoles | 2020 |
Predicting MCI progression with FDG-PET and cognitive scores: a longitudinal study.
Topics: Algorithms; Alzheimer Disease; Brain; Cognitive Dysfunction; Disease Progression; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Mental Status and Dementia Tests; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity | 2020 |
Individual brain metabolic connectome indicator based on Kullback-Leibler Divergence Similarity Estimation predicts progression from mild cognitive impairment to Alzheimer's dementia.
Topics: Alzheimer Disease; Brain; Cognitive Dysfunction; Connectome; Disease Progression; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Tomography, X-Ray Computed | 2020 |
The combined effects of microglia activation and brain glucose hypometabolism in early-onset Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain; Fluorodeoxyglucose F18; Glucose; Humans; Microglia; Positron-Emission Tomography | 2020 |
Integrity of Neurocognitive Networks in Dementing Disorders as Measured with Simultaneous PET/Functional MRI.
Topics: Alzheimer Disease; Cognition; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neural Pathways; Positron-Emission Tomography; Retrospective Studies | 2020 |
Head-to-head comparison of cerebral blood flow single-photon emission computed tomography and
Topics: Alzheimer Disease; Cerebrovascular Circulation; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Tomography, Emission-Computed, Single-Photon | 2021 |
CSF p-tau/Aβ
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Brain; Cognitive Dysfunction; Disease Progression; Fluorodeoxyglucose F18; Humans; Peptide Fragments; tau Proteins | 2020 |
Evaluating 2-[
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Cognitive Dysfunction; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Magnetic Resonance Imaging; Male; Middle Aged; Tomography, Emission-Computed, Single-Photon | 2020 |
The impact of atlas-based MR attenuation correction on the diagnosis of FDG-PET/MR for Alzheimer's diseases- A simulation study combining multi-center data and ADNI-data.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cognitive Dysfunction; Computer Simulation; Datasets as Topic; Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Neuroimaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2020 |
Utility of FDG-PET in diagnosis of Alzheimer-related TDP-43 proteinopathy.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; TDP-43 Proteinopathies | 2020 |
Selection of the optimal intensity normalization region for FDG-PET studies of normal aging and Alzheimer's disease.
Topics: Adipose Tissue; Adolescent; Adult; Aged; Aged, 80 and over; Aging; Alzheimer Disease; Brain; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Positron-Emission Tomography; Young Adult | 2020 |
Fascicle- and Glucose-Specific Deterioration in White Matter Energy Supply in Alzheimer's Disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognitive Dysfunction; Diffusion Magnetic Resonance Imaging; Diffusion Tensor Imaging; Female; Fluorodeoxyglucose F18; Glucose; Gray Matter; Gyrus Cinguli; Humans; Male; Middle Aged; White Matter | 2020 |
Sex-driven modifiers of Alzheimer risk: A multimodality brain imaging study.
Topics: Adult; Aged; Alzheimer Disease; Aniline Compounds; Apolipoproteins E; Female; Fluorodeoxyglucose F18; Hormones; Humans; Life Style; Magnetic Resonance Imaging; Male; Menopause; Middle Aged; Multimodal Imaging; Neuroimaging; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Risk Factors; Sex Factors; Thiazoles | 2020 |
Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study.
Topics: Adult; Alzheimer Disease; Amyloid beta-Peptides; Amyloidosis; Apolipoproteins E; Biomarkers; Case-Control Studies; Cognitive Dysfunction; Cross-Sectional Studies; Down Syndrome; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neurofilament Proteins; Positron-Emission Tomography; Prevalence; Spain; tau Proteins; United Kingdom | 2020 |
Brain Regional Glucose Metabolism, Neuropsychiatric Symptoms, and the Risk of Incident Mild Cognitive Impairment: The Mayo Clinic Study of Aging.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies | 2021 |
Serum albumin and beta-amyloid deposition in the human brain.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Amyloidosis; Brain; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Serum Albumin | 2020 |
Simultaneous FDG-PET/MRI detects hippocampal subfield metabolic differences in AD/MCI.
Topics: Aged; Alzheimer Disease; Brain; Case-Control Studies; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography | 2020 |
Clinical impact of
Topics: Alzheimer Disease; Cognitive Dysfunction; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Memory; Positron-Emission Tomography | 2021 |
Genome-Wide Association Study of Brain Alzheimer's Disease-Related Metabolic Decline as Measured by [18F] FDG-PET Imaging.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cohort Studies; Female; Fluorodeoxyglucose F18; Genome-Wide Association Study; Humans; Male; Polymorphism, Single Nucleotide; Positron-Emission Tomography | 2020 |
Multi-slice representational learning of convolutional neural network for Alzheimer's disease classification using positron emission tomography.
Topics: Alzheimer Disease; Cognition; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Neural Networks, Computer; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity | 2020 |
Multi-View Separable Pyramid Network for AD Prediction at MCI Stage by
Topics: Aged; Alzheimer Disease; Brain; Cognitive Dysfunction; Disease Progression; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography | 2021 |
A Novel Metabolic Connectome Method to Predict Progression to Mild Cognitive Impairment.
Topics: Alzheimer Disease; Brain; Cognitive Dysfunction; Connectome; Disease Progression; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography | 2020 |
Posterior Cingulate Cortex Hypometabolism in Non-Amnestic Variants of Alzheimer's Disease.
Topics: Aged; Alzheimer Disease; Female; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies | 2020 |
Relationship Between PET-Assessed Amyloid Burden and Visual and Verbal Episodic Memory Performance in Elderly Subjects.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Cognition; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Male; Memory, Episodic; Neuropsychological Tests; Positron-Emission Tomography; Thiazoles | 2020 |
The role of anterior prefrontal cortex in prospective memory: an exploratory FDG-PET study in early Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Male; Memory, Episodic; Positron-Emission Tomography; Prefrontal Cortex; Radiopharmaceuticals; Retrospective Studies | 2020 |
Neural correlates of naming errors across different neurodegenerative diseases: An FDG-PET study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aphasia, Primary Progressive; Connectome; Dementia; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Language; Male; Neurodegenerative Diseases; Occipital Lobe; Pattern Recognition, Visual; Positron-Emission Tomography; Retrospective Studies; Semantics; Speech; Supranuclear Palsy, Progressive; Temporal Lobe | 2020 |
FDG-PET hypermetabolism is associated with higher tau-PET in mild cognitive impairment at low amyloid-PET levels.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; tau Proteins | 2020 |
In the era of FDG PET, is it time for brain perfusion SPECT to gain a place in Alzheimer's disease imaging biomarkers?
Topics: Alzheimer Disease; Biomarkers; Brain; Fluorodeoxyglucose F18; Humans; Perfusion; Positron-Emission Tomography; Tomography, Emission-Computed, Single-Photon | 2021 |
Principal-Component Analysis-Based Measures of PET Data Closely Reflect Neuropathologic Staging Schemes.
Topics: Aged; Alzheimer Disease; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neuroimaging; Positron-Emission Tomography; Principal Component Analysis | 2021 |
Biomarkers for dementia: too soon for routine clinical use.
Topics: Alzheimer Disease; Amyloidosis; Biomarkers; Dementia; Fluorodeoxyglucose F18; Humans | 2020 |
Synchronous nonmonotonic changes in functional connectivity and white matter integrity in a rat model of sporadic Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Brain; Demyelinating Diseases; Diabetes Mellitus, Experimental; Diffusion Magnetic Resonance Imaging; Disease Models, Animal; Fluorodeoxyglucose F18; Functional Neuroimaging; Glucose; Injections, Intraventricular; Longitudinal Studies; Magnetic Resonance Imaging; Male; Neural Pathways; Neurofibrillary Tangles; Plaque, Amyloid; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Streptozocin; White Matter | 2021 |
Protective Factors Modulate the Risk of Beta Amyloid in Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Protective Factors | 2020 |
Biomarker-based stability in limbic-predominant amnestic mild cognitive impairment.
Topics: Alzheimer Disease; Biomarkers; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Retrospective Studies | 2021 |
FDG-PET Patterns Predict Amyloid Deposition and Clinical Profile in Corticobasal Syndrome.
Topics: Alzheimer Disease; Amyloid; Aniline Compounds; Brain; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
The Differential Influence of Immune, Endocytotic, and Lipid Metabolism Genes on Amyloid Deposition and Neurodegeneration in Subjects at Risk of Alzheimer's Disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Brain; Case-Control Studies; Cognitive Dysfunction; Endocytosis; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Immunity; Linear Models; Lipid Metabolism; Male; Multifactorial Inheritance; Polymorphism, Single Nucleotide; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Severe Obstructive Sleep Apnea and Increased Cortical Amyloid-β Deposition.
Topics: Adult; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Severity of Illness Index; Sleep Apnea, Obstructive; Thiazoles | 2021 |
Diagnostic Accuracy of Amyloid versus
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Autopsy; Brain; DNA-Binding Proteins; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Frontotemporal Lobar Degeneration; Humans; Male; Middle Aged; Pick Disease of the Brain; Plaque, Amyloid; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; tau Proteins; Thiazoles | 2021 |
Lewy Body Disease is a Contributor to Logopenic Progressive Aphasia Phenotype.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aphasia, Primary Progressive; Female; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Humans; Language Tests; Lewy Body Disease; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Partial Inhibition of Mitochondrial Complex I Reduces Tau Pathology and Improves Energy Homeostasis and Synaptic Function in 3xTg-AD Mice.
Topics: Alzheimer Disease; Animals; Cognition; Electron Transport Complex I; Energy Metabolism; Fluorodeoxyglucose F18; Hippocampus; Homeostasis; Humans; Long-Term Potentiation; Memory; Mice; Mice, Transgenic; Morris Water Maze Test; Positron-Emission Tomography; Pyrones; Radiopharmaceuticals; Synapses; tau Proteins | 2021 |
Neuropsychiatric symptoms are early indicators of an upcoming metabolic decline in Alzheimer's disease.
Topics: Adult; Age of Onset; Aged; Alzheimer Disease; Disease Progression; Factor Analysis, Statistical; Female; Fluorodeoxyglucose F18; Heterozygote; Humans; Longitudinal Studies; Male; Mental Disorders; Middle Aged; Mutation; Nervous System Diseases; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Validation of the Alzheimer Disease Dementia Conversion-Related Pattern as an ATN Biomarker of Neurodegeneration.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cognitive Dysfunction; Cohort Studies; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neurofilament Proteins; Neuropsychological Tests; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Risk Assessment; tau Proteins | 2021 |
Correlation Between Brain 18F-AV45 and 18F-FDG PET Distribution Characteristics and Cognitive Function in Patients with Mild and Moderate Alzheimer's Disease.
Topics: Aged; Alzheimer Disease; Aniline Compounds; Brain; Cognition; Ethylene Glycols; Fluorodeoxyglucose F18; Humans; Male; Mental Status and Dementia Tests; Neuroimaging; Plaque, Amyloid; Positron-Emission Tomography; Severity of Illness Index | 2021 |
Modeling autosomal dominant Alzheimer's disease with machine learning.
Topics: Adult; Alzheimer Disease; Amyloid; Aniline Compounds; Atrophy; Female; Fluorodeoxyglucose F18; Humans; Machine Learning; Magnetic Resonance Imaging; Male; Mutation; Positron-Emission Tomography; Thiazoles | 2021 |
MiRNA-15b and miRNA-125b are associated with regional Aβ-PET and FDG-PET uptake in cognitively normal individuals with subjective memory complaints.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Brain; Cross-Sectional Studies; Fluorodeoxyglucose F18; Humans; MicroRNAs; Pilot Projects; Positron-Emission Tomography | 2021 |
Associations among education, age, and the dementia with Lewy bodies (DLB) metabolic pattern: A European-DLB consortium project.
Topics: Age Factors; Aged; Alzheimer Disease; Brain; Educational Status; Europe; Fluorodeoxyglucose F18; Frontal Lobe; Gyrus Cinguli; Humans; Image Processing, Computer-Assisted; Lewy Body Disease; Positron-Emission Tomography | 2021 |
Blinded Clinical Evaluation for Dementia of Alzheimer's Type Classification Using FDG-PET: A Comparison Between Feature-Engineered and Non-Feature-Engineered Machine Learning Methods.
Topics: Alzheimer Disease; Brain; Cognitive Dysfunction; Dementia; Fluorodeoxyglucose F18; Humans; Machine Learning; Neural Networks, Computer; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
A Comparison of Two Statistical Mapping Tools for Automated Brain FDG-PET Analysis in Predicting Conversion to Alzheimer's Disease in Subjects with Mild Cognitive Impairment.
Topics: Aged; Alzheimer Disease; Brain; Brain Mapping; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Models, Statistical; Positron-Emission Tomography; Radiopharmaceuticals; Sweden | 2020 |
Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer's subjects?
Topics: Alzheimer Disease; Brain; Diabetes Mellitus, Type 2; Fluorodeoxyglucose F18; Glucose; Humans; Insulin Resistance; Magnetic Resonance Imaging; Positron-Emission Tomography | 2021 |
Data-driven FDG-PET subtypes of Alzheimer's disease-related neurodegeneration.
Topics: Alzheimer Disease; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography | 2021 |
Clinical Relevance of [
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Brain; Cognitive Dysfunction; Dementia; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; tau Proteins | 2021 |
New Trajectory of Clinical and Biomarker Changes in Sporadic Alzheimer's Disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Biomarkers; Brain; Cognitive Dysfunction; Disease Progression; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Linear Models; Longitudinal Studies; Magnetic Resonance Imaging; Male; Organ Size; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Comparison of the clinical impact of 2-[18F]FDG-PET and cerebrospinal fluid biomarkers in patients suspected of Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies | 2021 |
Comparison of [
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography | 2021 |
Long-Term Caloric Restriction Attenuates β-Amyloid Neuropathology and Is Accompanied by Autophagy in APPswe/PS1delta9 Mice.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animal Nutritional Physiological Phenomena; Animals; Aspartic Acid; Autophagy; Calcium-Binding Proteins; Caloric Restriction; Cerebral Cortex; Creatine; Disease Models, Animal; Fluorodeoxyglucose F18; Glucose; Hippocampus; Magnetic Resonance Spectroscopy; Maze Learning; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Transgenic; Microfilament Proteins; Neurons; Plaque, Amyloid; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2021 |
Glucose metabolism in the right middle temporal gyrus could be a potential biomarker for subjective cognitive decline: a study of a Han population.
Topics: Alzheimer Disease; Biomarkers; Cognitive Dysfunction; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Temporal Lobe | 2021 |
F-18 ML-104 tau PET imaging in mild cognitive impairment.
Topics: Aged; Alzheimer Disease; Amnesia; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography | 2021 |
Functional Neural Correlates of the WAIS-IV Block Design Test in Older Adult with Mild Cognitive Impairment and Alzheimer's Disease.
Topics: Aged; Alzheimer Disease; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography | 2021 |
Behavioural disorders in Alzheimer's disease: the descriptive and predictive role of brain
Topics: Aged; Alzheimer Disease; Brain; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Problem Behavior; Retrospective Studies; Tomography, X-Ray Computed | 2021 |
Detection of Alzheimer's disease using ECD SPECT images by transfer learning from FDG PET.
Topics: Alzheimer Disease; Brain; Cysteine; Fluorodeoxyglucose F18; Humans; Male; Organotechnetium Compounds; Positron-Emission Tomography; Tomography, Emission-Computed, Single-Photon | 2021 |
123I-Ioflupane SPECT and 18F-FDG PET Combined Use in the Characterization of Movement and Cognitive Associated Disorders in Neurodegenerative Diseases.
Topics: Alzheimer Disease; Brain; Cognition Disorders; Fluorodeoxyglucose F18; Humans; Movement Disorders; Neurodegenerative Diseases; Nortropanes; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed, Single-Photon | 2021 |
Differential trajectories of hypometabolism across cognitively-defined Alzheimer's disease subgroups.
Topics: Alzheimer Disease; Amyloid; Brain; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography | 2021 |
Hypermetabolic Cerebellar Connectome in Alzheimer's Disease.
Topics: Alzheimer Disease; Brain; Cerebellum; Connectome; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography | 2023 |
Intranasal 15d-PGJ2 ameliorates brain glucose hypometabolism via PPARγ-dependent activation of PGC-1α/GLUT4 signalling in APP/PS1 transgenic mice.
Topics: Administration, Intranasal; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Anilides; Animals; Behavior, Animal; Brain; Cytokines; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 4; Hippocampus; Immunologic Factors; Mice; Mice, Transgenic; Morris Water Maze Test; Neurons; Peptide Fragments; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Positron-Emission Tomography; PPAR gamma; Presenilin-1; Prostaglandin D2; Radiopharmaceuticals; Signal Transduction | 2021 |
Generation of synthetic PET images of synaptic density and amyloid from
Topics: Alzheimer Disease; Aniline Compounds; Brain; Deep Learning; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography | 2021 |
Evaluation of the early-phase [
Topics: Alzheimer Disease; Aniline Compounds; Biomarkers; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography | 2021 |
FDG PET metabolic signatures distinguishing prodromal DLB and prodromal AD.
Topics: Alzheimer Disease; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Positron-Emission Tomography | 2021 |
Coupling relationship between glucose and oxygen metabolisms to differentiate preclinical Alzheimer's disease and normal individuals.
Topics: Aged; Alzheimer Disease; Biomarkers; Brain; Connectome; Default Mode Network; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Net; Oxygen; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer's disease, and mild cognitive impairment using brain 18F-FDG PET.
Topics: Alzheimer Disease; Brain; Cognitive Dysfunction; Deep Learning; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Neurodegenerative Diseases; Positron-Emission Tomography; Retrospective Studies | 2022 |
High Correlation of Static First-Minute-Frame (FMF) PET Imaging after
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Aniline Compounds; Brain; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography | 2021 |
Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid; Apolipoprotein E4; Atrophy; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; tau Proteins | 2022 |
Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Apolipoproteins E; Biomarkers; Cerebral Cortex; Cognitive Dysfunction; Disease Progression; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Neurodegenerative Diseases; Parietal Lobe; Positron-Emission Tomography; Temporal Lobe | 2017 |
Biomarkers and Functional Decline in Prodromal Alzheimer's Disease.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Prodromal Symptoms; Time Factors | 2017 |
Arterial spin labeling-based Z-maps have high specificity and positive predictive value for neurodegenerative dementia compared to FDG-PET.
Topics: Aged; Alzheimer Disease; Arteries; Brain; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity; Spin Labels | 2017 |
Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease.
Topics: Aged; Alzheimer Disease; Aniline Compounds; Apolipoprotein E4; Biomarkers; Brain; Brain Mapping; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Irritable Mood; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Positron-Emission Tomography; Prodromal Symptoms; Prognosis; Radiopharmaceuticals; Sleep; tau Proteins | 2017 |
Regional 18F-Fluorodeoxyglucose Hypometabolism is Associated with Higher Apathy Scores Over Time in Early Alzheimer Disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Apathy; Cognitive Dysfunction; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Functional Neuroimaging; Humans; Longitudinal Studies; Male; Middle Aged; Parietal Lobe; Positron-Emission Tomography; Radiopharmaceuticals | 2017 |
How the cognitive reserve interacts with β-amyloid deposition in mitigating FDG metabolism: An observational study.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Brain; Brain Mapping; Cognitive Reserve; Educational Status; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Mental Status Schedule; Neuropsychological Tests; Peptide Fragments; Phosphorylation; Positron-Emission Tomography; Radiopharmaceuticals; tau Proteins | 2017 |
Dual-phase
Topics: Aged; Alzheimer Disease; Aniline Compounds; Aphasia, Primary Progressive; Brain; Case-Control Studies; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Taiwan | 2017 |
Is Tau Imaging More Than Just Upside-Down
Topics: Alzheimer Disease; Clinical Trials as Topic; Diagnosis, Differential; Early Diagnosis; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; tau Proteins | 2017 |
Everyday cognition scales are related to cognitive function in the early stage of probable Alzheimer's disease and FDG-PET findings.
Topics: Aged; Aging; Alzheimer Disease; Cognition; Demography; Female; Fluorodeoxyglucose F18; Humans; Male; Neuropsychological Tests; Positron-Emission Tomography; ROC Curve | 2017 |
Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer's disease dementia.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Brain; Cognition; Cognitive Dysfunction; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Longitudinal Studies; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Quinolines; Radiopharmaceuticals; tau Proteins | 2018 |
Moderate Physical Activity is Associated with Cerebral Glucose Metabolism in Adults at Risk for Alzheimer's Disease.
Topics: Accelerometry; Aged; Alzheimer Disease; Cerebral Cortex; Cross-Sectional Studies; Exercise; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Positron-Emission Tomography; Registries | 2017 |
Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia.
Topics: Aged; Alzheimer Disease; Amyloid; Aniline Compounds; Atrophy; Blood Pressure; Brain; Cerebral Cortex; Cognitive Dysfunction; Disease Progression; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neuroimaging; Neurons; Neuropsychological Tests; Positron-Emission Tomography; Spin Labels; Vascular Resistance; White Matter | 2017 |
Spontaneous low frequency BOLD signal variations from resting-state fMRI are decreased in Alzheimer disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amygdala; Amyloid beta-Peptides; Case-Control Studies; Cerebellum; Databases, Factual; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Nucleus Accumbens; Peptide Fragments; Positron-Emission Tomography; Radiopharmaceuticals | 2017 |
F-18 FDG and F-18 Tau PET in posterior cortical atrophy.
Topics: Alzheimer Disease; Atrophy; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; tau Proteins | 2017 |
Functional Disintegration of the Default Mode Network in Prodromal Alzheimer's Disease.
Topics: Aged; Alzheimer Disease; Analysis of Variance; Cognition Disorders; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Models, Neurological; Neural Pathways; Neuropsychological Tests; Oxygen; Positron-Emission Tomography; Prodromal Symptoms; Psychiatric Status Rating Scales; Surveys and Questionnaires | 2017 |
Brain and Brown Adipose Tissue Metabolism in Transgenic Tg2576 Mice Models of Alzheimer Disease Assessed Using
Topics: Adipose Tissue, Brown; Alzheimer Disease; Animals; Brain; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Male; Mice; Mice, Transgenic; Positron-Emission Tomography | 2017 |
Early identification of MCI converting to AD: a FDG PET study.
Topics: Alzheimer Disease; Case-Control Studies; Cognitive Dysfunction; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Positron-Emission Tomography; Support Vector Machine | 2017 |
A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting.
Topics: Aged; Alzheimer Disease; Amyloid; Aniline Compounds; Biomarkers; Cognitive Dysfunction; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; ROC Curve; Thiazoles | 2017 |
A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease.
Topics: Acetoacetates; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Case-Control Studies; Cognitive Dysfunction; Cross-Sectional Studies; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glucose; Humans; Linear Models; Magnetic Resonance Imaging; Male; Positron-Emission Tomography | 2018 |
Functional correlates of TSH, fT3 and fT4 in Alzheimer disease: a F-18 FDG PET/CT study.
Topics: Aged; Alzheimer Disease; Brain; Case-Control Studies; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thyrotropin; Thyroxine; Triiodothyronine | 2017 |
Cerebral PET glucose hypometabolism in subjects with mild cognitive impairment and higher EEG high-alpha/low-alpha frequency power ratio.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Brain; Cognitive Dysfunction; Electroencephalography; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Peptide Fragments; Positron-Emission Tomography; Radiopharmaceuticals; tau Proteins | 2017 |
Activation of brain glucose metabolism ameliorating cognitive impairment in APP/PS1 transgenic mice by electroacupuncture.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Brain Mapping; Cerebral Cortex; Cognitive Dysfunction; DNA-Binding Proteins; Electroacupuncture; Energy Metabolism; Exploratory Behavior; Fluorodeoxyglucose F18; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Glucose; Glucose Transporter Type 1; Glucose Transporter Type 3; Hippocampus; Humans; Mice; Mice, Transgenic; Nerve Tissue Proteins; Nuclear Proteins; Positron-Emission Tomography; Spatial Learning | 2017 |
18F-FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer's disease (AD) patients at the mild cognitive impairment (MCI) stage.
Topics: Alzheimer Disease; Case-Control Studies; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Positron-Emission Tomography; Prognosis | 2017 |
Associations of thyroid hormone serum levels with in-vivo Alzheimer's disease pathologies.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Apolipoprotein E4; Benzothiazoles; Biomarkers; Brain; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Thiazoles; Thyroid Hormones; Thyrotropin | 2017 |
Sex differences in Alzheimer risk: Brain imaging of endocrine vs chronologic aging.
Topics: Adult; Aging; Alzheimer Disease; Apolipoproteins E; Biomarkers; Brain; Endocrine System; Endophenotypes; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Menopause; Middle Aged; Multimodal Imaging; Organ Size; Positron-Emission Tomography; Radiopharmaceuticals; Risk; Sex Characteristics | 2017 |
Cortical Metabolic and Cognitive Correlates of Disorientation in Alzheimer's Disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cerebral Cortex; Cognition Disorders; Confusion; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Tomography Scanners, X-Ray Computed | 2017 |
Alzheimer's Disease Diagnosis Relies on a Twofold Clinical-Biological Algorithm: Three Memory Clinic Case Reports.
Topics: Aged; Algorithms; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Psychiatric Status Rating Scales; tau Proteins; Tomography, Emission-Computed, Single-Photon; Tropanes | 2017 |
Topics: Alzheimer Disease; Atrophy; Cerebral Cortex; Cognition; Female; Fluorodeoxyglucose F18; Gray Matter; Humans; Male; Middle Aged; Neuropsychological Tests; Organ Size; Positron-Emission Tomography; Radiopharmaceuticals | 2017 |
Tau positron emission tomography using [
Topics: Aged; Alzheimer Disease; Aminopyridines; Amnesia; Brain; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Quinolines; Radiopharmaceuticals; Severity of Illness Index; tau Proteins | 2017 |
Quantification of brain cholinergic denervation in Alzheimer's disease using PET imaging with [
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Brain; Case-Control Studies; Cholinergic Agents; Cholinergic Neurons; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Piperidines; Positron-Emission Tomography; Presynaptic Terminals; Radioactive Tracers; Vesicular Acetylcholine Transport Proteins | 2017 |
Longer-Term Investigation of the Value of 18F-FDG-PET and Magnetic Resonance Imaging for Predicting the Conversion of Mild Cognitive Impairment to Alzheimer's Disease: A Multicenter Study.
Topics: Aged; Alzheimer Disease; Brain; Cognitive Dysfunction; Disease Progression; Educational Status; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Logistic Models; Magnetic Resonance Imaging; Male; Multivariate Analysis; Neuropsychological Tests; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2017 |
Intranasal Insulin Ameliorates Cerebral Hypometabolism, Neuronal Loss, and Astrogliosis in Streptozotocin-Induced Alzheimer's Rat Model.
Topics: Administration, Intranasal; Alzheimer Disease; Animals; Antibiotics, Antineoplastic; Apoptosis; Cerebral Cortex; Disease Models, Animal; Fluorodeoxyglucose F18; Glial Fibrillary Acidic Protein; Gliosis; Hypoglycemic Agents; Insulin; Magnetic Resonance Imaging; Male; Neurons; Positron-Emission Tomography; Rats; Rats, Sprague-Dawley; Streptozocin | 2018 |
The Alzheimer's disease metabolic brain pattern in mild cognitive impairment.
Topics: Aging; Alzheimer Disease; Brain; Cognitive Dysfunction; Disease Progression; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Positron-Emission Tomography; Radiopharmaceuticals | 2017 |
Learning Metabolic Brain Networks in MCI and AD by Robustness and Leave-One-Out Analysis: An FDG-PET Study.
Topics: Aged; Alzheimer Disease; Brain; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Learning; Male; Metabolic Networks and Pathways; Neuropsychological Tests; Positron-Emission Tomography | 2018 |
Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Neuropsychological Tests; Peptide Fragments; Phosphorylation; Positron-Emission Tomography; tau Proteins | 2017 |
Retinal Microperimetry: A New Tool for Identifying Patients With Type 2 Diabetes at Risk for Developing Alzheimer Disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Prospective Studies; Visual Field Tests | 2017 |
Perimenopause and emergence of an Alzheimer's bioenergetic phenotype in brain and periphery.
Topics: Adult; Aging; Alzheimer Disease; Blood Platelets; Brain; Brain Mapping; Electron Transport Complex IV; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glucose; Humans; Memory; Middle Aged; Mitochondria; Neuropsychological Tests; Perimenopause; Phenotype; Positron-Emission Tomography; Postmenopause; Radiopharmaceuticals | 2017 |
Cerebral metabolic correlates of attention networks in Alzheimer's Disease: A study of the Stroop.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Attention; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neural Pathways; Positron-Emission Tomography; Stroop Test | 2017 |
Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer's disease patients: A CSF and FDG PET study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Brain; Brain Mapping; Cohort Studies; Female; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Italy; Male; Parietal Lobe; Peptide Fragments; Phosphorylation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; tau Proteins; Temporal Lobe | 2018 |
Multimodal Imaging in Rat Model Recapitulates Alzheimer's Disease Biomarkers Abnormalities.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloidosis; Animals; Animals, Genetically Modified; Biomarkers; Brain; Brain Chemistry; Cognitive Dysfunction; Disease Models, Animal; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Magnetic Resonance Imaging; Male; Memory Disorders; Multimodal Imaging; Mutation; Neuroimaging; Plaque, Amyloid; Positron-Emission Tomography; Protein Aggregation, Pathological; Radiopharmaceuticals; Rats; Rats, Transgenic; Rats, Wistar | 2017 |
Comparison between FCSRT and LASSI-L to Detect Early Stage Alzheimer's Disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cues; Female; Fluorodeoxyglucose F18; Humans; Male; Memory Disorders; Mental Recall; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Psychiatric Status Rating Scales; ROC Curve; Semantics | 2018 |
Prediction of Alzheimer's Dementia in Patients with Amnestic Mild Cognitive Impairment in Clinical Routine: Incremental Value of Biomarkers of Neurodegeneration and Brain Amyloidosis Added Stepwise to Cognitive Status.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloidosis; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Survival Analysis; tau Proteins | 2018 |
Alzheimer-Like Pattern of Hypometabolism Emerges with Elevated Amyloid-β Burden in Down Syndrome.
Topics: Adult; Alzheimer Disease; Amyloid beta-Peptides; Down Syndrome; Female; Fluorodeoxyglucose F18; Gray Matter; Humans; Linear Models; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; United States | 2018 |
Longitudinal uncoupling of cerebral perfusion, glucose metabolism, and tau deposition in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Aniline Compounds; Brain; Cognitive Dysfunction; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Perfusion; Positron-Emission Tomography; Quinolines; tau Proteins | 2018 |
Topics: Aged; Alzheimer Disease; Amyloid; Fluorodeoxyglucose F18; Humans; Male; Memory Disorders; Positron-Emission Tomography | 2018 |
A new data analysis approach for measuring longitudinal changes of metabolism in cognitively normal elderly adults.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Apolipoprotein E4; Biomarkers; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Time Factors | 2017 |
Assessment of change in glucose metabolism in white matter of amyloid-positive patients with Alzheimer disease using F-18 FDG PET.
Topics: Aged; Alzheimer Disease; Amyloid; Aniline Compounds; Brain; Cognition; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Male; Mental Status Schedule; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Stilbenes; White Matter | 2017 |
An Aspartyl Cathepsin Targeted PET Agent: Application in an Alzheimer's Disease Mouse Model.
Topics: Alzheimer Disease; Animals; Brain; Cathepsin D; Contrast Media; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Glucose; Mice; Mice, Transgenic; Positron-Emission Tomography | 2018 |
FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Brain; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Male; Middle Aged; Neuropsychological Tests; Phosphorylation; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; tau Proteins | 2018 |
Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Biomarkers; Brain; Disease Progression; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Positron-Emission Tomography; tau Proteins | 2018 |
Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study.
Topics: Adult; Alzheimer Disease; Amyloid beta-Protein Precursor; Aniline Compounds; Brain; Brain Mapping; Family Health; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Presenilin-1; Presenilin-2; Statistics, Nonparametric; Thiazoles | 2018 |
Reduced blood oxygenation level dependent connectivity is related to hypoperfusion in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cerebrovascular Circulation; Female; Fluorodeoxyglucose F18; Hemodynamics; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neurons; Oxygen; Positron-Emission Tomography; Signal Transduction | 2019 |
Joint Assessment of Quantitative 18F-Florbetapir and 18F-FDG Regional Uptake Using Baseline Data from the ADNI.
Topics: Aged; Alzheimer Disease; Aniline Compounds; Brain; Brain Mapping; Cognitive Dysfunction; Cross-Sectional Studies; Disease Progression; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2018 |
Predicting cognitive decline with deep learning of brain metabolism and amyloid imaging.
Topics: Aged; Alzheimer Disease; Amyloid; Aniline Compounds; Brain; Cognitive Dysfunction; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Male; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Support Vector Machine | 2018 |
Longitudinal Changes in Serum Glucose Levels are Associated with Metabolic Changes in Alzheimer's Disease Related Brain Regions.
Topics: Aged; Alzheimer Disease; Apolipoprotein E4; Blood Glucose; Brain; Brain Mapping; Female; Fluorodeoxyglucose F18; Heterozygote; Humans; Longitudinal Studies; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals | 2018 |
Thiamine diphosphate reduction strongly correlates with brain glucose hypometabolism in Alzheimer's disease, whereas amyloid deposition does not.
Topics: Age Factors; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Aniline Compounds; Animals; Brain; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Middle Aged; Positron-Emission Tomography; Presenilin-1; Psychiatric Status Rating Scales; Thiamine; Thiamine Pyrophosphate; Thiazoles | 2018 |
Multiscale deep neural network based analysis of FDG-PET images for the early diagnosis of Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Male; Neural Networks, Computer; Positron-Emission Tomography; Radiopharmaceuticals | 2018 |
Impact of plasma glucose level on the pattern of brain FDG uptake and the predictive power of FDG PET in mild cognitive impairment.
Topics: Aged; Alzheimer Disease; Blood Glucose; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography | 2018 |
Hybrid PET-MRI in Alzheimer's Disease Research.
Topics: Alzheimer Disease; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2018 |
Amyloid PET Imaging: Standardization and Integration with Other Alzheimer's Disease Biomarkers.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Biomarkers; Carbon Radioisotopes; Fluorodeoxyglucose F18; Humans; Plaque, Amyloid; Positron-Emission Tomography; Radiopharmaceuticals; Stilbenes; Thiazoles | 2018 |
The Use of
Topics: Alzheimer Disease; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals | 2018 |
Preferential degradation of cognitive networks differentiates Alzheimer's disease from ageing.
Topics: Adult; Aged; Aged, 80 and over; Aging; Alzheimer Disease; Aniline Compounds; Brain Mapping; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Models, Neurological; Neural Pathways; Positron-Emission Tomography; Thiazoles | 2018 |
Regional association of pCASL-MRI with FDG-PET and PiB-PET in people at risk for autosomal dominant Alzheimer's disease.
Topics: Adult; Alzheimer Disease; Amyloid beta-Protein Precursor; Aniline Compounds; Brain; Cerebrovascular Circulation; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Presenilin-1; Presenilin-2; Spin Labels; Thiazoles; Young Adult | 2018 |
Metabolic brain networks in aging and preclinical Alzheimer's disease.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aging; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Apolipoprotein E4; Brain; Correlation of Data; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Positron-Emission Tomography; Thiazoles; Young Adult | 2018 |
Amyloid load but not regional glucose metabolism predicts conversion to Alzheimer's dementia in a memory clinic population.
Topics: Aged; Alzheimer Disease; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies | 2018 |
Multi-Modality Sparse Representation for Alzheimer's Disease Classification.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognitive Dysfunction; Fluorodeoxyglucose F18; Hippocampus; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Support Vector Machine | 2018 |
Study of the Influence of Age in
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Case-Control Studies; Databases, Factual; Female; Fluorodeoxyglucose F18; Healthy Volunteers; Humans; Male; Middle Aged; Models, Theoretical; Positron-Emission Tomography; Young Adult | 2018 |
Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD).
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloidosis; Brain; Cognitive Dysfunction; Cohort Studies; Disease Progression; Educational Status; Female; Fluorodeoxyglucose F18; Humans; Male; Mental Status Schedule; Middle Aged; Positron-Emission Tomography | 2018 |
Predicting Imminent Progression to Clinically Significant Memory Decline Using Volumetric MRI and FDG PET.
Topics: Aged; Alzheimer Disease; Apolipoproteins E; Brain; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2018 |
Multimodal and Multiscale Deep Neural Networks for the Early Diagnosis of Alzheimer's Disease using structural MR and FDG-PET images.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Case-Control Studies; Cognitive Dysfunction; Deep Learning; Early Diagnosis; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neural Networks, Computer; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2018 |
Mediterranean diet and 3-year Alzheimer brain biomarker changes in middle-aged adults.
Topics: Adult; Alzheimer Disease; Brain; Diet, Mediterranean; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Surveys and Questionnaires | 2018 |
Simultaneous resting-state FDG-PET/fMRI in Alzheimer Disease: Relationship between glucose metabolism and intrinsic activity.
Topics: Adult; Aged; Aging; Alzheimer Disease; Amnesia; Cognitive Dysfunction; Connectome; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography | 2018 |
Visual Rating and Computer-Assisted Analysis of FDG PET in the Prediction of Conversion to Alzheimer's Disease in Mild Cognitive Impairment.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Area Under Curve; Cognitive Dysfunction; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Image Processing, Computer-Assisted; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; ROC Curve | 2018 |
Cerebrospinal Fluid BACE1 Activity and sAβPPβ as Biomarker Candidates of Alzheimer's Disease.
Topics: Aged; Alzheimer Disease; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Aspartic Acid Endopeptidases; Biomarkers; Cognitive Dysfunction; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2018 |
Spatial Patterns of Hypometabolism and Amyloid Deposition in Variants of Alzheimer's Disease Corresponding to Brain Networks: a Prospective Cohort Study.
Topics: Aged; Alzheimer Disease; Amyloid; Aniline Compounds; Benzothiazoles; Brain; Brain Diseases, Metabolic; Carbon Radioisotopes; Case-Control Studies; Cohort Studies; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Net; Plaque, Amyloid; Positron-Emission Tomography; Thiazoles; Time Factors; Tissue Distribution | 2019 |
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Hydrocephalus, Normal Pressure; Lewy Body Disease; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2018 |
Ketogenic Medium Chain Triglycerides Increase Brain Energy Metabolism in Alzheimer's Disease.
Topics: Acetates; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Carbon; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Ketones; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Triglycerides | 2018 |
Do Cardiometabolic Risk Factors Influence Amyloid, Tau, and Neuronal Function in APOE4 Carriers and Non-Carriers in Alzheimer's Disease Trajectory?
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Apolipoprotein E4; Female; Fluorodeoxyglucose F18; Glucose; Humans; International Cooperation; Male; Positron-Emission Tomography; Psychiatric Status Rating Scales; Risk Factors; tau Proteins | 2018 |
Regional glucose metabolism due to the presence of cerebral amyloidopathy in older adults with depression and mild cognitive impairment.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Aniline Compounds; Cerebral Cortex; Cognitive Dysfunction; Cross-Sectional Studies; Depressive Disorder; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Stilbenes | 2018 |
Spatially Adaptive Varying Correlation Analysis for Multimodal Neuroimaging Data.
Topics: Aged; Aged, 80 and over; Algorithms; Alzheimer Disease; Brain; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Neuroimaging; Positron-Emission Tomography | 2019 |
Multilevel Feature Representation of FDG-PET Brain Images for Diagnosing Alzheimer's Disease.
Topics: Algorithms; Alzheimer Disease; Brain; Cognitive Dysfunction; Databases, Factual; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Machine Learning; Neuroimaging; Positron-Emission Tomography; Support Vector Machine | 2019 |
Can 11C-PiB-PET Relative Delivery R1 or 11C-PiB-PET Perfusion Replace 18F-FDG-PET in the Assessment of Brain Neurodegeneration?
Topics: Aged; Aged, 80 and over; Algorithms; Alzheimer Disease; Brain; Carbon Radioisotopes; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neurodegenerative Diseases; Positron-Emission Tomography; Tomography Scanners, X-Ray Computed | 2018 |
Involvement of the Cingulate Cortex in Anosognosia: A Multimodal Neuroimaging Study in Alzheimer's Disease Patients.
Topics: Aged; Agnosia; Alzheimer Disease; Brain Mapping; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals | 2018 |
In vivo quantification of neurofibrillary tangles with [
Topics: Adult; Age Factors; Aged; Alzheimer Disease; Autopsy; Autoradiography; Brain; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; In Vitro Techniques; Isoquinolines; Magnetic Resonance Imaging; Male; Middle Aged; Neurofibrillary Tangles; Positron-Emission Tomography; Young Adult | 2018 |
Greater tau load and reduced cortical thickness in APOE ε4-negative Alzheimer's disease: a cohort study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Apolipoprotein E4; Carbolines; Cerebral Cortex; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Mental Status and Dementia Tests; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; tau Proteins | 2018 |
Imaging Biomarkers of Neurodegeneration in Alzheimer's Disease: Distinct Contributions of Cortical MRI Atrophy and FDG-PET Hypometabolism.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Atrophy; Biomarkers; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Degeneration; Peptide Fragments; Positron-Emission Tomography; tau Proteins | 2018 |
Reproducible evaluation of classification methods in Alzheimer's disease: Framework and application to MRI and PET data.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Atlases as Topic; Data Interpretation, Statistical; Datasets as Topic; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Machine Learning; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals | 2018 |
Unfavourable gender effect of high body mass index on brain metabolism and connectivity.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Body Mass Index; Brain; Female; Fluorodeoxyglucose F18; Humans; Male; Membrane Potentials; Neural Pathways; Neurodegenerative Diseases; Neuropsychological Tests; Obesity; Positron-Emission Tomography; Risk Factors; Sex Factors | 2018 |
Machine learning identified an Alzheimer's disease-related FDG-PET pattern which is also expressed in Lewy body dementia and Parkinson's disease dementia.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Machine Learning; Male; Middle Aged; Neuroimaging; Parkinson Disease; Positron-Emission Tomography; Support Vector Machine | 2018 |
Crossed Cerebellar Diaschisis in Alzheimer's Disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Cerebellum; Cognition Disorders; Depression; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Thiazoles | 2018 |
Characteristic patterns of inter- and intra-hemispheric metabolic connectivity in patients with stable and progressive mild cognitive impairment and Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain; Cognitive Dysfunction; Connectome; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Net; Positron-Emission Tomography | 2018 |
Association of vascular endothelial growth factor levels in CSF and cerebral glucose metabolism across the Alzheimer's disease spectrum.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Vascular Endothelial Growth Factor A | 2018 |
Amyloid and FDG PET of Successful Cognitive Aging: Global and Cingulate-Specific Differences.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognitive Aging; Cognitive Dysfunction; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Glucose; Gyrus Cinguli; Humans; Male; Plaque, Amyloid; Positron-Emission Tomography | 2018 |
Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Area Under Curve; Carbolines; Cerebral Cortex; Cognitive Dysfunction; Cross-Sectional Studies; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neurodegenerative Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2018 |
Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Bile Acids and Salts; Biomarkers; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neuroimaging; Positron-Emission Tomography; Prospective Studies; tau Proteins | 2019 |
Accuracy and generalization capability of an automatic method for the detection of typical brain hypometabolism in prodromal Alzheimer disease.
Topics: Aged; Alzheimer Disease; Automation; Brain; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Positron-Emission Tomography; Support Vector Machine | 2019 |
Principal Components Analysis of Brain Metabolism Predicts Development of Alzheimer Dementia.
Topics: Aged; Alzheimer Disease; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Principal Component Analysis; Proportional Hazards Models; Risk Assessment | 2019 |
A Deep Learning Model to Predict a Diagnosis of Alzheimer Disease by Using
Topics: Aged; Aged, 80 and over; Algorithms; Alzheimer Disease; Cognitive Dysfunction; Deep Learning; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity | 2019 |
Machine Learning in Radiology: Resistance Is Futile.
Topics: Alzheimer Disease; Brain; Deep Learning; Fluorodeoxyglucose F18; Humans; Machine Learning | 2019 |
Microglial response to increasing amyloid load saturates with aging: a longitudinal dual tracer in vivo μPET-study.
Topics: Aging; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloidosis; Animals; Calcium-Binding Proteins; Carbazoles; Disease Models, Animal; Fluorodeoxyglucose F18; Longitudinal Studies; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microfilament Proteins; Microglia; Positron-Emission Tomography; Radiochemistry; Receptors, GABA | 2018 |
Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer's Dementia.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; White Matter | 2019 |
Longitudinal association between astrocyte function and glucose metabolism in autosomal dominant Alzheimer's disease.
Topics: Adult; Alzheimer Disease; Astrocytes; Female; Fluorodeoxyglucose F18; Glucose; Humans; Longitudinal Studies; Male; Middle Aged; Mutation; Positron-Emission Tomography | 2019 |
Regional multimodal relationships between tau, hypometabolism, atrophy, and fractional anisotropy in atypical Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Anisotropy; Aphasia, Primary Progressive; Atrophy; Brain Mapping; Diffusion Tensor Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals; Tauopathies; White Matter | 2019 |
Plasma Aβ42/40 Ratio Detects Early Stages of Alzheimer's Disease and Correlates with CSF and Neuroimaging Biomarkers in the AB255 Study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Apolipoproteins E; Biomarkers; Case-Control Studies; Cognitive Dysfunction; Cross-Sectional Studies; Early Diagnosis; Female; Fluorodeoxyglucose F18; Genotype; Humans; Male; Neuroimaging; Peptide Fragments; Phosphorylation; Plaque, Amyloid; Positron-Emission Tomography; Prodromal Symptoms; tau Proteins; Thiazoles | 2019 |
Cognitive, behavioral and metabolic effects of oral galactose treatment in the transgenic Tg2576 mice.
Topics: Administration, Oral; Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Functional Neuroimaging; Galactose; Glucagon-Like Peptide 1; Glucose Tolerance Test; Glycogen Synthase Kinase 3 beta; Hippocampus; Insulin; Male; Maze Learning; Mice; Mice, Transgenic; Peptide Fragments; Positron-Emission Tomography; Rats; Receptor, Insulin; Streptozocin | 2019 |
Brain
Topics: Aged; Alzheimer Disease; Blood Glucose; Brain; Fluorodeoxyglucose F18; Humans | 2019 |
Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Male; Middle Aged; Positron-Emission Tomography; tau Proteins | 2019 |
Relative cerebral flow from dynamic PIB scans as an alternative for FDG scans in Alzheimer's disease PET studies.
Topics: Aged; Alzheimer Disease; Aniline Compounds; Brain; Carbon Radioisotopes; Case-Control Studies; Cerebrovascular Circulation; Cognitive Dysfunction; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles | 2019 |
Association of muscle and visceral adipose tissues with the probability of Alzheimer's disease in healthy subjects.
Topics: Age Factors; Aged; Alzheimer Disease; Female; Fluorodeoxyglucose F18; Humans; Intra-Abdominal Fat; Male; Middle Aged; Muscle, Skeletal; Positron-Emission Tomography; Retrospective Studies; Risk Factors | 2019 |
Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer's Disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Disease Progression; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Prodromal Symptoms; Support Vector Machine | 2019 |
Covariance statistics and network analysis of brain PET imaging studies.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Case-Control Studies; Cross-Sectional Studies; Dihydroxyphenylalanine; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Neuroimaging; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals | 2019 |
Intrathecal cell therapy with autologous stromal cells increases cerebral glucose metabolism and can offer a new approach to the treatment of Alzheimer's type dementia.
Topics: Aged; Alzheimer Disease; Brain; Dementia; Female; Fluorodeoxyglucose F18; Glucose; Humans; Injections, Spinal; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Middle Aged; Positron-Emission Tomography; Transplantation, Autologous | 2019 |
Amygdala sign, a FDG-PET signature of dementia with Lewy Bodies.
Topics: Aged; Alzheimer Disease; Amygdala; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Gyrus Cinguli; Humans; Lewy Body Disease; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2019 |
Correlation of Lobar Cerebral Microbleeds with Amyloid, Perfusion, and Metabolism in Alzheimer's Disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Brain; Cerebral Hemorrhage; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography | 2019 |
Effect of genotype and age on cerebral [
Topics: Age Factors; Alzheimer Disease; Animals; Brain; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Mice; Mice, Transgenic; Positron-Emission Tomography | 2019 |
Deep learning only by normal brain PET identify unheralded brain anomalies.
Topics: Alzheimer Disease; Area Under Curve; Brain; Brain Diseases; Cognitive Dysfunction; Deep Learning; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Neuroimaging; Positron-Emission Tomography; ROC Curve | 2019 |
Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Case-Control Studies; Cerebral Cortex; Cerebral Ventricles; Cognitive Dysfunction; Cohort Studies; Disease Progression; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Mental Status and Dementia Tests; Neurofilament Proteins; Organ Size; Peptide Fragments; Phosphoproteins; Positron-Emission Tomography; Radiopharmaceuticals; tau Proteins | 2019 |
Is Cerebrospinal Fluid Superoxide Dismutase 1 a Biomarker of Tau But Not Amyloid-Induced Neurodegeneration in Alzheimer's Disease?
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Apolipoproteins E; Biomarkers; Cognition; Disease Susceptibility; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Memory; Neurodegenerative Diseases; Positron-Emission Tomography; Superoxide Dismutase-1; tau Proteins | 2019 |
Biopathological Significance of Early-Phase Amyloid Imaging in the Spectrum of Alzheimer's Disease.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Carbon Radioisotopes; Cognitive Dysfunction; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Thiazoles | 2019 |
MRI and PET image fusion using the nonparametric density model and the theory of variable-weight.
Topics: Algorithms; Alzheimer Disease; Brain; Brain Mapping; Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Normal Distribution; Positron-Emission Tomography; Principal Component Analysis | 2019 |
Aβ-induced vulnerability propagates via the brain's default mode network.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Animals; Animals, Genetically Modified; Brain; Cognitive Dysfunction; Ethylene Glycols; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neural Pathways; Neurofibrillary Tangles; Positron-Emission Tomography; Radiopharmaceuticals; Rats | 2019 |
The Cingulate Island Sign on FDG-PET vs. IMP-SPECT to Assess Mild Cognitive Impairment in Alzheimer's Disease vs. Dementia with Lewy Bodies.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Cognitive Dysfunction; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Lewy Body Disease; Male; Middle Aged; Positron-Emission Tomography; Tomography, Emission-Computed, Single-Photon | 2019 |
Brain metabolic patterns in patients with suspected non-Alzheimer's pathophysiology (SNAP) and Alzheimer's disease (AD): is [
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Brain; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Peptide Fragments; Positron Emission Tomography Computed Tomography | 2019 |
Predicting long-term clinical stability in amyloid-positive subjects by FDG-PET.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Brain; Clinical Trials as Topic; Cognitive Dysfunction; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Healthy Volunteers; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography | 2019 |
EEG evidence of compensatory mechanisms in preclinical Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Biomarkers; Brain Waves; Case-Control Studies; Disease Progression; Electroencephalography; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Nerve Degeneration; Positron-Emission Tomography; Prodromal Symptoms | 2019 |
Metabolic Brain Network Analysis of FDG-PET in Alzheimer's Disease Using Kernel-Based Persistent Features.
Topics: Aged; Alzheimer Disease; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Metabolic Networks and Pathways; Positron-Emission Tomography | 2019 |
FDG-PET as an independent biomarker for Alzheimer's biological diagnosis: a longitudinal study.
Topics: Aged; Alzheimer Disease; Biomarkers; Brain; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Male; Positron-Emission Tomography | 2019 |
Associations of Neprilysin Activity in CSF with Biomarkers for Alzheimer's Disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Apolipoprotein E4; Biomarkers; Brain; Brain Chemistry; Carbon Radioisotopes; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Mental Status and Dementia Tests; Middle Aged; Neprilysin; Neuroimaging; Peptide Fragments; Positron-Emission Tomography; Radiopharmaceuticals; tau Proteins; Thiazoles | 2019 |
Prognostic value of Alzheimer's biomarkers in mild cognitive impairment: the effect of age at onset.
Topics: Age of Onset; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cerebral Cortex; Cognitive Dysfunction; Datasets as Topic; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Peptide Fragments; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; tau Proteins | 2019 |
18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer's Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Cognitive Dysfunction; Ethylene Glycols; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Mental Status and Dementia Tests; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2019 |
Controls-based denoising, a new approach for medical image analysis, improves prediction of conversion to Alzheimer's disease with FDG-PET.
Topics: Aged; Algorithms; Alzheimer Disease; Brain; Cognitive Dysfunction; Diagnosis, Computer-Assisted; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Machine Learning; Male; Middle Aged; Models, Theoretical; Pattern Recognition, Automated; Positron-Emission Tomography; Principal Component Analysis; Signal-To-Noise Ratio | 2019 |
Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers.
Topics: Aged; Alanine Transaminase; Alkaline Phosphatase; Alzheimer Disease; Aspartate Aminotransferases; Bilirubin; Biomarkers; Cognition; Cognitive Dysfunction; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Liver Function Tests; Magnetic Resonance Imaging; Male; Neuroimaging; Neuropsychological Tests; Positron-Emission Tomography; Reproducibility of Results; Serum Albumin | 2019 |
In vivo imaging of the 18-kDa translocator protein (TSPO) with [18F]FEDAA1106 and PET does not show increased binding in Alzheimer's disease patients.
Topics: Acetamides; Aged; Alzheimer Disease; Automation; Brain Mapping; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Receptors, GABA; Time Factors; Tissue Distribution; Treatment Outcome | 2013 |
Dissociating memory networks in early Alzheimer's disease and frontotemporal lobar degeneration - a combined study of hypometabolism and atrophy.
Topics: Aged; Alzheimer Disease; Brain; Female; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Glucose; Humans; Magnetic Resonance Imaging; Male; Memory; Middle Aged; Positron-Emission Tomography | 2013 |
Comparing brain amyloid deposition, glucose metabolism, and atrophy in mild cognitive impairment with and without a family history of dementia.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloidosis, Familial; Atrophy; Blood Glucose; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Reference Values | 2013 |
Equal sensitivity of early and late scans after injection of FDG for the detection of Alzheimer pattern: an analysis of 3D PET data from J-ADNI, a multi-center study.
Topics: Aged; Alzheimer Disease; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Imaging, Three-Dimensional; Injections, Intravenous; Japan; Male; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity | 2013 |
Semi-supervised multimodal relevance vector regression improves cognitive performance estimation from imaging and biological biomarkers.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Artificial Intelligence; Biomarkers; Brain Mapping; Cognition Disorders; Databases, Factual; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Mental Status Schedule; Middle Aged; National Institutes of Health (U.S.); Neuropsychological Tests; Positron-Emission Tomography; Regression Analysis; Reproducibility of Results; United States | 2013 |
Regional amyloid deposition in amnestic mild cognitive impairment and Alzheimer's disease evaluated by [18F]AV-45 positron emission tomography in Chinese population.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amnesia; Amyloid; Asian People; Brain; Cerebral Cortex; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography | 2013 |
Alzheimer's disease neurodegenerative biomarkers are associated with decreased cognitive function but not β-amyloid in cognitively normal older individuals.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Amyloid; Analysis of Variance; Aniline Compounds; Biomarkers; Brain Mapping; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Linear Models; Longitudinal Studies; Magnetic Resonance Imaging; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Radioisotopes; Reproducibility of Results; Thiazoles | 2013 |
Generative FDG-PET and MRI model of aging and disease progression in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Brain; Case-Control Studies; Disease Progression; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Software | 2013 |
Amyloid cascade and tau pathology cerebrospinal fluid markers in mild cognitive impairment with regards to Alzheimer's disease cerebral metabolic signature.
Topics: Adaptor Proteins, Vesicular Transport; Adult; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Apolipoprotein E4; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuropsychological Tests; Peptide Fragments; Positron-Emission Tomography; Psychiatric Status Rating Scales; Statistics, Nonparametric; tau Proteins | 2013 |
Brain [18F]FDDNP binding and glucose metabolism in advanced elderly healthy subjects and Alzheimer's disease patients.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Brain Mapping; Diprenorphine; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Mental Status Schedule; Positron-Emission Tomography | 2013 |
FDG PET and MRI in logopenic primary progressive aphasia versus dementia of the Alzheimer's type.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aphasia, Primary Progressive; Brain; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography | 2013 |
FDG-PET in early AD diagnosis.
Topics: Aged; Alzheimer Disease; Asymptomatic Diseases; Blood Glucose; Brain; Cognitive Dysfunction; Diagnosis, Differential; Disease Progression; Early Diagnosis; Energy Metabolism; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Neuropsychological Tests; Positron-Emission Tomography; Prognosis | 2013 |
Application of the National Institute on Aging-Alzheimer's Association AD criteria to ADNI.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Brain; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; National Institute on Aging (U.S.); Positron-Emission Tomography; Registries; Societies, Medical; United States | 2013 |
Psychosis in Alzheimer's disease is associated with frontal metabolic impairment and accelerated decline in working memory: findings from the Alzheimer's Disease Neuroimaging Initiative.
Topics: Aged; Alzheimer Disease; Case-Control Studies; Female; Fluorodeoxyglucose F18; Frontal Lobe; Functional Neuroimaging; Glucose; Humans; Longitudinal Studies; Male; Memory Disorders; Memory, Short-Term; Neuropsychological Tests; Positron-Emission Tomography; Psychotic Disorders | 2014 |
Functional neuroanatomical correlates of the executive clock drawing task (CLOX) performance in Alzheimer's disease: a FDG-PET study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Executive Function; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Psychomotor Performance | 2013 |
Automated analysis of FDG PET as a tool for single-subject probabilistic prediction and detection of Alzheimer's disease dementia.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Case-Control Studies; Cognitive Dysfunction; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Models, Statistical; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2013 |
Functional variability in butyrylcholinesterase activity regulates intrathecal cytokine and astroglial biomarker profiles in patients with Alzheimer's disease.
Topics: Acetylcholine; Acetylcholinesterase; Aged; Alzheimer Disease; Aniline Compounds; Astrocytes; Butyrylcholinesterase; Calcium-Binding Proteins; Cells, Cultured; Cognition Disorders; Complement System Proteins; Cytokines; DNA-Binding Proteins; Female; Fluorodeoxyglucose F18; Glial Fibrillary Acidic Protein; Humans; Male; Mental Status Schedule; Microfilament Proteins; Neuropsychological Tests; Polymorphism, Single Nucleotide; Radionuclide Imaging; S100 Calcium Binding Protein beta Subunit; Thiazoles | 2013 |
Diagnosed mild cognitive impairment due to Alzheimer's disease with PET biomarkers of beta amyloid and neuronal dysfunction.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Biomarkers; Cerebral Cortex; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thiazoles | 2013 |
Cholinergic activity correlates with reserve proxies in Alzheimer's disease.
Topics: Acetates; Acetylcholine; Aged; Aged, 80 and over; Alzheimer Disease; Carbon Isotopes; Cognitive Dysfunction; Cognitive Reserve; Educational Status; Employment; Female; Fluorodeoxyglucose F18; Humans; Male; Mental Status Schedule; Middle Aged; Piperidines; Positron-Emission Tomography; Radiography; Statistics, Nonparametric; Tomography Scanners, X-Ray Computed | 2013 |
Apolipoprotein Ε ε4 frequency is increased among Chinese patients with frontotemporal dementia and Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Aniline Compounds; Apolipoprotein E4; Asian People; China; Diagnostic and Statistical Manual of Mental Disorders; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Gene Frequency; Genotype; Humans; Male; Middle Aged; Polymerase Chain Reaction; Positron-Emission Tomography; Radiopharmaceuticals; Risk Factors; Thiazoles; Tomography, X-Ray Computed | 2013 |
Glucose metabolism during resting state reveals abnormal brain networks organization in the Alzheimer's disease and mild cognitive impairment.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain Mapping; Case-Control Studies; Cell Physiological Phenomena; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Neural Networks, Computer; Neuroimaging; Positron-Emission Tomography | 2013 |
Identification and mapping of linear antibody epitopes in human serum albumin using high-density Peptide arrays.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Animals; Brain Mapping; Case-Control Studies; Cattle; Cell Physiological Phenomena; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Longitudinal Studies; Male; Middle Aged; Neural Networks, Computer; Neuroimaging; Positron-Emission Tomography; Rabbits | 2013 |
Visual-statistical interpretation of (18)F-FDG-PET images for characteristic Alzheimer patterns in a multicenter study: inter-rater concordance and relationship to automated quantitative evaluation.
Topics: Algorithms; Alzheimer Disease; Artificial Intelligence; Cognitive Dysfunction; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Japan; Male; Middle Aged; Observer Variation; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2014 |
Dorsomedial prefrontal metabolism and unawareness of current characteristics of personality traits in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Agnosia; Alzheimer Disease; Female; Fluorodeoxyglucose F18; Humans; Intelligence; Male; Neuropsychological Tests; Personality; Positron-Emission Tomography; Prefrontal Cortex; Regression Analysis; Self-Assessment | 2014 |
Early clinical PET imaging results with the novel PHF-tau radioligand [F18]-T808.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Benzimidazoles; Brain; Brain Mapping; Female; Fluorodeoxyglucose F18; Humans; Male; Mental Status Schedule; Middle Aged; Positron-Emission Tomography; Pyrimidines; tau Proteins; Time Factors | 2014 |
Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Aniline Compounds; Apolipoproteins E; Brain; Cognitive Dysfunction; Cohort Studies; Disease Progression; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Forecasting; Genotype; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Temporal Lobe; Thiazoles | 2014 |
Greater medial temporal hypometabolism and lower cortical amyloid burden in ApoE4-positive AD patients.
Topics: Aged; Alzheimer Disease; Amyloid; Aniline Compounds; Apolipoprotein E4; Brain; Case-Control Studies; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Neuropsychological Tests; Positron-Emission Tomography; Temporal Lobe; Thiazoles | 2014 |
Amyloid-β load predicts medial temporal lobe dysfunction in Alzheimer dementia.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Benzothiazoles; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Memory; Positron-Emission Tomography; Temporal Lobe; Thiazoles | 2013 |
Classification of Alzheimer's disease from FDG-PET images using favourite class ensembles.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Neuroimaging; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Support Vector Machine | 2013 |
Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Brain; Cognition Disorders; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Incidence; Magnetic Resonance Imaging; Male; Neurodegenerative Diseases; Oxygen; Positron-Emission Tomography | 2013 |
Chemistry. Expanding the scope of fluorine tags for PET imaging.
Topics: Alzheimer Disease; Aniline Compounds; Celecoxib; Ethylene Glycols; Fluorescent Dyes; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluoxetine; Glucose; Halogenation; Humans; Melanoma; Neoplasms; Patient Selection; Plaque, Amyloid; Positron-Emission Tomography; Pyrazoles; Radiopharmaceuticals; Sulfonamides | 2013 |
Associations between Alzheimer disease biomarkers, neurodegeneration, and cognition in cognitively normal older people.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Biomarkers; Cognition Disorders; Cohort Studies; Community-Based Participatory Research; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Nerve Fibers, Myelinated; Neurodegenerative Diseases; Neuropsychological Tests; Positron-Emission Tomography; Psychiatric Status Rating Scales; Thiazoles | 2013 |
Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease.
Topics: Adult; Age of Onset; Alzheimer Disease; Aniline Compounds; Biomarkers; Brain; Carbon Radioisotopes; Cohort Studies; Female; Fluorodeoxyglucose F18; Genes, Dominant; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Models, Biological; Positron-Emission Tomography; Regression Analysis; Thiazoles; Time Factors | 2013 |
Reduced FDG-PET brain metabolism and executive function predict clinical progression in elderly healthy subjects.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Cerebral Cortex; Cognitive Dysfunction; Disease Progression; Executive Function; Female; Fluorodeoxyglucose F18; Gray Matter; Humans; Logistic Models; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Predictive Value of Tests; ROC Curve | 2014 |
Plasma antioxidants and brain glucose metabolism in elderly subjects with cognitive complaints.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Catalase; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Glucose; Glutathione Peroxidase; Humans; Male; Middle Aged; Oxidative Stress; Positron-Emission Tomography; Radiopharmaceuticals; Superoxide Dismutase | 2014 |
18F-Fluorodeoxyglycosylamines: Maillard reaction of 18F-fluorodeoxyglucose with biological amines.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Benzothiazoles; Biogenic Amines; Case-Control Studies; Fluorodeoxyglucose F18; Humans; Maillard Reaction; Protein Binding; Pyrrolidines; Radionuclide Imaging | 2014 |
Practical utility of amyloid and FDG-PET in an academic dementia center.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Brain; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Severity of Illness Index; Thiazoles | 2014 |
White matter lesion load is associated with resting state functional MRI activity and amyloid PET but not FDG in mild cognitive impairment and early Alzheimer's disease patients.
Topics: Aged; Alzheimer Disease; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Plaque, Amyloid; Positron-Emission Tomography; Radiopharmaceuticals; Rest; White Matter | 2015 |
Analysis of early phase [11C]BF-227 PET, and its application for anatomical standardization of late-phase images for 3D-SSP analysis.
Topics: Aged; Alzheimer Disease; Benzoxazoles; Brain; Carbon Radioisotopes; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Thiazoles | 2014 |
Beta-amyloid associated differential effects of APOE ε4 on brain metabolism in cognitively normal elderly.
Topics: Aged; Aging; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Apolipoprotein E4; Cerebral Cortex; Cognition; Female; Fluorodeoxyglucose F18; Functional Neuroimaging; Genotype; Glucose; Humans; Male; Memory, Episodic; Neuropsychological Tests; Positron-Emission Tomography; Thiazoles | 2014 |
Differential diagnosis of neurodegenerative dementias using metabolic phenotypes on F-18 FDG PET/CT.
Topics: Aged; Alzheimer Disease; Creutzfeldt-Jakob Syndrome; Dementia; Dementia, Vascular; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Lewy Body Disease; Male; Middle Aged; Neurodegenerative Diseases; Neuropsychological Tests; Phenotype; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2014 |
Regional neuronal network failure and cognition in late-onset sporadic Alzheimer disease.
Topics: Age of Onset; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cognitive Dysfunction; Diffusion Tensor Imaging; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Nerve Net; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals | 2014 |
Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Brain; Cognition; Cognitive Dysfunction; Cohort Studies; Cross-Sectional Studies; Databases, Factual; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Neuropsychological Tests; Peptide Fragments; Psychiatric Status Rating Scales; Radionuclide Imaging; tau Proteins; Time Factors | 2014 |
Small vessel disease, but neither amyloid load nor metabolic deficit, is dependent on age at onset in Alzheimer's disease.
Topics: Age of Onset; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Aniline Compounds; Apolipoproteins E; Benzothiazoles; Brain; Female; Fluorodeoxyglucose F18; Humans; Male; Metabolic Diseases; Middle Aged; Radionuclide Imaging; Thiazoles; Vascular Diseases | 2015 |
Extension and refinement of the predictive value of different classes of markers in ADNI: four-year follow-up data.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Apolipoproteins E; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Longitudinal Studies; Magnetic Resonance Imaging; Male; Memory, Episodic; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Psychiatric Status Rating Scales; tau Proteins | 2014 |
The effect of amyloid pathology and glucose metabolism on cortical volume loss over time in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Aniline Compounds; Benzothiazoles; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Glucose; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Plaque, Amyloid; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles | 2014 |
Diabetes and elevated hemoglobin A1c levels are associated with brain hypometabolism but not amyloid accumulation.
Topics: Aged; Aged, 80 and over; Alleles; Alzheimer Disease; Amyloid; Apolipoprotein E4; Brain; Carbon Radioisotopes; Cognition; Diabetes Mellitus, Type 2; Female; Fluorodeoxyglucose F18; Glycated Hemoglobin; Humans; Hyperglycemia; Insulin; Male; Odds Ratio; Positron-Emission Tomography; Radiopharmaceuticals | 2014 |
Concordance between (99m)Tc-ECD SPECT and 18F-FDG PET interpretations in patients with cognitive disorders diagnosed according to NIA-AA criteria.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cognition Disorders; Cysteine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Observer Variation; Organotechnetium Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2014 |
CMS issues new instructions on PET coverage.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Centers for Medicare and Medicaid Services, U.S.; Fluorodeoxyglucose F18; Humans; Insurance Claim Review; Positron-Emission Tomography; Radiopharmaceuticals; United States | 2014 |
18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
Topics: Adult; Aged; Aged, 80 and over; Aging; Alleles; Alzheimer Disease; Apolipoprotein E4; Brain; Cognitive Dysfunction; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Genotype; Glucose; Heterozygote; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2014 |
A novel PSEN1 mutation in a patient with sporadic early-onset Alzheimer's disease and prominent cerebellar ataxia.
Topics: Adult; Alzheimer Disease; Cerebellar Ataxia; Cholinesterase Inhibitors; DNA Mutational Analysis; Donepezil; Female; Fluorodeoxyglucose F18; Humans; Indans; Magnetic Resonance Imaging; Male; Mutation; Piperidines; Positron-Emission Tomography; Presenilin-1; Young Adult | 2014 |
Deep brain stimulation of the nucleus basalis of Meynert in Alzheimer's dementia.
Topics: Aged; Alzheimer Disease; Basal Nucleus of Meynert; Deep Brain Stimulation; Electroencephalography; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Psychiatric Status Rating Scales; Quality of Life; Treatment Outcome | 2015 |
Early detection of cerebral glucose uptake changes in the 5XFAD mouse.
Topics: Age Factors; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Brain; Cerebral Cortex; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Mice; Mice, Transgenic; Mutation; Plaque, Amyloid; Positron-Emission Tomography; Presenilin-1; Tomography Scanners, X-Ray Computed | 2014 |
Distinct pattern of hypometabolism and atrophy in preclinical and predementia Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloidogenic Proteins; Atrophy; Cognitive Dysfunction; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gray Matter; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Synapses | 2014 |
Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Benzothiazoles; Biomarkers; Brain; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Principal Component Analysis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thiazoles | 2014 |
Clinical profiles of dementia with Lewy bodies with and without Alzheimer's disease-like hypometabolism.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Brain; Case-Control Studies; Female; Fluorodeoxyglucose F18; Glucose; Hallucinations; Humans; Lewy Body Disease; Male; Middle Aged; Occipital Lobe; Parietal Lobe; Positron-Emission Tomography | 2015 |
Limited agreement between biomarkers of neuronal injury at different stages of Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Apolipoproteins E; Atrophy; Biomarkers; Chi-Square Distribution; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Male; Mental Status Schedule; Middle Aged; Positron-Emission Tomography; tau Proteins | 2014 |
In Alzheimer's disease, hypometabolism in low-amyloid brain regions may be a functional consequence of pathologies in connected brain regions.
Topics: Aged; Alzheimer Disease; Amyloid; Aniline Compounds; Brain; Carbon Radioisotopes; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles | 2014 |
Regional fluorodeoxyglucose metabolism and instrumental activities of daily living across the Alzheimer's disease spectrum.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Brain Mapping; Cognitive Dysfunction; Cross-Sectional Studies; Databases, Factual; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Longitudinal Studies; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Surveys and Questionnaires | 2014 |
Alzheimer's disease-like pattern of (18)F-FDG uptake during a hyperglycemic state and negative (11)C-PiB binding in a patient with mild cognitive impairment.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Benzothiazoles; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Hyperglycemia; Male; Middle Aged; Positron-Emission Tomography; Thiazoles | 2014 |
Apathy as a feature of prodromal Alzheimer's disease: an FDG-PET ADNI study.
Topics: Aged; Alzheimer Disease; Apathy; Atrophy; Brain; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Positron-Emission Tomography | 2015 |
Nutrient intake and brain biomarkers of Alzheimer's disease in at-risk cognitively normal individuals: a cross-sectional neuroimaging pilot study.
Topics: Adult; Aged; Alzheimer Disease; Biomarkers; Brain; Cross-Sectional Studies; Energy Intake; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuroimaging; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Risk Factors | 2014 |
Biomarker progressions explain higher variability in stage-specific cognitive decline than baseline values in Alzheimer disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Cognition Disorders; Databases, Factual; Disease Progression; Executive Function; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Memory; Mental Status Schedule; Neuropsychological Tests; Positron-Emission Tomography | 2014 |
A postmortem study to compare agonist and antagonist 5-HT1A receptor-binding sites in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Autopsy; Autoradiography; Binding Sites; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Male; Middle Aged; Piperazines; Piperidines; Positron-Emission Tomography; Protein Binding; Pyrimidines; Receptor, Serotonin, 5-HT1A; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists | 2014 |
Comparison of dual-biomarker PIB-PET and dual-tracer PET in AD diagnosis.
Topics: Aged; Alzheimer Disease; Aniline Compounds; Benzothiazoles; Biomarkers; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Thiazoles | 2014 |
Lower brain 18F-fluorodeoxyglucose uptake but normal 11C-acetoacetate metabolism in mild Alzheimer's disease dementia.
Topics: Acetoacetates; Aged; Alzheimer Disease; Brain; Brain Mapping; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Glucose; Gray Matter; Humans; Ketones; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals; Signal Processing, Computer-Assisted | 2015 |
Temporal evolution of biomarkers and cognitive markers in the asymptomatic, MCI, and dementia stage of Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Peptide Fragments; Positron-Emission Tomography; tau Proteins | 2015 |
The use of biomarkers for the etiologic diagnosis of MCI in Europe: an EADC survey.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Atrophy; Biomarkers; Brain; Cognitive Dysfunction; Europe; Fluorodeoxyglucose F18; Internet; Magnetic Resonance Imaging; Peptide Fragments; Positron-Emission Tomography; Practice Patterns, Physicians'; Radiopharmaceuticals; Surveys and Questionnaires; tau Proteins | 2015 |
Associative memory and its cerebral correlates in Alzheimer׳s disease: evidence for distinct deficits of relational and conjunctive memory.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Humans; Male; Memory, Episodic; Positron-Emission Tomography | 2014 |
The Alzheimer's disease-related glucose metabolic brain pattern.
Topics: Aged; Alzheimer Disease; Brain; Brain Mapping; Cognition Disorders; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography | 2014 |
Influence of microglial activation on neuronal function in Alzheimer's and Parkinson's disease dementia.
Topics: Alzheimer Disease; Amyloid; Brain; Brain Mapping; Carbon Radioisotopes; Cognitive Dysfunction; Fluorodeoxyglucose F18; Glucose; Humans; Isoquinolines; Magnetic Resonance Imaging; Microglia; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Signal Processing, Computer-Assisted | 2015 |
Differentiating the frontal presentation of Alzheimer's disease with FDG-PET.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Female; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Image Processing, Computer-Assisted; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Regional glucose metabolic reduction in dementia with Lewy bodies is independent of amyloid deposition.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Aniline Compounds; Benzothiazoles; Brain; Brain Mapping; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lewy Body Disease; Male; Radionuclide Imaging; Radiopharmaceuticals; Thiazoles | 2015 |
Manifold regularized multitask feature learning for multimodality disease classification.
Topics: Aged; Algorithms; Alzheimer Disease; Artificial Intelligence; Brain; Brain Mapping; Cognitive Dysfunction; Databases, Factual; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Studying ventricular abnormalities in mild cognitive impairment with hyperbolic Ricci flow and tensor-based morphometry.
Topics: Aged; Aged, 80 and over; Algorithms; Alzheimer Disease; Cerebral Ventricles; Cognitive Dysfunction; Diffusion Tensor Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Models, Neurological; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Hierarchical multivariate covariance analysis of metabolic connectivity.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Brain; Cognitive Dysfunction; Connectome; Databases, Factual; Female; Fluorodeoxyglucose F18; Humans; Male; Metabolome; Middle Aged; Models, Neurological; Multivariate Analysis; Positron-Emission Tomography; Radiopharmaceuticals | 2014 |
Physical activity attenuates age-related biomarker alterations in preclinical AD.
Topics: Adult; Age Factors; Aged; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Apolipoprotein E4; Brain; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Male; Middle Aged; Motor Activity; Neuroimaging; Neuropsychological Tests; Radionuclide Imaging; Risk Factors; Surveys and Questionnaires; Thiazoles; Visual Perception | 2014 |
Hole detection in metabolic connectivity of Alzheimer's disease using kappa-Laplacian.
Topics: Algorithms; Alzheimer Disease; Artificial Intelligence; Brain; Cognitive Dysfunction; Connectome; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2014 |
Neurobiological correlates of depressive symptoms in people with subjective and mild cognitive impairment.
Topics: Adult; Aged; Alzheimer Disease; Biomarkers; Cerebral Cortex; Cognition Disorders; Cognitive Dysfunction; Depression; Diffusion Tensor Imaging; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Visual versus semi-quantitative analysis of 18F-FDG-PET in amnestic MCI: an European Alzheimer's Disease Consortium (EADC) project.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognitive Dysfunction; Europe; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Psychiatric Status Rating Scales; Sensitivity and Specificity | 2015 |
The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Aniline Compounds; Brain; Calibration; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Middle Aged; Plaque, Amyloid; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles | 2015 |
The mediational effects of FDG hypometabolism on the association between cerebrospinal fluid biomarkers and neurocognitive function.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
18F-FDG PET and perfusion SPECT in the diagnosis of Alzheimer and Lewy body dementias.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Male; Neuropsychological Tests; Perfusion; Positron-Emission Tomography; Prospective Studies; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon | 2014 |
Degree of abnormality is associated with rate of change in measures of beta-amyloid, glucose metabolism and cognition in an autopsy-verified Alzheimer's disease case.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Brain; Cognition; Disease Progression; Fatal Outcome; Female; Fluorodeoxyglucose F18; Glucose; Humans; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Thiazoles | 2015 |
Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Apolipoprotein E4; Cognition Disorders; Cohort Studies; Ethylene Glycols; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Peptide Fragments; Positron-Emission Tomography | 2015 |
18F-FDG and 18F-florbetapir PET in clinical practice: regional analysis in mild cognitive impairment and Alzheimer disease.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Brain; Case-Control Studies; Cognitive Dysfunction; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Multivariate analysis of structural MRI and PET (FDG and 18F-AV-45) for Alzheimer's disease and its prodromal stages.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Case-Control Studies; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Least-Squares Analysis; Magnetic Resonance Imaging; Male; Multivariate Analysis; Positron-Emission Tomography; Prodromal Symptoms | 2014 |
Longitudinal FDG-PET features for the classification of Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Algorithms; Alzheimer Disease; Biomarkers; Brain; Cognitive Dysfunction; Cross-Sectional Studies; Data Collection; Databases, Factual; Diagnosis, Computer-Assisted; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Longitudinal Studies; Magnetic Resonance Imaging; Male; Neuroimaging; Positron-Emission Tomography; Reproducibility of Results | 2014 |
Relationship between Alzheimer disease-like pattern of 18F-FDG and fasting plasma glucose levels in cognitively normal volunteers.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Blood Glucose; Brain; Cognition; Female; Fluorodeoxyglucose F18; Healthy Volunteers; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Prediction of Outcomes in Mild Cognitive Impairment by Using 18F-FDG-PET: A Multicenter Study.
Topics: Aged; Alzheimer Disease; Brain; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Longitudinal Studies; Magnetic Resonance Imaging; Male; Mental Status Schedule; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity | 2015 |
Volume of interest-based [18F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Optimal likelihood-ratio multiple testing with application to Alzheimer's disease and questionable dementia.
Topics: Alzheimer Disease; Brain; Computer Simulation; Dementia; Fluorodeoxyglucose F18; Frontal Lobe; Hippocampus; Humans; Likelihood Functions; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity | 2015 |
Functional correlates of t-Tau, p-Tau and Aβ₁₋₄₂ amyloid cerebrospinal fluid levels in Alzheimer's disease: a ¹⁸F-FDG PET/CT study.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Brain; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Peptide Fragments; Phosphorylation; Positron-Emission Tomography; tau Proteins; Tomography, X-Ray Computed | 2015 |
Prediction of AD dementia by biomarkers following the NIA-AA and IWG diagnostic criteria in MCI patients from three European memory clinics.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Amyloidosis; Atrophy; Biomarkers; Disease Progression; Fluorodeoxyglucose F18; Hippocampus; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Sensitivity and Specificity; tau Proteins | 2015 |
Clinical and neuroimaging biomarkers of amyloid-negative logopenic primary progressive aphasia.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Aphasia, Primary Progressive; Atrophy; Biomarkers; Brain Mapping; Cerebral Cortex; Dominance, Cerebral; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography | 2015 |
Prefrontal hypometabolism in Alzheimer disease is related to longitudinal amyloid accumulation in remote brain regions.
Topics: Aged; Alzheimer Disease; Amyloid; Brain; Carbon Radioisotopes; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prefrontal Cortex; Radiopharmaceuticals | 2015 |
Depressive Symptoms and Biomarkers of Alzheimer's Disease in Cognitively Normal Older Adults.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Animals; Biomarkers; Depression; Female; Fluorodeoxyglucose F18; Geriatric Assessment; Hippocampus; Humans; Linear Models; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Principal Component Analysis; Psychiatric Status Rating Scales; Residence Characteristics; Thiazoles | 2015 |
Functional Neuroanatomical Correlates of The Frontal Assessment Battery Performance in Alzheimer Disease: A FDG-PET Study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Disease Progression; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Neuropsychological Tests; Positron-Emission Tomography | 2015 |
Cognitive dysfunction in patients with very mild Alzheimer's disease and amnestic mild cognitive impairment showing hemispheric asymmetries of hypometabolism on ¹⁸F-FDG PET.
Topics: Aged; Alzheimer Disease; Amnesia; Brain; Cerebral Cortex; Cognition; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
Florbetapir PET, FDG PET, and MRI in Down syndrome individuals with and without Alzheimer's dementia.
Topics: Adult; Alzheimer Disease; Aniline Compounds; Brain; Down Syndrome; Emergency Services, Psychiatric; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography | 2015 |
Connectivity analysis of normal and mild cognitive impairment patients based on FDG and PiB-PET images.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Brain; Case-Control Studies; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles | 2015 |
Cerebral perfusion and glucose metabolism in Alzheimer's disease and frontotemporal dementia: two sides of the same coin?
Topics: Alzheimer Disease; Analysis of Variance; Blood Glucose; Case-Control Studies; Cerebrovascular Circulation; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Spin Labels | 2015 |
Rhinal hypometabolism on FDG PET in healthy APO-E4 carriers: impact on memory function and metabolic networks.
Topics: Adult; Aged; Alzheimer Disease; Apolipoprotein E4; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Genetic Predisposition to Disease; Heterozygote; Humans; Male; Memory; Metabolic Networks and Pathways; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2015 |
Gaussian Mixture Models and Model Selection for [18F] Fluorodeoxyglucose Positron Emission Tomography Classification in Alzheimer's Disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Female; Fluorodeoxyglucose F18; Humans; Male; Models, Theoretical; Normal Distribution; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2014 |
Topography of primitive reflexes in dementia: an F-18 fluorodeoxyglucose positron emission tomography study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Dementia; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Male; Middle Aged; Positron-Emission Tomography; Prefrontal Cortex; Prospective Studies; Putamen; Reflex; Thalamus | 2015 |
Multiple testing for neuroimaging via hidden Markov random field.
Topics: Algorithms; Alzheimer Disease; Cognitive Dysfunction; Computer Simulation; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Markov Chains; Models, Statistical; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2015 |
An evidence-based algorithm for the utility of FDG-PET for diagnosing Alzheimer's disease according to presence of medial temporal lobe atrophy.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Atrophy; Evidence-Based Practice; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Temporal Lobe | 2016 |
Multimodal Discrimination of Alzheimer's Disease Based on Regional Cortical Atrophy and Hypometabolism.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2015 |
Prevalence and prognosis of prodromal Alzheimer's disease as assessed by magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography in a community: reanalysis from the Osaki-Tajiri Project.
Topics: Age Factors; Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Female; Fluorodeoxyglucose F18; Humans; Incidence; Japan; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prevalence; Prognosis; Retrospective Studies | 2016 |
Visualization of regional tau deposits using (3)H-THK5117 in Alzheimer brain tissue.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Autoradiography; Brain; Dose-Response Relationship, Drug; Female; Fluorodeoxyglucose F18; Humans; In Vitro Techniques; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Protein Binding; Quinolines; Statistics as Topic; tau Proteins; Tritium | 2015 |
Quantitative μPET Imaging of Cerebral Glucose Metabolism and Amyloidosis in the TASTPM Double Transgenic Mouse Model of Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloidosis; Animals; Biomarkers; Brain; Disease Models, Animal; Fluorodeoxyglucose F18; Glucose; Immunohistochemistry; Male; Mice, Inbred C57BL; Mice, Transgenic; Neurons; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Drug-induced cerebral glucose metabolism resembling Alzheimer's Disease: a case study.
Topics: Aged; Alzheimer Disease; Anticonvulsants; Antidepressive Agents; Attention; Cognition Disorders; Depressive Disorder, Major; Diagnosis, Differential; Drug Therapy, Combination; Essential Tremor; Fluorodeoxyglucose F18; Glucose Metabolism Disorders; Humans; Lithium Compounds; Male; Memory Disorders; Memory, Episodic; Mental Recall; Neuropsychological Tests; Positron-Emission Tomography; Primidone; Radiopharmaceuticals; Recurrence; Venlafaxine Hydrochloride | 2015 |
Neurosyphilis mimicking young-onset Alzheimer's disease: a case report explaining the pitfalls of FDG-PET.
Topics: Alzheimer Disease; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neurosyphilis; Positron-Emission Tomography | 2016 |
The relative importance of imaging markers for the prediction of Alzheimer's disease dementia in mild cognitive impairment - Beyond classical regression.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Biomarkers; Cognitive Dysfunction; Disease Progression; Ethylene Glycols; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Predictive Value of Tests; Prognosis | 2015 |
Parametric imaging and quantitative analysis of the PET amyloid ligand [(18)F]flutemetamol.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Benzothiazoles; Cerebellar Cortex; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prefrontal Cortex; Radiopharmaceuticals | 2015 |
Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease.
Topics: Aged; Alzheimer Disease; Cerebral Cortex; Cognition Disorders; Cross-Sectional Studies; Diabetes Mellitus; Female; Fluorodeoxyglucose F18; Glucose; Humans; Ideal Body Weight; Insulin Resistance; Male; Middle Aged; Positron-Emission Tomography; Statistics as Topic | 2015 |
Brain Metabolism of Less-Educated Patients With Alzheimer Dementia Studied by Positron Emission Tomography.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Brain Diseases, Metabolic; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Severity of Illness Index | 2015 |
18F-FDG PET Improves Diagnosis in Patients with Focal-Onset Dementias.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Aphasia, Primary Progressive; Brain; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results | 2015 |
Alzheimer's Association International Conference on Alzheimer's Disease 2015 (AAIC 2015) (July 18-23, 2015 - Washington, D.C., USA).
Topics: Alzheimer Disease; Animals; Antibodies, Monoclonal, Humanized; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Receptors, sigma; Sigma-1 Receptor | 2015 |
Reduction of Glucose Metabolism in Olfactory Bulb is an Earlier Alzheimer's Disease-related Biomarker in 5XFAD Mice.
Topics: Alzheimer Disease; Amyloid; Animals; Animals, Genetically Modified; Biomarkers; Fluorodeoxyglucose F18; Glucose; Mice; Olfactory Bulb; Positron-Emission Tomography | 2015 |
A Pilot Study on Clinical and Neuroimaging Characteristics of Chinese Posterior Cortical Atrophy: Comparison with Typical Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Atrophy; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Occipital Lobe; Pilot Projects; Positron-Emission Tomography | 2015 |
Comparison of Visual and Quantitative Florbetapir F 18 Positron Emission Tomography Analysis in Predicting Mild Cognitive Impairment Outcomes.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Treatment Outcome | 2015 |
Asymmetries of amyloid-β burden and neuronal dysfunction are positively correlated in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Cognition Disorders; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Nervous System Diseases; Positron-Emission Tomography; Retrospective Studies; Statistics, Nonparametric; Tomography, Emission-Computed, Single-Photon | 2015 |
Construction and comparative evaluation of different activity detection methods in brain FDG-PET.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Case-Control Studies; Databases, Factual; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Software | 2015 |
Altered whole-brain white matter networks in preclinical Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Biomarkers; Brain; Diffusion Tensor Imaging; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Glucose; Hippocampus; Humans; Male; Nerve Net; Positron-Emission Tomography; Radiopharmaceuticals; White Matter | 2015 |
Dissociation of amyloid biomarkers in PET and CSF in Alzheimer's disease: a case report.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Atrophy; Biomarkers; Brain; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Peptide Fragments; Phosphorylation; Positron-Emission Tomography; Radiopharmaceuticals; tau Proteins | 2015 |
Early-onset Alzheimer's disease versus frontotemporal dementia: resolution with genetic diagnoses?
Topics: Alzheimer Disease; Aniline Compounds; Apolipoproteins E; Brain; C9orf72 Protein; Carbon Isotopes; Emotions; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Magnetic Resonance Imaging; Male; Memory; Middle Aged; Mutation; Neuropsychological Tests; Positron-Emission Tomography; Proteins; Social Behavior; Thiazoles; Verbal Learning | 2016 |
Discriminative multi-task feature selection for multi-modality classification of Alzheimer's disease.
Topics: Algorithms; Alzheimer Disease; Cognitive Dysfunction; Datasets as Topic; Fluorodeoxyglucose F18; Humans; Linear Models; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve | 2016 |
Effects of imaging modalities, brain atlases and feature selection on prediction of Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Atlases as Topic; Brain; Cognitive Dysfunction; Cohort Studies; Datasets as Topic; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Support Vector Machine | 2015 |
Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical setting.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cognitive Dysfunction; Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Humans; Lewy Body Disease; Magnetic Resonance Imaging; Male; Middle Aged; Peptide Fragments; Positron-Emission Tomography; Predictive Value of Tests; Reproducibility of Results; tau Proteins | 2016 |
A simulation system for biomarker evolution in neurodegenerative disease.
Topics: Alzheimer Disease; Biomarkers; Brain; Computer Simulation; Disease Progression; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Longitudinal Studies; Models, Neurological; Nerve Tissue Proteins; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2015 |
Visual Assessment of Brain Perfusion MRI Scans in Dementia: A Pilot Study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Brain Stem; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Angiography; Male; Mental Status Schedule; Middle Aged; Pilot Projects; Positron-Emission Tomography; Regional Blood Flow; Spin Labels | 2016 |
Metabolic Topology of Neurodegenerative Disorders: Influence of Cognitive and Motor Deficits.
Topics: Aged; Alzheimer Disease; Brain Mapping; Cognition; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lewy Body Disease; Male; Movement Disorders; Neurodegenerative Diseases; Parkinson Disease; Parkinson Disease, Postencephalitic; Radionuclide Imaging; Radiopharmaceuticals | 2015 |
Alzheimer's Disease FDG PET Imaging Pattern in an Amyloid-Negative Mild Cognitive Impairment Subject.
Topics: Alzheimer Disease; Biomarkers; Brain; Cognitive Dysfunction; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Cerebral Amyloid Angiopathy-Related Microbleeds Correlate with Glucose Metabolism and Brain Volume in Alzheimer's Disease.
Topics: Aged; Alzheimer Disease; Brain; Cerebral Amyloid Angiopathy; Cerebral Hemorrhage; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Glucose; Gray Matter; Humans; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Organ Size; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Simultaneous PET-MRI Studies of the Concordance of Atrophy and Hypometabolism in Syndromic Variants of Alzheimer's Disease and Frontotemporal Dementia: An Extended Case Series.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Atrophy; Brain; Brain Mapping; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Psychiatric Status Rating Scales; Reproducibility of Results | 2015 |
The Association of Glucose Metabolism and Eigenvector Centrality in Alzheimer's Disease.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Brain; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
Role of β-Amyloidosis and Neurodegeneration in Subsequent Imaging Changes in Mild Cognitive Impairment.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloidosis; Aniline Compounds; Cognitive Dysfunction; Cohort Studies; Disease Progression; Female; Fluorodeoxyglucose F18; Gray Matter; Humans; Male; Neurodegenerative Diseases; Positron-Emission Tomography; Thiazoles | 2015 |
Spatial patterns of atrophy, hypometabolism, and amyloid deposition in Alzheimer's disease correspond to dissociable functional brain networks.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Atrophy; Brain; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Mental Status Schedule; Metabolic Diseases; Middle Aged; Models, Neurological; Neural Pathways; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
Associations between Neuropsychiatric Symptoms and Cerebral Amyloid Deposition in Cognitively Impaired Elderly People.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloidogenic Proteins; Cerebral Cortex; Cognition Disorders; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Mental Status Schedule; Mood Disorders; Neuropsychological Tests; Positron-Emission Tomography | 2016 |
Functional neural correlates of figure copy and recall task performances in cognitively impaired individuals: an 18F-FDG-PET study.
Topics: Aged; Alzheimer Disease; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Male; Mental Recall; Neuropsychological Tests; Positron-Emission Tomography; Visual Perception | 2015 |
Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Amyloid; Aniline Compounds; Brain; Case-Control Studies; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Functional Neuroimaging; Glucose; Humans; Isoquinolines; Male; Microglia; Middle Aged; Neurons; Positron-Emission Tomography; Thiazoles | 2015 |
Early astrocytosis in autosomal dominant Alzheimer's disease measured in vivo by multi-tracer positron emission tomography.
Topics: Age of Onset; Aged; Alzheimer Disease; Amyloid beta-Peptides; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Genes, Dominant; Genotype; Gliosis; Humans; Male; Memory, Episodic; Middle Aged; Mutation; Neuropsychological Tests; Plaque, Amyloid; Positron-Emission Tomography; Principal Component Analysis | 2015 |
Does posterior cingulate hypometabolism result from disconnection or local pathology across preclinical and clinical stages of Alzheimer's disease?
Topics: Aged; Aging; Alzheimer Disease; Atrophy; Cognition; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Gray Matter; Gyrus Cinguli; Hippocampus; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography | 2016 |
Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Brain; Cerebrovascular Circulation; Cognitive Dysfunction; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals; Regional Blood Flow; ROC Curve; Severity of Illness Index | 2016 |
Combining Feature Extraction Methods to Assist the Diagnosis of Alzheimer's Disease.
Topics: Aged; Aged, 80 and over; Algorithms; Alzheimer Disease; Databases, Factual; Diagnosis, Computer-Assisted; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Support Vector Machine | 2016 |
Label-aligned multi-task feature learning for multimodal classification of Alzheimer's disease and mild cognitive impairment.
Topics: Aged; Alzheimer Disease; Brain; Cognitive Dysfunction; Databases, Factual; Disease Progression; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Machine Learning; Multimodal Imaging; Neuroimaging; Pattern Recognition, Automated; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; ROC Curve | 2016 |
Optimization of Statistical Single Subject Analysis of Brain FDG PET for the Prognosis of Mild Cognitive Impairment-to-Alzheimer's Disease Conversion.
Topics: Aged; Alzheimer Disease; Area Under Curve; Brain; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Image Interpretation, Computer-Assisted; Male; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; ROC Curve | 2016 |
Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Benzothiazoles; Cognitive Dysfunction; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Thiazoles | 2016 |
Based on the Network Degeneration Hypothesis: Separating Individual Patients with Different Neurodegenerative Syndromes in a Preliminary Hybrid PET/MR Study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aphasia, Broca; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Multimodal Imaging; Nerve Net; Neurodegenerative Diseases; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results | 2016 |
Accurate Prediction of Conversion to Alzheimer's Disease using Imaging, Genetic, and Neuropsychological Biomarkers.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Apolipoproteins E; Area Under Curve; Brain; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity | 2016 |
Cerebral Glucose Metabolism Assessment in Rat Models of Alzheimer's Disease: An 18F-FDG-PET Study.
Topics: Alzheimer Disease; Animals; Cerebral Cortex; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Glucose; Male; Positron-Emission Tomography; Rats; Rats, Wistar | 2016 |
Basal Forebrain Cholinergic Deficits Reduce Glucose Metabolism and Function of Cholinergic and GABAergic Systems in the Cingulate Cortex.
Topics: Acetylcholine; Alzheimer Disease; Animals; Antibodies, Monoclonal; Basal Forebrain; Cholinergic Agents; Cholinergic Neurons; Fluorodeoxyglucose F18; GABAergic Neurons; Glucose; Gyrus Cinguli; Humans; Injections; Maze Learning; Motor Activity; Positron-Emission Tomography; Rats; Ribosome Inactivating Proteins, Type 1; Saporins | 2016 |
Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjects.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Benzothiazoles; Brain; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Thiazoles | 2015 |
In vivo molecular neuroimaging of glucose utilization and its association with fibrillar amyloid-β load in aged APPPS1-21 mice.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Protein Precursor; Aniline Compounds; Animals; Autoradiography; Brain; Brain Mapping; Carbon Radioisotopes; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Glucose; Humans; Immunohistochemistry; Mice, Inbred C57BL; Mice, Transgenic; Phenanthrolines; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles | 2015 |
Metabolic connectivity for differential diagnosis of dementing disorders.
Topics: Aged; Alzheimer Disease; Brain Mapping; Case-Control Studies; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Humans; Male; Metabolic Networks and Pathways; Parietal Lobe; Positron-Emission Tomography; Temporal Lobe | 2017 |
Neuroprotective effects of bee venom phospholipase A2 in the 3xTg AD mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Antigens, CD; Bee Venoms; Body Weight; Disease Models, Animal; Escape Reaction; Fluorodeoxyglucose F18; Hippocampus; Humans; Learning Disabilities; Maze Learning; Mice; Mice, Transgenic; Mutation; Neuroprotective Agents; Phospholipases A2; Presenilin-1; Radionuclide Imaging; T-Lymphocytes, Regulatory; tau Proteins | 2016 |
Multimodal Magnetic Resonance Imaging in Alzheimer's Disease Patients at Prodromal Stage.
Topics: Aged; Alzheimer Disease; Biomarkers; Brain; Cognitive Dysfunction; Diffusion Tensor Imaging; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Mental Status Schedule; Multimodal Imaging; Neuropsychological Tests; Organ Size; Positron-Emission Tomography; Prodromal Symptoms; Radiopharmaceuticals | 2016 |
Posterior Accumulation of Tau and Concordant Hypometabolism in an Early-Onset Alzheimer's Disease Patient with Presenilin-1 Mutation.
Topics: Adult; Age of Onset; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Benzothiazoles; Brain; Brain Mapping; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Presenilin-1; Radiopharmaceuticals; tau Proteins | 2016 |
Early differential diagnosis between Alzheimer's disease and dementia with Lewy bodies: Comparison between (18)F-FDG PET and (123)I-IMP SPECT.
Topics: Aged; Alzheimer Disease; Cognitive Dysfunction; Diagnosis, Differential; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Iofetamine; Lewy Body Disease; Male; Middle Aged; Occipital Lobe; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Tomography, Emission-Computed, Single-Photon | 2016 |
Plasma Glucose Levels Affect Cerebral 18F-FDG Distribution in Cognitively Normal Subjects With Diabetes.
Topics: Aged; Alzheimer Disease; Blood Glucose; Brain; Cognition; Diabetes Mellitus; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography | 2016 |
Use of dynamic (18)F-fluorodeoxyglucose positron emission tomography to investigate choroid plexus function in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Case-Control Studies; Choroid Plexus; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; ROC Curve | 2016 |
Comparison of Early-Phase 11C-Deuterium-l-Deprenyl and 11C-Pittsburgh Compound B PET for Assessing Brain Perfusion in Alzheimer Disease.
Topics: Aged; Alzheimer Disease; Aniline Compounds; Cerebellum; Cerebrovascular Circulation; Cognitive Dysfunction; Deuterium; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gliosis; Gray Matter; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Perfusion; Pons; Positron-Emission Tomography; Radiopharmaceuticals; Selegiline; Thiazoles | 2016 |
What are the Most Frequently Impaired Markers of Neurodegeneration in ADNI Subjects?
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Brain; Cognitive Dysfunction; Databases, Factual; Female; Fluorodeoxyglucose F18; Humans; Male; Peptide Fragments; Phosphorylation; Positron-Emission Tomography; Radiopharmaceuticals; tau Proteins | 2016 |
Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Biomarkers; Brain; Cognitive Dysfunction; Disease Progression; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Predictive Value of Tests; Psychiatric Status Rating Scales; Sensitivity and Specificity | 2016 |
Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Amyloid; Aniline Compounds; Apolipoproteins E; Benzothiazoles; Brain; Carbolines; Case-Control Studies; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Neuroimaging; Neuropsychological Tests; Positron-Emission Tomography; tau Proteins; Thiazoles | 2016 |
Alzheimer's Disease Brain Areas: The Machine Learning Support for Blind Localization.
Topics: Aged; Aged, 80 and over; Algorithms; Alzheimer Disease; Brain; Brain Mapping; Cognitive Dysfunction; Databases, Factual; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Machine Learning; Male; Mental Status Schedule; Middle Aged; Positron-Emission Tomography | 2016 |
Hypometabolism in Brain of Cognitively Normal Patients with Depressive Symptoms is Accompanied by Atrophy-Related Partial Volume Effects.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Atrophy; Brain; Databases as Topic; Depression; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Psychiatric Status Rating Scales | 2016 |
Functional Biomedical Images of Alzheimer's Disease. A Green's Function-based Empirical Mode Decomposition Study.
Topics: Alzheimer Disease; Brain; Brain Mapping; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Nonlinear Dynamics; Positron-Emission Tomography; Radiopharmaceuticals; Support Vector Machine | 2016 |
Left Anterior Temporal Glucose Metabolism and not Amyloid-beta Load Predicts Naming Impairment in Alzheimer's Disease.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Female; Fluorodeoxyglucose F18; Glucose; Humans; Linear Models; Male; Mental Status Schedule; Neuropsychological Tests; Pattern Recognition, Visual; Positron-Emission Tomography; Radiopharmaceuticals; Temporal Lobe; Terminology as Topic; Thiazoles | 2016 |
Amyloid-β and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cognition; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Male; Positron-Emission Tomography; tau Proteins | 2017 |
Impact of MRI-based Segmentation Artifacts on Amyloid- and FDG-PET Quantitation.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Aniline Compounds; Artifacts; Brain; Brain Mapping; Cognitive Dysfunction; Cohort Studies; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Positron-Emission Tomography | 2016 |
The Effects of Physiological and Methodological Determinants on 18F-FDG Mouse Brain Imaging Exemplified in a Double Transgenic Alzheimer Model.
Topics: Alzheimer Disease; Animals; Blood Glucose; Cerebellum; Disease Models, Animal; Fasting; Fluorodeoxyglucose F18; Humans; Mice; Mice, Transgenic; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals; Thalamus | 2016 |
Does Microglial Activation Influence Hippocampal Volume and Neuronal Function in Alzheimer's Disease and Parkinson's Disease Dementia?
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antineoplastic Agents; Brain Mapping; Cognition; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Isoquinolines; Magnetic Resonance Imaging; Male; Microglia; Middle Aged; Neurons; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Psychiatric Status Rating Scales; Supranuclear Palsy, Progressive | 2016 |
Prediction of Alzheimer's Disease in Amnestic Mild Cognitive Impairment Subtypes: Stratification Based on Imaging Biomarkers.
Topics: Aged; Alzheimer Disease; Biomarkers; Brain; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Glucose; Gray Matter; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Neuroimaging; Positron-Emission Tomography; Temporal Lobe | 2016 |
Comparison between MRI-based attenuation correction methods for brain PET in dementia patients.
Topics: Aged; Alzheimer Disease; Artifacts; Brain; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2016 |
Comparability of [
Topics: Alzheimer Disease; Aniline Compounds; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Positron-Emission Tomography; Quinolines; Radiopharmaceuticals; Thiazoles | 2017 |
Potential Clinical Value of Multiparametric PET in the Prediction of Alzheimer's Disease Progression.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Databases, Factual; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; ROC Curve | 2016 |
Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aging; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Cerebral Cortex; Cohort Studies; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles; Young Adult | 2016 |
Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain; Brain Diseases, Metabolic; Fluorodeoxyglucose F18; Glucose; Humans; Lactic Acid; Metabolic Clearance Rate; Nerve Net; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2016 |
Impact of (18)FDG PET and (11)C-PIB PET brain imaging on the diagnosis of Alzheimer's disease and other dementias in a regional memory clinic in Hong Kong.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Brain; Dementia; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Lewy Body Disease; Male; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thiazoles | 2016 |
Longitudinal Positron Emission Tomography in Preventive Alzheimer's Disease Drug Trials, Critical Barriers from Imaging Science Perspective.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Brain; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Longitudinal Studies; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; PubMed; Retrospective Studies; tau Proteins; Time Factors | 2016 |
Validation of a New Imaging Technique Using the Glucose Metabolism to Amyloid Deposition Ratio in the Diagnosis of Alzheimer's Disease.
Topics: Aged; Alzheimer Disease; Amyloid; Aniline Compounds; Area Under Curve; Databases, Factual; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve | 2017 |
Diagnostic role of 11C-Pittsburgh compound B retention patterns and glucose metabolism by fluorine-18-fluorodeoxyglucose PET/CT in amnestic and nonamnestic mild cognitive impairment patients.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Amnesia; Amyloid beta-Peptides; Aniline Compounds; Brain; Carbon Radioisotopes; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thiazoles | 2016 |
Do we still need positron emission tomography for early Alzheimer's disease diagnosis?
Topics: Alzheimer Disease; Brain; Early Diagnosis; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography | 2016 |
Reply: Do we still need positron emission tomography for early Alzheimer's disease diagnosis?
Topics: Alzheimer Disease; Brain; Early Diagnosis; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography | 2016 |
Neuropsychiatric subsyndromes and brain metabolic network dysfunctions in early onset Alzheimer's disease.
Topics: Affect; Age of Onset; Alzheimer Disease; Apathy; Brain; Brain Mapping; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Mood Disorders; Motor Activity; Neural Pathways; Neuropsychological Tests; Positron-Emission Tomography; Psychiatric Status Rating Scales; Psychotic Disorders; Radiopharmaceuticals; Retrospective Studies | 2016 |
Age and neurodegeneration imaging biomarkers in persons with Alzheimer disease dementia.
Topics: Age Factors; Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Biomarkers; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles | 2016 |
Predicting the transition from normal aging to Alzheimer's disease: A statistical mechanistic evaluation of FDG-PET data.
Topics: Aged; Aging; Alzheimer Disease; Biomarkers; Brain; Cognitive Dysfunction; Computer Simulation; Data Interpretation, Statistical; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Models, Statistical; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2016 |
Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between β-Amyloid and Tauopathy.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Carbolines; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Outcome Assessment, Health Care; Peptide Fragments; Positron-Emission Tomography; Severity of Illness Index; tau Proteins; Tauopathies | 2016 |
Applied multimodal diagnostics in a case of presenile dementia.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Atrophy; Biomarkers; Early Diagnosis; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Magnetic Resonance Imaging; Middle Aged; Neuroimaging; Parietal Lobe; Peptide Fragments; Positron-Emission Tomography; tau Proteins | 2016 |
Is cerebral glucose metabolism related to blood-brain barrier dysfunction and intrathecal IgG synthesis in Alzheimer disease?: A 18F-FDG PET/CT study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Blood-Brain Barrier; Brain; Female; Fluorodeoxyglucose F18; Glucose; Humans; Immunoglobulin G; Male; Positron Emission Tomography Computed Tomography | 2016 |
Clinical impact and diagnostic accuracy of 2-[
Topics: Adult; Aged; Alzheimer Disease; Cognitive Dysfunction; Comorbidity; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prevalence; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Tertiary Care Centers; United Kingdom | 2017 |
Characteristics of mild cognitive impairment tending to convert into Alzheimer's disease or dementia with Lewy bodies: A follow-up study in a memory clinic.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Gyrus Cinguli; Humans; Lewy Body Disease; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Retrospective Studies; Visual Cortex | 2016 |
Plasma tau in Alzheimer disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Brain; Cognition Disorders; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Neuropsychological Tests; Positron-Emission Tomography; Psychiatric Status Rating Scales; tau Proteins | 2016 |
Defining imaging biomarker cut points for brain aging and Alzheimer's disease.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aging; Alzheimer Disease; Amyloidosis; Aniline Compounds; Brain; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Sensitivity and Specificity; Thiazoles | 2017 |
Female advantage in verbal memory: Evidence of sex-specific cognitive reserve.
Topics: Acoustic Stimulation; Aged; Aged, 80 and over; Alzheimer Disease; Apolipoproteins E; Cognition Disorders; Cognitive Reserve; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Humans; Linear Models; Male; Mental Status Schedule; Neuropsychological Tests; Positron-Emission Tomography; Sex Characteristics; Verbal Learning | 2016 |
Distinct brain networks underlie cognitive dysfunction in Parkinson and Alzheimer diseases.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Brain; Case-Control Studies; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuropsychological Tests; Parkinsonian Disorders; Positron-Emission Tomography; Psychiatric Status Rating Scales; Severity of Illness Index | 2016 |
Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using
Topics: Aging; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Brain; Cognition; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Glucose; Glucose Metabolism Disorders; Hippocampus; Humans; Maze Learning; Memory Disorders; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Positron-Emission Tomography; Presenilin-1 | 2016 |
In vivo Patterns of Tau Pathology, Amyloid-β Burden, and Neuronal Dysfunction in Clinical Variants of Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Atrophy; Brain; Carbolines; Cognition Disorders; Corticomedial Nuclear Complex; Executive Function; Female; Fluorodeoxyglucose F18; Humans; Language Disorders; Male; Neuropsychological Tests; Positron-Emission Tomography; tau Proteins | 2017 |
The functional neuroanatomy of verbal memory in Alzheimer's disease: [
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain Mapping; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Humans; Male; Mental Recall; Middle Aged; Positron-Emission Tomography; Recognition, Psychology; Registries; Verbal Learning | 2017 |
Longitudinal Characterization of [18F]-FDG and [18F]-AV45 Uptake in the Double Transgenic TASTPM Mouse Model.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Aniline Compounds; Animals; Brain; Disease Models, Animal; Ethylene Glycols; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Positron-Emission Tomography; Presenilin-1; Time Factors | 2017 |
Autotaxin is Related to Metabolic Dysfunction and Predicts Alzheimer's Disease Outcomes.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Apolipoproteins E; Fasting; Female; Fluorodeoxyglucose F18; Glucose; Humans; Insulin Resistance; Magnetic Resonance Imaging; Male; Mass Spectrometry; Mental Status Schedule; Metabolic Diseases; Middle Aged; Neuropsychological Tests; Peptide Fragments; Phosphoric Diester Hydrolases; Positron-Emission Tomography; Prefrontal Cortex; tau Proteins | 2017 |
Famous faces and voices: Differential profiles in early right and left semantic dementia and in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Association; Atrophy; Brain; Discrimination, Psychological; Facial Recognition; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Functional Laterality; Humans; Male; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Recognition, Psychology; Speech Perception | 2017 |
Usefulness of 3-dimensional stereotactic surface projection FDG PET images for the diagnosis of dementia.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Chi-Square Distribution; Cohort Studies; Dementia; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Lewy Body Disease; Positron-Emission Tomography; Republic of Korea; Retrospective Studies; ROC Curve | 2016 |
First PET Imaging Studies With 63Zn-Zinc Citrate in Healthy Human Participants and Patients With Alzheimer Disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Citrates; Female; Fluorodeoxyglucose F18; Healthy Volunteers; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution; Urine; Zinc Radioisotopes | 2016 |
Validation of
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Databases, Factual; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Public-Private Sector Partnerships; Reproducibility of Results; Sensitivity and Specificity | 2017 |
18F-AV-1451 positron emission tomography in Alzheimer's disease and progressive supranuclear palsy.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Autopsy; Autoradiography; Brain; Carbolines; Case-Control Studies; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Protein Binding; Psychiatric Status Rating Scales; Supranuclear Palsy, Progressive; tau Proteins | 2017 |
Convergent Results from Neuropsychology and from Neuroimaging in Patients with Mild Cognitive Impairment.
Topics: Aged; Alzheimer Disease; Cerebral Cortex; Cognition; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Neuropsychological Tests; Neuropsychology; Positron-Emission Tomography; Radiopharmaceuticals; Statistics as Topic | 2017 |
Elevated
Topics: Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Carbolines; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography | 2017 |
Left frontal cortex connectivity underlies cognitive reserve in prodromal Alzheimer disease.
Topics: Alzheimer Disease; Chi-Square Distribution; Cognition Disorders; Cognitive Reserve; Epilepsy; Female; Fluorodeoxyglucose F18; Frontal Lobe; Functional Laterality; Humans; Magnetic Resonance Imaging; Male; Nerve Net; Neuropsychological Tests; Oxygen; Positron-Emission Tomography; Prodromal Symptoms | 2017 |
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cerebral Cortex; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Functional Neuroimaging; Humans; Irritable Mood; Male; Middle Aged; Positron-Emission Tomography; Psychomotor Agitation | 2017 |
Early identification of mild cognitive impairment using incomplete random forest-robust support vector machine and FDG-PET imaging.
Topics: Aged; Alzheimer Disease; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Prodromal Symptoms; Support Vector Machine; Uncertainty | 2017 |
Neural Basis of Cognitive Assessment in Alzheimer Disease, Amnestic Mild Cognitive Impairment, and Subjective Memory Complaints.
Topics: Aged; Alzheimer Disease; Brain; Case-Control Studies; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Functional Neuroimaging; Humans; Male; Memory Disorders; Neuropsychological Tests; Positron-Emission Tomography | 2017 |
Different apathy clinical profile and neural correlates in behavioral variant frontotemporal dementia and Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Apathy; Brain; Case-Control Studies; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Gyrus Cinguli; Humans; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography | 2018 |
Creutzfeldt-Jakob Disease Mimicking Alzheimer Disease and Dementia With Lewy Bodies-Findings of FDG PET With 3-Dimensional Stereotactic Surface Projection.
Topics: Aged; Alzheimer Disease; Creutzfeldt-Jakob Syndrome; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lewy Body Disease; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2017 |
Fluorodeoxyglucose metabolism associated with tau-amyloid interaction predicts memory decline.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Humans; Male; Memory Disorders; Palmitates; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; tau Proteins; Thiazoles; Thiones | 2017 |
The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: A European Alzheimer's Disease Consortium study.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Cognition Disorders; Diagnosis, Computer-Assisted; Diagnosis, Differential; Disease Progression; Europe; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Male; Neuropsychological Tests; Peptide Fragments; Positron-Emission Tomography; tau Proteins; Tomography, Emission-Computed, Single-Photon | 2017 |
Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Mental Recall; Neuroimaging; Neuropsychological Tests; Organ Size; Positron-Emission Tomography; Prodromal Symptoms; Radiopharmaceuticals; Survival Analysis; Thiazoles | 2017 |
Progressive Disintegration of Brain Networking from Normal Aging to Alzheimer Disease: Analysis of Independent Components of
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Brain; Cognitive Dysfunction; Connectome; Disease Progression; Fluorodeoxyglucose F18; Humans; Middle Aged; Nerve Net; Positron-Emission Tomography; Principal Component Analysis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index | 2017 |
Functional neuroanatomical associations of working memory in early-onset Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Analysis of Variance; Apolipoprotein E4; Biomarkers; Brain; Female; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Language; Magnetic Resonance Imaging; Male; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography | 2018 |
Relationships between hippocampal atrophy, white matter disruption, and gray matter hypometabolism in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Atrophy; Brain Mapping; Case-Control Studies; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neuroglia; Neurons; Neuropsychological Tests; Positron-Emission Tomography; Statistics as Topic | 2008 |
Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Aniline Compounds; Benzothiazoles; Brain; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Regression Analysis; Sensitivity and Specificity; Thiazoles | 2008 |
Principal component analysis of FDG PET in amnestic MCI.
Topics: Aged; Alzheimer Disease; Amnesia; Case-Control Studies; Discriminant Analysis; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Memory; Positron-Emission Tomography; Principal Component Analysis; Sensitivity and Specificity | 2008 |
Comparison of grey matter and metabolic reductions in frontotemporal dementia using FDG-PET and voxel-based morphometric MR studies.
Topics: Aged; Alzheimer Disease; Brain; Dementia; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography | 2008 |
On the effect of sample size of the normal database on statistical power of single subject analysis.
Topics: Alzheimer Disease; Area Under Curve; Brain; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Models, Statistical; Radionuclide Imaging; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Sample Size; Sensitivity and Specificity | 2008 |
SPM-based count normalization provides excellent discrimination of mild Alzheimer's disease and amnestic mild cognitive impairment from healthy aging.
Topics: Aged; Aging; Algorithms; Alzheimer Disease; Brain; Brain Mapping; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Radionuclide Imaging; Retrospective Studies | 2009 |
CSF total and phosphorylated tau protein, regional glucose metabolism and dementia severity in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Biomarkers; Brain; Brain Mapping; Disability Evaluation; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Neuropsychological Tests; Phosphorylation; Positron-Emission Tomography; Predictive Value of Tests; Severity of Illness Index; tau Proteins | 2008 |
Effect of citalopram in treating hypersexuality in an Alzheimer's disease case.
Topics: Alzheimer Disease; Brain; Citalopram; Cognition Disorders; Disease Progression; Donepezil; Fluorodeoxyglucose F18; Humans; Indans; Male; Memory Disorders; Middle Aged; Mood Disorders; Nootropic Agents; Obsessive-Compulsive Disorder; Piperidines; Positron-Emission Tomography; Selective Serotonin Reuptake Inhibitors; Serotonin; Sexual Behavior; Sexual Dysfunctions, Psychological; Treatment Outcome | 2008 |
[Familial Alzheimer's disease with presenilin 2 N141I mutation. A case report].
Topics: Adult; Alzheimer Disease; Antidepressive Agents, Second-Generation; Brain; Citalopram; Codon; Donepezil; Electroencephalography; Female; Fluorodeoxyglucose F18; Humans; Indans; Mutation, Missense; Neuropsychological Tests; Nootropic Agents; Pedigree; Piperidines; Positron-Emission Tomography; Presenilin-2; Radiopharmaceuticals | 2008 |
Neural correlates of the Clock Drawing Test performance in Alzheimer's disease: a FDG-PET study.
Topics: Aged; Alzheimer Disease; Brain Chemistry; Brain Mapping; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Functional Laterality; Glucose; Humans; Image Processing, Computer-Assisted; Male; Neuropsychological Tests; Parietal Lobe; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
Functional and structural synergy for resolution recovery and partial volume correction in brain PET.
Topics: Algorithms; Alzheimer Disease; Artifacts; Brain; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2009 |
Choice of reference area in studies of Alzheimer's disease using positron emission tomography with fluorodeoxyglucose-F18.
Topics: Adolescent; Aged; Alzheimer Disease; Cerebellum; Cognition Disorders; Female; Fluorodeoxyglucose F18; Frontal Lobe; Gyrus Cinguli; Humans; Male; Motor Cortex; Neuropsychological Tests; Parietal Lobe; Positron-Emission Tomography; Radiopharmaceuticals; Severity of Illness Index; Somatosensory Cortex; Temporal Lobe | 2008 |
Education and occupation as proxies for reserve in aMCI converters and AD: FDG-PET evidence.
Topics: Aged; Alzheimer Disease; Brain; Brain Mapping; Cognition Disorders; Educational Status; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Occupations; Positron-Emission Tomography | 2008 |
Voxel-based analysis of cerebral glucose metabolism in mono- and dizygotic twins discordant for Alzheimer disease.
Topics: Aged; Alzheimer Disease; Blood Glucose; Brain; Diseases in Twins; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Male; Mental Status Schedule; Positron-Emission Tomography; Radiography; Reference Values; Twins, Dizygotic; Twins, Monozygotic | 2009 |
Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Analysis of Variance; Aniline Compounds; Aphasia, Primary Progressive; Carbon Isotopes; Dementia; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Language; Language Tests; Male; Middle Aged; Positron-Emission Tomography; Thiazoles | 2008 |
Decreased cortical glucose metabolism in converters from CDR 0.5 to Alzheimer's disease in a community: the Osaki-Tajiri Project.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Blood Glucose; Brain; Cognition Disorders; Disease Progression; Dominance, Cerebral; Energy Metabolism; Female; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Japan; Magnetic Resonance Imaging; Male; Mental Status Schedule; Neuropsychological Tests; Parietal Lobe; Positron-Emission Tomography; Psychometrics; Reference Values; Temporal Lobe | 2009 |
FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Autopsy; Brain; Cognition Disorders; Dementia, Vascular; Female; Fluorodeoxyglucose F18; Glucose; Hippocampus; Humans; Lewy Body Disease; Male; Positron-Emission Tomography | 2009 |
Genetic algorithm-based PCA eigenvector selection and weighting for automated identification of dementia using FDG-PET imaging.
Topics: Algorithms; Alzheimer Disease; Brain; Dementia; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Positron-Emission Tomography; Principal Component Analysis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2008 |
Association between FDG uptake, CSF biomarkers and cognitive performance in patients with probable Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Apolipoproteins E; Biomarkers; Brain; Cognition; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Genotype; Humans; Linear Models; Male; Middle Aged; Positron-Emission Tomography; Probability; Retrospective Studies; Software | 2009 |
Beta amyloid in Alzheimer's disease: increased deposition in brain is reflected in reduced concentration in cerebrospinal fluid.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Apolipoproteins E; Benzothiazoles; Brain; Brain Mapping; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Humans; Linear Models; Magnetic Resonance Imaging; Male; Middle Aged; Peptide Fragments; Positron-Emission Tomography; Thiazoles | 2009 |
Dissecting molecular mechanisms in the living brain of dementia patients.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Brain; Disease Progression; Fluorodeoxyglucose F18; Humans; Nitriles; Positron-Emission Tomography; Radiopharmaceuticals; tau Proteins | 2009 |
The neural correlates of naming and fluency deficits in Alzheimer's disease: an FDG-PET study.
Topics: Aged; Alzheimer Disease; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Humans; Language Disorders; Male; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Temporal Lobe; Vocabulary | 2009 |
Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI).
Topics: Aged; Alzheimer Disease; Cerebral Cortex; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2009 |
Robustness of multivariate image analysis assessed by resampling techniques and applied to FDG-PET scans of patients with Alzheimer's disease.
Topics: Algorithms; Alzheimer Disease; Brain; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Principal Component Analysis; Radiopharmaceuticals; Reproducibility of Results; Sample Size; Sensitivity and Specificity; Young Adult | 2009 |
Preclinical evidence of Alzheimer changes: convergent cerebrospinal fluid biomarker and fluorodeoxyglucose positron emission tomography findings.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Brain; Cerebrospinal Fluid; Disease Progression; Early Diagnosis; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Neurofibrillary Tangles; Peptide Fragments; Plaque, Amyloid; Positron-Emission Tomography; Predictive Value of Tests; tau Proteins | 2009 |
Brain metabolic correlates of cerebrospinal fluid beta-amyloid 42 and tau in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Brain Chemistry; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Male; Neurons; Neuropsychological Tests; Peptide Fragments; Positron-Emission Tomography; Radiopharmaceuticals; tau Proteins | 2009 |
Comparison of 18F-FDG and PiB PET in cognitive impairment.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Cognition Disorders; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles | 2009 |
Reducing between scanner differences in multi-center PET studies.
Topics: Algorithms; Alzheimer Disease; Brain; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results | 2009 |
Longitudinal brain metabolic changes from amnestic mild cognitive impairment to Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amnesia; Brain; Brain Mapping; Cognition Disorders; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography | 2009 |
Spatially augmented LPboosting for AD classification with evaluations on the ADNI dataset.
Topics: Aged; Algorithms; Alzheimer Disease; Brain; Databases, Factual; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Organ Size; Positron-Emission Tomography; Psychiatric Status Rating Scales; ROC Curve; Sensitivity and Specificity | 2009 |
Positron emission tomography in diagnosis of visual variant Alzheimer disease.
Topics: Aged; Alzheimer Disease; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Vision Disorders | 2009 |
Altered brain serotonin transporter and associated glucose metabolism in Alzheimer disease.
Topics: Alzheimer Disease; Aniline Compounds; Brain; Depression; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Serotonin Plasma Membrane Transport Proteins; Sulfides; Tissue Distribution | 2009 |
Assessment of mental deterioration with the Cognitive Abilities Screening Instrument (CASI) and glucose hypometabolism in Alzheimer's disease: the Osaki-Tajiri Project.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Brain; Brain Mapping; Cognition Disorders; Community-Based Participatory Research; Female; Fluorodeoxyglucose F18; Functional Laterality; Glucose Metabolism Disorders; Humans; Male; Mental Disorders; Mental Status Schedule; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Ultrasonography | 2009 |
HAI Seattle: does brain amyloid correlate with sagging metabolism?
Topics: Alzheimer Disease; Amyloid beta-Peptides; Brain; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Washington | 2009 |
PET of brain prion protein amyloid in Gerstmann-Sträussler-Scheinker disease.
Topics: Adult; Aged; Alzheimer Disease; Amyloid; Brain; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gerstmann-Straussler-Scheinker Disease; Glucose; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Nitriles; Positron-Emission Tomography; Prion Proteins; Prions; tau Proteins | 2010 |
Differential effects of global and cerebellar normalization on detection and differentiation of dementia in FDG-PET studies.
Topics: Age Factors; Alzheimer Disease; Analysis of Variance; Brain; Brain Mapping; Cerebellum; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Glucose; Humans; Male; Memory Disorders; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Severity of Illness Index; Signal Processing, Computer-Assisted | 2010 |
Acute toxicity of two Alzheimer's disease radiopharmaceuticals: FDDNP and IMPY.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Dementia; Female; Fluorescent Dyes; Fluorodeoxyglucose F18; Humans; Image Enhancement; Male; Neurodegenerative Diseases; Neurofibrillary Tangles; Pyrazoles; Radiopharmaceuticals; Tissue Distribution | 2009 |
Relationships between biomarkers in aging and dementia.
Topics: Aged; Aging; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Biomarkers; Brain; Case-Control Studies; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Male; Peptide Fragments; Positron-Emission Tomography; Psychiatric Status Rating Scales; tau Proteins; Thiazoles | 2009 |
Posterior cingulate hypometabolism in early Alzheimer's disease: what is the contribution of local atrophy versus disconnection?
Topics: Alzheimer Disease; Atrophy; Biomarkers; Early Diagnosis; Energy Metabolism; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Neural Pathways; Positron-Emission Tomography; Predictive Value of Tests | 2009 |
FDG-PET mapping the brain substrates of visuo-constructive processing in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Brain Mapping; Female; Fluorodeoxyglucose F18; Folic Acid; Humans; Linear Models; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Photic Stimulation; Positron-Emission Tomography; Visual Perception; Vitamin B 12 | 2010 |
A novel presenilin1 mutation (Q223R) associated with early onset Alzheimer's disease, dysarthria and spastic paraparesis and decreased Abeta levels in CSF.
Topics: Adult; Age of Onset; Alzheimer Disease; Amyloid beta-Peptides; Brain; Dysarthria; Family; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Mutation, Missense; Paraparesis, Spastic; Pedigree; Positron-Emission Tomography; Presenilin-1 | 2010 |
Amyloid PET in mild cognitive impairment and Alzheimer's disease with BF-227: comparison to FDG-PET.
Topics: Aged; Alzheimer Disease; Amyloid; Benzoxazoles; Brain; Brain Mapping; Carbon Radioisotopes; Cognition Disorders; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Plaque, Amyloid; Positron-Emission Tomography; ROC Curve; Sensitivity and Specificity; Thiazoles | 2010 |
B-spline-based stereotactical normalization of brain FDG PET scans in suspected neurodegenerative disease: impact on voxel-based statistical single-subject analysis.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Area Under Curve; Brain; Computer Simulation; Dementia; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Lewy Body Disease; Male; Middle Aged; Models, Statistical; Neurodegenerative Diseases; Positron-Emission Tomography; ROC Curve; Signal Processing, Computer-Assisted | 2010 |
Executive deficits and regional brain metabolism in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cerebral Cortex; Cognition Disorders; Executive Function; Female; Fluorodeoxyglucose F18; Geriatric Assessment; Glucose; Humans; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Psychiatric Status Rating Scales; Radiopharmaceuticals | 2010 |
Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Databases, Factual; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hippocampus; Humans; Logistic Models; Magnetic Resonance Imaging; Male; Middle Aged; Peptide Fragments; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; ROC Curve; Sensitivity and Specificity; tau Proteins | 2010 |
Metabolic compensation and depression in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Atrophy; Brain; Brain Chemistry; Depression; Executive Function; Female; Fluorodeoxyglucose F18; Health Status; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Memory; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Psychiatric Status Rating Scales; Radiopharmaceuticals | 2010 |
White matter integrity and cortical metabolic associations in aging and dementia.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Brain Mapping; Cerebral Cortex; Cerebrovascular Disorders; Cohort Studies; Corpus Callosum; Dementia; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Nerve Fibers, Myelinated; Neuropsychological Tests; Positron-Emission Tomography; Retrospective Studies | 2010 |
Multi-center study on Alzheimer's disease using FDG PET: group and individual analyses.
Topics: Aged; Alzheimer Disease; Brain; Female; Fluorodeoxyglucose F18; Humans; Male; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Severity of Illness Index | 2010 |
Worldwide distribution of PSEN1 Met146Leu mutation: a large variability for a founder mutation.
Topics: Adult; Alzheimer Disease; Brain; Cognition Disorders; Family Health; Female; Fluorodeoxyglucose F18; Gene Frequency; Genetic Predisposition to Disease; Genetic Testing; Genotype; Global Health; History, 17th Century; History, 21st Century; Humans; International Cooperation; Italy; Leucine; Male; Memory Disorders; Methionine; Middle Aged; Mutation; Phenotype; Positron-Emission Tomography; Presenilin-1 | 2010 |
Controlled memory processes in questionable Alzheimer's disease: a view from neuroimaging research.
Topics: Aged; Alzheimer Disease; Analysis of Variance; Brain; Brain Mapping; Cognition; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Male; Memory Disorders; Middle Aged; Neuropsychological Tests; Tomography, Emission-Computed | 2010 |
High PIB retention in Alzheimer's disease is an early event with complex relationship with CSF biomarkers and functional parameters.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Benzothiazoles; Biomarkers; Early Diagnosis; Enzyme-Linked Immunosorbent Assay; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Interpretation, Computer-Assisted; Male; Memory Disorders; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles | 2010 |
Comparison of neuropsychological and FDG-PET findings between early- versus late-onset mild cognitive impairment: A five-year longitudinal study.
Topics: Age of Onset; Aged; Alzheimer Disease; Attention; Brain Chemistry; Cognition Disorders; Executive Function; Female; Fluorodeoxyglucose F18; Glucose; Humans; Language; Language Disorders; Logistic Models; Longitudinal Studies; Male; Memory; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Verbal Behavior | 2010 |
Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
Topics: Aged; Alzheimer Disease; Aniline Compounds; Brain; Brain Mapping; Case-Control Studies; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Neurofibrillary Tangles; Nitriles; Plaque, Amyloid; Positron-Emission Tomography; Radiopharmaceuticals; Signal Processing, Computer-Assisted; Thiazoles | 2010 |
Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele.
Topics: Aged; Alzheimer Disease; Apolipoprotein E4; Brain; Brain Diseases, Metabolic; Brain Mapping; Cohort Studies; Cross-Sectional Studies; DNA Mutational Analysis; Female; Fluorodeoxyglucose F18; Gene Frequency; Genetic Carrier Screening; Genetic Markers; Genetic Predisposition to Disease; Genetic Testing; Genotype; Heterozygote; Hispanic or Latino; Humans; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Risk Factors | 2010 |
Pittsburgh compound B (11C-PIB) and fluorodeoxyglucose (18 F-FDG) PET in patients with Alzheimer disease, mild cognitive impairment, and healthy controls.
Topics: Aged; Alzheimer Disease; Aniline Compounds; Area Under Curve; Brain; Cerebellum; Chromatography, High Pressure Liquid; Cognition Disorders; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Memory; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Thiazoles | 2010 |
Fluorodeoxyglucose positron emission tomography of mild cognitive impairment with clinical follow-up at 3 years.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognition Disorders; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Lewy Body Disease; Male; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results | 2010 |
[Positron emission tomography imaging of cell transplantation in a rat model of Alzheimer's disease].
Topics: Alzheimer Disease; Animals; Disease Models, Animal; Fluorodeoxyglucose F18; Male; Positron-Emission Tomography; Rats; Rats, Sprague-Dawley; Stem Cell Transplantation; Thiazoles | 2010 |
The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Aniline Compounds; Brain Mapping; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Male; Positron-Emission Tomography; Retrospective Studies; Thiazoles | 2010 |
Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans.
Topics: Alzheimer Disease; Biomarkers; Cognition Disorders; Diagnostic Imaging; Disease Progression; Fluorodeoxyglucose F18; Gene Expression Regulation; Genetic Predisposition to Disease; Genome-Wide Association Study; Genotype; Humans; Image Interpretation, Computer-Assisted; MicroRNAs; Monomeric Clathrin Assembly Proteins; Mutation; Phenotype; Radiopharmaceuticals | 2010 |
Alzheimer's disease: spect and pet tracers for beta-amyloid imaging.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Benzothiazoles; Brain Mapping; Cerebral Cortex; Congo Red; Fluorodeoxyglucose F18; Humans; Neurofibrillary Tangles; Positron-Emission Tomography; Protein Binding; Radiopharmaceuticals; Thiazoles; Tomography, Emission-Computed, Single-Photon | 2010 |
The dynamics of Alzheimer's disease biomarkers in the Alzheimer's Disease Neuroimaging Initiative cohort.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Apolipoprotein E4; Biomarkers; Cohort Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Genetic Carrier Screening; Glucose-6-Phosphate; Hippocampus; Humans; Longitudinal Studies; Male; Neurobiology; Organ Size; Peptide Fragments; Positron-Emission Tomography; Prospective Studies; tau Proteins | 2010 |
The value of PET in mild cognitive impairment, typical and atypical/unclear dementias: A retrospective memory clinic study.
Topics: Aged; Alzheimer Disease; Cholinesterase Inhibitors; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies | 2010 |
Molecular imaging in the diagnosis of Alzheimer's disease: visual assessment of [11C]PIB and [18F]FDDNP PET images.
Topics: Aged; Alzheimer Disease; Aniline Compounds; Atrophy; Benzothiazoles; Brain Chemistry; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Likelihood Functions; Magnetic Resonance Imaging; Male; Middle Aged; Nitriles; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Temporal Lobe; Thiazoles | 2010 |
Tarot decks and PET scans: predicting the future of MCI.
Topics: Alzheimer Disease; Cognition Disorders; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography | 2010 |
Comparing predictors of conversion and decline in mild cognitive impairment.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Apolipoprotein E4; Cognition Disorders; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Memory Disorders; Middle Aged; Neuropsychological Tests; Peptide Fragments; Positron-Emission Tomography; Predictive Value of Tests; ROC Curve; Statistics, Nonparametric; tau Proteins; Time Factors | 2010 |
Robustness of correlations between PCA of FDG-PET scans and biological variables in healthy and demented subjects.
Topics: Alzheimer Disease; Brain; Brain Mapping; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Neuropsychological Tests; Positron-Emission Tomography; Principal Component Analysis; Radiopharmaceuticals | 2011 |
Progression of cerebral amyloid load is associated with the apolipoprotein E ε4 genotype in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Aniline Compounds; Apolipoprotein E4; Brain; Disease Progression; Female; Fluorodeoxyglucose F18; Genotype; Humans; Male; Middle Aged; Plaque, Amyloid; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles | 2010 |
New research criteria for the diagnosis of Alzheimer's disease applied in a memory clinic population.
Topics: Aged; Alzheimer Disease; Ambulatory Care Facilities; Amyloid beta-Peptides; Cognition Disorders; Data Interpretation, Statistical; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Likelihood Functions; Magnetic Resonance Imaging; Male; Memory; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Psychometrics; Reproducibility of Results; tau Proteins | 2010 |
[Application of positron emission tomography in evaluation of Alzheimer's disease rat model].
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Carbon Radioisotopes; Disease Models, Animal; Fluorodeoxyglucose F18; Male; Positron-Emission Tomography; Rats; Rats, Sprague-Dawley | 2010 |
Regional cerebral glucose uptake in the 3xTG model of Alzheimer's disease highlights common regional vulnerability across AD mouse models.
Topics: Age Factors; Alzheimer Disease; Amyloid beta-Protein Precursor; Analysis of Variance; Animals; Cerebral Cortex; Disease Models, Animal; Fluorodeoxyglucose F18; Glucose; Humans; Mice; Mice, Inbred C57BL; Mice, Transgenic; Presenilin-1; Radionuclide Imaging; tau Proteins | 2010 |
Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Benzothiazoles; Brain; Carbon Radioisotopes; Cognition; Cognitive Dysfunction; Disease Progression; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles; Time Factors | 2012 |
Relative capability of MR imaging and FDG PET to depict changes associated with prodromal and early Alzheimer disease.
Topics: Aged; Alzheimer Disease; Case-Control Studies; Chi-Square Distribution; Early Diagnosis; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Monte Carlo Method; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity | 2010 |
Amyloid imaging: coming to a PET scanner near you.
Topics: Alzheimer Disease; Amyloid; Fluorodeoxyglucose F18; Humans; Tomography, Emission-Computed | 2010 |
Functional representation of olfactory impairment in early Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Odorants; Olfaction Disorders; Positron-Emission Tomography; Smell | 2010 |
Cerebrospinal fluid tau protein levels and 18F-fluorodeoxyglucose positron emission tomography in the differential diagnosis of Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Area Under Curve; Cognition Disorders; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Memory Disorders; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; tau Proteins | 2010 |
Unawareness of memory deficit in amnestic MCI: FDG-PET findings.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amnesia; Awareness; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Male; Memory Disorders; Neuropsychological Tests; Positron-Emission Tomography | 2010 |
A comparison of the diagnostic sensitivity of MRI, CBF-SPECT, FDG-PET and cerebrospinal fluid biomarkers for detecting Alzheimer's disease in a memory clinic.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Atrophy; Biomarkers; Cerebrospinal Fluid; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Peptide Fragments; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Severity of Illness Index; Single-Blind Method; tau Proteins; Temporal Lobe; Tomography, Emission-Computed, Single-Photon | 2010 |
Association between GAB2 haplotype and higher glucose metabolism in Alzheimer's disease-affected brain regions in cognitively normal APOEε4 carriers.
Topics: Adaptor Proteins, Signal Transducing; Aged; Alzheimer Disease; Apolipoprotein E4; Brain; Brain Chemistry; Cognition; DNA; Female; Fluorodeoxyglucose F18; Glucose; Haplotypes; Heterozygote; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Polymorphism, Single Nucleotide; Radionuclide Imaging; Radiopharmaceuticals | 2011 |
Brain glucose metabolism in vascular white matter disease with dementia: differentiation from Alzheimer disease.
Topics: Aged; Alzheimer Disease; Brain; Brain Chemistry; Dementia, Vascular; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Interpretation, Computer-Assisted; Leukoencephalopathies; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |
Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors.
Topics: Adult; Age of Onset; Aged; Alzheimer Disease; Brain; Diagnosis, Differential; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neuropsychological Tests; Observer Variation; Parietal Lobe; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Temporal Lobe | 2011 |
Validation of consensus panel diagnosis in dementia.
Topics: Alzheimer Disease; Consensus; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Positron-Emission Tomography; Predictive Value of Tests; Reproducibility of Results; Sensitivity and Specificity | 2010 |
Feature selection using factor analysis for Alzheimer's diagnosis using 18F-FDG PET images.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognition Disorders; Diagnosis, Computer-Assisted; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Middle Aged; Models, Statistical; Multivariate Analysis; Normal Distribution; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results | 2010 |
Usefulness of 18F-fluorodeoxyglucose positron emission tomography for diagnosis of asymptomatic giant cell arteritis in a patient with Alzheimer's disease.
Topics: Aged, 80 and over; Alzheimer Disease; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
PET has no clothes.
Topics: Alzheimer Disease; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography | 2011 |
A visual [18F]FDG-PET rating scale for the differential diagnosis of frontotemporal lobar degeneration.
Topics: Aged; Aging; Alzheimer Disease; Atrophy; Brain; Brain Mapping; Cerebrospinal Fluid Proteins; Cognitive Dysfunction; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Functional Laterality; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neuropsychological Tests; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
Early 11C-PIB frames and 18F-FDG PET measures are comparable: a study validated in a cohort of AD and FTLD patients.
Topics: Aged; Alzheimer Disease; Aniline Compounds; Benzothiazoles; Cohort Studies; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Logistic Models; Male; Middle Aged; Models, Statistical; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Thiazoles; Time Factors | 2011 |
Horizontal versus longitudinal axis of the hippocampus: metabolic differentiation as measured with high-resolution PET/MRI.
Topics: Aging; Alzheimer Disease; Amnesia; Fluorodeoxyglucose F18; Glucose; Hippocampus; Humans; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
Computer-assisted system for diagnosis of Alzheimer disease using data base- independent estimation and fluorodeoxyglucose- positron-emission tomography and 3D-stereotactic surface projection.
Topics: Aged; Algorithms; Alzheimer Disease; Artificial Intelligence; Brain; Cluster Analysis; Computer Graphics; Computer Simulation; Databases, Factual; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Information Storage and Retrieval; Male; Models, Biological; Models, Statistical; Numerical Analysis, Computer-Assisted; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Signal Processing, Computer-Assisted; Subtraction Technique; User-Computer Interface | 2011 |
Time course of glucose metabolism in relation to cognitive performance and postmortem neuropathology in Met146Val PSEN1 mutation carriers.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Brain Mapping; Cognition Disorders; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Mental Status Schedule; Methionine; Middle Aged; Mutation; Neuropsychological Tests; Plaque, Amyloid; Positron-Emission Tomography; Postmortem Changes; Presenilin-1; Statistics as Topic; Time Factors; Valine | 2011 |
Relationships between hippocampal microstructure, metabolism, and function in early Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Diffusion Tensor Imaging; Female; Fluorodeoxyglucose F18; Glucose; Hippocampus; Humans; Male; Memory Disorders; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Statistics, Nonparametric | 2011 |
Verification of predicted robustness and accuracy of multivariate analysis.
Topics: Aged; Alzheimer Disease; Databases, Factual; Discriminant Analysis; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Multivariate Analysis; Positron-Emission Tomography; Principal Component Analysis; Radiopharmaceuticals; Reproducibility of Results | 2011 |
18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease.
Topics: Alzheimer Disease; Analysis of Variance; Aniline Compounds; Animals; Autoradiography; Binding Sites; Brain; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Male; Mice; Quinolines; Radionuclide Imaging; Radiopharmaceuticals; tau Proteins | 2011 |
Spatial distribution of glucose hypometabolism induced by intracerebroventricular streptozotocin in monkeys.
Topics: Alzheimer Disease; Animals; Brain; Brain Mapping; Disease Models, Animal; Fluorodeoxyglucose F18; Glucose Metabolism Disorders; Injections, Intraventricular; Macaca fascicularis; Magnetic Resonance Imaging; Positron-Emission Tomography; Streptozocin; Time Factors | 2011 |
Neuronal dysfunction and disconnection of cortical hubs in non-demented subjects with elevated amyloid burden.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Aniline Compounds; Benzothiazoles; Brain Mapping; Cerebral Cortex; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Oxygen; Positron-Emission Tomography; Statistics as Topic; Thiazoles | 2011 |
Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Positron-Emission Tomography; Syndrome | 2011 |
"Reversible" Alzheimer's disease?
Topics: Aged; Alzheimer Disease; Atrophy; Cohort Studies; Combined Modality Therapy; Donepezil; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Indans; Life Style; Magnetic Resonance Imaging; Male; Mental Status Schedule; Motor Activity; Neuropsychological Tests; Nootropic Agents; Piperidines; Positron-Emission Tomography; Psychometrics; Remission, Spontaneous; Temporal Lobe | 2011 |
Longitudinal change of biomarkers in cognitive decline.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Apolipoprotein E4; Biomarkers; Cognition Disorders; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Outcome Assessment, Health Care; Peptide Fragments; Positron-Emission Tomography; Regression Analysis; Retrospective Studies | 2011 |
Bihemispheric cerebral FDG PET correlates of cognitive dysfunction as assessed by the CERAD in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain Mapping; Cerebral Cortex; Cognition Disorders; Dominance, Cerebral; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Mental Recall; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Registries; Severity of Illness Index | 2011 |
Regional expansion of hypometabolism in Alzheimer's disease follows amyloid deposition with temporal delay.
Topics: Aged; Alzheimer Disease; Amyloid; Aniline Compounds; Biomarkers; Brain; Case-Control Studies; Female; Fluorodeoxyglucose F18; Functional Neuroimaging; Humans; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles; Time Factors | 2012 |
Evaluation of a calibrated (18)F-FDG PET score as a biomarker for progression in Alzheimer disease and mild cognitive impairment.
Topics: Aged; Alzheimer Disease; Biomarkers; Calibration; Cognition; Cognition Disorders; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Mental Status Schedule; Middle Aged; Neurology; Neuropsychological Tests; Positron-Emission Tomography; Reproducibility of Results | 2011 |
Functional implications of hippocampal degeneration in early Alzheimer's disease: a combined DTI and PET study.
Topics: Alzheimer Disease; Brain; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Functional Neuroimaging; Glucose; Hippocampus; Humans; Male; Memory Disorders; Neural Pathways; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique | 2011 |
Atypical presentation of a novel Presenilin 1 R377W mutation: sporadic, late-onset Alzheimer disease with epilepsy and frontotemporal atrophy.
Topics: Aged; Alzheimer Disease; Arginine; Atrophy; Epilepsy; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Male; Mutation; Positron-Emission Tomography; Presenilin-2; Temporal Lobe; Tomography, X-Ray Computed; Tryptophan | 2012 |
Clinical course of patients with familial early-onset Alzheimer's disease potentially lacking senile plaques bearing the E693Δ mutation in amyloid precursor protein.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Aniline Compounds; Apolipoproteins E; Atrophy; Benzothiazoles; Brain; Cerebellar Ataxia; Cognition; Disease Progression; Female; Fluorodeoxyglucose F18; Gait Disorders, Neurologic; Humans; Magnetic Resonance Imaging; Memory Disorders; Middle Aged; Mutation; Neuropsychological Tests; Pedigree; Plaque, Amyloid; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles | 2011 |
Posterior cingulate atrophy and metabolic decline in early stage Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Apolipoproteins E; Atrophy; Attention; Brain Mapping; Cognition; Female; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Learning; Magnetic Resonance Imaging; Male; Mental Status Schedule; Metabolic Diseases; Middle Aged; Neuropsychological Tests; Peptide Fragments; Positron-Emission Tomography | 2012 |
Seizures can precede cognitive symptoms in late-onset Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Amyloid beta-Protein Precursor; Apolipoprotein E3; Cognition Disorders; Disease Progression; Electroencephalography; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Seizures | 2011 |
Value of neuropsychological tests, neuroimaging, and biomarkers for diagnosing Alzheimer's disease in younger and older age cohorts.
Topics: Age Factors; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cerebrospinal Fluid; Cognitive Dysfunction; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; tau Proteins | 2011 |
Effect of an age-mismatched and sex-mismatched normal database on the diagnostic performance of ¹⁸F-FDG PET for Alzheimer's disease: the Ishikawa Brain Imaging Study.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Alzheimer Disease; Data Collection; Databases, Factual; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; ROC Curve; Sex Factors; Young Adult | 2011 |
Empirical derivation of the reference region for computing diagnostic sensitive ¹⁸fluorodeoxyglucose ratios in Alzheimer's disease based on the ADNI sample.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cerebellum; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Longitudinal Studies; Male; Middle Aged; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals | 2012 |
Amyloid-β and glucose metabolism in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Benzothiazoles; Brain Mapping; Cohort Studies; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Positron-Emission Tomography; Statistics as Topic; Thiazoles | 2011 |
Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain Mapping; Case-Control Studies; Cerebrovascular Circulation; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Spin Labels | 2012 |
Multimodality imaging characteristics of dementia with Lewy bodies.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Brain Mapping; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lewy Body Disease; Magnetic Resonance Imaging; Male; Middle Aged; Occipital Lobe; Positron-Emission Tomography; ROC Curve; Statistics, Nonparametric; Thiazoles | 2012 |
Neuropathological investigation of the hypometabolic regions on positron emission tomography with [18F] fluorodeoxyglucose in patients with dementia with Lewy bodies.
Topics: Aged; Aged, 80 and over; alpha-Synuclein; Alzheimer Disease; Amyloid beta-Peptides; Autopsy; Brain; Cell Count; Data Interpretation, Statistical; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lewy Body Disease; Male; Middle Aged; Neurofibrillary Tangles; Neurons; Positron-Emission Tomography; Radiopharmaceuticals; tau Proteins | 2012 |
Stage-dependent agreement between cerebrospinal fluid proteins and FDG-PET findings in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Apolipoprotein E4; Area Under Curve; Biomarkers; Cerebrospinal Fluid Proteins; Cognition Disorders; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neuropsychological Tests; Peptide Fragments; Positron-Emission Tomography; Psychiatric Status Rating Scales; Retrospective Studies; Sensitivity and Specificity; tau Proteins | 2012 |
Negative amyloid PET imaging in a patient with probable Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography | 2011 |
Increased regional cerebral glucose uptake in an APP/PS1 model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Analysis of Variance; Animals; Calcium-Binding Proteins; Cerebral Cortex; Cerebrovascular Circulation; Disease Models, Animal; Fluorodeoxyglucose F18; Glial Fibrillary Acidic Protein; Glucose; Humans; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microfilament Proteins; Positron-Emission Tomography; Presenilin-1 | 2012 |
Asymmetric loss of parietal activity causes spatial bias in prodromal and mild Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Attention; Early Diagnosis; Female; Fluorodeoxyglucose F18; Functional Laterality; Functional Neuroimaging; Humans; Male; Middle Aged; Parietal Lobe; Positron-Emission Tomography; Psychomotor Performance; Space Perception | 2012 |
Evaluation of therapeutic response to donepezil by positron emission tomography.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Chi-Square Distribution; Cholinesterase Inhibitors; Cognition; Donepezil; Drug Monitoring; Female; Fluorodeoxyglucose F18; Glucose; Humans; Indans; Japan; Male; Middle Aged; Neuropsychological Tests; Nootropic Agents; Piperidines; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Severity of Illness Index; Time Factors; Treatment Outcome | 2011 |
The use of PIB-PET as a dual pathological and functional biomarker in AD.
Topics: Aged; Alzheimer Disease; Amyloid; Aniline Compounds; Benzothiazoles; Biomarkers; Carbon Radioisotopes; Cognitive Dysfunction; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Parietal Lobe; Positron-Emission Tomography; Regional Blood Flow; Thiazoles | 2012 |
Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Brain; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography | 2011 |
Education and occupation provide reserve in both ApoE ε4 carrier and noncarrier patients with probable Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Apolipoprotein E4; Brain; Cognitive Reserve; Educational Status; Female; Fluorodeoxyglucose F18; Heterozygote; Humans; Male; Occupations; Positron-Emission Tomography; Radiopharmaceuticals | 2012 |
Glucose metabolism and gray-matter concentration in apolipoprotein E ε4 positive normal subjects.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Apolipoprotein E4; Brain; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Young Adult | 2012 |
Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Benzothiazoles; Brain; Case-Control Studies; Cognitive Dysfunction; Deuterium; Female; Fluorodeoxyglucose F18; Gliosis; Humans; Male; Middle Aged; Monoamine Oxidase; Neuropsychological Tests; Positron-Emission Tomography; Radioactive Tracers; Retrospective Studies; Selegiline; Thiazoles | 2012 |
Multi-region analysis of longitudinal FDG-PET for the classification of Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2012 |
Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice.
Topics: Administration, Oral; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Analysis of Variance; Animals; Benzoxazines; Cannabinoids; Choroid Plexus; Cognition Disorders; Corpus Striatum; Cyclooxygenase 2; Disease Models, Animal; Encephalitis; Enzyme-Linked Immunosorbent Assay; Fluorodeoxyglucose F18; Gene Expression Regulation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Mice; Mice, Transgenic; Microglia; Morpholines; Naphthalenes; Positron-Emission Tomography; Receptor, Cannabinoid, CB2; RNA, Messenger; Time Factors | 2012 |
Correlation of early-phase 18F-florbetapir (AV-45/Amyvid) PET images to FDG images: preliminary studies.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Cerebrovascular Circulation; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Time Factors | 2012 |
PET imaging with [18F]AV-45 in an APP/PS1-21 murine model of amyloid plaque deposition.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Autoradiography; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Plaque, Amyloid; Positron-Emission Tomography | 2012 |
Value of diagnostic tests to predict conversion to Alzheimer's disease in young and old patients with amnestic mild cognitive impairment.
Topics: Age Factors; Aged; Aged, 80 and over; Aging; Alzheimer Disease; Amyloid beta-Peptides; Canada; Cognitive Dysfunction; Databases, Bibliographic; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Peptide Fragments; Positron-Emission Tomography; Predictive Value of Tests; tau Proteins; United States | 2012 |
Summary metrics to assess Alzheimer disease-related hypometabolic pattern with 18F-FDG PET: head-to-head comparison.
Topics: Aged; Alzheimer Disease; Biomarkers; Discriminant Analysis; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies | 2012 |
Correlations between FDG PET glucose uptake-MRI gray matter volume scores and apolipoprotein E ε4 gene dose in cognitively normal adults: a cross-validation study using voxel-based multi-modal partial least squares.
Topics: Algorithms; Alzheimer Disease; Apolipoprotein E4; Brain; Female; Fluorodeoxyglucose F18; Gene Dosage; Glucose; Humans; Image Interpretation, Computer-Assisted; Least-Squares Analysis; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Risk Factors | 2012 |
Resting metabolic connectivity in prodromal Alzheimer's disease. A European Alzheimer Disease Consortium (EADC) project.
Topics: Aged; Alzheimer Disease; Brain Mapping; Cognition Disorders; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hippocampus; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Rest | 2012 |
Toward a dynamic biomarker model in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Models, Statistical; Nonlinear Dynamics; Peptide Fragments; Positron-Emission Tomography; tau Proteins | 2012 |
Shapes of the trajectories of 5 major biomarkers of Alzheimer disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Aniline Compounds; Apolipoprotein E4; Biomarkers; Cognition Disorders; Cohort Studies; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Immunoassay; Magnetic Resonance Imaging; Male; Mental Status Schedule; Nonlinear Dynamics; Peptide Fragments; Positron-Emission Tomography; tau Proteins; Thiazoles | 2012 |
An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Biomarkers; Brain; Cognition Disorders; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Male; Mental Status Schedule; National Institute on Aging (U.S.); Neuropsychological Tests; Positron-Emission Tomography; Thiazoles; United States | 2012 |
Predicting missing biomarker data in a longitudinal study of Alzheimer disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cognitive Dysfunction; Cohort Studies; Dementia, Vascular; Fluorodeoxyglucose F18; Homocysteine; Humans; Logistic Models; Longitudinal Studies; Magnetic Resonance Imaging; Neuropsychological Tests; Patient Dropouts; Peptide Fragments; Positron-Emission Tomography; Research Design; Risk Factors; tau Proteins | 2012 |
Multi-source feature learning for joint analysis of incomplete multiple heterogeneous neuroimaging data.
Topics: Aged; Algorithms; Alzheimer Disease; Artificial Intelligence; Cognitive Dysfunction; Databases, Factual; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Positron-Emission Tomography; Proteomics; Radiopharmaceuticals | 2012 |
Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer's parents.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Aniline Compounds; Brain; Brain Mapping; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Psychiatric Status Rating Scales; Sensitivity and Specificity; Thiazoles | 2013 |
Resting state FDG-PET functional connectivity as an early biomarker of Alzheimer's disease using conjoint univariate and independent component analyses.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Male; Neural Pathways; Positron-Emission Tomography; Radiopharmaceuticals; Rest | 2012 |
IgA NMDA receptor antibodies are markers of synaptic immunity in slow cognitive impairment.
Topics: Adrenal Cortex Hormones; Aged; Alzheimer Disease; Antibodies, Monoclonal, Murine-Derived; Atrophy; Autoimmunity; Biomarkers; Blotting, Western; Cognition Disorders; Cyclophosphamide; Disease Progression; Electrophysiology; Female; Fluorodeoxyglucose F18; Frontal Lobe; Hippocampus; Humans; Immunoglobulin A; Immunohistochemistry; Immunotherapy; Lewy Body Disease; Magnetic Resonance Imaging; Neurons; Plasma Exchange; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, N-Methyl-D-Aspartate; Rituximab; Synapses; Temporal Lobe; Treatment Outcome | 2012 |
Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Brain; Chi-Square Distribution; Cognition Disorders; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; National Institute on Aging (U.S.); Neuropsychological Tests; Positron-Emission Tomography; Psychiatric Status Rating Scales; Thiazoles; United States | 2012 |
Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.
Topics: Age of Onset; Aged; Alzheimer Disease; Amyloid; Aniline Compounds; Apolipoproteins E; Brain Mapping; Carbon Radioisotopes; Case-Control Studies; Cognition Disorders; Female; Fluorodeoxyglucose F18; Genotype; Glucose; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Parietal Lobe; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles | 2012 |
Initial clinical comparison of 18F-florbetapir and 18F-FDG PET in patients with Alzheimer disease and controls.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Ethylene Glycols; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Severity of Illness Index | 2012 |
Imaging microglial activation and glucose consumption in a mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Analysis of Variance; Animals; Brain; Brain Mapping; Carbon Radioisotopes; CD11b Antigen; Disease Models, Animal; Fluorodeoxyglucose F18; Glucose; Humans; Isoquinolines; Mice; Mice, Transgenic; Microglia; Mutation; Positron-Emission Tomography; Presenilin-1 | 2013 |
Whither the hippocampus? FDG-PET hippocampal hypometabolism in Alzheimer disease revisited.
Topics: Aged; Alzheimer Disease; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2012 |
Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers.
Topics: Adult; Aged; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Atrophy; Biomarkers; Carbon Radioisotopes; Cognition; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Neuropsychological Tests; Peptide Fragments; Presenilin-1; Radionuclide Imaging; Radiopharmaceuticals; tau Proteins; Thiazoles | 2012 |
Parietal variant Alzheimer's disease presenting with dyscalculia.
Topics: Alzheimer Disease; Aniline Compounds; Dyscalculia; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Thiazoles | 2013 |
Nonfluent/agrammatic PPA with in-vivo cortical amyloidosis and Pick's disease pathology.
Topics: Aged; Alzheimer Disease; Amyloidosis; Aniline Compounds; Carbon Radioisotopes; Disease Progression; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Frontal Lobe; Functional Neuroimaging; Humans; Magnetic Resonance Imaging; Neuropsychological Tests; Pick Disease of the Brain; Positron-Emission Tomography; Primary Progressive Nonfluent Aphasia; Thiazoles | 2013 |
Predicting brain activity using a Bayesian spatial model.
Topics: Algorithms; Alzheimer Disease; Bayes Theorem; Biostatistics; Brain; Case-Control Studies; Cognitive Dysfunction; Computer Simulation; Disease Progression; Fluorodeoxyglucose F18; Functional Neuroimaging; Humans; Magnetic Resonance Imaging; Models, Neurological; Normal Distribution; Positron-Emission Tomography; Radiopharmaceuticals | 2013 |
[FDG-PET].
Topics: Alzheimer Disease; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
Broad-based nutritional supplementation in 3xTg mice corrects mitochondrial function and indicates sex-specificity in response to Alzheimer's disease intervention.
Topics: Alzheimer Disease; Amyloidosis; Animals; Cognition; Dietary Supplements; Electron Transport Complex IV; Enzyme-Linked Immunosorbent Assay; Female; Fluorodeoxyglucose F18; Glial Fibrillary Acidic Protein; Image Processing, Computer-Assisted; Immunohistochemistry; Inflammation; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mitochondrial Diseases; Nutritional Physiological Phenomena; Plant Extracts; Psychomotor Performance; Radionuclide Imaging; Radiopharmaceuticals; Sex Characteristics; Synaptophysin; tau Proteins | 2012 |
[Multi-center study of inter-scanner difference in brain positron emission tomography].
Topics: Alzheimer Disease; Aniline Compounds; Brain; Fluorodeoxyglucose F18; Humans; Phantoms, Imaging; Positron-Emission Tomography; Quality Control; Radiopharmaceuticals; Thiazoles | 2012 |
Dysgraphia in Korean patients with Alzheimer's disease as a manifestation of bilateral hemispheric dysfunction.
Topics: Aged; Aged, 80 and over; Agraphia; Alzheimer Disease; Asian People; Case-Control Studies; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Functional Neuroimaging; Humans; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Psychomotor Performance; Radiopharmaceuticals | 2012 |
PET/MRI: challenges, solutions and perspectives.
Topics: Alzheimer Disease; Animals; Brain; Carbon Radioisotopes; Contrast Media; Diffusion Magnetic Resonance Imaging; Efficiency; Electron Spin Resonance Spectroscopy; Equipment Design; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Models, Animal; Multimodal Imaging; Positron-Emission Tomography; Raclopride; Rats; Sensitivity and Specificity; Software; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2012 |
Quantitative longitudinal interrelationships between brain metabolism and amyloid deposition during a 2-year follow-up in patients with early Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Amyloid; Aniline Compounds; Brain; Case-Control Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles | 2012 |
Clinical features of Pittsburgh compound-B-negative dementia.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Case-Control Studies; Dementia; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lewy Body Disease; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Perfusion Imaging; Positron-Emission Tomography; Radiopharmaceuticals; tau Proteins; Thiazoles | 2012 |
Neuropsychological and neuroimaging markers in early versus late-onset Alzheimer's disease.
Topics: Age of Onset; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cognition Disorders; Female; Fluorodeoxyglucose F18; Functional Neuroimaging; Humans; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals | 2012 |
Markov random field and Gaussian mixture for segmented MRI-based partial volume correction in PET.
Topics: Alzheimer Disease; Brain; Epilepsy; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Markov Chains; Normal Distribution; Phantoms, Imaging; Positron-Emission Tomography; Reproducibility of Results | 2012 |
Combination of 18F-FDG PET and cerebrospinal fluid biomarkers as a better predictor of the progression to Alzheimer's disease in mild cognitive impairment patients.
Topics: Aged; Alzheimer Disease; Biomarkers; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Longitudinal Studies; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Predictive Value of Tests | 2013 |
My belief or yours? Differential theory of mind deficits in frontotemporal dementia and Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Cerebral Cortex; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Male; Middle Aged; Neuropsychological Tests; Theory of Mind | 2012 |
Supporting evidence for using biomarkers in the diagnosis of MCI due to AD.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Analysis of Variance; Apolipoproteins E; Biomarkers; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Genetic Testing; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Peptide Fragments; Positron-Emission Tomography; tau Proteins | 2013 |
Suicide attempt as the presenting symptom of C9orf72 dementia.
Topics: Aged; Alzheimer Disease; C9orf72 Protein; Cerebral Cortex; Diagnosis, Differential; Fluorodeoxyglucose F18; Frontotemporal Dementia; Genotype; Humans; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Positron-Emission Tomography; Proteins; Suicide, Attempted; Trinucleotide Repeat Expansion | 2012 |
Symptomatic treatment of memory decline in Alzheimer's disease by deep brain stimulation: a feasibility study.
Topics: Adult; Alzheimer Disease; Brain; Deep Brain Stimulation; Feasibility Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Memory Disorders; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Pilot Projects; Positron-Emission Tomography; Time Factors; Young Adult | 2013 |
Relationship between baseline brain metabolism measured using [¹⁸F]FDG PET and memory and executive function in prodromal and early Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain; Cognition Disorders; Early Diagnosis; Executive Function; Female; Fluorodeoxyglucose F18; Humans; Male; Memory; Memory Disorders; Positron-Emission Tomography; Prodromal Symptoms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Tissue Distribution | 2012 |
Impaired cerebral glucose metabolism in prodromal Alzheimer's disease differs by regional intensity normalization.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Case-Control Studies; Cerebellum; Cognition Disorders; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Gyrus Cinguli; Humans; Male; Middle Aged; Parietal Lobe; Positron-Emission Tomography; Prodromal Symptoms; Radiopharmaceuticals; Temporal Lobe | 2013 |
The GGGGCC repeat expansion in C9ORF72 in a case with discordant clinical and FDG-PET findings: PET trumps syndrome.
Topics: Aged; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Brain; C9orf72 Protein; Chromosomes, Human, Pair 9; Disease Progression; DNA Repeat Expansion; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Longitudinal Studies; Male; Positron-Emission Tomography; Proteins; Radiopharmaceuticals | 2014 |
Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers.
Topics: Aged; Alzheimer Disease; Area Under Curve; Biomarkers; Chi-Square Distribution; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Logistic Models; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Regression Analysis; Retrospective Studies; Risk Factors | 2013 |
Differential effect of APOE genotype on amyloid load and glucose metabolism in AD dementia.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Amyloidosis; Aniline Compounds; Apolipoproteins E; Benzothiazoles; Blood Glucose; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Genotype; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Severity of Illness Index; Thiazoles | 2013 |
Whole-brain functional networks in cognitively normal, mild cognitive impairment, and Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain; Brain Mapping; Cognition; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Male; Metabolic Networks and Pathways; Middle Aged; Positron-Emission Tomography | 2013 |
Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Amyloid; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Neuropsychological Tests; Phenotype; Plaque, Amyloid; Positron-Emission Tomography; Radiopharmaceuticals | 2013 |
Diagnostic accuracy of markers for prodromal Alzheimer's disease in independent clinical series.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cognition Disorders; Databases, Factual; Disease Progression; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Peptide Fragments; Positron-Emission Tomography; Sensitivity and Specificity; Statistics, Nonparametric; Time Factors | 2013 |
In vivo imaging of region and cell type specific neocortical neurodegeneration in Alzheimer's disease. Perspectives of MRI derived corpus callosum measurement for mapping disease progression and effects of therapy. Evidence from studies with MRI, EEG and
Topics: Alzheimer Disease; Atrophy; Corpus Callosum; Disease Progression; Electroencephalography; Fluorodeoxyglucose F18; Hippocampus; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Neocortex; Nerve Degeneration; Neurons; Radiography; Radiopharmaceuticals; Severity of Illness Index; Tomography, Emission-Computed | 2002 |
Clinical and biomarker investigation of a patient with a novel presenilin-1 mutation (A431V) in the mild cognitive impairment stage of Alzheimer's disease.
Topics: Alzheimer Disease; Cognition Disorders; Fluorodeoxyglucose F18; Genetic Markers; Glucose; Gyrus Cinguli; Humans; Male; Membrane Proteins; Middle Aged; Neuropsychological Tests; Point Mutation; Polymerase Chain Reaction; Presenilin-1; Radiopharmaceuticals; Severity of Illness Index; Tomography, Emission-Computed | 2002 |
Correlations between visual recognition memory and neocortical and hippocampal glucose metabolism after bilateral rhinal cortex lesions in the baboon: implications for Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Behavior, Animal; Disease Models, Animal; Entorhinal Cortex; Fluorodeoxyglucose F18; Glucose; Hippocampus; Male; Memory; Neocortex; Neurotoxins; Papio; Parahippocampal Gyrus; Pattern Recognition, Visual; Photic Stimulation; Tomography, Emission-Computed | 2002 |
Inositol phospholipid metabolism in Alzheimer's disease: a positron emission tomographic study.
Topics: Aged; Alzheimer Disease; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Phosphatidylinositols; Radiopharmaceuticals; Reference Values; Tomography, Emission-Computed; Wechsler Scales | 2002 |
Neuroanatomical correlates of low body weight in Alzheimer's disease: a PET study.
Topics: Age Factors; Aged; Aged, 80 and over; Alzheimer Disease; Body Mass Index; Brain; Female; Fluorodeoxyglucose F18; Glucose; Gyrus Cinguli; Humans; Male; Middle Aged; Nutrition Disorders; Nutritional Status; Radiopharmaceuticals; Sex Factors; Tomography, Emission-Computed; Weight Loss | 2002 |
Influence of the apolipoprotein E type 4 allele on cerebral glucose metabolism in Alzheimer's disease patients.
Topics: Aged; Alleles; Alzheimer Disease; Apolipoprotein E4; Apolipoproteins E; Blood Glucose; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Genetic Carrier Screening; Genotype; Humans; Male; Middle Aged; Temporal Lobe; Tomography, Emission-Computed | 2003 |
Delusional thoughts and regional frontal/temporal cortex metabolism in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Cognition Disorders; Delusions; Female; Fluorodeoxyglucose F18; Frontal Lobe; Functional Laterality; Geriatric Assessment; Humans; Male; Psychiatric Status Rating Scales; Regression Analysis; Severity of Illness Index; Temporal Lobe; Tomography, Emission-Computed | 2003 |
Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease?
Topics: Alzheimer Disease; Brain; Disease Progression; Female; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Male; Memory Disorders; Middle Aged; Neuropsychological Tests; Parietal Lobe; Prospective Studies; Radiopharmaceuticals; Risk Factors; Single-Blind Method; Temporal Lobe; Tomography, Emission-Computed | 2003 |
A linear wavelet filter for parametric imaging with dynamic PET.
Topics: Aged; Algorithms; Alzheimer Disease; Brain; Computer Simulation; Fluorodeoxyglucose F18; Humans; Image Enhancement; Linear Models; Male; Models, Biological; Phantoms, Imaging; Raclopride; Radioisotopes; Reproducibility of Results; Sensitivity and Specificity; Signal Processing, Computer-Assisted; Stochastic Processes; Tomography, Emission-Computed | 2003 |
Brain metabolism in the cerebellum and visual cortex correlates with neuropsychological testing in patients with Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Behavior; Brain; Cerebellum; Cognition; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuropsychological Tests; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Statistics as Topic; Visual Cortex | 2003 |
Limbic hypometabolism in Alzheimer's disease and mild cognitive impairment.
Topics: Alzheimer Disease; Amnesia; Brain Mapping; Cognition Disorders; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Limbic System; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Tomography, Emission-Computed | 2003 |
Regional cerebral glucose metabolism in monozygotic twins discordant for Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain; Case-Control Studies; Diseases in Twins; Female; Fluorodeoxyglucose F18; Glucose; Hippocampus; Humans; Neuropsychological Tests; Radiopharmaceuticals; Temporal Lobe; Tomography, Emission-Computed; Twins, Monozygotic | 2003 |
Hippocampal glucose metabolism is associated with cerebrospinal fluid estrogen levels in postmenopausal women with Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Blood Glucose; Dominance, Cerebral; Estradiol; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Image Processing, Computer-Assisted; Middle Aged; Postmenopause; Radionuclide Imaging; Reference Values | 2003 |
Brain metabolic differences between sporadic and familial Alzheimer's disease.
Topics: Age of Onset; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Female; Fluorodeoxyglucose F18; Genetic Testing; Glucose; Humans; Male; Middle Aged; Neuropsychological Tests; Phenotype; Reference Values; Tomography, Emission-Computed | 2003 |
The topography of metabolic deficits in posterior cortical atrophy (the visual variant of Alzheimer's disease) with FDG-PET.
Topics: Aged; Alzheimer Disease; Atrophy; Brain Mapping; Case-Control Studies; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuropsychological Tests; Radiopharmaceuticals; Tomography, Emission-Computed; Vision Disorders; Visual Perception | 2003 |
In vivo study of acetylcholine esterase in basal forebrain, amygdala, and cortex in mild to moderate Alzheimer disease.
Topics: Acetates; Acetylcholinesterase; Aged; Alzheimer Disease; Amygdala; Basal Nucleus of Meynert; Blood Glucose; Carbon Radioisotopes; Cerebral Cortex; Cholinergic Fibers; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Piperidines; Tomography, Emission-Computed | 2004 |
Brain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Apolipoprotein E4; Apolipoproteins E; Brain; Case-Control Studies; Female; Fluorodeoxyglucose F18; Gene Dosage; Genetic Predisposition to Disease; Glucose; Humans; Male; Phenotype; Radiopharmaceuticals; Severity of Illness Index; Tomography, Emission-Computed | 2004 |
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Aniline Compounds; Autoradiography; Binding Sites; Brain; Brain Chemistry; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Thiazoles; Time Factors; Tomography, Emission-Computed | 2004 |
Neuro-ophthalmic findings in the visual variant of Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Atrophy; Blindness, Cortical; Female; Fluorodeoxyglucose F18; Hemianopsia; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Occipital Lobe; Parietal Lobe; Retrospective Studies; Tomography, Emission-Computed; Vision Disorders; Visual Field Tests; Visual Fields | 2004 |
Age and ApoE genotype interaction in Alzheimer's disease: an FDG-PET study.
Topics: Age Factors; Aged; Aged, 80 and over; Alleles; Alzheimer Disease; Apolipoprotein E4; Apolipoproteins E; Blood Glucose; Brain; Brain Mapping; Cerebellum; Dominance, Cerebral; Energy Metabolism; Female; Fluorodeoxyglucose F18; Frontal Lobe; Genetic Carrier Screening; Genotype; Gyrus Cinguli; Humans; Image Processing, Computer-Assisted; Male; Motor Cortex; Parahippocampal Gyrus; Phenotype; Tomography, Emission-Computed | 2004 |
Subclinical hyperthyroidism in dementia and correlation of the metabolic index in FDG-PET.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Basal Metabolism; Brain; Female; Fluorodeoxyglucose F18; Humans; Hyperthyroidism; Immunoglobulins, Thyroid-Stimulating; Male; Radiopharmaceuticals; Thyrotropin; Thyroxine; Tomography, Emission-Computed; Triiodothyronine | 2003 |
Activation in the premotor cortex during mental calculation in patients with Alzheimer's disease: relevance of reduction in posterior cingulate metabolism.
Topics: Aged; Alzheimer Disease; Brain Chemistry; Brain Mapping; Cognition; Female; Fluorodeoxyglucose F18; Glucose; Gyrus Cinguli; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Mental Processes; Middle Aged; Motor Cortex; Psychomotor Performance; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
[Lithium intoxication mimics Alzheimer's disease in PET and clinical findings].
Topics: Aged; Alzheimer Disease; Brain; Diagnosis, Differential; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Lithium; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
Association of elevated phospho-tau levels with Alzheimer-typical 18F-fluoro-2-deoxy-D-glucose positron emission tomography findings in patients with mild cognitive impairment.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain Chemistry; Brain Mapping; Case-Control Studies; Cognition Disorders; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Neuropsychological Tests; Phosphorylation; Predictive Value of Tests; Statistics, Nonparametric; tau Proteins; Tomography, Emission-Computed | 2004 |
[18F]FDG-PET in patients with Alzheimer's disease: marker of disease spread.
Topics: Aged; Alzheimer Disease; Amnesia; Blood Glucose; Brain; Disease Progression; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Image Processing, Computer-Assisted; Male; Memory, Short-Term; Mental Status Schedule; Middle Aged; Parietal Lobe; Positron-Emission Tomography; Statistics as Topic; Temporal Lobe | 2005 |
[Differences in cerebral glucose metabolism between frontotemporal lobar degeneration and Alzheimer's disease].
Topics: Aged; Alzheimer Disease; Blood Glucose; Cerebral Cortex; Dementia; Diagnosis, Differential; Dominance, Cerebral; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Reference Values | 2004 |
Hemispheric asymmetries of hypometabolism associated with semantic memory impairment in Alzheimer's disease: a study using positron emission tomography with fluorodeoxyglucose-F18.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Language; Male; Memory Disorders; Middle Aged; Neuropsychological Tests; Parietal Lobe; Positron-Emission Tomography; Radiopharmaceuticals; Semantics; Severity of Illness Index; Temporal Lobe | 2004 |
Metabolic interaction between ApoE genotype and onset age in Alzheimer's disease: implications for brain reserve.
Topics: Age of Onset; Aged; Aged, 80 and over; Alzheimer Disease; Apolipoproteins E; Brain; Case-Control Studies; Female; Fluorodeoxyglucose F18; Genotype; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
One-year change in cerebral glucose metabolism in patients with Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain Chemistry; Brain Mapping; Disease Progression; Donepezil; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Indans; Magnetic Resonance Imaging; Male; Nootropic Agents; Piperidines; Radionuclide Imaging; Radiopharmaceuticals | 2004 |
MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET.
Topics: Aged; Alleles; Alzheimer Disease; Apolipoprotein E4; Apolipoproteins E; Brain; Cognition Disorders; Disease Progression; Energy Metabolism; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Genetic Predisposition to Disease; Genotype; Humans; Male; Memory Disorders; Mental Recall; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Single-Blind Method | 2004 |
Cerebral glucose metabolism in patients with AD and different APOE genotypes.
Topics: Aged; Alzheimer Disease; Apolipoprotein E4; Apolipoproteins E; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Genotype; Glucose; Humans; Male; Middle Aged; Positron-Emission Tomography | 2005 |
Working memory and FDG-PET dissociate early and late onset Alzheimer disease patients.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Female; Fluorodeoxyglucose F18; Humans; Male; Memory; Middle Aged; Positron-Emission Tomography; Prospective Studies | 2005 |
Atlas-guided non-uniform attenuation correction in cerebral 3D PET imaging.
Topics: Aged; Aged, 80 and over; Algorithms; Alzheimer Disease; Artifacts; Blood Glucose; Brain; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Positron-Emission Tomography; Reproducibility of Results; Stereotaxic Techniques; Tomography, X-Ray Computed | 2005 |
Brain FDG PET study of normal aging in Japanese: effect of atrophy correction.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aging; Alzheimer Disease; Atrophy; Brain; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Japan; Magnetic Resonance Imaging; Male; Middle Aged; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2005 |
Detectability of hypometabolic regions in mild Alzheimer disease: function of time after the injection of 2-[fluorine 18]-fluoro-2-deoxy-D-glucose.
Topics: Aged; Alzheimer Disease; Female; Fluorodeoxyglucose F18; Humans; Injections; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Severity of Illness Index; Time Factors | 2005 |
Resting state glucose utilization and the CERAD cognitive battery in patients with Alzheimer's disease.
Topics: Aged; Aging; Alzheimer Disease; Brain Chemistry; Cognition; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Functional Laterality; Glucose; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Registries; Sex Characteristics | 2006 |
11C-DTBZ and 18F-FDG PET measures in differentiating dementias.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Carbon Radioisotopes; Cerebral Cortex; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Regional Blood Flow; Regression Analysis; Tetrabenazine | 2005 |
Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognition Disorders; Cohort Studies; Down-Regulation; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glucose; Hippocampus; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Reproducibility of Results; Software Design | 2005 |
Association between cognitive performance and cortical glucose metabolism in patients with mild Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Atrophy; Brain; Cerebral Cortex; Cognition; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Mental Status Schedule; Middle Aged; Positron-Emission Tomography | 2005 |
Neural correlates of anosognosia for cognitive impairment in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Awareness; Caregivers; Cerebral Cortex; Cognition; Cognition Disorders; Energy Metabolism; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Male; Middle Aged; Models, Neurological; Nerve Net; Neuropsychological Tests; Positron-Emission Tomography; Predictive Value of Tests; Prefrontal Cortex; Self-Assessment; Surveys and Questionnaires | 2006 |
Adjusted scaling of FDG positron emission tomography images for statistical evaluation in patients with suspected Alzheimer's disease.
Topics: Alzheimer Disease; Brain; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
PET is better than perfusion SPECT for early diagnosis of Alzheimer's disease -- for.
Topics: Alzheimer Disease; Disease Progression; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technology Assessment, Biomedical; Tomography, Emission-Computed, Single-Photon | 2005 |
PET is better than perfusion SPECT for early diagnosis of Alzheimer's disease -- against.
Topics: Alzheimer Disease; Disease Progression; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technology Assessment, Biomedical; Tomography, Emission-Computed, Single-Photon | 2005 |
Frontal lobe hypometabolism and impaired insight in Alzheimer disease.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Awareness; Blood Glucose; Cognition Disorders; Dominance, Cerebral; Energy Metabolism; Female; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Male; Mental Status Schedule; Neuropsychological Tests; Positron-Emission Tomography; Psychometrics; Statistics as Topic | 2005 |
Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease.
Topics: Aged; Alzheimer Disease; Brain Mapping; Case-Control Studies; Cognition Disorders; Demography; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Psychological Tests; ROC Curve | 2005 |
Visual rating of medial temporal lobe metabolism in mild cognitive impairment and Alzheimer's disease using FDG-PET.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Regression Analysis; Temporal Lobe | 2006 |
[Measurement of regional cerebral metabolism rate of glucose in patients with Alzheimer's disease in different levels of severity].
Topics: Aged; Alzheimer Disease; Case-Control Studies; Cerebral Cortex; Diagnostic and Statistical Manual of Mental Disorders; Female; Fluorodeoxyglucose F18; Glucose; Humans; Intelligence Tests; Male; Middle Aged; Severity of Illness Index; Tomography, Emission-Computed | 2005 |
Serotonin 1A receptors in the living brain of Alzheimer's disease patients.
Topics: Alzheimer Disease; Autoradiography; Brain; Female; Fluorodeoxyglucose F18; Humans; Male; Nitriles; Positron-Emission Tomography; Protein Binding; Receptor, Serotonin, 5-HT1A | 2006 |
Brain imaging evidence of preclinical Alzheimer's disease in normal aging.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain Mapping; Case-Control Studies; Female; Fluorodeoxyglucose F18; Glucose; Hispanic or Latino; Humans; Image Processing, Computer-Assisted; Longitudinal Studies; Male; Mental Recall; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography | 2006 |
18FDG PET in vascular dementia: differentiation from Alzheimer's disease using voxel-based multivariate analysis.
Topics: Aged; Alzheimer Disease; Basal Ganglia; Cerebellum; Cerebral Cortex; Data Interpretation, Statistical; Dementia, Vascular; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multivariate Analysis; Neuropsychological Tests; Positron-Emission Tomography; Principal Component Analysis; Radiopharmaceuticals | 2006 |
Change of central cholinergic receptors following lesions of nucleus basalis magnocellularis in rats: search for an imaging index suitable for the early detection of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Basal Nucleus of Meynert; Biomarkers; Fluorodeoxyglucose F18; Frontal Lobe; Male; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Wistar; Receptors, Cholinergic; Severity of Illness Index; Tissue Distribution | 2006 |
Comparison of the diagnostic performance of FDG-PET and VBM-MRI in very mild Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index | 2006 |
Perceived loss of memory ability and cerebral metabolic decline in persons with the apolipoprotein E-IV genetic risk for Alzheimer disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Apolipoprotein E4; Apolipoproteins E; Awareness; Brain; Cognition Disorders; Fluorodeoxyglucose F18; Functional Laterality; Genetic Predisposition to Disease; Genotype; Glucose; Health Status; Heterozygote; Humans; Longitudinal Studies; Memory Disorders; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Surveys and Questionnaires | 2006 |
Advantage of late scanning in brain 18F-FDG PET.
Topics: Alzheimer Disease; Brain; Cerebellum; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Parietal Lobe; Phosphorylation; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
Schooling mediates brain reserve in Alzheimer's disease: findings of fluoro-deoxy-glucose-positron emission tomography.
Topics: Aged; Alzheimer Disease; Brain; Brain Chemistry; Case-Control Studies; Educational Status; Female; Fluorodeoxyglucose F18; Glucose; Humans; Intelligence; Male; Mental Status Schedule; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Regional Blood Flow; Regression Analysis; Severity of Illness Index | 2006 |
Frontal dysfunction underlies depressive syndrome in Alzheimer disease: a FDG-PET study.
Topics: Aged; Alzheimer Disease; Depressive Disorder, Major; Female; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
Autonoetic consciousness in Alzheimer's disease: neuropsychological and PET findings using an episodic learning and recognition task.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain Mapping; Consciousness; Female; Fluorodeoxyglucose F18; Humans; Male; Mental Recall; Neuropsychological Tests; Positron-Emission Tomography; Statistics as Topic; Statistics, Nonparametric | 2007 |
Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Brain; Cholinesterase Inhibitors; Cognition Disorders; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Psychiatric Status Rating Scales; Radiopharmaceuticals; Thiazoles | 2006 |
Evaluation of a new expert system for fully automated detection of the Alzheimer's dementia pattern in FDG PET.
Topics: Aged; Alzheimer Disease; Automation; Data Interpretation, Statistical; Diagnosis, Computer-Assisted; Expert Systems; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Software | 2006 |
Evaluation of voxel-based methods for the statistical analysis of PIB PET amyloid imaging studies in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Amyloid; Aniline Compounds; Cerebellum; Cerebral Cortex; Contrast Media; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Male; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles | 2006 |
Neuroscience. A better view of brain disorders.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Brain; Brain Chemistry; Brain Diseases; Brain Mapping; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Obsessive-Compulsive Disorder; Pain; Pain Management; Parkinson Disease; Positron-Emission Tomography | 2006 |
Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study.
Topics: Aged; Alzheimer Disease; Amyloid; Aniline Compounds; Benzothiazoles; Brain; Carbon Radioisotopes; Cognition; Face; Female; Fluorodeoxyglucose F18; Glucose; Humans; Language; Male; Mental Recall; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Recognition, Psychology; Thiazoles | 2007 |
Patterns of regional brain hypometabolism associated with knowledge of semantic features and categories in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain; Brain Chemistry; Brain Mapping; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Humans; Knowledge; Male; Memory; Neuropsychological Tests; Positron-Emission Tomography; Psycholinguistics; Radiopharmaceuticals; Regression Analysis; Semantics | 2006 |
Anxiety and regional cortical glucose metabolism in patients with Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Anxiety; Brain Mapping; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Positron-Emission Tomography; Psychiatric Status Rating Scales | 2006 |
PET of brain amyloid and tau in mild cognitive impairment.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Brain; Case-Control Studies; Cognition Disorders; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neurofibrillary Tangles; Nitriles; Plaque, Amyloid; Positron-Emission Tomography; tau Proteins | 2006 |
Testing a test for Alzheimer disease.
Topics: Alzheimer Disease; Amyloid; Cognition; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Memory; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
Fully automatic differential diagnosis system for dementia with Lewy bodies and Alzheimer's disease using FDG-PET and 3D-SSP.
Topics: Aged; Alzheimer Disease; Automation; Brain; Dementia; Diagnosis, Differential; Fluorodeoxyglucose F18; Glucose; Humans; Lewy Bodies; Middle Aged; Pattern Recognition, Automated; Positron-Emission Tomography; Reproducibility of Results; ROC Curve | 2007 |
Metabolic correlates of executive dysfunction. Different patterns in mild and very mild Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Brain Mapping; Cognition Disorders; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Neuropsychological Tests; Positron-Emission Tomography; Problem Solving; Statistics as Topic | 2007 |
Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Aniline Compounds; Benzothiazoles; Brain; Carbon Radioisotopes; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Models, Statistical; Observer Variation; ROC Curve; Thiazoles | 2007 |
Comparison of regional brain volume and glucose metabolism between patients with mild dementia with lewy bodies and those with mild Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lewy Body Disease; Male; Radionuclide Imaging; Radiopharmaceuticals | 2007 |
PET imaging of amyloid deposition in patients with mild cognitive impairment.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Benzothiazoles; Cerebral Cortex; Cognition Disorders; Disease Progression; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Neuropsychological Tests; Plaque, Amyloid; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Thiazoles | 2008 |
Partial volume effect-corrected FDG PET and grey matter volume loss in patients with mild Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Artifacts; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Imaging, Three-Dimensional; Male; Middle Aged; Neurons; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain; Brain Mapping; Cerebral Cortex; Cognition Disorders; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Frontal Lobe; Functional Laterality; Glucose; Gyrus Cinguli; Humans; Image Processing, Computer-Assisted; Male; Positron-Emission Tomography; Severity of Illness Index; Temporal Lobe; Tissue Distribution | 2007 |
Metabolic correlates of clinical heterogeneity in questionable Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals | 2008 |
Cerebral metabolic correlates of the clinical dementia rating scale in mild cognitive impairment.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Blood Glucose; Brain; Cognition Disorders; Disease Progression; Dominance, Cerebral; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gyrus Cinguli; Humans; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Parietal Lobe; Positron-Emission Tomography; Statistics as Topic; Temporal Lobe | 2007 |
(18)F-FDG PET database of longitudinally confirmed healthy elderly individuals improves detection of mild cognitive impairment and Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Databases, Factual; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reference Values | 2007 |
Positron emission tomography metabolic correlates of apathy in Alzheimer disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Brain Mapping; Cerebrovascular Circulation; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glucose; Gyrus Cinguli; Humans; Male; Mood Disorders; Neural Pathways; Neuropsychological Tests; Positron-Emission Tomography; Predictive Value of Tests; Prefrontal Cortex; Thalamus | 2007 |
Quantifying metabolic asymmetry modulo structure in Alzheimer's disease.
Topics: Algorithms; Alzheimer Disease; Brain; Brain Mapping; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2007 |
On the multivariate nature of brain metabolic impairment in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Brain Diseases, Metabolic; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Principal Component Analysis; Radiopharmaceuticals | 2009 |
FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease.
Topics: Adult; Aged; Alzheimer Disease; Brain; Dementia; Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2007 |
Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaints.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Apolipoprotein E4; Biomarkers; Blood Glucose; Brain; Energy Metabolism; Female; Fluorodeoxyglucose F18; Genetic Carrier Screening; Humans; Male; Memory Disorders; Middle Aged; Peptide Fragments; Positron-Emission Tomography; Reference Values; tau Proteins | 2008 |
What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia?
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Brain Mapping; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Male; Neurologic Examination; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity | 2007 |
Positron emission tomography facilitates diagnosis of early-onset Alzheimer's disease.
Topics: Alzheimer Disease; Case-Control Studies; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Humans; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Regression Analysis; Retrospective Studies; Severity of Illness Index | 2008 |
Gender differences in brain reserve : an (18)F-FDG PET study in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Sex Characteristics | 2007 |
Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Aniline Compounds; Apolipoproteins E; Benzothiazoles; Brain; Brain Chemistry; Dementia; Female; Fluorodeoxyglucose F18; Functional Laterality; Genotype; Glucose; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Plaque, Amyloid; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles | 2008 |
Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Apolipoprotein E4; Brain Mapping; Cerebral Cortex; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Genes, Mitochondrial; Genetic Heterogeneity; Genetic Predisposition to Disease; Genomic Imprinting; Glucose; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mothers; Positron-Emission Tomography; Retrospective Studies; Risk | 2007 |
Comparison of 18F-FDG PET and optimized voxel-based morphometry for detection of Alzheimer's disease: aging effect on diagnostic performance.
Topics: Age Factors; Aged; Alzheimer Disease; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
Cognitive reserve hypothesis: Pittsburgh Compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer's disease.
Topics: Age Factors; Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Carbon Radioisotopes; Cerebral Cortex; Cerebrovascular Circulation; Disease Susceptibility; Educational Status; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Neuropsychological Tests; Plaque, Amyloid; Positron-Emission Tomography; Recovery of Function; Thiazoles | 2008 |
PET sheds light on Alzheimer's disease genetic risk.
Topics: Aging; Algorithms; Alzheimer Disease; Cerebral Cortex; Family Health; Fathers; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Genes, Mitochondrial; Genetic Heterogeneity; Genetic Predisposition to Disease; Genomic Imprinting; Glucose; Humans; Longevity; Male; Mothers; Positron-Emission Tomography; Risk | 2007 |
Cerebral glucose metabolism in dizygotic twin pairs discordant for Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain; Cognition Disorders; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Neuropsychological Tests; Registries; Surveys and Questionnaires; Twins, Dizygotic | 2008 |
The binomial distribution of meta-analysis was preferred to model within-study variability.
Topics: Alzheimer Disease; Binomial Distribution; Data Interpretation, Statistical; Diagnostic Techniques and Procedures; Fluorodeoxyglucose F18; Humans; Meta-Analysis as Topic; Models, Statistical; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
Amyloid and tau imaging, neuronal losses and function in mild cognitive impairment.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Brain; Diagnosis, Differential; Disease Progression; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nitriles; Positron-Emission Tomography; tau Proteins | 2008 |
Cholesterol-related genetic risk scores are associated with hypometabolism in Alzheimer's-affected brain regions.
Topics: Aged; Alzheimer Disease; Apolipoproteins E; Brain; Brain Chemistry; Cholesterol; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Risk Factors | 2008 |
Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognition Disorders; Dementia; Europe; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; United States | 2008 |
The neural substrates of semantic memory deficits in early Alzheimer's disease: clues from semantic priming effects and FDG-PET.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Association Learning; Brain Mapping; Female; Fluorodeoxyglucose F18; Humans; Male; Memory Disorders; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Semantics | 2008 |
Multivariate and univariate neuroimaging biomarkers of Alzheimer's disease.
Topics: Aged; Algorithms; Alzheimer Disease; Analysis of Variance; Biomarkers; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Principal Component Analysis; Radiopharmaceuticals | 2008 |
Effect of sample size for normal database on diagnostic performance of brain FDG PET for the detection of Alzheimer's disease using automated image analysis.
Topics: Aged; Alzheimer Disease; Artificial Intelligence; Databases, Factual; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Sample Size; Sensitivity and Specificity | 2008 |
Fluoro-2-deoxy-D-glucose (FDG)-PET in APOEepsilon4 carriers in the Australian population.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Apolipoprotein E4; Australia; Carrier Proteins; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Memory Disorders; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Risk Factors | 2008 |
CSF phosporylated TAU protein levels correlate with cerebral glucose metabolism assessed with PET in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Cerebrum; Disease Progression; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Positron-Emission Tomography; Statistics as Topic; tau Proteins | 2008 |
Individual cerebral metabolic deficits in Alzheimer's disease and amnestic mild cognitive impairment: an FDG PET study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amnesia; Brain; Case-Control Studies; Cognition Disorders; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
Biological characters of [18F]O-FEt-PIB in a rat model of Alzheimer's disease using micro-PET imaging.
Topics: Algorithms; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Animals; Brain; Diagnostic Imaging; Disease Models, Animal; Fluorodeoxyglucose F18; Hippocampus; Male; Peptide Fragments; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Thalamus; Thiazoles; Tissue Distribution | 2008 |
Value of combining activated brain FDG-PET and cardiac MIBG for the differential diagnosis of dementia: differentiation of dementia with Lewy bodies and Alzheimer disease when the diagnoses based on clinical and neuroimaging criteria are difficult.
Topics: 3-Iodobenzylguanidine; Aged; Alzheimer Disease; Diagnosis, Differential; Fluorodeoxyglucose F18; Heart; Humans; Image Enhancement; Lewy Body Disease; Male; Radionuclide Imaging; Radiopharmaceuticals | 2008 |
Simultaneous demonstration of metabolic lesions consistent with Alzheimer disease and brain metastases on FDG-PET imaging.
Topics: Alzheimer Disease; Brain Neoplasms; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
NIH Conference. Brain imaging: aging and dementia.
Topics: Adult; Aged; Aging; Alzheimer Disease; Brain; Deoxyglucose; Down Syndrome; Female; Fluorine; Fluorodeoxyglucose F18; Glucose; Humans; Male; Mental Processes; Middle Aged; Radioisotopes; Tomography, Emission-Computed; Tomography, X-Ray Computed; Wechsler Scales | 1984 |
The diagnosis of Alzheimer-type dementia. A preliminary comparison of positron emission tomography and proton magnetic resonance.
Topics: Alzheimer Disease; Deoxyglucose; Fluorine; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Radioisotopes; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1984 |
Cortical abnormalities in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Cerebral Cortex; Deoxyglucose; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Male; Middle Aged; Occipital Lobe; Parietal Lobe; Psychological Tests; Temporal Lobe; Tomography, Emission-Computed | 1984 |
Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [18F]fluorodeoxyglucose.
Topics: Aged; Alzheimer Disease; Cerebral Cortex; Dementia; Deoxy Sugars; Deoxyglucose; Female; Fluorine; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radioisotopes; Tomography, Emission-Computed | 1983 |
Alzheimer's disease: focal cortical changes shown by positron emission tomography.
Topics: Aged; Alzheimer Disease; Brain; Cerebral Cortex; Dementia; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiography; Tomography, Emission-Computed | 1983 |
The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia.
Topics: Aged; Alzheimer Disease; Brain; Dementia; Deoxy Sugars; Deoxyglucose; Female; Fluorine; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiography; Radioisotopes; Tomography, Emission-Computed | 1983 |
Cognitive and cerebral metabolic function in early and advanced Alzheimer's disease.
Topics: Alzheimer Disease; Blood Glucose; Cerebral Cortex; Cognition Disorders; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Psychometrics; Tomography, Emission-Computed; Wechsler Scales | 1984 |
18F-2-deoxy-2-fluoro-D-glucose as a tracer in the positron emission tomographic study of senile dementia.
Topics: Aged; Alzheimer Disease; Blood Glucose; Brain; Dementia; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Male; Tomography, Emission-Computed | 1982 |
Quantitative topographical EEG compared to FDG PET for classification of vascular and degenerative dementia.
Topics: Aged; Alzheimer Disease; Brain; Brain Mapping; Dementia, Vascular; Deoxyglucose; Discriminant Analysis; Electroencephalography; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Tomography, Emission-Computed | 1994 |
Positron emission tomography in familial Alzheimer disease.
Topics: Aged; Alzheimer Disease; Amyloid beta-Protein Precursor; Blood Glucose; Brain; Chromosomes, Human, Pair 14; Deoxyglucose; Energy Metabolism; Fluorodeoxyglucose F18; Genetic Linkage; Humans; Longitudinal Studies; Phenotype; Risk Factors; Tomography, Emission-Computed | 1995 |
Alzheimer's dementia.
Topics: Adult; Alzheimer Disease; Cerebral Cortex; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Humans; Middle Aged; Tomography, Emission-Computed | 1995 |
Preclinical stages in subjects at risk for neurological disorders: can PET-FDG tell us more?
Topics: Adult; Alzheimer Disease; Basal Ganglia Diseases; Brain; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Huntington Disease; Tomography, Emission-Computed | 1995 |
A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET.
Topics: Aged; Alzheimer Disease; Brain; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Sensitivity and Specificity; Stereotaxic Techniques; Tomography, Emission-Computed | 1995 |
[A longitudinal study of CMRGlu in dementia of Alzheimer type].
Topics: Alzheimer Disease; Brain; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Longitudinal Studies; Male; Middle Aged; Time Factors; Tomography, Emission-Computed | 1994 |
Functional neuroimaging in Alzheimer's disease: how far should we go?
Topics: Alzheimer Disease; Brain; Cerebrovascular Circulation; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Organotechnetium Compounds; Oximes; Technetium Tc 99m Exametazime; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1994 |
Positron emission tomography measures of benzodiazepine binding in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Benzodiazepines; Brain; Cerebrovascular Circulation; Deoxyglucose; Female; Flumazenil; Fluorodeoxyglucose F18; Glucose; Humans; Male; Receptors, GABA-A; Tomography, Emission-Computed | 1995 |
Difference of regional cerebral metabolic pattern between presenile and senile dementia of the Alzheimer type: a factor analytic study.
Topics: Age Factors; Age of Onset; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cerebellum; Cerebral Cortex; Dementia; Deoxyglucose; Factor Analysis, Statistical; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Functional Laterality; Humans; Male; Middle Aged; Organ Specificity; Tomography, Emission-Computed | 1994 |
Anatomic standardization: linear scaling and nonlinear warping of functional brain images.
Topics: Algorithms; Alzheimer Disease; Brain; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Oxygen Radioisotopes; Reference Standards; Tomography, Emission-Computed; Water | 1994 |
Stereotactic PET atlas of the human brain: aid for visual interpretation of functional brain images.
Topics: Adult; Alzheimer Disease; Brain; Brain Mapping; Contrast Media; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Reference Values; Stereotaxic Techniques; Tomography, Emission-Computed | 1994 |
Altered cerebral energy metabolism in Alzheimer's disease: a PET study.
Topics: Aged; Alzheimer Disease; Cerebral Cortex; Cerebrovascular Circulation; Contrast Media; Deoxyglucose; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Oxygen Consumption; Tomography, Emission-Computed | 1994 |
Neural-network classification of normal and Alzheimer's disease subjects using high-resolution and low-resolution PET cameras.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Contrast Media; Deoxyglucose; Diagnosis, Computer-Assisted; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Male; Middle Aged; Neural Networks, Computer; ROC Curve; Tomography, Emission-Computed | 1994 |
High-resolution technetium-99m-HMPAO SPECT in patients with probable Alzheimer's disease: comparison with fluorine-18-FDG PET.
Topics: Adult; Aged; Alzheimer Disease; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Organotechnetium Compounds; Oximes; Technetium Tc 99m Exametazime; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1994 |
Comparability of FDG PET studies in probable Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed | 1993 |
Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Atrophy; Brain; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Tomography, Emission-Computed | 1993 |
Early detection of Alzheimer's disease: a statistical approach using positron emission tomographic data.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Deoxyglucose; Discriminant Analysis; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Regression Analysis; Risk Factors; Time Factors; Tissue Distribution; Tomography, Emission-Computed | 1993 |
PET of peripheral benzodiazepine binding sites in the microgliosis of Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Carbon Radioisotopes; Case-Control Studies; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Isoquinolines; Male; Microglia; Receptors, GABA-A; Tomography, Emission-Computed | 1995 |
The relationship between psychiatric symptoms and regional cortical metabolism in Alzheimer's disease.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Arousal; Blood Glucose; Brain Mapping; Cerebral Cortex; Deoxyglucose; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Tomography, Emission-Computed | 1995 |
Visual versus auditory memory stimulation in patients with probable Alzheimer's disease. A PET study with 18 FDG.
Topics: Aged; Alzheimer Disease; Brain; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Memory; Middle Aged; Neuropsychological Tests; Pattern Recognition, Visual; Sound; Tissue Distribution; Tomography, Emission-Computed | 1996 |
Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET.
Topics: Aged; Alzheimer Disease; Biological Transport, Active; Brain; Case-Control Studies; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Hexokinase; Humans; Image Processing, Computer-Assisted; Male; Models, Theoretical; Phosphorylation; Tomography, Emission-Computed | 1996 |
Functional MR in the evaluation of dementia: correlation of abnormal dynamic cerebral blood volume measurements with changes in cerebral metabolism on positron emission tomography with fludeoxyglucose F 18.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Blood Volume; Brain; Cerebrovascular Circulation; Dementia; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Middle Aged; Tomography, Emission-Computed | 1995 |
A human friendly reporting and database system for brain PET analysis.
Topics: Alzheimer Disease; Brain; Brain Diseases; Computer Graphics; Computer Systems; Data Interpretation, Statistical; Databases, Factual; Deoxyglucose; Epilepsy, Temporal Lobe; Evaluation Studies as Topic; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Supranuclear Palsy, Progressive; Tissue Distribution; Tomography, Emission-Computed | 1996 |
Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications.
Topics: Aged; Alzheimer Disease; Brain; Cerebral Cortex; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Neuropsychological Tests; Prognosis; Psychomotor Performance; Tomography, Emission-Computed; Vision Disorders; Visual Cortex | 1996 |
Association of premorbid intellectual function with cerebral metabolism in Alzheimer's disease: implications for the cognitive reserve hypothesis.
Topics: Aged; Alzheimer Disease; Brain; Deoxyglucose; Educational Status; Female; Fluorodeoxyglucose F18; Functional Laterality; Glucose; Humans; Intelligence; Intelligence Tests; Male; Neuropsychological Tests; Parietal Lobe; Psychiatric Status Rating Scales; Regression Analysis; Tomography, Emission-Computed | 1997 |
Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.
Topics: Aged; Alzheimer Disease; Brain; Brain Mapping; Case-Control Studies; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Neuropsychological Tests; Parkinson Disease; Stereotaxic Techniques; Tomography, Emission-Computed | 1997 |
Reduction of cerebellar glucose metabolism in advanced Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain; Case-Control Studies; Cerebellum; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Tomography, Emission-Computed | 1997 |
Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Cognition; Deoxyglucose; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glucose; Gyrus Cinguli; Humans; Male; Memory; Prospective Studies; Psychiatric Status Rating Scales; Radiopharmaceuticals; Stereotaxic Techniques; Time Factors; Tissue Distribution; Tomography, Emission-Computed | 1997 |
Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia.
Topics: Acoustic Stimulation; Adult; Age Factors; Alzheimer Disease; Auditory Perception; Brain; Deoxyglucose; Down Syndrome; Fluorodeoxyglucose F18; Glucose; Humans; Middle Aged; Motion Pictures; Parietal Lobe; Photic Stimulation; Risk Factors; Temporal Lobe; Tomography, Emission-Computed; Visual Perception | 1997 |
Dynamic FDG-PET study in probable Alzheimer's disease.
Topics: Adult; Aged; Alzheimer Disease; Brain; Fluorodeoxyglucose F18; Glucose; Humans; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 1997 |
Striatal dopamine metabolism correlated with frontotemporal glucose utilization in Alzheimer's disease: a double-tracer PET study.
Topics: Aged; Alzheimer Disease; Brain; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Male; Radiopharmaceuticals; Temporal Lobe; Tissue Distribution; Tomography, Emission-Computed | 1997 |
Mapping histology to metabolism: coregistration of stained whole-brain sections to premortem PET in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Blood Glucose; Brain; Brain Mapping; Energy Metabolism; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Neurofibrillary Tangles; Reproducibility of Results; Tomography, Emission-Computed | 1997 |
[Clinical applications of positron-emission tomography in brain pathology].
Topics: Aged; Alzheimer Disease; Brain Diseases; Brain Neoplasms; Epilepsy; Fluorodeoxyglucose F18; Humans; Male; Obsessive-Compulsive Disorder; Radiopharmaceuticals; Schizophrenia; Tomography, Emission-Computed | 1997 |
Frontal lobe hypometabolism and depression in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain; Depression; Depressive Disorder; Emotions; Female; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Male; Neuropsychological Tests; Organ Specificity; Tomography, Emission-Computed | 1998 |
The neural substrates of memory systems impairment in Alzheimer's disease. A PET study of resting brain glucose utilization.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Brain Mapping; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Memory; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Organ Specificity; Radiopharmaceuticals; Reference Values; Tomography, Emission-Computed | 1998 |
Apolipoprotein E polymorphism influences the cerebral metabolic pattern in Alzheimer's disease.
Topics: Age Factors; Age of Onset; Aged; Aged, 80 and over; Alleles; Alzheimer Disease; Apolipoprotein E4; Apolipoproteins E; Basal Ganglia; Brain Stem; Cerebellum; Cerebral Cortex; Dementia; DNA; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Frontal Lobe; Gene Frequency; Genotype; Heterozygote; Homozygote; Humans; Intelligence Tests; Leukocytes; Linear Models; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Genetic; Temporal Lobe; Tomography, Emission-Computed | 1998 |
Cerebral glucose metabolism in patients with frontotemporal dementia.
Topics: Aged; Alzheimer Disease; Brain; Case-Control Studies; Dementia; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Male; Radiopharmaceuticals; Temporal Lobe; Tomography, Emission-Computed | 1998 |
Lack of association of apolipoprotein E epsilon4 allele dose with cerebral glucose metabolism in Alzheimer disease.
Topics: Aged; Alleles; Alzheimer Disease; Apolipoprotein E4; Apolipoproteins E; Blood Glucose; Brain; Brain Mapping; Energy Metabolism; Female; Fluorodeoxyglucose F18; Genotype; Humans; Male; Middle Aged; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and nonquantitative [18F]FDG PET: A clinical validation of statistical parametric mapping.
Topics: Adolescent; Adult; Aged; Alzheimer Disease; Aphasia; Blood Glucose; Brain; Brain Diseases; Brain Mapping; Energy Metabolism; Epilepsy; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Language Development Disorders; Male; Middle Aged; Multiple Sclerosis; Reference Values; Tomography, Emission-Computed | 1999 |
Association between brain functional failure and dementia severity in Alzheimer's disease: resting versus stimulation PET study.
Topics: Acoustic Stimulation; Aged; Alzheimer Disease; Auditory Cortex; Brain; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Parietal Lobe; Photic Stimulation; Psychiatric Status Rating Scales; Severity of Illness Index; Tomography, Emission-Computed; Visual Cortex | 1999 |
Neocortical and hippocampal glucose hypometabolism following neurotoxic lesions of the entorhinal and perirhinal cortices in the non-human primate as shown by PET. Implications for Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Brain; Entorhinal Cortex; Fluorodeoxyglucose F18; Glucose; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Neocortex; Neurotoxins; Organ Specificity; Papio; Radiography; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed | 1999 |
Tc-99m ethyl cysteinate dimer SPECT and 2-[F-18]fluoro-2-deoxy-D-glucose PET in Alzheimer's disease. Comparison of perfusion and metabolic patterns.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cerebrovascular Circulation; Cysteine; Female; Fluorodeoxyglucose F18; Humans; Male; Organotechnetium Compounds; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1999 |
Cerebrospinal fluid levels of amyloid beta-peptide1-42, but not tau have positive correlation with brain glucose metabolism in humans.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Brain; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Peptide Fragments; Radiopharmaceuticals; tau Proteins; Tomography, Emission-Computed | 1999 |
Mapping biochemistry to metabolism: FDG-PET and amyloid burden in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Algorithms; Alzheimer Disease; Amyloid beta-Peptides; Body Burden; Brain Chemistry; Brain Mapping; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
Discordance between traditional pathologic and energy metabolic changes in very early Alzheimer's disease. Pathophysiological implications.
Topics: Acetylcholinesterase; Alzheimer Disease; Atrophy; Brain; Cerebellum; Cerebral Cortex; Energy Metabolism; Fluorodeoxyglucose F18; Glucose; Humans; Longitudinal Studies; Neurofibrillary Tangles; Neuroglia; Neurons; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 1999 |
Anterior choroidal artery infarction presenting as a progressive cognitive deficit.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cerebral Infarction; Cerebrovascular Circulation; Cognition Disorders; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Radiopharmaceuticals; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon | 2000 |
Semi-automatic ROI placement system for analysis of brain PET images based on elastic model: application to diagnosis of Alzheimer's disease.
Topics: Adult; Aged; Alzheimer Disease; Case-Control Studies; Fluorodeoxyglucose F18; Humans; Middle Aged; Sensitivity and Specificity; Software; Tomography, Emission-Computed | 2000 |
Cerebral metabolic response to passive audiovisual stimulation in patients with Alzheimer's disease and healthy volunteers assessed by PET.
Topics: Acoustic Stimulation; Aged; Alzheimer Disease; Brain; Case-Control Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Photic Stimulation; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
Tracking Alzheimer's disease in transgenic mice using fluorodeoxyglucose autoradiography.
Topics: Age Factors; Alzheimer Disease; Animals; Brain; Carbon Radioisotopes; Energy Metabolism; Fluorodeoxyglucose F18; Glucose; Gyrus Cinguli; Mice; Mice, Transgenic; Radionuclide Imaging | 2000 |
Evaluating dementia using PET: how do we put into clinical perspective what we know to date?
Topics: Alzheimer Disease; Brain; Dementia; Fluorodeoxyglucose F18; Humans; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
FDG PET imaging in patients with pathologically verified dementia.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Dementia; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parietal Lobe; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Temporal Lobe; Tomography, Emission-Computed | 2000 |
Differential regional cerebral uptake of (18)F-fluoro-2-deoxy-D-glucose in Alzheimer's disease and frontotemporal dementia at initial diagnosis.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Dementia; Female; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Male; Middle Aged; Temporal Lobe; Tomography, Emission-Computed | 2001 |
Patterns of cortical activity and memory performance in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain; Cerebral Cortex; Cerebrovascular Circulation; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Magnetic Resonance Imaging; Male; Memory Disorders; Neuropsychological Tests; Prefrontal Cortex; Radiopharmaceuticals; Temporal Lobe; Time Factors; Tomography, Emission-Computed | 2001 |
[18F]FDG-PET study in dementia with Lewy bodies and Alzheimer's disease.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Brain Mapping; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lewy Body Disease; Male; Middle Aged; Nuclear Family; Occipital Lobe; Pedigree; Radiopharmaceuticals; Reference Values; Tomography, Emission-Computed | 2001 |
Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains.
Topics: Aged; Alzheimer Disease; Atrophy; Brain; Brain Mapping; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Reference Values; Software Validation; Tomography, Emission-Computed | 2001 |
Delayed synaptic dysfunction of association cortices in carbon monoxide intoxication.
Topics: Alzheimer Disease; Antidotes; Carbon Monoxide Poisoning; Carbon Radioisotopes; Cerebral Cortex; Flumazenil; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Synapses; Time Factors; Tomography, Emission-Computed | 2001 |
Direct comparison of spatially normalized PET and SPECT scans in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Radiopharmaceuticals; Technetium Tc 99m Exametazime; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2002 |
Changes in brain functional homogeneity in subjects with Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain Mapping; Cerebral Cortex; Dominance, Cerebral; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parietal Lobe; Reference Values; Temporal Lobe; Tomography, Emission-Computed | 2002 |
The neural substrates of episodic memory impairment in Alzheimer's disease as revealed by FDG-PET: relationship to degree of deterioration.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Linear Models; Male; Memory Disorders; Mental Recall; Tomography, Emission-Computed | 2002 |
Effects of image resolution on autoradiographic measurements of posterior cingulate activity in PDAPP mice: implications for functional brain imaging studies of transgenic mouse models of Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Autoradiography; Brain; Brain Chemistry; Fluorodeoxyglucose F18; Gyrus Cinguli; Image Processing, Computer-Assisted; Mice; Mice, Transgenic; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
Topics: Aged; Alzheimer Disease; Brain; Cerebral Cortex; Clinical Trials as Topic; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Longitudinal Studies; Male; Middle Aged; Neuropsychological Tests; Outcome Assessment, Health Care; Placebos; Psychiatric Status Rating Scales; Research Design; Severity of Illness Index; Tomography, Emission-Computed; Treatment Outcome | 2002 |
Viability of neocortical function shown in behavioral activation state PET studies in Alzheimer disease.
Topics: Alzheimer Disease; Brain; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Memory; Occipital Lobe; Tomography, Emission-Computed | 1992 |
Reliability of drawing regions of interest for positron emission tomographic data.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Blood Flow Velocity; Blood Glucose; Brain; Brain Mapping; Deoxyglucose; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Male; Mental Recall; Middle Aged; Models, Anatomic; Observer Variation; Radiation Dosage; Reproducibility of Results; Tomography, Emission-Computed | 1992 |
A comparison of FDG PET and IQNB SPECT in normal subjects and in patients with dementia.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Blood Glucose; Brain; Cerebral Cortex; Dementia; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Models, Anatomic; Neuropsychological Tests; Quinuclidinyl Benzilate; Receptors, Cholinergic; Reference Values; Regional Blood Flow; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1992 |
Positron emission tomography in degenerative disorders of the dopaminergic system.
Topics: Adult; Aged; Alzheimer Disease; Basal Ganglia; Brain; Brain Stem; Deoxyglucose; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Male; Middle Aged; Parietal Lobe; Parkinson Disease; Supranuclear Palsy, Progressive; Tomography, Emission-Computed | 1992 |
Positron emission tomography and familial Alzheimer's disease: a pilot study.
Topics: Aged; Alzheimer Disease; Brain; Case-Control Studies; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Pilot Projects; Tomography, Emission-Computed | 1992 |
Abnormalities of energy metabolism in Alzheimer's disease studied with PET.
Topics: Adult; Aged; Aging; Alzheimer Disease; Brain; Deoxyglucose; Energy Metabolism; Fluorodeoxyglucose F18; Glucose; Humans; Middle Aged; Parasympathomimetics; Piracetam; Succinimides; Tomography, Emission-Computed; Vision, Ocular | 1991 |
Changes in glucose metabolism in dementia of the Alzheimer type compared with depression: a preliminary report.
Topics: Aged; Alzheimer Disease; Blood Glucose; Brain; Deoxyglucose; Depressive Disorder; Diagnosis, Differential; Energy Metabolism; Fluorodeoxyglucose F18; Frontal Lobe; Hippocampus; Humans; Tomography, Emission-Computed | 1991 |
Coronal reconstruction images of glucose metabolism in Alzheimer's disease.
Topics: Adult; Alzheimer Disease; Brain; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Functional Laterality; Glucose; Humans; Intelligence; Male; Middle Aged; Occipital Lobe; Organ Specificity; Parietal Lobe; Tomography, Emission-Computed | 1991 |
Temporal and hippocampal metabolic rate during an olfactory memory task assessed by positron emission tomography in patients with dementia of the Alzheimer type and controls. Preliminary studies.
Topics: Aged; Alzheimer Disease; Deoxyglucose; Discrimination, Psychological; Female; Fluorodeoxyglucose F18; Glucose; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Memory; Psychomotor Performance; Smell; Temporal Lobe; Tomography, Emission-Computed; Visual Perception | 1991 |
Diminished glucose transport in Alzheimer's disease: dynamic PET studies.
Topics: Aged; Alzheimer Disease; Biological Transport; Brain; Cerebral Cortex; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Kinetics; Middle Aged; Phosphorylation; Temporal Lobe; Tomography, Emission-Computed | 1991 |
High-resolution PET studies in Alzheimer's disease.
Topics: Alzheimer Disease; Brain; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuropsychological Tests; Organ Specificity; Reference Values; Tomography, Emission-Computed | 1991 |
Impaired metabolic activation in Alzheimer's disease: a PET study during continuous visual recognition.
Topics: Alzheimer Disease; Brain Chemistry; Cognition; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Psychological Tests; Psychomotor Performance; Tomography, Emission-Computed; Vision, Ocular | 1991 |
Characteristics of cerebral glucose utilization in dementia.
Topics: Aged; Alzheimer Disease; Brain; Cerebral Infarction; Dementia; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Humans; Reference Values; Tomography, Emission-Computed | 1990 |
Cerebral metabolic and cognitive studies in dementia with frontal lobe behavioral features.
Topics: Aged; Alzheimer Disease; Blood Glucose; Brain; Deoxyglucose; Energy Metabolism; Female; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Male; Neuropsychological Tests; Tomography, Emission-Computed | 1990 |
18Fluorodeoxyglucose positron emission tomography studies in presumed Alzheimer cases, including 13 serial scans.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cerebral Cortex; Deoxy Sugars; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Psychological Tests; Tomography, Emission-Computed | 1990 |
Clinical evaluation of a high-resolution (2.6-mm) positron emission tomography.
Topics: Alzheimer Disease; Brain; Brain Diseases; Brain Neoplasms; Deoxyglucose; Epilepsy, Temporal Lobe; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Necrosis; Radiation Injuries; Tomography, Emission-Computed | 1990 |
Positron emission tomography as an imaging tool in psychiatric disorders.
Topics: Alzheimer Disease; Blood Glucose; Brain; Dementia; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Huntington Disease; Tomography, Emission-Computed | 1989 |
Sensitivity and specificity of positron emission tomography and magnetic resonance imaging studies in Alzheimer's disease and multi-infarct dementia.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Dementia, Multi-Infarct; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Radionuclide Imaging | 1989 |
Crossed cerebellar and uncrossed basal ganglia and thalamic diaschisis in Alzheimer's disease.
Topics: Alzheimer Disease; Basal Ganglia; Brain; Cerebellum; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Reference Values; Thalamus; Tomography, Emission-Computed | 1989 |
Cortical glutaminase, beta-glucuronidase and glucose utilization in Alzheimer's disease.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Glucuronidase; Glutaminase; Humans; Middle Aged; Tomography, Emission-Computed | 1989 |
Regional cerebral glucose transport and utilization in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Biological Transport; Brain; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Kinetics; Male; Middle Aged; Tissue Distribution; Tomography, Emission-Computed | 1989 |
Cerebral metabolism as measured with positron emission tomography (PET) and [18F] 2-deoxy-D-glucose: healthy aging, Alzheimer's disease and Down syndrome.
Topics: Aging; Alzheimer Disease; Brain; Deoxyglucose; Down Syndrome; Fluorodeoxyglucose F18; Glucose; Humans; Memory; Oxygen Consumption; Radioisotopes; Tomography, Emission-Computed | 1986 |
Local cerebral glucose utilization in symptomatic and presymptomatic Huntington's disease.
Topics: Adolescent; Adult; Alzheimer Disease; Brain; Caudate Nucleus; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Humans; Huntington Disease; Middle Aged; Parkinson Disease; Putamen; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1985 |
Longitudinal study of the early neuropsychological and cerebral metabolic changes in dementia of the Alzheimer type.
Topics: Aged; Alzheimer Disease; Arousal; Attention; Blood Glucose; Cerebral Cortex; Deoxyglucose; Dominance, Cerebral; Female; Fluorodeoxyglucose F18; Humans; Male; Mental Recall; Middle Aged; Neuropsychological Tests; Tomography, Emission-Computed | 1988 |
Cerebral mapping of apraxia in Alzheimer's disease by positron emission tomography.
Topics: Aged; Alzheimer Disease; Apraxias; Brain Mapping; Cerebral Cortex; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Neural Pathways; Psychomotor Performance; Tomography, Emission-Computed | 1986 |
Positron emission tomography in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Atrophy; Dementia; Deoxyglucose; Electroencephalography; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Male; Middle Aged; Occipital Lobe; Parietal Lobe; Psychiatric Status Rating Scales; Psychological Tests; Rest; Temporal Lobe; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1986 |
Comparison of PET, MRI, and CT with pathology in a proven case of Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Atrophy; Brain; Deoxyglucose; Fluorodeoxyglucose F18; Gliosis; Humans; Magnetic Resonance Spectroscopy; Male; Neurofibrils; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1986 |
Towards a behavioral typology of Alzheimer's patients.
Topics: Adult; Aged; Alzheimer Disease; Cerebral Cortex; Cognition; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuropsychological Tests; Tomography, Emission-Computed | 1986 |
Cerebral metabolism, anatomy, and cognition in monozygotic twins discordant for dementia of the Alzheimer type.
Topics: Alzheimer Disease; Brain; Cognition Disorders; Deoxyglucose; Diseases in Twins; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuropsychological Tests; Tomography, Emission-Computed; Tomography, X-Ray Computed; Twins, Monozygotic | 1987 |
Intercorrelations of regional cerebral glucose metabolic rates in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Deoxyglucose; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Male; Middle Aged; Parietal Lobe; Tomography, Emission-Computed | 1987 |
The effect of diazepam sedation on cerebral glucose metabolism in Alzheimer's disease as measured using positron emission tomography.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Deoxyglucose; Diazepam; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Tomography, Emission-Computed | 1987 |
Dominantly inherited Alzheimer's disease: cerebral glucose metabolism.
Topics: Adult; Alzheimer Disease; Blood Glucose; Brain; Deoxyglucose; Female; Fluorodeoxyglucose F18; Genes, Dominant; Humans; Middle Aged; Pedigree; Tomography, Emission-Computed | 1987 |
Cerebellar glucose consumption in normal and pathologic states using fluorine-FDG and PET.
Topics: Adult; Aged; Aged, 80 and over; Aging; Alzheimer Disease; Brain Neoplasms; Cerebellum; Cerebral Infarction; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Middle Aged; Sense Organs; Sensory Deprivation; Tomography, Emission-Computed | 1987 |
Neuropsychological and cerebral metabolic function in early vs late onset dementia of the Alzheimer type.
Topics: Age Factors; Aged; Aged, 80 and over; Alzheimer Disease; Blood Glucose; Cerebral Cortex; Concept Formation; Deoxyglucose; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Male; Mental Recall; Middle Aged; Neuropsychological Tests; Tomography, Emission-Computed | 1987 |
Alzheimer's disease: anterior-posterior and lateral hemispheric alterations in cortical glucose utilization.
Topics: Alzheimer Disease; Cerebral Cortex; Deoxyglucose; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Male; Middle Aged; Parietal Lobe; Temporal Lobe; Tomography, Emission-Computed | 1985 |
Differences in lateral hemispheric asymmetries of glucose utilization between early- and late-onset Alzheimer-type dementia.
Topics: Age Factors; Aged; Alzheimer Disease; Brain; Deoxyglucose; Dominance, Cerebral; Female; Fluorine; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Radioisotopes; Tomography, Emission-Computed; Wechsler Scales | 1985 |
Determinations of cerebral glucose utilization in dementia using positron emission tomography.
Topics: Aged; Alzheimer Disease; Basal Ganglia Diseases; Blood Glucose; Dementia; Deoxyglucose; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Tomography, Emission-Computed | 1985 |
Brain metabolism as measured with positron emission tomography: serial assessment in a patient with familial Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Psychological Tests; Tomography, Emission-Computed | 1985 |
Positron emission tomography with [18F]fluorodeoxyglucose differentiates normal pressure hydrocephalus from Alzheimer-type dementia.
Topics: Aged; Alzheimer Disease; Cerebral Cortex; Cerebral Ventricles; Deoxyglucose; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Hydrocephalus; Hydrocephalus, Normal Pressure; Intracranial Aneurysm; Male; Middle Aged; Subarachnoid Hemorrhage; Tomography, Emission-Computed | 1985 |
Patterns of cerebral glucose utilization in depression, multiple infarct dementia, and Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain; Dementia; Deoxyglucose; Depressive Disorder; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Tomography, X-Ray Computed | 1985 |